data_1co1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1co1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -152.52 -173.68 4.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 131.336 3.854 . . . . 1.0 105.063 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.766 HG21 ' HB2' ' A' ' 32' ' ' CYS 0.356 9.9 m -69.01 72.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.54 1.973 . . . . 1.0 109.926 170.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -51.13 158.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.355 2.262 . . . . 1.0 113.54 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 30' ' ' PHE 0.296 9.0 t -101.94 -120.77 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.365 -0.826 . . . . 1.0 110.745 177.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -55.88 -37.83 69.35 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.354 1.434 . . . . 1.0 113.169 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 m -136.86 156.83 75.74 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 127.648 2.379 . . . . 1.0 112.663 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -2.4 6.71 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.228 3.285 . . . . 1.0 115.041 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.79 -27.49 60.34 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.03 2.932 . . . . 1.0 114.024 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.543 ' HB2' HG23 ' A' ' 25' ' ' THR . 2.5 m-85 -118.6 108.35 14.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.677 1.591 . . . . 1.0 107.706 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.3 mt -115.12 135.02 54.64 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.894 2.878 . . . . 1.0 112.729 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.766 ' HB2' HG21 ' A' ' 23' ' ' VAL . 4.5 m -118.88 160.09 22.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.899 1.28 . . . . 1.0 112.505 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -138.93 100.02 3.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.413 2.285 . . . . 1.0 108.655 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -137.23 162.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 129.111 2.964 . . . . 1.0 109.362 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD21 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -103.57 155.06 37.39 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.394 1.078 . . . . 1.0 110.607 170.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HD2' HD21 ' A' ' 35' ' ' LEU . 17.1 Cg_exo -51.69 149.85 18.15 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.915 3.077 . . . . 1.0 115.559 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -127.85 29.29 5.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 127.12 2.168 . . . . 1.0 114.23 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -64.2 37.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 127.495 2.318 . . . . 1.0 116.195 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -162.28 162.65 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 129.184 2.994 . . . . 1.0 111.746 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.22 150.84 31.5 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.536 1.935 . . . . 1.0 113.987 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.7 t 49.13 71.76 0.35 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.645 1.978 . . . . 1.0 112.53 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -50.69 -39.46 51.31 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.226 1.565 . . . . 1.0 115.226 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt 62.75 171.78 0.14 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.575 2.75 . . . . 1.0 114.541 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -74.82 79.17 2.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.047 1.339 . . . . 1.0 110.741 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -69.37 146.25 96.35 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 125.616 1.566 . . . . 1.0 111.821 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.67 -3.73 8.49 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.098 3.199 . . . . 1.0 116.074 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 pt -59.44 -30.67 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.05 2.94 . . . . 1.0 115.698 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.55 173.5 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 127.331 2.252 . . . . 1.0 114.752 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.481 ' HB2' ' HD1' ' A' ' 91' ' ' PHE . 16.6 m-85 -144.99 151.58 38.81 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -174.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -143.92 148.45 35.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.544 1.937 . . . . 1.0 112.525 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.97 143.2 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.15 2.18 . . . . 1.0 111.013 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.89 119.5 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 128.077 2.551 . . . . 1.0 108.782 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.65 107.2 9.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.495 1.118 . . . . 1.0 110.744 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mt -90.56 118.07 29.73 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.969 1.707 . . . . 1.0 112.531 -172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.18 -167.69 30.13 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 127.555 2.502 . . . . 1.0 114.07 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.77 -4.42 25.0 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 115.451 1.648 . . . . 1.0 115.451 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.06 142.8 55.97 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.445 1.498 . . . . 1.0 112.081 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.91 -38.89 27.27 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 124.501 3.467 . . . . 1.0 112.951 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.88 -167.62 1.95 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 126.838 2.055 . . . . 1.0 110.542 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.04 -55.73 0.86 Allowed Glycine 0 C--N 1.344 0.984 0 O-C-N 120.032 -1.668 . . . . 1.0 113.091 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t 152.28 -177.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 129.264 3.025 . . . . 1.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.49 116.14 21.33 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.534 2.334 . . . . 1.0 110.542 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 p -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 120.451 -1.406 . . . . 1.0 109.3 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -123.0 123.55 41.14 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.118 1.367 . . . . 1.0 113.307 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 m -96.26 116.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.549 -1.344 . . . . 1.0 108.261 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 93.2 mtp -122.82 113.32 19.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.59 115.12 26.9 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 120.806 1.639 . . . . 1.0 114.071 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.43 -149.48 6.99 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 129.386 3.374 . . . . 1.0 112.451 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.46 ' C ' ' H ' ' A' ' 71' ' ' GLU . 67.0 t30 -156.78 40.5 0.33 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.021 1.728 . . . . 1.0 112.145 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 62.85 -26.6 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.778 2.831 . . . . 1.0 114.453 -170.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -140.02 84.52 1.97 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 132.142 4.177 . . . . 1.0 106.702 169.668 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.86 -45.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.876 1.67 . . . . 1.0 113.725 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 43.57 23.72 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.543 3.137 . . . . 1.0 117.25 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -49.28 -30.4 7.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.34 2.656 . . . . 1.0 115.0 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.06 -75.24 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.412 2.285 . . . . 1.0 114.915 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 33.81 99.17 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 131.474 3.909 . . . . 1.0 116.419 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.69 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -131.93 165.46 23.85 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.868 1.267 . . . . 1.0 113.377 174.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.67 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.66 84.24 2.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.104 2.162 . . . . 1.0 109.797 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER 69.25 8.62 6.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.434 1.493 . . . . 1.0 114.376 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.69 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -70.22 13.95 0.14 Allowed 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 120.958 1.708 . . . . 1.0 113.645 168.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.514 ' H ' ' C ' ' A' ' 79' ' ' ASN . 47.7 m -100.33 110.52 22.75 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 168.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.53 125.02 13.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.979 0.912 . . . . 1.0 113.402 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.09 155.89 17.75 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.21 1.404 . . . . 1.0 113.155 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.616 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 63.1 mtp -127.17 148.33 50.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 128.907 2.883 . . . . 1.0 107.889 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 87' ' ' GLN . 44.1 pttt -126.53 -73.13 0.63 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.869 1.268 . . . . 1.0 114.287 -170.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -72.93 33.5 0.07 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.419 1.488 . . . . 1.0 111.448 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 85' ' ' LYS . 63.6 mt-30 62.0 14.24 6.28 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.114 2.966 . . . . 1.0 114.544 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.63 152.61 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 129.556 3.142 . . . . 1.0 112.339 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB1' ' HG2' ' A' ' 84' ' ' MET . . . -137.91 146.93 43.89 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.248 1.819 . . . . 1.0 113.895 170.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -132.66 123.7 26.85 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 128.199 2.599 . . . . 1.0 111.312 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HD1' ' HB2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -172.15 173.39 4.31 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.813 1.783 . . . . 1.0 115.813 -174.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -141.44 1.36 1.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.528 1.931 . . . . 1.0 114.926 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -28.35 59.25 Favored 'General case' 0 CA--C 1.545 0.786 1 C-N-CA 131.824 4.05 . . . . 1.0 115.161 -172.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 6.8 mp -55.53 129.49 39.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.407 2.283 . . . . 1.0 112.176 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.67 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 36.4 mtm180 -137.47 123.14 19.85 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.555 1.07 . . . . 1.0 111.741 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -93.28 143.52 26.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.481 2.712 . . . . 1.0 110.611 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 0.7 OUTLIER 44.61 46.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 125.677 1.591 . . . . 1.0 112.516 -175.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -35.37 -92.27 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 1 C-N-CA 132.956 5.074 . . . . 1.0 116.945 -171.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttp-105 -73.11 42.41 0.11 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.913 2.085 . . . . 1.0 113.94 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 t 73.04 157.21 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 131.596 3.958 . . . . 1.0 115.638 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 169.14 30.06 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 127.982 2.706 . . . . 1.0 112.632 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -160.53 142.9 12.89 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.446 1.898 . . . . 1.0 112.465 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.48 ' C ' ' HE2' ' A' ' 127' ' ' LYS . . . 57.72 30.72 63.02 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.298 1.428 . . . . 1.0 116.547 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -126.61 156.87 40.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.146 2.579 . . . . 1.0 112.559 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -109.45 147.44 32.85 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.865 2.466 . . . . 1.0 110.931 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.728 ' CE1' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.25 89.27 7.8 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.229 1.811 . . . . 1.0 111.778 -173.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.4 m -77.39 74.68 3.95 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.642 1.577 . . . . 1.0 110.119 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 9.0 tt -61.54 119.52 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.229 -0.919 . . . . 1.0 108.968 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 t -127.82 139.97 52.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 123.445 1.593 . . . . 1.0 114.814 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.37 113.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -102.6 114.89 29.49 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.792 1.237 . . . . 1.0 111.894 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.26 151.77 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 123.235 1.493 . . . . 1.0 112.446 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -102.0 25.35 8.83 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 129.024 2.93 . . . . 1.0 116.671 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.561 HG21 ' HD2' ' A' ' 116' ' ' PRO . 13.6 t -132.31 176.34 8.49 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.687 1.195 . . . . 1.0 113.828 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 70.2 m-80 -43.0 -47.33 13.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 128.213 2.605 . . . . 1.0 113.062 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.561 ' HD2' HG21 ' A' ' 114' ' ' THR . 95.7 Cg_endo -87.96 95.99 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 124.983 3.789 . . . . 1.0 108.272 168.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.85 109.11 1.21 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.656 2.904 . . . . 1.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 103.45 15.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.316 1.531 . . . . 1.0 108.772 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.68 114.94 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.882 2.073 . . . . 1.0 108.976 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.73 142.95 50.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.455 2.302 . . . . 1.0 110.77 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 t -121.95 146.5 47.08 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.552 1.541 . . . . 1.0 113.246 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.403 ' HB2' HD21 ' A' ' 108' ' ' LEU . 8.1 t80 -87.51 128.79 35.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.947 1.356 . . . . 1.0 112.865 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -63.16 103.44 0.48 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.755 2.422 . . . . 1.0 111.591 172.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 96.78 125.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 1 C-N-CA 132.212 4.205 . . . . 1.0 109.285 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.92 -21.1 10.27 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.325 1.602 . . . . 1.0 115.325 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 38.53 122.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 131.144 3.778 . . . . 1.0 115.866 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HE2' ' C ' ' A' ' 103' ' ' GLY . 21.5 tttt -75.55 137.74 41.04 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.979 -1.7 . . . . 1.0 110.689 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -91.59 141.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.838 1.655 . . . . 1.0 113.468 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.2 t -88.67 142.89 27.31 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.533 0.938 . . . . 1.0 113.533 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.64 -53.52 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.521 1.529 . . . . 1.0 110.445 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.37 -70.5 0.74 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.921 2.889 . . . . 1.0 111.378 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.176 0 C-N-CA 126.147 1.832 . . . . 1.0 115.829 -177.117 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 114.322 1.231 . . . . 1.0 114.322 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.94 -173.23 4.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 131.138 3.775 . . . . 1.0 105.074 -173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.89 73.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 O-C-N 120.119 -1.613 . . . . 1.0 107.652 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -60.63 169.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.034 0.933 . . . . 1.0 111.978 169.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.8 p -133.06 -105.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.29 1.036 . . . . 1.0 109.972 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 121' ' ' THR . 1.1 m-20 -143.09 64.83 1.35 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.812 2.845 . . . . 1.0 108.425 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 22.1 m -157.05 161.61 29.16 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 119.884 -1.76 . . . . 1.0 115.158 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.26 146.74 95.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.259 1.973 . . . . 1.0 109.677 169.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 52.96 32.99 13.66 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 124.867 1.267 . . . . 1.0 113.881 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.61 110.36 16.01 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.895 1.443 . . . . 1.0 114.895 -173.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.08 115.48 9.95 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.562 1.545 . . . . 1.0 113.304 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' ' HA ' ' A' ' 51' ' ' VAL 0.253 0.0 OUTLIER -127.15 165.39 19.65 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 123.533 1.635 . . . . 1.0 114.826 175.512 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.616 ' HB2' ' CG ' ' A' ' 50' ' ' LYS . 66.6 m -151.47 93.2 1.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.104 2.962 . . . . 1.0 108.933 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.29 150.06 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 131.152 3.781 . . . . 1.0 107.797 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.703 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -65.22 174.35 1.43 Allowed Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 123.803 0.841 . . . . 1.0 113.141 175.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.703 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -60.3 165.26 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.105 2.537 . . . . 1.0 113.786 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 96' ' ' PHE . 3.8 t -125.0 9.63 8.13 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.44 1.896 . . . . 1.0 114.691 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -67.51 47.69 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.954 2.502 . . . . 1.0 115.747 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.86 173.57 14.36 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.187 1.921 . . . . 1.0 116.187 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.687 ' CD ' ' HB2' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.0 122.97 38.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 128.1 2.56 . . . . 1.0 110.717 177.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.1 t 62.8 95.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.74 2.016 . . . . 1.0 113.769 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.562 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -39.65 -46.04 1.76 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.151 2.181 . . . . 1.0 112.924 171.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 51.7 tttt 74.14 177.33 0.23 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 129.163 2.985 . . . . 1.0 112.25 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.6 m -61.18 -33.93 74.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.906 1.282 . . . . 1.0 114.138 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.449 ' HB2' HD22 ' A' ' 92' ' ' ASN . 43.6 mt 51.22 87.16 0.14 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 127.126 2.17 . . . . 1.0 114.657 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.9 61.62 0.59 Allowed 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 125.092 3.862 . . . . 1.0 113.489 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 136.85 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 1 C-N-CA 132.431 4.292 . . . . 1.0 108.337 -178.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.38 24.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.845 1.658 . . . . 1.0 111.968 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.05 150.46 42.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.888 1.675 . . . . 1.0 112.113 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.616 ' CG ' ' HB2' ' A' ' 33' ' ' SER . 3.4 ptmm? -131.37 108.8 9.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.759 2.023 . . . . 1.0 108.521 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . 57.3 t -131.31 121.87 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 117.507 -1.235 . . . . 1.0 109.293 -172.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.47 120.71 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.805 1.642 . . . . 1.0 110.451 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 27' ' ' SER . . . -133.07 106.68 7.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.024 -1.843 . . . . 1.0 106.024 170.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 155.32 37.67 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.086 2.254 . . . . 1.0 117.086 -169.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.39 -26.52 0.97 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.546 2.022 . . . . 1.0 115.218 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.11 86.87 7.34 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.826 2.45 . . . . 1.0 112.225 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.6 -50.02 67.37 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-O 117.573 -1.204 . . . . 1.0 110.042 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.58 129.86 6.66 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.294 3.329 . . . . 1.0 111.058 170.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.11 169.34 12.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.131 2.172 . . . . 1.0 115.492 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.13 3.23 45.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.936 2.207 . . . . 1.0 115.241 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.708 ' CG2' ' HB2' ' A' ' 84' ' ' MET . 13.8 t -53.82 121.03 7.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.618 1.709 . . . . 1.0 112.537 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.06 102.77 12.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.832 1.301 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 110' ' ' ILE . 84.0 t -92.03 107.62 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.901 -1.889 . . . . 1.0 105.901 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.5 p -107.76 118.14 35.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.196 -0.911 . . . . 1.0 113.167 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.339 0.5 OUTLIER -107.0 112.98 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.377 -1.452 . . . . 1.0 111.152 -177.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 mtt -139.51 171.28 14.48 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.615 1.566 . . . . 1.0 114.591 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . . . -125.83 112.36 15.92 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.76 178.17 40.07 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 128.232 2.825 . . . . 1.0 115.623 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 73' ' ' TYR . 33.6 p-10 -121.74 -61.9 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.789 2.435 . . . . 1.0 108.48 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -113.89 46.73 1.27 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 131.222 3.809 . . . . 1.0 106.534 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 64.82 -26.94 0.09 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.77 2.828 . . . . 1.0 114.209 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -102.35 49.33 0.85 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 129.495 3.118 . . . . 1.0 115.329 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.609 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 4.5 t80 -132.35 -19.2 2.48 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.903 1.681 . . . . 1.0 115.076 173.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 m 14.92 72.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 132.111 4.164 . . . . 1.0 114.654 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.04 149.34 6.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.129 2.172 . . . . 1.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -51.92 142.57 15.28 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.045 2.138 . . . . 1.0 114.161 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.816 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -127.59 168.56 14.82 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.495 2.318 . . . . 1.0 112.615 178.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.809 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -136.01 102.94 5.19 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.22 1.808 . . . . 1.0 108.536 172.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 81' ' ' THR . 7.9 m120 79.71 -9.03 1.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 117.171 -1.395 . . . . 1.0 111.99 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.816 ' HB1' ' HB2' ' A' ' 77' ' ' LEU 0.259 . . -68.91 20.82 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 122.298 2.317 . . . . 1.0 115.228 174.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.533 ' H ' ' C ' ' A' ' 79' ' ' ASN . 12.3 t -126.29 113.58 17.13 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.353 1.861 . . . . 1.0 109.591 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.5 151.63 41.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.561 1.545 . . . . 1.0 112.274 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 129.53 40.41 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 127.026 2.13 . . . . 1.0 111.589 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.708 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -124.71 168.93 12.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.165 1.386 . . . . 1.0 113.682 -171.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.588 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 2.6 mptt -96.0 -72.05 0.65 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.187 2.595 . . . . 1.0 112.567 -168.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.7 48.39 1.7 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 129.836 3.254 . . . . 1.0 106.475 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.9 26.41 7.82 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.472 2.709 . . . . 1.0 113.143 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' A' ' 85' ' ' LYS . 12.8 p -92.76 114.35 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 127.955 2.502 . . . . 1.0 112.169 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.06 146.54 24.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.776 2.031 . . . . 1.0 113.181 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HG2' ' N ' ' A' ' 91' ' ' PHE . 20.7 ttp180 -136.69 157.36 46.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.719 2.808 . . . . 1.0 111.796 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 0.8 OUTLIER 51.33 -139.69 0.94 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.225 1.81 . . . . 1.0 112.654 176.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.449 HD22 ' HB2' ' A' ' 45' ' ' LEU . 55.5 t-20 -135.41 109.19 8.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.922 1.237 . . . . 1.0 113.306 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -149.7 68.13 1.01 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.132 2.573 . . . . 1.0 108.458 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.88 118.56 2.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.795 1.638 . . . . 1.0 112.266 172.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.809 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 38.3 mtp180 -136.75 119.38 16.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 114.212 1.19 . . . . 1.0 114.212 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.562 ' H ' ' HB2' ' A' ' 42' ' ' ASN . 5.5 p90 -93.64 165.75 12.57 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.455 2.302 . . . . 1.0 116.598 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 96' ' ' PHE . 2.5 t 46.76 35.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 129.742 3.217 . . . . 1.0 114.584 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.51 -41.46 41.55 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.315 2.388 . . . . 1.0 114.843 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -76.28 -9.24 58.48 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.873 2.069 . . . . 1.0 115.852 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.687 ' HB2' ' CD ' ' A' ' 40' ' ' ARG . 4.6 t 58.71 -177.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.165 1.386 . . . . 1.0 114.483 -175.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.15 129.57 3.45 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 128.186 2.803 . . . . 1.0 113.716 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -68.04 164.07 20.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.626 1.97 . . . . 1.0 112.145 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.49 27.64 58.98 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -115.96 150.34 37.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.871 1.668 . . . . 1.0 114.152 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 t -125.21 122.22 36.39 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.319 3.448 . . . . 1.0 110.077 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -84.64 133.6 34.4 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.075 1.88 . . . . 1.0 116.075 -170.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -122.19 105.15 9.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.687 2.395 . . . . 1.0 115.162 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 122' ' ' TYR . 4.8 tt -79.43 90.04 5.03 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.103 -2.184 . . . . 1.0 105.103 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.3 m -92.25 101.47 13.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.799 2.84 . . . . 1.0 110.27 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 63' ' ' VAL . 62.8 mt -92.32 121.14 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.429 1.492 . . . . 1.0 108.015 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -122.93 118.1 27.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.323 1.014 . . . . 1.0 112.14 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.667 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 0.4 OUTLIER -71.7 170.67 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 122.929 1.347 . . . . 1.0 113.286 -176.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 33.3 5.0 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.207 2.203 . . . . 1.0 114.82 -174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.464 ' H ' HG12 ' A' ' 112' ' ' VAL . 14.2 t -126.64 175.37 8.0 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.019 1.728 . . . . 1.0 112.132 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.52 -49.29 89.38 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 125.981 1.712 . . . . 1.0 113.483 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.91 111.16 3.18 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 124.348 3.365 . . . . 1.0 110.237 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.79 105.87 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.122 3.215 . . . . 1.0 112.473 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.667 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -100.1 98.72 9.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.793 0.806 . . . . 1.0 109.466 -175.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.59 133.6 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.421 . . . . 1.0 111.744 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.14 154.87 49.17 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.22 1.408 . . . . 1.0 112.828 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 63.3 m -128.32 149.46 50.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.331 1.852 . . . . 1.0 111.596 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.93 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 82.9 t80 -83.74 165.47 18.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.579 1.951 . . . . 1.0 112.705 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -57.96 62.73 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 126.177 1.791 . . . . 1.0 111.461 169.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -87.82 98.31 11.4 Favored 'General case' 0 N--CA 1.469 0.502 1 C-N-CA 131.982 4.113 . . . . 1.0 114.364 -170.495 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.83 -103.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.561 2.745 . . . . 1.0 104.862 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 43.15 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 129.388 3.075 . . . . 1.0 113.304 170.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 161.35 37.3 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.133 1.773 . . . . 1.0 114.684 173.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.3 tt -93.1 146.12 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 127.654 2.382 . . . . 1.0 111.693 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 t -70.33 137.0 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.008 0.744 . . . . 1.0 113.008 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -91.57 -15.55 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.146 1.378 . . . . 1.0 113.424 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -67.64 0.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.606 2.762 . . . . 1.0 112.309 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.862 0 C-N-CA 129.366 3.365 . . . . 1.0 113.629 178.202 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' OE2' ' HG2' ' A' ' 24' ' ' ARG . 12.9 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.459 -0.782 . . . . 1.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mt -146.65 -173.61 4.25 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 128.545 2.738 . . . . 1.0 104.989 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 2.4 t -69.77 71.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 119.458 -2.027 . . . . 1.0 109.664 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HG2' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.97 172.11 0.09 Allowed 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.498 1.666 . . . . 1.0 115.498 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 t -108.28 -135.1 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.814 1.645 . . . . 1.0 108.528 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.2 -47.45 24.26 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.462 1.905 . . . . 1.0 111.579 170.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.5 m -131.38 159.12 73.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.485 1.914 . . . . 1.0 111.843 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.94 -7.32 20.86 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 123.882 3.055 . . . . 1.0 116.191 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -67.18 -36.11 81.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.802 2.441 . . . . 1.0 114.398 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -104.49 109.72 21.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.189 2.196 . . . . 1.0 110.405 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 155.52 22.48 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.629 1.714 . . . . 1.0 115.629 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 2.7 m -132.41 164.75 25.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.311 2.245 . . . . 1.0 112.038 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.661 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 42.9 m -153.4 91.24 1.48 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.455 2.302 . . . . 1.0 108.488 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.82 149.37 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 129.414 3.086 . . . . 1.0 108.933 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.923 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -83.7 178.88 2.16 Favored Pre-proline 0 CA--C 1.561 1.381 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -175.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.923 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 50.6 Cg_endo -66.3 48.06 0.25 Allowed 'Trans proline' 0 CA--C 1.557 1.656 1 C-N-CA 125.615 4.21 . . . . 1.0 116.581 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -65.02 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 129.144 2.978 . . . . 1.0 114.04 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.653 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 5.4 p-80 -55.21 69.45 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.98 1 C-N-CA 132.198 4.199 . . . . 1.0 114.4 174.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -154.62 169.29 24.22 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.169 2.188 . . . . 1.0 112.848 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.17 116.29 7.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.533 2.333 . . . . 1.0 110.737 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t 59.04 84.21 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.584 1.954 . . . . 1.0 110.516 -169.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -38.21 73.17 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.334 0.654 . . . . 1.0 112.743 -174.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 tttt 71.77 160.29 0.22 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 131.436 3.894 . . . . 1.0 114.71 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -72.79 68.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.557 1.543 . . . . 1.0 109.907 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.07 159.75 78.21 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.862 1.265 . . . . 1.0 113.704 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.59 -8.37 22.09 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.373 3.382 . . . . 1.0 116.465 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -65.39 -14.65 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.401 1.88 . . . . 1.0 115.541 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.795 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . . . 66.09 175.72 0.23 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.725 2.41 . . . . 1.0 112.982 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -131.31 84.06 2.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.672 1.589 . . . . 1.0 109.784 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 86.8 mttt -87.25 111.59 21.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 105.366 -2.087 . . . . 1.0 105.366 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.69 HG21 ' HG2' ' A' ' 87' ' ' GLN . 14.7 p -133.97 122.19 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.95 1.7 . . . . 1.0 107.819 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.8 t -139.06 148.25 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 128.377 2.671 . . . . 1.0 112.588 -172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.85 143.89 49.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.394 -1.441 . . . . 1.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.73 113.26 21.18 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.112 0.482 . . . . 1.0 110.513 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.05 -178.16 37.12 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.412 2.435 . . . . 1.0 114.173 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -176.37 0.72 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 126.129 1.771 . . . . 1.0 115.457 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.4 95.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 125.441 1.497 . . . . 1.0 113.692 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.25 -4.0 5.92 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 124.616 3.544 . . . . 1.0 117.944 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER 29.23 79.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 130.159 3.383 . . . . 1.0 115.552 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.23 51.57 0.01 OUTLIER Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.841 1.21 . . . . 1.0 113.574 -171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -129.54 94.05 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.138 1.775 . . . . 1.0 108.604 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -91.12 117.46 29.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.47 1.508 . . . . 1.0 111.627 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.97 111.84 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 105.678 -1.971 . . . . 1.0 105.678 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -112.56 114.03 26.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 0.1 OUTLIER -125.77 111.55 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.478 -1.389 . . . . 1.0 113.425 -170.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.619 ' HG2' ' H ' ' A' ' 67' ' ' ALA . 15.8 ttm -138.8 172.7 12.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.728 2.121 . . . . 1.0 116.728 -172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.619 ' H ' ' HG2' ' A' ' 66' ' ' MET . . . -98.45 143.94 28.34 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.724 1.249 . . . . 1.0 110.278 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.55 100.07 0.21 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 128.019 2.723 . . . . 1.0 112.424 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 27.6 t-20 -124.05 -39.21 2.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.765 2.426 . . . . 1.0 109.629 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.9 -45.3 30.46 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 129.012 2.925 . . . . 1.0 112.706 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -144.03 -11.94 0.65 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.46 2.304 . . . . 1.0 116.256 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 m120 84.37 151.78 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 130.525 3.53 . . . . 1.0 110.367 -170.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 33.26 43.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 128.519 2.728 . . . . 1.0 114.862 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -83.52 -26.27 30.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.331 3.052 . . . . 1.0 114.482 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -141.65 122.2 14.18 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 120.167 1.349 . . . . 1.0 112.088 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -58.23 172.13 0.48 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.13 2.27 . . . . 1.0 117.13 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.909 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 3.8 pp -116.07 167.27 11.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.637 3.175 . . . . 1.0 110.816 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 3.4 mtp180 -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.577 -0.702 . . . . 1.0 110.212 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 81' ' ' THR . 3.2 m-20 73.34 12.21 4.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.259 1.824 . . . . 1.0 111.65 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.909 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -62.92 7.11 0.09 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.171 1.388 . . . . 1.0 114.35 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 79' ' ' ASN . 48.6 p -105.98 110.76 23.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.479 1.111 . . . . 1.0 109.705 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.29 135.21 30.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.353 1.461 . . . . 1.0 111.613 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.32 144.06 25.77 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.786 2.034 . . . . 1.0 112.345 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.3 mtm -151.88 -173.72 4.62 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.316 1.846 . . . . 1.0 111.69 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 38.9 mttp -110.89 -96.82 0.41 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.477 2.311 . . . . 1.0 109.146 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.14 56.57 4.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.951 2.101 . . . . 1.0 108.836 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.69 ' HG2' HG21 ' A' ' 51' ' ' VAL . 19.0 tt0 51.25 32.46 8.21 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.801 1.64 . . . . 1.0 113.539 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.12 115.39 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.821 2.049 . . . . 1.0 111.845 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.7 147.52 50.11 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.618 1.567 . . . . 1.0 112.102 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 152.71 32.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.76 2.424 . . . . 1.0 111.911 -174.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.6 t80 57.38 -138.63 0.91 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.651 1.98 . . . . 1.0 112.405 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 32.3 t-20 -138.58 137.56 37.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.929 1.692 . . . . 1.0 110.9 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 t0 175.12 67.12 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.939 2.496 . . . . 1.0 112.75 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -160.52 142.74 12.8 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.14 2.576 . . . . 1.0 109.327 171.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 33.0 mtp180 -141.11 118.17 11.23 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.823 1.647 . . . . 1.0 113.897 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -94.07 153.09 18.33 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.456 1.122 . . . . 1.0 113.287 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 2.6 m 49.12 33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.553 2.741 . . . . 1.0 114.476 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.66 25.76 0.1 Allowed Glycine 0 CA--C 1.537 1.43 1 C-N-CA 131.796 4.522 . . . . 1.0 118.002 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.25 9.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 129.237 3.015 . . . . 1.0 111.665 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.2 p -67.59 92.68 0.33 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.692 2.797 . . . . 1.0 110.467 170.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.92 -133.71 4.15 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.55 2.5 . . . . 1.0 113.559 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -66.51 168.58 8.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.96 1.704 . . . . 1.0 112.419 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.34 -81.08 0.2 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.353 0.977 . . . . 1.0 111.019 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 94.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.291 1.837 . . . . 1.0 109.621 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -125.32 108.68 11.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.451 0.7 . . . . 1.0 111.813 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 56.7 t80 -139.21 93.43 2.68 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 128.093 2.557 . . . . 1.0 115.045 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.262 19.4 m -137.61 60.33 1.64 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.034 1.397 . . . . 1.0 109.248 169.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.06 97.18 10.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.59 1.956 . . . . 1.0 108.512 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.0 p -125.62 168.67 13.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.619 2.452 . . . . 1.0 117.619 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.0 tp -123.13 115.79 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.696 2.798 . . . . 1.0 107.666 174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -123.7 108.51 12.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.415 2.286 . . . . 1.0 113.569 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 2.4 t -72.34 147.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.02 -1.675 . . . . 1.0 111.648 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -115.7 48.52 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 1 C-N-CA 132.668 4.387 . . . . 1.0 110.533 -172.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.517 HG23 ' HD2' ' A' ' 116' ' ' PRO . 98.4 m -147.23 162.75 38.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 119.878 -1.764 . . . . 1.0 110.374 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.72 -42.71 11.23 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 126.308 1.843 . . . . 1.0 115.084 -173.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 114' ' ' THR . 74.9 Cg_endo -88.51 98.64 0.39 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.05 3.833 . . . . 1.0 107.619 168.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.06 118.23 5.56 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.3 2.667 . . . . 1.0 111.564 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.485 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 68.8 mt-30 -109.67 96.85 6.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.725 0.81 . . . . 1.0 110.877 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 m -107.85 122.43 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.982 2.113 . . . . 1.0 112.145 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.02 168.36 19.93 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.82 2.448 . . . . 1.0 112.33 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.3 m -117.31 145.81 43.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.053 -1.654 . . . . 1.0 113.335 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -87.56 115.77 25.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 1.0 107.539 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 74.34 170.95 0.29 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.764 2.026 . . . . 1.0 113.984 -172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -133.98 23.97 3.9 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.197 2.599 . . . . 1.0 113.38 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.64 119.39 14.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.863 2.065 . . . . 1.0 110.357 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.82 86.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.851 2.06 . . . . 1.0 110.624 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 11.9 mmtp -126.78 81.57 2.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.883 2.073 . . . . 1.0 111.638 -174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.25 119.05 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 126.492 1.917 . . . . 1.0 109.992 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.5 m -82.57 123.37 29.15 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.697 1.599 . . . . 1.0 110.364 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.13 -35.45 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -40.46 7.38 Favored 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 131.746 4.018 . . . . 1.0 113.967 174.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.194 0 C-N-CA 125.495 1.522 . . . . 1.0 115.325 176.57 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.98 -0.748 . . . . 1.0 108.98 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 tp -143.36 -174.67 4.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 104.373 -2.454 . . . . 1.0 104.373 162.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.93 74.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 121.993 2.179 . . . . 1.0 109.464 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' A' ' 28' ' ' PRO . 21.4 mtm105 -47.68 147.29 1.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.295 1.438 . . . . 1.0 112.898 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 122' ' ' TYR . 10.8 t -86.43 -154.53 0.22 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.264 1.826 . . . . 1.0 110.984 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.51 -18.37 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.123 2.169 . . . . 1.0 115.355 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 t -144.03 137.24 13.97 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.212 1.805 . . . . 1.0 111.919 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.491 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.0 Cg_exo -53.61 -19.74 14.77 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.727 2.952 . . . . 1.0 116.64 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -66.33 -23.24 66.33 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.578 1.325 . . . . 1.0 114.578 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.34 124.07 40.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.897 1.279 . . . . 1.0 111.747 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.437 ' CD2' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -139.28 154.62 47.98 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.485 1.661 . . . . 1.0 115.485 -171.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -141.75 164.51 30.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.916 1.686 . . . . 1.0 113.965 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 t -148.91 105.25 3.52 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 126.8 2.04 . . . . 1.0 109.378 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 167.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.217 1 C-N-CA 132.434 4.294 . . . . 1.0 110.346 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.716 ' HG ' ' HD2' ' A' ' 36' ' ' PRO . 1.2 tp -53.9 165.28 0.79 Allowed Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.439 2.295 . . . . 1.0 115.737 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.716 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 40.4 Cg_endo -63.61 146.1 92.24 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.998 3.798 . . . . 1.0 113.776 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.1 p -67.5 -23.85 65.51 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.914 2.086 . . . . 1.0 116.185 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.39 77.51 1.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.692 2.397 . . . . 1.0 109.116 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -155.94 165.62 35.93 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.873 3.269 . . . . 1.0 110.677 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.0 101.72 1.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.227 1.011 . . . . 1.0 110.657 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p 9.43 -107.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.545 2.738 . . . . 1.0 114.847 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 171.32 -57.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 1 C-N-CA 132.478 4.311 . . . . 1.0 110.738 170.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.97 -1.25 2.13 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.526 2.33 . . . . 1.0 116.781 172.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.316 1.4 t 142.6 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 1 C-N-CA 131.799 4.04 . . . . 1.0 113.462 172.048 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.83 150.98 17.44 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 127.237 2.215 . . . . 1.0 112.028 171.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.55 35.96 0.45 Allowed 'Trans proline' 0 CA--C 1.554 1.515 1 C-N-CA 125.567 4.178 . . . . 1.0 115.115 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -35.48 -71.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 129.732 3.213 . . . . 1.0 115.709 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.47 -30.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.48 1.912 . . . . 1.0 113.403 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.299 1.8 p90 41.52 39.26 1.04 Allowed 'General case' 0 C--N 1.353 0.756 0 N-CA-C 118.742 2.867 . . . . 1.0 118.742 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -126.25 106.89 9.85 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.769 0.713 . . . . 1.0 112.129 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.56 128.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.182 1.393 . . . . 1.0 110.702 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.55 145.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.771 2.028 . . . . 1.0 114.764 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.26 20.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.679 2.392 . . . . 1.0 108.9 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.98 112.28 16.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.395 1.478 . . . . 1.0 109.408 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.8 -61.49 0.6 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.932 1.253 . . . . 1.0 114.923 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.54 -18.94 11.83 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 118.093 2.627 . . . . 1.0 118.093 -171.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t 44.46 59.42 13.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 127.121 2.168 . . . . 1.0 114.739 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HB2' HG11 ' A' ' 112' ' ' VAL . 94.1 Cg_endo -88.34 109.48 0.58 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.56 2.84 . . . . 1.0 113.488 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.26 134.86 57.43 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.408 -0.807 . . . . 1.0 111.427 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.18 31.97 27.04 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.744 -0.597 . . . . 1.0 111.901 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 84.7 m -71.11 77.73 0.68 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 170.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -78.87 112.84 16.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.925 2.49 . . . . 1.0 111.767 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.52 107.77 18.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.454 -2.054 . . . . 1.0 105.454 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 m -105.36 119.52 39.28 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.753 -1.567 . . . . 1.0 110.042 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.31 116.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.152 -0.968 . . . . 1.0 108.449 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -125.34 81.24 1.95 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.655 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.95 107.4 19.91 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.346 -1.471 . . . . 1.0 107.189 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -39.15 132.25 1.91 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.567 2.508 . . . . 1.0 115.837 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.676 ' ND2' ' HG ' ' A' ' 100' ' ' SER . 5.4 m-80 170.74 -15.42 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.449 1 C-N-CA 131.797 4.039 . . . . 1.0 115.733 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 7.5 m-20 -58.05 -35.83 71.88 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.239 1.836 . . . . 1.0 112.749 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 148.26 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 1 C-N-CA 132.75 4.42 . . . . 1.0 115.414 172.966 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -156.84 -102.36 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 O-C-N 120.153 -1.592 . . . . 1.0 113.876 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.65 15.97 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.861 2.864 . . . . 1.0 113.543 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.1 m -168.63 111.9 0.57 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.277 1.831 . . . . 1.0 110.532 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.39 164.04 13.08 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.307 1.966 . . . . 1.0 116.307 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 156.78 21.41 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 126.577 1.951 . . . . 1.0 115.313 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.589 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -130.76 167.57 18.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.755 2.422 . . . . 1.0 112.409 -174.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.589 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.99 91.87 3.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.916 -1.74 . . . . 1.0 111.425 172.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 81' ' ' THR . 8.1 t30 67.73 12.59 8.92 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.504 1.522 . . . . 1.0 113.058 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -74.83 7.54 3.06 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 120.945 1.702 . . . . 1.0 112.491 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -95.9 113.2 24.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 130.089 3.356 . . . . 1.0 106.897 -177.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.57 160.0 40.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.574 1.95 . . . . 1.0 109.89 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.2 46.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.783 1.633 . . . . 1.0 114.05 173.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.811 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 48.8 mtm -101.01 151.61 21.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 1.0 109.671 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -112.13 -80.2 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.466 1.506 . . . . 1.0 107.545 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -62.27 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.213 0.46 . . . . 1.0 110.044 170.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.02 22.6 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.106 1.762 . . . . 1.0 114.421 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -133.88 119.8 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 126.21 1.804 . . . . 1.0 112.836 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.14 143.77 46.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.635 1.574 . . . . 1.0 109.727 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -106.09 106.1 16.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.794 0.838 . . . . 1.0 109.039 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.63 73.05 5.18 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.052 1.741 . . . . 1.0 111.946 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 94' ' ' LEU . 18.6 p30 -121.66 171.43 8.85 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 129.216 3.006 . . . . 1.0 110.531 172.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 t70 60.48 -20.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 130.179 3.391 . . . . 1.0 117.973 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -42.52 146.42 0.34 Allowed 'General case' 0 C--O 1.238 0.469 1 C-N-CA 133.11 4.564 . . . . 1.0 118.615 -171.441 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -139.95 129.21 23.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.21 -0.996 . . . . 1.0 111.104 170.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -119.85 135.88 54.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.13 1.772 . . . . 1.0 111.836 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 69' ' ' ASN 0.294 4.5 p 52.35 29.77 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 C-N-CA 125.043 1.337 . . . . 1.0 114.386 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.33 72.19 0.61 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 128.039 2.733 . . . . 1.0 113.345 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 132.27 84.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 1 C-N-CA 134.529 5.132 . . . . 1.0 109.425 -175.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.676 ' HG ' ' ND2' ' A' ' 69' ' ' ASN . 7.5 m -78.53 162.05 26.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.849 0.685 . . . . 1.0 112.849 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.34 -23.77 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 117.507 1.763 . . . . 1.0 117.507 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 169.64 150.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 129.771 3.228 . . . . 1.0 111.902 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.07 53.41 14.67 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.186 1.374 . . . . 1.0 115.246 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HG3' HD22 ' A' ' 69' ' ' ASN . 3.9 mptt -68.53 92.34 0.45 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.092 1.757 . . . . 1.0 112.206 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t -122.52 160.85 24.77 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 129.773 3.229 . . . . 1.0 113.973 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -128.4 90.18 3.03 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.021 1.86 . . . . 1.0 116.021 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -101.65 77.45 1.74 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.859 1.664 . . . . 1.0 110.575 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.85 92.84 6.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.561 -1.337 . . . . 1.0 109.255 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.7 t -116.8 122.01 43.19 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.39 114.32 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.003 1.321 . . . . 1.0 108.88 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.9 m -100.83 109.5 21.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.031 2.132 . . . . 1.0 113.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 58' ' ' PRO . 53.7 t -76.39 103.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.411 -1.431 . . . . 1.0 108.462 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.19 3.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.122 1 C-N-CA 134.981 5.312 . . . . 1.0 117.215 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -84.09 178.42 7.84 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.949 2.1 . . . . 1.0 114.02 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -44.93 -54.88 12.15 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.702 1.201 . . . . 1.0 109.814 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.99 116.89 4.72 Favored 'Trans proline' 0 CA--C 1.556 1.575 0 C-N-CA 123.495 2.797 . . . . 1.0 107.984 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.23 94.29 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 124.401 3.401 . . . . 1.0 108.603 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.44 92.39 5.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 -172.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -108.22 124.59 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 1.0 112.228 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.08 26.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.123 1.369 . . . . 1.0 111.692 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.2 m -113.31 140.07 48.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.591 1.957 . . . . 1.0 111.008 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.801 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 1.1 t80 -118.33 139.69 50.97 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.725 1.61 . . . . 1.0 111.843 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.61 64.0 0.8 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.939 1.459 . . . . 1.0 114.939 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.801 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 20.2 tpt85 -59.56 -27.83 66.58 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.859 2.54 . . . . 1.0 117.859 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 51.6 82.26 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 128.345 2.658 . . . . 1.0 114.705 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.46 -89.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 126.192 1.797 . . . . 1.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -88.17 153.9 20.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.585 1.954 . . . . 1.0 110.787 172.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.57 113.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.68 1.192 . . . . 1.0 110.986 173.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.5 m -89.84 126.31 35.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.0 110.81 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' ' 104' ' ' LYS . 10.9 p -92.43 -35.96 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 126.654 1.981 . . . . 1.0 115.485 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -56.21 10.95 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 131.163 3.785 . . . . 1.0 110.964 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.532 1.137 0 C-N-CA 127.434 2.445 . . . . 1.0 113.576 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.441 -0.79 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -157.45 -175.14 5.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.118 2.567 . . . . 1.0 105.259 -168.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.27 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 121.639 2.018 . . . . 1.0 109.676 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 31' ' ' LEU . 32.5 mtp180 -81.68 141.48 33.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.556 1.542 . . . . 1.0 110.031 169.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 p -81.92 -136.03 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.102 2.161 . . . . 1.0 109.367 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -48.66 -17.2 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.361 -1.462 . . . . 1.0 113.612 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.403 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 43.2 m 75.57 14.96 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 27' ' ' SER . 76.1 Cg_endo -70.32 30.01 0.2 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 124.749 3.633 . . . . 1.0 115.93 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.523 HD21 ' HB2' ' A' ' 56' ' ' ASP . 97.9 m-20 132.81 -20.48 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.478 1 C-N-CA 133.391 4.676 . . . . 1.0 113.581 -176.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -84.96 140.98 30.68 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 1.0 115.2 -171.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.522 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 3.6 pp -148.2 149.57 32.19 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.845 2.458 . . . . 1.0 112.004 171.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 t -129.77 122.14 28.22 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.048 1.339 . . . . 1.0 113.256 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 3.0 t -88.97 96.67 10.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.63 3.172 . . . . 1.0 108.594 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.04 162.58 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 129.988 3.315 . . . . 1.0 111.132 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -126.16 75.46 72.55 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 125.255 1.422 . . . . 1.0 112.386 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.77 -40.49 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 124.309 3.339 . . . . 1.0 113.814 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 m 38.39 45.3 0.81 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.126 3.37 . . . . 1.0 112.622 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . 6.8 p80 44.42 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.497 2.719 . . . . 1.0 114.039 173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -169.43 176.83 4.91 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 128.964 2.906 . . . . 1.0 108.793 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 97' ' ' VAL . 1.4 ptp180 -119.33 166.93 12.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.365 1.066 . . . . 1.0 113.763 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.2 m 75.68 12.83 3.0 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.923 2.564 . . . . 1.0 117.923 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -21.11 -46.94 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 130.674 3.59 . . . . 1.0 117.839 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.805 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 53.81 -29.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 1 C-N-CA 132.565 4.346 . . . . 1.0 119.512 171.583 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m 141.27 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 1 C-N-CA 133.339 4.656 . . . . 1.0 107.718 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.753 HD21 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -83.03 154.32 67.24 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.459 1.104 . . . . 1.0 112.217 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.753 ' HD2' HD21 ' A' ' 45' ' ' LEU . 58.8 Cg_endo -69.13 37.4 0.22 Allowed 'Trans proline' 0 CA--C 1.558 1.689 1 C-N-CA 125.528 4.152 . . . . 1.0 115.746 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 45' ' ' LEU . 26.3 pt -128.43 -29.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.292 3.037 . . . . 1.0 114.449 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.67 -174.0 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 127.417 2.287 . . . . 1.0 115.489 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.46 134.1 51.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.768 2.027 . . . . 1.0 112.847 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 69.8 mttt -130.24 109.35 10.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.599 1.56 . . . . 1.0 109.649 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -106.02 135.78 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.322 1.449 . . . . 1.0 109.02 173.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.56 140.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.394 1.077 . . . . 1.0 110.976 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.32 105.68 15.91 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.54 114.01 26.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.19 2.88 41.74 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.787 1.66 . . . . 1.0 115.923 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB2' HD21 ' A' ' 29' ' ' ASN . 2.1 t0 -133.67 162.05 33.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.741 2.017 . . . . 1.0 113.707 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.3 t -141.32 71.92 26.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.87 1.668 . . . . 1.0 111.661 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 87' ' ' GLN . 68.3 Cg_endo -79.63 -177.94 4.21 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.849 3.699 . . . . 1.0 114.277 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -148.73 95.76 2.47 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.051 2.14 . . . . 1.0 111.43 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.71 17.21 9.3 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 126.057 1.789 . . . . 1.0 116.955 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 81.1 m -52.14 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.688 2.395 . . . . 1.0 113.294 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -77.15 103.27 6.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.217 1.407 . . . . 1.0 110.971 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.47 108.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -112.36 115.85 29.4 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 123.944 0.777 . . . . 1.0 112.634 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.28 111.65 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.128 -0.982 . . . . 1.0 110.253 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.691 ' HG2' ' HB3' ' A' ' 77' ' ' LEU . 32.8 mtm -128.99 165.56 20.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.94 127.31 47.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.337 1.055 . . . . 1.0 109.158 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -35.57 -57.28 0.96 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 125.55 1.548 . . . . 1.0 113.187 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.453 ' H ' ' CB ' ' A' ' 105' ' ' SER . 12.7 t-20 72.94 109.35 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.504 3.522 . . . . 1.0 110.078 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.625 ' HA ' ' HD2' ' A' ' 102' ' ' ARG . 1.0 OUTLIER 54.33 32.91 17.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.202 1.401 . . . . 1.0 112.729 -168.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 53.97 54.92 9.02 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 129.161 2.984 . . . . 1.0 114.096 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' A' ' 73' ' ' TYR 0.361 0.0 OUTLIER -82.37 -108.3 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.494 0.717 . . . . 1.0 111.003 173.036 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.69 ' H ' ' ND2' ' A' ' 72' ' ' ASN . 17.4 m-85 -172.64 70.79 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 130.642 3.577 . . . . 1.0 110.394 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.472 ' HB2' ' HE1' ' A' ' 66' ' ' MET . 66.0 p 63.35 89.75 0.09 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.833 2.053 . . . . 1.0 114.477 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -147.37 74.21 1.32 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.869 1.063 . . . . 1.0 113.869 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 26.1 tt0 161.09 96.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.053 2.141 . . . . 1.0 115.628 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.836 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.98 165.48 24.61 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.615 3.566 . . . . 1.0 107.876 170.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -144.11 82.53 1.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.255 -1.528 . . . . 1.0 111.193 169.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 23.9 m120 84.16 4.07 0.76 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.089 1.756 . . . . 1.0 111.136 -170.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.836 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -64.07 9.85 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.587 3.155 . . . . 1.0 116.592 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 t -118.63 115.13 23.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.527 1.931 . . . . 1.0 110.834 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.1 32.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.589 1.956 . . . . 1.0 112.198 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.82 143.62 26.33 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.923 2.489 . . . . 1.0 111.898 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.435 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -121.37 149.25 43.26 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.876 2.47 . . . . 1.0 112.088 -170.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -79.48 -117.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.063 0.945 . . . . 1.0 111.057 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.7 -8.14 1.2 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.718 2.007 . . . . 1.0 115.246 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.604 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 135.69 6.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.192 1 C-N-CA 133.109 4.563 . . . . 1.0 113.128 -171.354 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.54 144.66 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 120.405 1.457 . . . . 1.0 112.613 -169.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 51' ' ' VAL . . . -99.92 146.34 26.79 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.188 2.195 . . . . 1.0 113.637 173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.938 2.495 . . . . 1.0 110.844 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 t80 45.93 -78.9 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.421 3.088 . . . . 1.0 116.842 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 44.88 160.99 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.537 1 C-N-CA 131.773 4.029 . . . . 1.0 118.497 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.55 -54.9 4.43 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.627 2.371 . . . . 1.0 113.567 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt 40.82 120.18 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.403 1 C-N-CA 133.093 4.557 . . . . 1.0 117.321 172.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.805 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.92 115.34 22.39 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.783 1.629 . . . . 1.0 113.196 -170.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -99.95 136.28 40.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.464 1.505 . . . . 1.0 110.82 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 1.8 t 50.43 56.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.848 -1.167 . . . . 1.0 107.848 -171.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -91.06 -8.06 65.18 Favored Glycine 0 N--CA 1.479 1.501 1 N-CA-C 126.499 5.36 . . . . 1.0 126.499 -167.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . 0.253 1.3 tmm_? -146.9 48.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.88 3.34 . . . . 1.0 117.488 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . 0.278 3.4 t 144.53 -81.49 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 132.126 4.17 . . . . 1.0 111.059 171.171 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 85.55 1.59 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.041 1.291 . . . . 1.0 114.799 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.625 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -44.41 -60.35 1.99 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 129.211 3.004 . . . . 1.0 116.951 -176.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.82 -79.95 0.03 OUTLIER Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.287 1.899 . . . . 1.0 111.592 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.64 98.1 1.91 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.701 1.6 . . . . 1.0 114.516 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.453 ' CB ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -127.51 136.13 51.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.824 2.05 . . . . 1.0 113.142 173.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.8 114.05 12.23 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.168 1.787 . . . . 1.0 111.747 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -139.21 75.84 1.54 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.939 1.696 . . . . 1.0 111.288 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.56 108.9 8.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 1.0 110.046 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -117.74 115.25 24.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.2 1.4 . . . . 1.0 112.14 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.4 116.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.472 1.509 . . . . 1.0 107.197 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -113.77 107.34 15.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.201 1.001 . . . . 1.0 113.239 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 55.5 t -77.3 145.56 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.514 1.526 . . . . 1.0 111.846 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -104.1 -6.99 20.56 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.316 3.046 . . . . 1.0 114.627 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.729 HG23 ' HD2' ' A' ' 116' ' ' PRO . 8.6 m -72.28 171.47 12.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.869 2.868 . . . . 1.0 111.742 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.99 -52.53 9.15 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.403 -1.284 . . . . 1.0 111.778 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.729 ' HD2' HG23 ' A' ' 114' ' ' THR . 58.1 Cg_endo -78.24 110.74 2.93 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 124.624 3.55 . . . . 1.0 109.534 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 106.37 1.88 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.009 2.473 . . . . 1.0 109.624 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.626 HE22 ' HB2' ' A' ' 116' ' ' PRO . 1.7 mp0 -106.68 101.48 10.92 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 1.0 111.15 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.78 114.38 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.631 1.973 . . . . 1.0 111.423 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.08 127.66 32.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.91 1.684 . . . . 1.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 t -123.88 148.67 46.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.218 1.807 . . . . 1.0 114.712 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -87.32 112.66 22.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 1.0 109.073 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.42 49.91 2.28 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.006 2.522 . . . . 1.0 112.097 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -136.48 -99.94 0.21 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.217 2.207 . . . . 1.0 114.222 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.48 58.78 0.29 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 116.175 1.917 . . . . 1.0 116.175 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.27 72.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.329 2.252 . . . . 1.0 114.256 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -128.98 159.67 35.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.276 2.23 . . . . 1.0 111.769 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HA ' ' HB2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -149.88 161.21 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.899 2.079 . . . . 1.0 111.235 174.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.7 m -99.06 124.05 43.79 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.46 1.904 . . . . 1.0 110.334 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.85 -30.91 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 115.733 1.753 . . . . 1.0 115.733 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.55 -49.88 75.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.189 2.195 . . . . 1.0 112.605 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 40' ' ' ARG . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 129.203 3.287 . . . . 1.0 112.635 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 119.663 -0.208 . . . . 1.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mt -148.51 -173.89 4.46 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.689 2.396 . . . . 1.0 106.273 150.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.28 71.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 120.951 1.705 . . . . 1.0 106.677 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -127.98 82.04 2.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.269 3.428 . . . . 1.0 108.216 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.0 p -100.68 -73.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.433 1.893 . . . . 1.0 110.047 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.593 1.557 . . . . 1.0 114.01 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 29' ' ' ASN . 11.0 m 75.19 36.38 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 117.161 2.282 . . . . 1.0 117.161 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.74 37.37 0.24 Allowed 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 124.481 3.454 . . . . 1.0 112.971 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 27' ' ' SER 0.27 84.8 m-20 73.24 16.0 4.26 Favored 'General case' 0 CA--C 1.56 1.33 1 C-N-CA 132.328 4.251 . . . . 1.0 114.052 -170.457 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -108.68 137.14 47.09 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.495 1.665 . . . . 1.0 115.495 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 pp -122.31 122.1 38.29 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.557 2.343 . . . . 1.0 111.923 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 t -115.27 147.07 40.85 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.336 1.854 . . . . 1.0 112.65 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -130.14 95.17 3.86 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.969 2.908 . . . . 1.0 110.689 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -144.64 139.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 128.625 2.77 . . . . 1.0 110.877 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.77 146.69 80.16 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 126.252 1.821 . . . . 1.0 114.424 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.65 99.51 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.622 3.548 . . . . 1.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.5 t -93.69 -8.14 41.73 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 116.192 1.923 . . . . 1.0 116.192 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.1 p80 31.57 56.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 128.815 2.846 . . . . 1.0 115.869 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.79 176.15 9.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.927 2.091 . . . . 1.0 113.749 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.28 101.64 1.95 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.304 2.242 . . . . 1.0 109.569 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.49 -65.84 0.96 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.248 -0.908 . . . . 1.0 109.621 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 45.11 56.71 5.25 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.228 1.411 . . . . 1.0 113.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HB2' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER 68.93 1.66 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.966 2.58 . . . . 1.0 117.966 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -23.42 57.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.781 2.141 . . . . 1.0 116.781 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 109.63 10.31 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.549 1.522 . . . . 1.0 109.833 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.34 144.3 11.53 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 123.87 3.046 . . . . 1.0 110.731 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.58 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -141.34 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.556 1.543 . . . . 1.0 110.932 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.42 119.49 3.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.599 1.96 . . . . 1.0 109.75 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.58 ' CZ ' HG12 ' A' ' 47' ' ' ILE . 9.0 m-85 -122.98 113.4 19.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.134 1.773 . . . . 1.0 109.12 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -126.61 118.8 25.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.809 1.244 . . . . 1.0 109.964 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -134.56 134.75 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.909 1.284 . . . . 1.0 110.323 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.77 142.0 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.775 1.63 . . . . 1.0 110.69 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.63 146.33 37.63 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.136 1.375 . . . . 1.0 111.047 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -74.55 139.57 43.84 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.281 0.632 . . . . 1.0 110.257 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.93 -177.27 19.17 Favored Glycine 0 CA--C 1.545 1.96 0 C-N-CA 126.811 2.148 . . . . 1.0 112.225 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.99 94.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.311 1.044 . . . . 1.0 112.452 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 7.5 p -156.26 147.48 16.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.065 2.146 . . . . 1.0 112.427 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.7 Cg_endo -58.36 151.0 63.77 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.797 2.331 . . . . 1.0 112.455 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 69.59 97.11 0.06 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.602 2.361 . . . . 1.0 112.811 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.05 -14.76 25.68 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 126.821 2.153 . . . . 1.0 115.104 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 95.13 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 127.722 2.409 . . . . 1.0 114.231 171.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 110' ' ' ILE . 7.0 mp -103.77 129.02 51.12 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.981 1.474 . . . . 1.0 114.981 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -93.72 116.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.53 2.332 . . . . 1.0 105.37 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 p -129.2 117.54 20.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.121 2.169 . . . . 1.0 110.975 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.305 11.0 m -109.93 110.44 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.078 -1.014 . . . . 1.0 110.52 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.488 ' HB2' HG22 ' A' ' 107' ' ' THR . 53.4 mtt -144.42 107.72 4.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.494 2.317 . . . . 1.0 110.625 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.1 106.03 16.46 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 121.376 -0.828 . . . . 1.0 111.446 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.06 167.67 27.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.913 2.197 . . . . 1.0 112.278 172.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 104' ' ' LYS 0.265 0.1 OUTLIER 57.51 -33.01 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.27 2.628 . . . . 1.0 117.218 -175.563 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.625 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 38.9 t70 -64.73 -22.21 66.93 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 129.313 3.045 . . . . 1.0 113.515 170.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE1' ' HB2' ' A' ' 72' ' ' ASN . 9.6 tm-20 -120.78 -67.08 1.0 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.644 2.778 . . . . 1.0 109.629 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.502 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 3.1 m-80 -145.47 -85.23 0.12 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.906 2.082 . . . . 1.0 111.131 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -168.24 10.73 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.511 1.925 . . . . 1.0 114.994 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.2 m -59.51 -72.54 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.91 1.684 . . . . 1.0 113.995 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 46.75 -156.68 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.516 1.526 . . . . 1.0 114.965 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.755 ' HB2' ' HB2' ' A' ' 100' ' ' SER . 7.0 tp10 65.11 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.404 3.082 . . . . 1.0 115.227 -172.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.846 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -134.02 165.52 24.85 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.438 ' HD3' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -122.33 83.79 2.16 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.963 1.305 . . . . 1.0 109.603 172.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 81' ' ' THR . 4.1 m-20 70.82 10.63 7.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.865 0.866 . . . . 1.0 113.109 -176.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -65.51 2.63 0.87 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.304 1.411 . . . . 1.0 113.387 169.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 79' ' ' ASN . 5.4 t -100.02 112.61 24.9 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.044 0.938 . . . . 1.0 109.715 170.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.41 122.51 14.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.39 1.876 . . . . 1.0 109.689 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.8 153.48 18.84 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.184 0.994 . . . . 1.0 112.537 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.428 ' HB2' ' HE1' ' A' ' 84' ' ' MET . 3.1 mpp? -126.24 167.62 15.2 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.384 1.874 . . . . 1.0 110.084 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 -80.13 0.6 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.671 1.588 . . . . 1.0 110.389 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.65 45.71 0.81 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.23 1.412 . . . . 1.0 112.072 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 61.15 22.04 12.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.573 2.749 . . . . 1.0 114.752 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.89 133.25 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.76 129.88 49.23 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 130.383 3.473 . . . . 1.0 111.393 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.01 160.07 39.75 Favored 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 132.028 4.131 . . . . 1.0 110.334 176.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.5 t80 108.04 178.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 129.499 3.119 . . . . 1.0 114.717 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -82.32 -157.06 0.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 127.738 2.415 . . . . 1.0 108.252 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 66.99 47.53 1.38 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 117.724 2.49 . . . . 1.0 117.724 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 1.9 mp -139.25 123.92 18.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.371 2.268 . . . . 1.0 109.427 172.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -144.69 149.51 35.75 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-N 122.698 2.499 . . . . 1.0 115.371 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -118.31 169.11 10.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.935 2.094 . . . . 1.0 115.746 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 38.7 t 60.4 70.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.047 2.139 . . . . 1.0 109.927 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.59 -11.52 37.96 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 127.464 2.459 . . . . 1.0 115.906 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 99' ' ' ARG . 3.4 ttp180 73.05 -16.67 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 129.563 3.145 . . . . 1.0 118.57 173.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.755 ' HB2' ' HB2' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 30.78 -5.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 2 C-N-CA 134.807 5.243 . . . . 1.0 122.502 172.187 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.77 49.28 1.52 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 128.696 3.046 . . . . 1.0 110.653 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 90.7 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 129.861 3.264 . . . . 1.0 109.186 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.96 62.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 114.875 0.71 . . . . 1.0 114.875 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -71.48 84.93 0.83 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 123.153 1.454 . . . . 1.0 107.765 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -130.84 113.17 13.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.001 2.52 . . . . 1.0 113.177 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 70' ' ' ASP . 22.7 t80 -87.45 83.25 7.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.06 0.944 . . . . 1.0 108.988 174.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 66' ' ' MET . 5.0 t -148.65 52.05 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -96.26 68.35 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.442 1.497 . . . . 1.0 112.866 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 50.8 m 172.28 -77.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 128.944 2.898 . . . . 1.0 113.701 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -133.17 155.04 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.1 m -135.05 106.3 6.74 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.131 2.172 . . . . 1.0 111.612 170.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.22 103.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 123.379 1.561 . . . . 1.0 109.707 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.14 73.47 0.47 Allowed 'General case' 0 CA--C 1.545 0.773 1 C-N-CA 133.203 4.601 . . . . 1.0 109.771 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 116' ' ' PRO . 93.7 m -152.37 163.09 40.18 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.376 2.27 . . . . 1.0 109.41 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.98 -41.91 32.16 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.419 -1.277 . . . . 1.0 114.046 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.691 ' HD2' HG23 ' A' ' 114' ' ' THR . 83.5 Cg_endo -92.08 101.57 0.2 Allowed 'Trans proline' 0 CA--C 1.561 1.875 1 C-N-CA 125.883 4.389 . . . . 1.0 107.501 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.15 119.59 6.64 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 124.144 3.229 . . . . 1.0 111.138 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -118.92 102.45 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.3 1.048 . . . . 1.0 111.299 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.3 144.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.126 2.171 . . . . 1.0 113.163 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -122.45 155.1 36.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.805 1.642 . . . . 1.0 112.402 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 t -127.54 139.34 52.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.562 1.945 . . . . 1.0 113.319 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 9.4 t80 -89.11 109.82 20.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.074 -1.016 . . . . 1.0 108.773 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -97.0 57.19 1.47 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.979 0.895 . . . . 1.0 113.137 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.576 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -133.19 -61.73 0.82 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.24 2.616 . . . . 1.0 112.258 -175.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.09 -15.27 61.06 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.2 mm 11.94 -86.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 1 C-N-CA 131.848 4.059 . . . . 1.0 114.66 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 48.9 tptt -79.69 97.35 6.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.5 1.92 . . . . 1.0 110.57 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.458 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.87 161.74 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.73 1.612 . . . . 1.0 112.176 -178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.13 125.61 49.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.325 1.45 . . . . 1.0 112.804 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.01 -56.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.94 1.296 . . . . 1.0 112.032 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -99.1 -70.56 0.72 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.372 1.869 . . . . 1.0 112.83 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.583 0 C-N-CA 126.366 1.936 . . . . 1.0 114.009 175.379 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.301 -0.857 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 -173.91 4.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.356 2.663 . . . . 1.0 106.478 -160.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.9 t -72.96 71.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 122.143 2.247 . . . . 1.0 107.891 171.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.87 123.33 49.91 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 1.0 108.05 170.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.311 9.7 t -129.52 -101.1 0.32 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.553 0.946 . . . . 1.0 113.553 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -57.04 -34.89 68.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 127.746 2.418 . . . . 1.0 115.895 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.695 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 63.1 m -139.22 109.05 7.49 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.079 1.752 . . . . 1.0 107.616 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -46.26 -19.51 0.64 Allowed 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 124.706 3.604 . . . . 1.0 115.547 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.06 -36.59 70.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.544 2.738 . . . . 1.0 113.395 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -101.95 110.46 22.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.801 1.24 . . . . 1.0 109.813 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -117.96 122.28 42.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.028 1.731 . . . . 1.0 113.331 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.591 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 14.3 m -114.98 164.08 14.66 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.172 1.389 . . . . 1.0 113.861 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -152.06 126.96 9.64 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.793 1.637 . . . . 1.0 113.176 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.31 152.81 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 130.566 3.546 . . . . 1.0 109.375 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.55 150.8 95.57 Favored Pre-proline 0 CA--C 1.56 1.353 0 O-C-N 121.761 -0.587 . . . . 1.0 112.529 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.5 80.0 1.13 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.222 3.281 . . . . 1.0 112.414 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 p -77.64 -80.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.519 1.128 . . . . 1.0 110.246 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 44.37 78.21 0.06 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.844 2.458 . . . . 1.0 111.77 -173.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.521 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 1.6 p90 -166.28 173.56 9.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.474 2.309 . . . . 1.0 111.55 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -66.43 100.87 0.69 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.785 1.234 . . . . 1.0 110.908 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -87.23 -50.78 6.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.962 1.705 . . . . 1.0 113.446 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.509 ' C ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t-20 56.28 8.65 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 125.913 1.685 . . . . 1.0 114.528 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.804 ' HB2' ' HB2' ' A' ' 95' ' ' ARG 0.267 5.4 ttpt 65.42 27.31 11.84 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 130.806 3.643 . . . . 1.0 114.82 -170.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -57.51 -55.39 35.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 130.045 3.338 . . . . 1.0 114.457 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.21 106.49 17.77 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.867 2.067 . . . . 1.0 109.751 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.62 134.54 16.93 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.095 3.197 . . . . 1.0 113.301 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.87 -11.66 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.822 1.649 . . . . 1.0 114.563 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 68.51 162.09 0.2 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.133 2.573 . . . . 1.0 115.693 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -128.02 129.06 46.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.123 2.169 . . . . 1.0 109.506 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -124.67 109.13 12.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.02 1.328 . . . . 1.0 110.094 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.75 144.11 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.525 1.53 . . . . 1.0 111.459 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 147.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.476 3.11 . . . . 1.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.39 158.93 43.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.79 1.774 . . . . 1.0 115.79 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.4 mt -100.43 112.48 24.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.803 2.041 . . . . 1.0 108.2 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.27 168.72 34.48 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 125.492 1.52 . . . . 1.0 111.282 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.539 ' OD1' ' HD2' ' A' ' 58' ' ' PRO . 9.3 t0 56.8 169.38 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.656 ' HA ' ' HG2' ' A' ' 87' ' ' GLN 0.332 1.3 p -149.54 -43.86 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 115.788 1.773 . . . . 1.0 115.788 172.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 46.6 Cg_endo -81.16 169.41 16.04 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.282 2.654 . . . . 1.0 111.91 171.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 16.75 -122.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 129.367 3.067 . . . . 1.0 114.386 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 86' ' ' ASN . . . 144.42 -70.5 0.39 Allowed Glycine 0 C--N 1.342 0.861 0 C-N-CA 126.274 1.893 . . . . 1.0 113.951 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -139.82 165.17 28.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.596 1.702 . . . . 1.0 115.596 -169.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 111' ' ' THR . 38.3 mt -108.42 106.22 16.24 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.632 3.173 . . . . 1.0 106.305 168.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.87 107.72 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 -173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.9 m -111.57 119.59 39.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.241 1.017 . . . . 1.0 111.157 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.67 114.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 120.948 -1.095 . . . . 1.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.781 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 8.1 mtt -121.12 78.03 1.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.127 0.971 . . . . 1.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.02 106.69 19.02 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.136 -1.431 . . . . 1.0 107.136 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.57 171.19 54.95 Favored Glycine 0 CA--C 1.543 1.8 0 C-N-CA 126.542 2.02 . . . . 1.0 116.838 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 17.8 p-10 -145.35 91.7 2.16 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.046 2.938 . . . . 1.0 110.135 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.92 20.37 12.18 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 126.426 1.89 . . . . 1.0 114.874 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.602 ' HG2' ' HB3' ' A' ' 73' ' ' TYR . 4.4 tt0 -148.41 -25.98 0.33 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.141 2.177 . . . . 1.0 116.279 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 45.09 38.7 3.33 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.963 2.105 . . . . 1.0 114.301 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.602 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 60.9 t80 -149.84 68.67 1.01 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.645 1.978 . . . . 1.0 111.973 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.781 ' HB2' ' HG2' ' A' ' 66' ' ' MET . 42.5 t 63.08 78.79 0.28 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 128.664 2.785 . . . . 1.0 116.73 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.79 -62.82 1.4 Allowed 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.426 ' CD ' HH21 ' A' ' 95' ' ' ARG . 0.1 OUTLIER 173.22 143.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.894 2.878 . . . . 1.0 112.165 174.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.63 163.26 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.65 2.38 . . . . 1.0 110.782 170.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.766 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . 56.1 mtt-85 -141.08 90.03 2.29 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.092 2.157 . . . . 1.0 109.173 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.64 ' C ' ' H ' ' A' ' 81' ' ' THR . 1.3 t-20 88.84 -2.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.801 2.04 . . . . 1.0 110.848 -172.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 77' ' ' LEU 0.334 . . -76.01 34.12 0.13 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 123.272 2.76 . . . . 1.0 114.475 170.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.64 ' H ' ' C ' ' A' ' 79' ' ' ASN . 1.2 t -126.56 108.37 11.08 Favored 'General case' 0 CA--C 1.542 0.653 1 C-N-CA 132.704 4.402 . . . . 1.0 101.238 167.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.18 152.82 42.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.57 1.148 . . . . 1.0 112.113 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.15 159.4 15.3 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 129.452 3.101 . . . . 1.0 114.1 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 88' ' ' VAL 0.306 0.5 OUTLIER 86.54 -127.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 128.057 2.543 . . . . 1.0 113.041 176.278 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 110' ' ' ILE . 5.9 tmtt? 70.08 -25.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 128.267 2.627 . . . . 1.0 117.13 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 2.4 m-20 -81.48 0.99 35.34 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 120.057 1.299 . . . . 1.0 113.497 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.656 ' HG2' ' HA ' ' A' ' 57' ' ' VAL . 4.1 tp-100 -148.41 -47.54 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.037 2.135 . . . . 1.0 112.395 170.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 84' ' ' MET . 90.7 t -133.9 134.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 114.972 1.471 . . . . 1.0 114.972 -172.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.24 121.62 16.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.775 1.63 . . . . 1.0 110.632 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.15 158.8 43.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.497 2.319 . . . . 1.0 110.23 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.45 -167.6 0.19 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.548 1.539 . . . . 1.0 114.565 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.63 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 9.0 p30 -107.99 -174.44 2.52 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.02 2.128 . . . . 1.0 111.559 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.63 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.265 8.4 m-20 121.0 74.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.565 3.546 . . . . 1.0 112.379 174.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 2.9 pp -160.2 141.72 12.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.198 2.599 . . . . 1.0 109.299 169.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.804 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 3.7 ttt180 -129.49 148.48 51.4 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 119.073 0.851 . . . . 1.0 112.166 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.45 152.0 38.32 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.453 1.649 . . . . 1.0 115.453 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.3 m 43.95 31.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 129.194 2.998 . . . . 1.0 117.569 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.54 -35.18 36.44 Favored Glycine 0 N--CA 1.48 1.577 0 C-N-CA 128.848 3.118 . . . . 1.0 118.336 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 -0.15 4.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.511 1.924 . . . . 1.0 115.08 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 13.3 p -65.27 119.2 10.47 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.429 1.491 . . . . 1.0 113.122 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -117.17 128.47 7.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.78 1.657 . . . . 1.0 114.004 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER 69.01 164.18 0.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.928 2.891 . . . . 1.0 113.496 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 42.36 36.4 2.15 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.172 1.844 . . . . 1.0 113.918 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -67.43 101.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.769 2.028 . . . . 1.0 108.701 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -115.5 156.45 25.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 130.614 3.565 . . . . 1.0 110.17 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.9 90.82 2.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.502 1.668 . . . . 1.0 115.502 -171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.0 m -112.38 80.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.545 1.138 . . . . 1.0 112.208 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.4 115.0 19.7 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.611 -1.306 . . . . 1.0 110.949 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.9 m -121.1 111.98 18.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.664 1.186 . . . . 1.0 111.148 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.408 HG22 ' HD2' ' A' ' 85' ' ' LYS . 4.0 mp -93.0 113.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.497 HG21 ' HB2' ' A' ' 62' ' ' LEU . 14.8 t -89.98 151.1 21.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 122.834 0.453 . . . . 1.0 111.769 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.624 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 2.0 p -72.68 170.95 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 123.451 1.596 . . . . 1.0 112.325 172.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -118.15 11.5 13.27 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.891 2.877 . . . . 1.0 114.339 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.7 p -120.59 167.51 12.34 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.222 1.409 . . . . 1.0 112.682 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -29.06 5.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 117.536 2.421 . . . . 1.0 117.536 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -87.6 99.34 0.46 Allowed 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 124.421 3.414 . . . . 1.0 109.715 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.91 94.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.355 1 C-N-CA 125.428 4.085 . . . . 1.0 116.217 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.624 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 1.5 tm0? -97.78 90.47 4.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.152 0.977 . . . . 1.0 108.413 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.23 114.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.191 1.396 . . . . 1.0 108.616 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.42 151.78 27.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.561 2.345 . . . . 1.0 111.516 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 m -118.74 131.01 56.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.135 0.974 . . . . 1.0 112.905 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.24 120.29 23.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.394 1.078 . . . . 1.0 111.518 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -167.17 -166.45 0.8 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.794 2.437 . . . . 1.0 111.484 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -33.62 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 130.077 3.351 . . . . 1.0 117.697 172.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -28.99 -74.97 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 128.915 2.886 . . . . 1.0 115.183 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.3 mm -145.66 169.04 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 130.039 3.336 . . . . 1.0 107.654 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -76.39 150.06 36.84 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.7 -1.25 . . . . 1.0 110.717 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.8 tt -92.32 124.5 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.461 1.904 . . . . 1.0 110.119 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -81.21 125.11 29.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.44 1.496 . . . . 1.0 111.923 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.3 t -53.95 -65.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.786 1.635 . . . . 1.0 114.153 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.44 -2.93 27.77 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.521 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . . . . . . 0 CA--C 1.55 2.261 0 C-N-CA 125.356 1.455 . . . . 1.0 112.494 -172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.59 0.219 . . . . 1.0 111.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -152.5 -174.53 4.93 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 23.2 t -67.63 71.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 107.173 -1.417 . . . . 1.0 107.173 170.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.12 169.73 0.77 Allowed 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.965 1.468 . . . . 1.0 114.965 171.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 24.9 p -132.64 176.51 8.39 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.408 2.283 . . . . 1.0 110.17 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.37 21.19 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 128.129 2.572 . . . . 1.0 112.584 171.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.599 ' OG ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -79.11 168.37 27.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 127.269 2.227 . . . . 1.0 114.558 -177.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HD2' ' OG ' ' A' ' 27' ' ' SER . 53.6 Cg_endo -64.55 -33.02 57.9 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.426 2.751 . . . . 1.0 113.741 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -174.19 72.08 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 128.606 2.762 . . . . 1.0 111.303 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -125.4 129.45 49.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.422 -1.424 . . . . 1.0 114.248 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.72 133.88 53.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.697 1.599 . . . . 1.0 112.149 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 70.6 m -119.06 157.91 26.88 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.591 1.557 . . . . 1.0 111.868 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 6.7 t -137.81 98.16 3.6 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.213 2.205 . . . . 1.0 109.779 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.08 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.784 2.434 . . . . 1.0 110.225 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.659 ' HB3' HG12 ' A' ' 47' ' ' ILE . 11.5 tp -72.95 -66.74 0.53 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.65 1.58 . . . . 1.0 112.951 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.579 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 39.5 Cg_endo -66.01 142.43 68.32 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.757 2.972 . . . . 1.0 113.37 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -126.65 -46.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.822 2.049 . . . . 1.0 113.843 175.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 m-70 -138.78 62.8 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.509 1.524 . . . . 1.0 112.23 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.657 ' HB2' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -139.81 157.06 46.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 130.237 3.415 . . . . 1.0 110.628 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 7.9 ttp180 -68.37 104.92 2.0 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.997 1.719 . . . . 1.0 113.372 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.7 t 95.62 113.33 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.586 3.155 . . . . 1.0 116.429 170.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 96' ' ' PHE . 57.2 t30 -57.1 -71.47 0.1 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.701 2.4 . . . . 1.0 112.814 171.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -78.08 165.65 23.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.426 2.29 . . . . 1.0 113.099 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 91.47 -8.22 0.25 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 130.075 3.35 . . . . 1.0 112.496 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.07 162.56 63.99 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 129.643 3.177 . . . . 1.0 113.831 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.37 29.33 0.3 Allowed 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 125.104 3.87 . . . . 1.0 115.243 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.659 HG12 ' HB3' ' A' ' 35' ' ' LEU . 2.4 pp -146.33 172.55 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 129.723 3.209 . . . . 1.0 110.368 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.0 -179.32 5.34 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 128.923 2.889 . . . . 1.0 112.355 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -120.46 143.07 48.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.317 2.247 . . . . 1.0 113.12 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 78.9 mttt -147.27 146.66 29.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.433 1.893 . . . . 1.0 111.212 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . 0.273 1.0 OUTLIER -135.98 135.18 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.445 1.098 . . . . 1.0 109.435 168.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.62 118.11 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.546 1.538 . . . . 1.0 108.286 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . . . -97.79 159.94 14.62 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.493 1.117 . . . . 1.0 111.811 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.65 115.65 23.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.868 1.667 . . . . 1.0 111.687 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.2 169.77 40.88 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.583 1.563 . . . . 1.0 112.742 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 -168.74 0.19 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.12 1.768 . . . . 1.0 114.555 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 7.4 p 169.52 73.08 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 131.191 3.796 . . . . 1.0 109.843 172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -93.76 4.87 2.92 Favored 'Trans proline' 0 CA--C 1.556 1.584 1 C-N-CA 125.402 4.068 . . . . 1.0 117.689 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 30.09 93.4 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 130.669 3.587 . . . . 1.0 118.661 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.98 5.21 3.55 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.899 1.714 . . . . 1.0 115.721 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 m -55.22 111.88 0.96 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.23 2.212 . . . . 1.0 111.775 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.52 111.42 10.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.705 1.602 . . . . 1.0 111.303 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.583 HG11 HG12 ' A' ' 110' ' ' ILE . 35.0 m -93.06 107.64 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 172.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.81 116.86 30.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 123.418 1.58 . . . . 1.0 110.85 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.33 140.99 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 120.685 -1.259 . . . . 1.0 110.519 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -134.91 105.03 6.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.658 0.783 . . . . 1.0 111.436 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 96' ' ' PHE . . . -99.86 109.03 21.44 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.355 -1.466 . . . . 1.0 107.696 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' A' ' 74' ' ' SER . . . 131.9 91.27 0.52 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.281 2.848 . . . . 1.0 110.424 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -144.75 -87.84 0.11 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.361 2.265 . . . . 1.0 109.468 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 105' ' ' SER . 2.5 m-20 -43.33 -28.64 0.35 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.525 2.73 . . . . 1.0 116.435 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 104' ' ' LYS . 14.1 mm-40 -98.14 -24.69 15.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.963 2.105 . . . . 1.0 115.834 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -162.61 -79.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.399 1.454 . . . . 1.0 113.882 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 t80 136.33 108.3 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.62 1 C-N-CA 132.82 4.448 . . . . 1.0 107.432 -170.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.602 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -124.42 -77.79 0.59 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.381 1.473 . . . . 1.0 111.256 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.76 -2.16 0.1 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.39 1.996 . . . . 1.0 116.39 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.31 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 129.812 3.245 . . . . 1.0 112.612 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 97' ' ' VAL . 5.1 mt -96.61 167.43 11.14 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -171.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -132.85 83.78 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 -169.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.7 OUTLIER 95.25 2.53 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.964 2.906 . . . . 1.0 111.033 -173.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.838 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . . . -46.77 -6.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.991 2.589 . . . . 1.0 117.991 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.567 ' H ' ' C ' ' A' ' 79' ' ' ASN . 98.1 m -115.47 113.68 24.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.563 1.545 . . . . 1.0 111.58 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.7 163.0 34.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 128.93 2.892 . . . . 1.0 109.939 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.97 45.58 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.032 2.133 . . . . 1.0 112.563 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 85' ' ' LYS . 17.6 mmt -123.25 158.96 29.75 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.823 1.649 . . . . 1.0 111.195 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 84' ' ' MET . 2.0 mptm? -118.05 -87.01 0.63 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -168.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 8.2 m120 -75.69 43.83 0.27 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 129.041 2.936 . . . . 1.0 110.705 175.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 1.4 pm0 48.94 32.55 3.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.776 2.83 . . . . 1.0 114.02 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.06 144.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.625 1.97 . . . . 1.0 113.449 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.52 146.91 52.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.268 2.627 . . . . 1.0 112.241 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 ptt-85 -136.66 163.16 31.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 129.485 3.114 . . . . 1.0 113.886 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 61.11 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 128.303 2.641 . . . . 1.0 113.456 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.27 -66.72 0.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.198 2.199 . . . . 1.0 109.709 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 69.13 -21.25 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.037 3.335 . . . . 1.0 115.987 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.838 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.79 163.24 30.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 127.052 2.141 . . . . 1.0 115.741 178.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.655 ' HD2' ' HA3' ' A' ' 98' ' ' GLY . 5.5 ttm180 -141.11 115.95 9.73 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.297 1.962 . . . . 1.0 116.297 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.579 ' HZ ' ' HB2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -86.74 126.64 34.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.557 1.943 . . . . 1.0 111.201 177.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.435 ' H ' ' CD2' ' A' ' 77' ' ' LEU 0.289 2.6 m 38.67 41.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 129.247 3.019 . . . . 1.0 112.808 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -56.95 54.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.093 1 C-N-CA 132.453 4.835 . . . . 1.0 119.238 -171.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 117.88 -5.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 1 C-N-CA 132.735 4.414 . . . . 1.0 113.549 -175.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -141.21 92.48 2.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.604 2.362 . . . . 1.0 111.27 -174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 40' ' ' ARG . . . -168.99 138.42 5.09 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 127.472 2.463 . . . . 1.0 112.04 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -177.17 89.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.899 2.879 . . . . 1.0 107.37 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.06 81.54 0.59 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.759 1.171 . . . . 1.0 112.532 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -153.94 162.01 41.54 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.251 2.22 . . . . 1.0 112.341 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 23.3 t -104.84 154.82 19.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.892 2.077 . . . . 1.0 113.178 172.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.617 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.4 t80 -95.03 103.1 14.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.424 2.29 . . . . 1.0 111.184 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -108.07 82.95 1.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.331 1.063 . . . . 1.0 112.525 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.27 111.25 8.22 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.555 1.542 . . . . 1.0 111.202 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 m -109.02 104.66 13.91 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.384 0.883 . . . . 1.0 113.384 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.583 HG12 HG11 ' A' ' 63' ' ' VAL . 8.8 mt -93.45 113.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.128 -1.607 . . . . 1.0 108.199 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.7 p -111.61 121.2 44.5 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.569 1.948 . . . . 1.0 111.951 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.628 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 0.3 OUTLIER -71.57 172.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 123.0 1.381 . . . . 1.0 112.391 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -131.12 40.07 3.5 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.719 2.408 . . . . 1.0 113.598 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.465 ' H ' HG12 ' A' ' 112' ' ' VAL . 9.8 t -129.58 165.39 21.82 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.803 2.041 . . . . 1.0 111.023 172.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.57 -48.58 68.02 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 126.126 1.77 . . . . 1.0 112.684 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.34 111.54 3.28 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.876 3.05 . . . . 1.0 110.505 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.23 106.8 1.06 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.591 3.527 . . . . 1.0 112.707 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.628 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 7.9 tp-100 -105.32 92.85 4.38 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.812 0.815 . . . . 1.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.74 120.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.495 1.518 . . . . 1.0 111.453 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.53 146.18 44.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.79 2.036 . . . . 1.0 110.966 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.9 m -122.3 141.12 51.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.8 1.64 . . . . 1.0 110.102 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -92.25 143.88 25.96 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.067 0.947 . . . . 1.0 113.183 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -149.39 171.86 15.87 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.499 2.72 . . . . 1.0 111.15 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.533 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 15.2 ttt180 74.46 176.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 127.41 2.284 . . . . 1.0 112.557 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.533 ' H ' ' HG2' ' A' ' 124' ' ' ARG . . . -149.96 164.96 34.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.607 1.706 . . . . 1.0 115.607 175.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.66 -39.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.537 1.935 . . . . 1.0 113.716 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.56 110.32 8.69 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.395 1.478 . . . . 1.0 113.28 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 38' ' ' HIS . 1.2 pp -121.34 124.77 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.734 1.214 . . . . 1.0 110.586 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.657 ' HB ' ' HB2' ' A' ' 39' ' ' TRP . 86.5 m -125.87 120.51 30.67 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 170.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.56 -24.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 115.198 1.555 . . . . 1.0 115.198 -170.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.97 -69.02 0.78 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.757 2.423 . . . . 1.0 113.391 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.163 0 C-N-CA 127.148 2.309 . . . . 1.0 114.994 -175.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -173.63 3.82 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 129.764 3.226 . . . . 1.0 104.753 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.17 74.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 O-C-N 119.664 -1.897 . . . . 1.0 108.533 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 123' ' ' HIS . 73.9 mtt180 -41.72 113.48 0.42 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 130.452 3.501 . . . . 1.0 111.9 171.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.916 ' H ' ' HB2' ' A' ' 30' ' ' PHE . 3.4 t -149.32 92.54 1.96 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.949 0.9 . . . . 1.0 112.791 -170.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 121' ' ' THR . 31.8 t0 118.01 -58.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 1 C-N-CA 133.033 4.533 . . . . 1.0 112.849 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 30' ' ' PHE . 50.9 m 133.47 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.951 1 C-N-CA 132.306 4.242 . . . . 1.0 113.455 -172.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 30.8 Cg_endo -62.43 90.99 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 125.118 3.878 . . . . 1.0 111.969 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 54' ' ' LEU . 3.8 t-20 36.14 58.3 0.98 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.331 2.253 . . . . 1.0 110.686 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.916 ' HB2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -79.77 103.41 9.66 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.461 1.904 . . . . 1.0 111.689 -170.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -139.71 108.9 6.08 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.8 t -114.95 149.71 36.88 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.971 1.308 . . . . 1.0 111.818 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . 3.0 m -126.58 93.61 3.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.125 3.77 . . . . 1.0 108.058 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.597 HG23 ' HD2' ' A' ' 36' ' ' PRO . 5.4 p -149.68 155.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.503 2.321 . . . . 1.0 110.531 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.4 -58.32 0.5 Allowed Pre-proline 0 CA--C 1.552 1.038 0 CA-C-O 117.217 -1.373 . . . . 1.0 114.198 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.769 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 9.6 Cg_endo -50.78 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 1 C-N-CA 125.602 4.201 . . . . 1.0 112.99 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -102.57 -76.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.893 1.677 . . . . 1.0 109.938 -171.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -125.73 44.16 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.964 2.506 . . . . 1.0 113.143 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.777 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 5.5 p90 -161.93 169.19 21.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.244 2.218 . . . . 1.0 114.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -66.52 106.69 1.84 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.745 2.418 . . . . 1.0 114.622 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 42.7 t -81.02 -70.56 0.52 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.511 1.05 . . . . 1.0 111.334 173.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.2 t30 45.31 51.7 9.24 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.315 1.446 . . . . 1.0 113.584 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.37 -7.13 1.22 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.871 2.868 . . . . 1.0 116.492 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -65.19 142.27 58.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.8 1.182 . . . . 1.0 109.89 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 56.39 62.26 6.65 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 126.002 1.721 . . . . 1.0 110.881 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.0 41.83 0.58 Allowed 'Trans proline' 0 CA--C 1.554 1.497 1 C-N-CA 125.762 4.308 . . . . 1.0 114.315 -176.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.07 -1.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 129.892 3.277 . . . . 1.0 114.84 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.13 173.79 0.3 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 129.28 3.032 . . . . 1.0 113.164 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -140.1 166.67 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 5.2 tttp -142.91 135.99 28.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.577 2.351 . . . . 1.0 110.843 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 123.36 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.757 2.423 . . . . 1.0 107.368 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -138.19 131.85 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.059 2.144 . . . . 1.0 109.988 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.45 157.1 36.01 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.325 1.45 . . . . 1.0 111.179 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -128.44 113.05 15.05 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.741 1.386 . . . . 1.0 114.741 174.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.4 3.82 5.55 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 117.965 1.946 . . . . 1.0 117.965 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.85 177.44 4.84 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 128.384 2.673 . . . . 1.0 116.933 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.644 HG12 ' HD2' ' A' ' 58' ' ' PRO . 69.2 t -68.36 157.67 87.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 131.688 3.995 . . . . 1.0 113.495 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.644 ' HD2' HG12 ' A' ' 57' ' ' VAL . 61.1 Cg_endo -70.71 -150.76 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 125.121 3.881 . . . . 1.0 113.275 171.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' H ' ' HB2' ' A' ' 58' ' ' PRO . 9.6 p-10 -50.99 101.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.641 2.376 . . . . 1.0 112.317 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.43 -8.67 0.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.025 -1.43 . . . . 1.0 116.447 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 104.47 4.32 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.759 1.779 . . . . 1.0 108.894 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.56 112.46 16.84 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -89.64 107.32 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 101.93 -3.359 . . . . 1.0 101.93 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -130.9 117.55 19.42 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.812 1.32 . . . . 1.0 112.583 -170.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -106.35 111.54 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.531 1.133 . . . . 1.0 110.534 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.582 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 8.1 mtm -146.98 102.24 3.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.872 2.069 . . . . 1.0 111.431 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.2 107.74 20.15 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.713 1.142 . . . . 1.0 112.125 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.84 147.75 18.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.165 0.888 . . . . 1.0 115.059 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -155.13 -52.61 0.09 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.87 1.268 . . . . 1.0 112.579 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -149.19 -48.25 0.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.281 2.232 . . . . 1.0 114.891 -170.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -147.29 -10.24 0.43 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 130.397 3.479 . . . . 1.0 114.216 -168.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -48.43 -15.57 0.08 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.912 2.885 . . . . 1.0 115.473 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.85 2.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.821 3.648 . . . . 1.0 117.616 171.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.614 ' HB2' HG12 ' A' ' 97' ' ' VAL . 2.8 t -92.33 -99.46 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.732 1.613 . . . . 1.0 113.548 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 57.07 -65.51 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 126.871 2.068 . . . . 1.0 112.496 -169.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.51 137.65 53.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.379 2.272 . . . . 1.0 114.329 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.865 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.77 165.51 24.39 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 128.317 2.647 . . . . 1.0 111.599 -176.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.66 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -118.11 82.25 1.81 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.347 -0.846 . . . . 1.0 111.321 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.687 ' ND2' HH21 ' A' ' 95' ' ' ARG . 7.6 m-80 78.92 0.59 2.43 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.438 2.295 . . . . 1.0 112.508 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.865 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -57.25 -11.14 1.56 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.554 2.741 . . . . 1.0 117.214 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 m -105.01 112.66 25.88 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.223 1.577 . . . . 1.0 110.93 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 160.75 39.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.998 2.119 . . . . 1.0 111.35 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 127.19 42.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.779 2.432 . . . . 1.0 112.916 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -144.5 -164.7 1.97 Allowed 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 127.988 2.515 . . . . 1.0 112.846 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -112.87 -101.47 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.629 2.372 . . . . 1.0 111.502 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -79.57 45.35 0.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.628 2.371 . . . . 1.0 111.966 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.757 ' HG2' HG12 ' A' ' 110' ' ' ILE . 0.4 OUTLIER 51.24 32.7 8.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.167 2.187 . . . . 1.0 111.609 -171.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -90.39 109.92 21.4 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-O 122.894 1.33 . . . . 1.0 107.526 -171.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.51 116.36 11.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.22 2.208 . . . . 1.0 109.178 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -135.77 128.7 31.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.347 1.859 . . . . 1.0 109.969 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.0 t80 130.87 -151.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 130.696 3.598 . . . . 1.0 111.542 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -122.43 164.21 18.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.604 1.962 . . . . 1.0 110.599 171.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . 0.44 94.1 m-20 108.02 44.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.481 3.512 . . . . 1.0 116.341 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -139.95 132.19 28.21 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.299 2.639 . . . . 1.0 108.604 170.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.687 HH21 ' ND2' ' A' ' 79' ' ' ASN . 0.8 OUTLIER -138.86 120.63 15.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.026 1.739 . . . . 1.0 113.583 -171.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.45 115.99 30.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.714 1.206 . . . . 1.0 110.232 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 74' ' ' SER . 11.0 t 71.13 73.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.756 1.222 . . . . 1.0 107.995 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.63 90.24 0.65 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 128.506 2.955 . . . . 1.0 113.361 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.21 53.98 3.46 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 128.042 2.537 . . . . 1.0 115.01 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.5 t -70.93 -168.5 0.28 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.817 2.047 . . . . 1.0 115.798 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.88 -37.94 0.07 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.911 2.672 . . . . 1.0 115.044 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 159.85 42.72 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.905 2.082 . . . . 1.0 113.739 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.48 57.45 2.93 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.595 1.569 . . . . 1.0 115.188 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 104' ' ' LYS . 7.6 mtmt -68.79 104.7 2.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.223 1.809 . . . . 1.0 109.71 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.9 t -119.62 132.65 55.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.301 3.04 . . . . 1.0 110.878 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -84.75 87.12 7.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.185 0.994 . . . . 1.0 110.895 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 66' ' ' MET . 3.8 m -143.36 51.17 1.37 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.95 0.881 . . . . 1.0 111.319 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.35 90.41 3.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.894 2.077 . . . . 1.0 111.037 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 110' ' ' ILE . 10.2 t 152.38 -116.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 128.754 2.822 . . . . 1.0 115.545 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.757 HG12 ' HG2' ' A' ' 87' ' ' GLN . 3.8 mp -133.78 151.69 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 128.25 2.62 . . . . 1.0 111.786 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.9 m -140.18 104.24 4.77 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.586 1.554 . . . . 1.0 113.562 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.48 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 54.3 t -74.05 122.16 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.562 -1.336 . . . . 1.0 107.814 170.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.15 -8.17 56.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.587 3.555 . . . . 1.0 116.971 -175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 2.2 m -82.16 166.11 19.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.762 2.025 . . . . 1.0 112.529 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -45.02 -31.78 0.94 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.601 1.96 . . . . 1.0 114.023 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 114' ' ' THR . 98.1 Cg_endo -95.26 81.8 0.11 Allowed 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 125.41 4.073 . . . . 1.0 106.197 167.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.61 114.08 3.56 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.201 3.267 . . . . 1.0 111.834 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.48 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -99.99 92.48 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 -177.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.86 115.33 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.59 171.23 8.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.592 1.957 . . . . 1.0 112.995 -168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.477 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 63.3 p -124.9 120.05 30.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.742 2.017 . . . . 1.0 113.46 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.06 125.82 33.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.13 1.786 . . . . 1.0 110.523 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 41.3 m-70 -106.82 68.66 0.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.071 1.748 . . . . 1.0 112.181 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.41 -179.7 0.09 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.807 2.843 . . . . 1.0 112.764 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.27 -58.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.689 2.796 . . . . 1.0 116.334 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mt 67.31 -62.12 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 129.085 2.954 . . . . 1.0 112.766 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -124.24 130.84 53.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.672 1.989 . . . . 1.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.25 129.96 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 128.046 2.539 . . . . 1.0 110.382 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -85.32 121.96 28.8 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.053 1.341 . . . . 1.0 109.296 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.74 -28.44 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.063 0.945 . . . . 1.0 112.112 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.52 -29.19 56.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.543 2.337 . . . . 1.0 115.048 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.777 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . . . . . . 0 CA--C 1.553 2.465 0 C-N-CA 125.822 1.677 . . . . 1.0 114.56 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.75 -172.52 2.9 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 129.086 2.955 . . . . 1.0 105.689 -174.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.08 73.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 O-C-N 119.808 -1.807 . . . . 1.0 107.172 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -61.02 148.2 40.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.61 2.764 . . . . 1.0 113.96 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.528 HG23 HG12 ' A' ' 110' ' ' ILE . 82.5 p -76.47 -167.28 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.509 2.724 . . . . 1.0 110.162 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.704 ' HB2' ' O ' ' A' ' 121' ' ' THR . 4.2 t0 -66.24 12.91 0.06 Allowed 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.561 -1.337 . . . . 1.0 112.959 169.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 25' ' ' THR . 44.9 p -150.72 152.45 32.24 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.109 2.563 . . . . 1.0 114.653 -172.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 -15.54 26.05 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 C-N-CA 123.466 2.778 . . . . 1.0 111.493 168.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -21.48 63.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.918 2.887 . . . . 1.0 115.568 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' HB2' ' OG1' ' A' ' 25' ' ' THR . 26.9 m-85 -138.16 114.51 10.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.993 1.317 . . . . 1.0 110.569 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 3.5 pp -149.91 140.26 22.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.198 1.399 . . . . 1.0 114.422 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 52' ' ' VAL 0.587 0.1 OUTLIER -164.82 173.05 12.17 Favored 'General case' 0 CA--C 1.542 0.644 1 N-CA-C 122.936 4.421 . . . . 1.0 122.936 -173.461 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -97.68 98.25 9.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.714 0.806 . . . . 1.0 110.946 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.61 130.03 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 126.606 1.962 . . . . 1.0 111.812 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.52 126.96 91.75 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.152 1.381 . . . . 1.0 112.413 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.701 ' HB2' ' CD2' ' A' ' 38' ' ' HIS . 72.4 Cg_endo -71.55 148.81 54.49 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 124.016 3.144 . . . . 1.0 113.556 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 ' HB ' ' CG ' ' A' ' 96' ' ' PHE . 5.0 t -83.02 -67.02 0.82 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.827 1.651 . . . . 1.0 114.176 -176.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.701 ' CD2' ' HB2' ' A' ' 36' ' ' PRO . 86.6 m-70 37.26 40.44 0.19 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.291 3.436 . . . . 1.0 116.792 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.49 173.72 14.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.156 1.782 . . . . 1.0 113.717 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.483 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -82.18 103.64 11.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.077 2.151 . . . . 1.0 110.654 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.412 ' HB2' ' C ' ' A' ' 98' ' ' GLY . 13.7 p 51.05 101.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.475 2.71 . . . . 1.0 115.3 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.552 ' OD1' ' HB2' ' A' ' 96' ' ' PHE . 2.0 m120 -47.17 -72.59 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.005 2.122 . . . . 1.0 115.687 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 22.16 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 1 C-N-CA 132.736 4.414 . . . . 1.0 118.417 175.306 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m 68.04 77.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 129.612 3.165 . . . . 1.0 111.922 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 2.3 pt? -161.75 171.54 6.65 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 127.038 2.135 . . . . 1.0 113.412 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.668 ' HD2' ' HB2' ' A' ' 45' ' ' LEU . 43.0 Cg_endo -70.47 140.52 40.2 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.87 3.046 . . . . 1.0 111.681 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 12.9 mm -134.64 -69.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.486 1.514 . . . . 1.0 113.918 -172.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 31.23 90.03 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 130.436 3.495 . . . . 1.0 116.453 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.77 171.04 10.44 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.64 2.089 . . . . 1.0 116.64 -172.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -140.04 146.07 38.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 129.762 3.225 . . . . 1.0 109.948 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 2.5 t -130.79 118.86 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 129.236 3.014 . . . . 1.0 110.616 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' H ' ' HB2' ' A' ' 32' ' ' CYS 0.278 14.2 m -128.02 145.92 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 120.582 1.537 . . . . 1.0 113.977 173.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . . . -112.12 145.07 40.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.131 1.373 . . . . 1.0 112.495 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 tp -77.12 151.86 35.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.606 1.562 . . . . 1.0 111.701 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.1 -141.62 15.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.954 1.264 . . . . 1.0 113.964 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.34 -169.11 3.18 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 129.101 2.96 . . . . 1.0 111.208 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.704 HG23 ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 78.54 157.81 0.14 Allowed Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 128.864 2.866 . . . . 1.0 115.398 171.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.704 ' HD2' HG23 ' A' ' 57' ' ' VAL . 61.0 Cg_endo -73.58 175.04 11.23 Favored 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 125.015 3.81 . . . . 1.0 114.545 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 41.28 69.14 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.877 2.071 . . . . 1.0 111.293 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.65 -18.63 72.74 Favored Glycine 0 C--N 1.346 1.096 0 C-N-CA 127.081 2.277 . . . . 1.0 117.518 -168.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t 154.22 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 129.624 3.169 . . . . 1.0 112.715 172.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.98 113.66 14.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.948 2.899 . . . . 1.0 109.1 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.53 118.24 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.291 -1.506 . . . . 1.0 107.961 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -112.21 151.6 29.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.922 2.089 . . . . 1.0 110.199 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.42 127.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.008 1.723 . . . . 1.0 109.363 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 mtt -128.52 107.5 9.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.604 0.762 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.47 108.81 21.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.166 0.984 . . . . 1.0 111.049 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.21 -154.02 6.75 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 128.638 3.018 . . . . 1.0 114.515 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 107.33 -72.42 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 1 C-N-CA 132.276 4.23 . . . . 1.0 109.434 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -47.06 -48.46 22.37 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.919 2.488 . . . . 1.0 113.631 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.48 8.24 44.7 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.04 1.736 . . . . 1.0 113.933 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 94.66 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 131.466 3.906 . . . . 1.0 111.212 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -157.92 65.95 0.47 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.329 1.974 . . . . 1.0 116.329 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -57.73 -56.23 24.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.62 1.568 . . . . 1.0 113.259 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.03 8.34 6.79 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 120.971 3.693 . . . . 1.0 120.971 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 26.1 mp0 -60.11 133.56 56.21 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 121.645 2.02 . . . . 1.0 116.197 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.657 HD21 ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -138.63 166.2 24.96 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.164 2.586 . . . . 1.0 112.556 170.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.703 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -127.86 86.22 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.089 1.755 . . . . 1.0 110.479 169.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.322 46.3 t30 69.24 13.27 8.57 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.635 1.574 . . . . 1.0 114.149 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.657 ' H ' HD21 ' A' ' 77' ' ' LEU . . . -65.24 1.25 1.09 Allowed 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.077 1.351 . . . . 1.0 114.388 169.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.2 p -98.12 111.01 23.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.408 -1.33 . . . . 1.0 107.408 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.7 125.74 21.27 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.792 1.637 . . . . 1.0 112.127 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.78 154.33 17.82 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.039 2.536 . . . . 1.0 114.21 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -133.41 144.17 49.37 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.271 2.229 . . . . 1.0 107.153 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -84.24 0.53 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.585 1.554 . . . . 1.0 107.925 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 55.9 m-20 -82.69 57.01 3.58 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.739 1.216 . . . . 1.0 108.585 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 5.4 pt20 56.94 19.98 4.98 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 130.904 3.681 . . . . 1.0 117.931 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.55 135.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 114.804 1.409 . . . . 1.0 114.804 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.98 26.92 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.479 2.311 . . . . 1.0 110.664 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -136.17 142.33 44.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.185 2.194 . . . . 1.0 110.905 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . 0.277 1.4 t80 147.44 -111.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 129.946 3.298 . . . . 1.0 112.973 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 p30 177.3 41.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 127.814 2.446 . . . . 1.0 115.261 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.21 -33.66 49.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 130.018 3.327 . . . . 1.0 115.042 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 pt? -66.39 139.36 58.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.174 2.589 . . . . 1.0 117.893 -172.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 3.2 mtt85 -140.63 116.58 10.42 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.628 1.558 . . . . 1.0 112.394 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.552 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 35.5 m-85 -83.07 145.93 29.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.033 1.733 . . . . 1.0 113.561 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 100' ' ' SER . 2.4 t 60.45 6.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 127.371 2.268 . . . . 1.0 114.424 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 41' ' ' CYS . . . -9.74 -24.71 0.0 OUTLIER Glycine 0 CA--C 1.547 2.035 2 C-N-CA 136.446 6.736 . . . . 1.0 123.646 -173.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.568 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 15.1 ttt180 -165.93 6.13 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.392 3.077 . . . . 1.0 114.785 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.485 ' HB2' HG13 ' A' ' 97' ' ' VAL . 49.1 m -58.25 -59.94 4.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.958 2.503 . . . . 1.0 114.946 -172.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.86 -174.22 20.27 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 125.441 1.496 . . . . 1.0 114.4 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 109.67 21.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.825 2.45 . . . . 1.0 111.735 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.97 -11.63 3.36 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 126.733 2.111 . . . . 1.0 116.303 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.856 2.462 . . . . 1.0 112.894 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.715 ' HB2' HG13 ' A' ' 126' ' ' ILE . 25.1 p -108.61 130.01 55.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.443 2.297 . . . . 1.0 110.483 172.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -85.22 83.87 7.86 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.048 0.928 . . . . 1.0 112.655 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 m -70.45 92.61 0.83 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.715 1.606 . . . . 1.0 110.162 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.42 101.55 2.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.196 1.398 . . . . 1.0 110.03 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.7 p -86.44 100.15 12.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.606 1.962 . . . . 1.0 109.669 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 25' ' ' THR . 4.1 mp -88.28 110.2 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 100.909 -3.737 . . . . 1.0 100.909 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.0 m -112.61 109.61 19.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.889 1.675 . . . . 1.0 114.087 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.434 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 7.0 t -73.74 143.76 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 123.681 1.705 . . . . 1.0 109.834 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -110.99 10.39 22.17 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 131.573 3.949 . . . . 1.0 113.931 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.1 t -105.53 -179.45 3.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.731 1.613 . . . . 1.0 113.162 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -45.77 -53.11 21.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 126.915 2.086 . . . . 1.0 112.298 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.21 102.04 1.56 Allowed 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 124.705 3.603 . . . . 1.0 109.884 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.39 99.66 1.05 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.254 3.303 . . . . 1.0 109.411 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.434 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 16.6 mt-30 -108.19 97.23 6.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.873 0.844 . . . . 1.0 110.842 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.74 114.95 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.011 1.724 . . . . 1.0 108.398 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.11 159.54 20.74 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.722 2.409 . . . . 1.0 110.977 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.704 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.4 m -121.61 121.33 37.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.068 0.947 . . . . 1.0 111.308 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -87.95 120.18 29.03 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.344 0.975 . . . . 1.0 110.912 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -130.6 122.12 26.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.99 2.516 . . . . 1.0 111.422 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.7 -52.1 0.11 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.613 1.565 . . . . 1.0 113.173 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.31 70.85 0.75 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.246 2.218 . . . . 1.0 109.401 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.715 HG13 ' HB2' ' A' ' 105' ' ' SER . 8.6 tp -47.14 -14.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 129.676 3.19 . . . . 1.0 118.296 -171.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -87.13 152.29 22.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 130.807 3.643 . . . . 1.0 115.765 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.58 162.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 128.025 2.53 . . . . 1.0 114.111 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.7 t -75.05 133.07 41.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.11 0.964 . . . . 1.0 112.74 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.74 -58.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.508 1.923 . . . . 1.0 113.196 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -53.77 -37.94 63.96 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.307 1.843 . . . . 1.0 114.452 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 127.533 2.492 . . . . 1.0 114.572 -179.32 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -152.52 -173.68 4.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 131.336 3.854 . . . . 1.0 105.063 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.766 HG21 ' HB2' ' A' ' 32' ' ' CYS 0.356 9.9 m -69.01 72.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.54 1.973 . . . . 1.0 109.926 170.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -51.13 158.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.355 2.262 . . . . 1.0 113.54 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 30' ' ' PHE 0.296 9.0 t -101.94 -120.77 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.365 -0.826 . . . . 1.0 110.745 177.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -55.88 -37.83 69.35 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.354 1.434 . . . . 1.0 113.169 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 m -136.86 156.83 75.74 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 127.648 2.379 . . . . 1.0 112.663 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -2.4 6.71 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.228 3.285 . . . . 1.0 115.041 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.79 -27.49 60.34 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.03 2.932 . . . . 1.0 114.024 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.543 ' HB2' HG23 ' A' ' 25' ' ' THR . 2.5 m-85 -118.6 108.35 14.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.677 1.591 . . . . 1.0 107.706 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.3 mt -115.12 135.02 54.64 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.894 2.878 . . . . 1.0 112.729 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.766 ' HB2' HG21 ' A' ' 23' ' ' VAL . 4.5 m -118.88 160.09 22.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.899 1.28 . . . . 1.0 112.505 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -138.93 100.02 3.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.413 2.285 . . . . 1.0 108.655 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -137.23 162.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 129.111 2.964 . . . . 1.0 109.362 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD21 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -103.57 155.06 37.39 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.394 1.078 . . . . 1.0 110.607 170.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HD2' HD21 ' A' ' 35' ' ' LEU . 17.1 Cg_exo -51.69 149.85 18.15 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.915 3.077 . . . . 1.0 115.559 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.9 t -127.85 29.29 5.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 127.12 2.168 . . . . 1.0 114.23 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -64.2 37.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 127.495 2.318 . . . . 1.0 116.195 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -162.28 162.65 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 129.184 2.994 . . . . 1.0 111.746 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.22 150.84 31.5 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.536 1.935 . . . . 1.0 113.987 -177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.7 t 49.13 71.76 0.35 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.645 1.978 . . . . 1.0 112.53 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -50.69 -39.46 51.31 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.226 1.565 . . . . 1.0 115.226 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt 62.75 171.78 0.14 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.575 2.75 . . . . 1.0 114.541 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -74.82 79.17 2.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.047 1.339 . . . . 1.0 110.741 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -69.37 146.25 96.35 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 125.616 1.566 . . . . 1.0 111.821 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.67 -3.73 8.49 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.098 3.199 . . . . 1.0 116.074 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.9 pt -59.44 -30.67 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.05 2.94 . . . . 1.0 115.698 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.55 173.5 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 127.331 2.252 . . . . 1.0 114.752 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.481 ' HB2' ' HD1' ' A' ' 91' ' ' PHE . 16.6 m-85 -144.99 151.58 38.81 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -174.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -143.92 148.45 35.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.544 1.937 . . . . 1.0 112.525 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.97 143.2 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.15 2.18 . . . . 1.0 111.013 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.89 119.5 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 128.077 2.551 . . . . 1.0 108.782 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.65 107.2 9.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.495 1.118 . . . . 1.0 110.744 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mt -90.56 118.07 29.73 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.969 1.707 . . . . 1.0 112.531 -172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.18 -167.69 30.13 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 127.555 2.502 . . . . 1.0 114.07 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.77 -4.42 25.0 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 115.451 1.648 . . . . 1.0 115.451 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.06 142.8 55.97 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.445 1.498 . . . . 1.0 112.081 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.91 -38.89 27.27 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 124.501 3.467 . . . . 1.0 112.951 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.88 -167.62 1.95 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 126.838 2.055 . . . . 1.0 110.542 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.04 -55.73 0.86 Allowed Glycine 0 C--N 1.344 0.984 0 O-C-N 120.032 -1.668 . . . . 1.0 113.091 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t 152.28 -177.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 129.264 3.025 . . . . 1.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.49 116.14 21.33 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.534 2.334 . . . . 1.0 110.542 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 p -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 120.451 -1.406 . . . . 1.0 109.3 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -123.0 123.55 41.14 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.118 1.367 . . . . 1.0 113.307 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 m -96.26 116.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.549 -1.344 . . . . 1.0 108.261 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 93.2 mtp -122.82 113.32 19.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.59 115.12 26.9 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 120.806 1.639 . . . . 1.0 114.071 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.43 -149.48 6.99 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 129.386 3.374 . . . . 1.0 112.451 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.46 ' C ' ' H ' ' A' ' 71' ' ' GLU . 67.0 t30 -156.78 40.5 0.33 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.021 1.728 . . . . 1.0 112.145 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 62.85 -26.6 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.778 2.831 . . . . 1.0 114.453 -170.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -140.02 84.52 1.97 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 132.142 4.177 . . . . 1.0 106.702 169.668 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.86 -45.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.876 1.67 . . . . 1.0 113.725 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 43.57 23.72 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.543 3.137 . . . . 1.0 117.25 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -49.28 -30.4 7.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.34 2.656 . . . . 1.0 115.0 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.06 -75.24 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.412 2.285 . . . . 1.0 114.915 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 33.81 99.17 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 131.474 3.909 . . . . 1.0 116.419 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.69 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -131.93 165.46 23.85 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.868 1.267 . . . . 1.0 113.377 174.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.67 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.66 84.24 2.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.104 2.162 . . . . 1.0 109.797 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER 69.25 8.62 6.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.434 1.493 . . . . 1.0 114.376 -173.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.69 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -70.22 13.95 0.14 Allowed 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 120.958 1.708 . . . . 1.0 113.645 168.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.514 ' H ' ' C ' ' A' ' 79' ' ' ASN . 47.7 m -100.33 110.52 22.75 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 168.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.53 125.02 13.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.979 0.912 . . . . 1.0 113.402 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.09 155.89 17.75 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.21 1.404 . . . . 1.0 113.155 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.616 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 63.1 mtp -127.17 148.33 50.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 128.907 2.883 . . . . 1.0 107.889 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 87' ' ' GLN . 44.1 pttt -126.53 -73.13 0.63 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.869 1.268 . . . . 1.0 114.287 -170.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -72.93 33.5 0.07 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.419 1.488 . . . . 1.0 111.448 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 85' ' ' LYS . 63.6 mt-30 62.0 14.24 6.28 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.114 2.966 . . . . 1.0 114.544 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.63 152.61 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 129.556 3.142 . . . . 1.0 112.339 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB1' ' HG2' ' A' ' 84' ' ' MET . . . -137.91 146.93 43.89 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.248 1.819 . . . . 1.0 113.895 170.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -132.66 123.7 26.85 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 128.199 2.599 . . . . 1.0 111.312 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HD1' ' HB2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -172.15 173.39 4.31 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.813 1.783 . . . . 1.0 115.813 -174.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -141.44 1.36 1.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.528 1.931 . . . . 1.0 114.926 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -28.35 59.25 Favored 'General case' 0 CA--C 1.545 0.786 1 C-N-CA 131.824 4.05 . . . . 1.0 115.161 -172.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 6.8 mp -55.53 129.49 39.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.407 2.283 . . . . 1.0 112.176 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.67 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 36.4 mtm180 -137.47 123.14 19.85 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.555 1.07 . . . . 1.0 111.741 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -93.28 143.52 26.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.481 2.712 . . . . 1.0 110.611 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 0.7 OUTLIER 44.61 46.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 125.677 1.591 . . . . 1.0 112.516 -175.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -35.37 -92.27 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 1 C-N-CA 132.956 5.074 . . . . 1.0 116.945 -171.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttp-105 -73.11 42.41 0.11 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.913 2.085 . . . . 1.0 113.94 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 t 73.04 157.21 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 131.596 3.958 . . . . 1.0 115.638 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.95 169.14 30.06 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 127.982 2.706 . . . . 1.0 112.632 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -160.53 142.9 12.89 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.446 1.898 . . . . 1.0 112.465 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.48 ' C ' ' HE2' ' A' ' 127' ' ' LYS . . . 57.72 30.72 63.02 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.298 1.428 . . . . 1.0 116.547 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -126.61 156.87 40.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.146 2.579 . . . . 1.0 112.559 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -109.45 147.44 32.85 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.865 2.466 . . . . 1.0 110.931 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.728 ' CE1' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.25 89.27 7.8 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.229 1.811 . . . . 1.0 111.778 -173.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.4 m -77.39 74.68 3.95 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.642 1.577 . . . . 1.0 110.119 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 9.0 tt -61.54 119.52 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.229 -0.919 . . . . 1.0 108.968 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 t -127.82 139.97 52.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 123.445 1.593 . . . . 1.0 114.814 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.37 113.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -102.6 114.89 29.49 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.792 1.237 . . . . 1.0 111.894 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.2 t -72.26 151.77 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 123.235 1.493 . . . . 1.0 112.446 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -102.0 25.35 8.83 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 129.024 2.93 . . . . 1.0 116.671 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.561 HG21 ' HD2' ' A' ' 116' ' ' PRO . 13.6 t -132.31 176.34 8.49 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.687 1.195 . . . . 1.0 113.828 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 70.2 m-80 -43.0 -47.33 13.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 128.213 2.605 . . . . 1.0 113.062 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.561 ' HD2' HG21 ' A' ' 114' ' ' THR . 95.7 Cg_endo -87.96 95.99 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 124.983 3.789 . . . . 1.0 108.272 168.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.85 109.11 1.21 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.656 2.904 . . . . 1.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.65 103.45 15.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.316 1.531 . . . . 1.0 108.772 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.68 114.94 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.882 2.073 . . . . 1.0 108.976 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.73 142.95 50.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.455 2.302 . . . . 1.0 110.77 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 t -121.95 146.5 47.08 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.552 1.541 . . . . 1.0 113.246 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.403 ' HB2' HD21 ' A' ' 108' ' ' LEU . 8.1 t80 -87.51 128.79 35.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.947 1.356 . . . . 1.0 112.865 -173.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -63.16 103.44 0.48 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.755 2.422 . . . . 1.0 111.591 172.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 96.78 125.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 1 C-N-CA 132.212 4.205 . . . . 1.0 109.285 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.92 -21.1 10.27 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.325 1.602 . . . . 1.0 115.325 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 38.53 122.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 131.144 3.778 . . . . 1.0 115.866 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HE2' ' C ' ' A' ' 103' ' ' GLY . 21.5 tttt -75.55 137.74 41.04 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.979 -1.7 . . . . 1.0 110.689 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -91.59 141.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.838 1.655 . . . . 1.0 113.468 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.2 t -88.67 142.89 27.31 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.533 0.938 . . . . 1.0 113.533 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.64 -53.52 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.521 1.529 . . . . 1.0 110.445 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.37 -70.5 0.74 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.921 2.889 . . . . 1.0 111.378 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.74 177.85 15.52 Favored Glycine 0 CA--C 1.549 2.176 0 C-N-CA 126.147 1.832 . . . . 1.0 115.829 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . 58.4 Cg_endo -71.51 -40.8 2.72 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.211 3.274 . . . . 1.0 113.353 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -174.94 145.26 0.82 Allowed 'General case' 0 N--CA 1.473 0.686 1 C-N-CA 131.884 4.074 . . . . 1.0 109.466 172.856 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.707 2.803 . . . . 1.0 111.157 173.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 114.322 1.231 . . . . 1.0 114.322 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.94 -173.23 4.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 131.138 3.775 . . . . 1.0 105.074 -173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.89 73.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 O-C-N 120.119 -1.613 . . . . 1.0 107.652 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -60.63 169.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.034 0.933 . . . . 1.0 111.978 169.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.8 p -133.06 -105.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.29 1.036 . . . . 1.0 109.972 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 121' ' ' THR . 1.1 m-20 -143.09 64.83 1.35 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.812 2.845 . . . . 1.0 108.425 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 22.1 m -157.05 161.61 29.16 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 119.884 -1.76 . . . . 1.0 115.158 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.26 146.74 95.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.259 1.973 . . . . 1.0 109.677 169.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 52.96 32.99 13.66 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 124.867 1.267 . . . . 1.0 113.881 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.61 110.36 16.01 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.895 1.443 . . . . 1.0 114.895 -173.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -140.08 115.48 9.95 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.562 1.545 . . . . 1.0 113.304 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' HB2' ' HA ' ' A' ' 51' ' ' VAL 0.253 0.0 OUTLIER -127.15 165.39 19.65 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 123.533 1.635 . . . . 1.0 114.826 175.512 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.616 ' HB2' ' CG ' ' A' ' 50' ' ' LYS . 66.6 m -151.47 93.2 1.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.104 2.962 . . . . 1.0 108.933 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.29 150.06 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 131.152 3.781 . . . . 1.0 107.797 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.703 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -65.22 174.35 1.43 Allowed Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 123.803 0.841 . . . . 1.0 113.141 175.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.703 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -60.3 165.26 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.105 2.537 . . . . 1.0 113.786 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 96' ' ' PHE . 3.8 t -125.0 9.63 8.13 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.44 1.896 . . . . 1.0 114.691 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -67.51 47.69 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.954 2.502 . . . . 1.0 115.747 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.86 173.57 14.36 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.187 1.921 . . . . 1.0 116.187 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.731 ' HD3' ' HB2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -95.0 122.97 38.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 128.1 2.56 . . . . 1.0 110.717 177.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.1 t 62.8 95.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.74 2.016 . . . . 1.0 113.769 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.562 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -39.65 -46.04 1.76 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.151 2.181 . . . . 1.0 112.924 171.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 51.7 tttt 74.14 177.33 0.23 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 129.163 2.985 . . . . 1.0 112.25 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.6 m -61.18 -33.93 74.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.906 1.282 . . . . 1.0 114.138 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.449 ' HB2' HD22 ' A' ' 92' ' ' ASN . 43.6 mt 51.22 87.16 0.14 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 127.126 2.17 . . . . 1.0 114.657 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.9 61.62 0.59 Allowed 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 125.092 3.862 . . . . 1.0 113.489 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 136.85 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 1 C-N-CA 132.431 4.292 . . . . 1.0 108.337 -178.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.38 24.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.845 1.658 . . . . 1.0 111.968 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.05 150.46 42.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.888 1.675 . . . . 1.0 112.113 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.616 ' CG ' ' HB2' ' A' ' 33' ' ' SER . 3.4 ptmm? -131.37 108.8 9.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.759 2.023 . . . . 1.0 108.521 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . 57.3 t -131.31 121.87 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 117.507 -1.235 . . . . 1.0 109.293 -172.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.47 120.71 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.805 1.642 . . . . 1.0 110.451 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 27' ' ' SER . . . -133.07 106.68 7.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.024 -1.843 . . . . 1.0 106.024 170.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 155.32 37.67 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.086 2.254 . . . . 1.0 117.086 -169.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.39 -26.52 0.97 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.546 2.022 . . . . 1.0 115.218 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.11 86.87 7.34 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.826 2.45 . . . . 1.0 112.225 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.6 -50.02 67.37 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-O 117.573 -1.204 . . . . 1.0 110.042 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.58 129.86 6.66 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.294 3.329 . . . . 1.0 111.058 170.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.11 169.34 12.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.131 2.172 . . . . 1.0 115.492 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.13 3.23 45.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.936 2.207 . . . . 1.0 115.241 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.708 ' CG2' ' HB2' ' A' ' 84' ' ' MET . 13.8 t -53.82 121.03 7.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.618 1.709 . . . . 1.0 112.537 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.06 102.77 12.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.832 1.301 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG23 HG12 ' A' ' 110' ' ' ILE . 84.0 t -92.03 107.62 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.901 -1.889 . . . . 1.0 105.901 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.5 p -107.76 118.14 35.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.196 -0.911 . . . . 1.0 113.167 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.339 0.5 OUTLIER -107.0 112.98 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.377 -1.452 . . . . 1.0 111.152 -177.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 mtt -139.51 171.28 14.48 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.615 1.566 . . . . 1.0 114.591 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . . . -125.83 112.36 15.92 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.76 178.17 40.07 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 128.232 2.825 . . . . 1.0 115.623 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 73' ' ' TYR . 33.6 p-10 -121.74 -61.9 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.789 2.435 . . . . 1.0 108.48 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -113.89 46.73 1.27 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 131.222 3.809 . . . . 1.0 106.534 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 64.82 -26.94 0.09 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.77 2.828 . . . . 1.0 114.209 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -102.35 49.33 0.85 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 129.495 3.118 . . . . 1.0 115.329 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.609 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 4.5 t80 -132.35 -19.2 2.48 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.903 1.681 . . . . 1.0 115.076 173.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 m 14.92 72.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 132.111 4.164 . . . . 1.0 114.654 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.04 149.34 6.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.129 2.172 . . . . 1.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -51.92 142.57 15.28 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.045 2.138 . . . . 1.0 114.161 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.816 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -127.59 168.56 14.82 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.495 2.318 . . . . 1.0 112.615 178.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.809 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -136.01 102.94 5.19 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.22 1.808 . . . . 1.0 108.536 172.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 81' ' ' THR . 7.9 m120 79.71 -9.03 1.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 117.171 -1.395 . . . . 1.0 111.99 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.816 ' HB1' ' HB2' ' A' ' 77' ' ' LEU 0.259 . . -68.91 20.82 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 122.298 2.317 . . . . 1.0 115.228 174.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.533 ' H ' ' C ' ' A' ' 79' ' ' ASN . 12.3 t -126.29 113.58 17.13 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.353 1.861 . . . . 1.0 109.591 168.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.5 151.63 41.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.561 1.545 . . . . 1.0 112.274 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 129.53 40.41 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 127.026 2.13 . . . . 1.0 111.589 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.708 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -124.71 168.93 12.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.165 1.386 . . . . 1.0 113.682 -171.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.588 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 2.6 mptt -96.0 -72.05 0.65 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.187 2.595 . . . . 1.0 112.567 -168.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.7 48.39 1.7 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 129.836 3.254 . . . . 1.0 106.475 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.9 26.41 7.82 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.472 2.709 . . . . 1.0 113.143 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' A' ' 85' ' ' LYS . 12.8 p -92.76 114.35 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 127.955 2.502 . . . . 1.0 112.169 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.06 146.54 24.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.776 2.031 . . . . 1.0 113.181 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HG2' ' N ' ' A' ' 91' ' ' PHE . 20.7 ttp180 -136.69 157.36 46.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.719 2.808 . . . . 1.0 111.796 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 0.8 OUTLIER 51.33 -139.69 0.94 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.225 1.81 . . . . 1.0 112.654 176.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.449 HD22 ' HB2' ' A' ' 45' ' ' LEU . 55.5 t-20 -135.41 109.19 8.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.922 1.237 . . . . 1.0 113.306 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -149.7 68.13 1.01 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.132 2.573 . . . . 1.0 108.458 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -160.88 118.56 2.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.795 1.638 . . . . 1.0 112.266 172.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.809 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 38.3 mtp180 -136.75 119.38 16.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 114.212 1.19 . . . . 1.0 114.212 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.562 ' H ' ' HB2' ' A' ' 42' ' ' ASN . 5.5 p90 -93.64 165.75 12.57 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.455 2.302 . . . . 1.0 116.598 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 96' ' ' PHE . 2.5 t 46.76 35.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 129.742 3.217 . . . . 1.0 114.584 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.51 -41.46 41.55 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.315 2.388 . . . . 1.0 114.843 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -76.28 -9.24 58.48 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.873 2.069 . . . . 1.0 115.852 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.687 ' HB2' ' CD ' ' A' ' 40' ' ' ARG . 4.6 t 58.71 -177.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.165 1.386 . . . . 1.0 114.483 -175.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.15 129.57 3.45 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 128.186 2.803 . . . . 1.0 113.716 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -68.04 164.07 20.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.626 1.97 . . . . 1.0 112.145 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.49 27.64 58.98 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -115.96 150.34 37.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.871 1.668 . . . . 1.0 114.152 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 t -125.21 122.22 36.39 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.319 3.448 . . . . 1.0 110.077 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -84.64 133.6 34.4 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.075 1.88 . . . . 1.0 116.075 -170.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -122.19 105.15 9.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.687 2.395 . . . . 1.0 115.162 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 122' ' ' TYR . 4.8 tt -79.43 90.04 5.03 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.103 -2.184 . . . . 1.0 105.103 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.3 m -92.25 101.47 13.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.799 2.84 . . . . 1.0 110.27 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 63' ' ' VAL . 62.8 mt -92.32 121.14 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.429 1.492 . . . . 1.0 108.015 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -122.93 118.1 27.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.323 1.014 . . . . 1.0 112.14 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.667 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 0.4 OUTLIER -71.7 170.67 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 122.929 1.347 . . . . 1.0 113.286 -176.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 33.3 5.0 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.207 2.203 . . . . 1.0 114.82 -174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.464 ' H ' HG12 ' A' ' 112' ' ' VAL . 14.2 t -126.64 175.37 8.0 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.019 1.728 . . . . 1.0 112.132 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.52 -49.29 89.38 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 125.981 1.712 . . . . 1.0 113.483 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.91 111.16 3.18 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 124.348 3.365 . . . . 1.0 110.237 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.79 105.87 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.122 3.215 . . . . 1.0 112.473 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.667 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -100.1 98.72 9.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.793 0.806 . . . . 1.0 109.466 -175.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.59 133.6 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.421 . . . . 1.0 111.744 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.14 154.87 49.17 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.22 1.408 . . . . 1.0 112.828 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 63.3 m -128.32 149.46 50.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.331 1.852 . . . . 1.0 111.596 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.93 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 82.9 t80 -83.74 165.47 18.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.579 1.951 . . . . 1.0 112.705 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -57.96 62.73 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 126.177 1.791 . . . . 1.0 111.461 169.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -87.82 98.31 11.4 Favored 'General case' 0 N--CA 1.469 0.502 1 C-N-CA 131.982 4.113 . . . . 1.0 114.364 -170.495 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.83 -103.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.561 2.745 . . . . 1.0 104.862 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 43.15 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 129.388 3.075 . . . . 1.0 113.304 170.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 161.35 37.3 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.133 1.773 . . . . 1.0 114.684 173.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.3 tt -93.1 146.12 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 127.654 2.382 . . . . 1.0 111.693 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 t -70.33 137.0 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.008 0.744 . . . . 1.0 113.008 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -91.57 -15.55 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.146 1.378 . . . . 1.0 113.424 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -67.64 0.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.606 2.762 . . . . 1.0 112.309 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -40.13 95.28 0.01 OUTLIER Glycine 0 CA--C 1.544 1.862 0 C-N-CA 129.366 3.365 . . . . 1.0 113.629 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.23 162.6 41.98 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.578 2.852 . . . . 1.0 115.337 -171.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.731 ' HB2' ' HD3' ' A' ' 40' ' ' ARG . 7.9 ttm180 -120.5 80.93 1.68 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.968 2.507 . . . . 1.0 111.063 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 129.463 3.105 . . . . 1.0 113.386 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' OE2' ' HG2' ' A' ' 24' ' ' ARG . 12.9 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.459 -0.782 . . . . 1.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mt -146.65 -173.61 4.25 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 128.545 2.738 . . . . 1.0 104.989 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 2.4 t -69.77 71.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 119.458 -2.027 . . . . 1.0 109.664 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HG2' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.97 172.11 0.09 Allowed 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.498 1.666 . . . . 1.0 115.498 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 t -108.28 -135.1 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.814 1.645 . . . . 1.0 108.528 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.2 -47.45 24.26 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.462 1.905 . . . . 1.0 111.579 170.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.5 m -131.38 159.12 73.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.485 1.914 . . . . 1.0 111.843 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.94 -7.32 20.86 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 123.882 3.055 . . . . 1.0 116.191 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -67.18 -36.11 81.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.802 2.441 . . . . 1.0 114.398 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -104.49 109.72 21.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.189 2.196 . . . . 1.0 110.405 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 155.52 22.48 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.629 1.714 . . . . 1.0 115.629 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 2.7 m -132.41 164.75 25.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.311 2.245 . . . . 1.0 112.038 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.661 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 42.9 m -153.4 91.24 1.48 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.455 2.302 . . . . 1.0 108.488 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.82 149.37 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 129.414 3.086 . . . . 1.0 108.933 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.923 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -83.7 178.88 2.16 Favored Pre-proline 0 CA--C 1.561 1.381 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -175.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.923 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 50.6 Cg_endo -66.3 48.06 0.25 Allowed 'Trans proline' 0 CA--C 1.557 1.656 1 C-N-CA 125.615 4.21 . . . . 1.0 116.581 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -65.02 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 129.144 2.978 . . . . 1.0 114.04 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.653 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 5.4 p-80 -55.21 69.45 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.98 1 C-N-CA 132.198 4.199 . . . . 1.0 114.4 174.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -154.62 169.29 24.22 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.169 2.188 . . . . 1.0 112.848 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.17 116.29 7.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.533 2.333 . . . . 1.0 110.737 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t 59.04 84.21 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.584 1.954 . . . . 1.0 110.516 -169.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -38.21 73.17 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.334 0.654 . . . . 1.0 112.743 -174.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 tttt 71.77 160.29 0.22 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 131.436 3.894 . . . . 1.0 114.71 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -72.79 68.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.557 1.543 . . . . 1.0 109.907 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.07 159.75 78.21 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.862 1.265 . . . . 1.0 113.704 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.59 -8.37 22.09 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.373 3.382 . . . . 1.0 116.465 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -65.39 -14.65 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.401 1.88 . . . . 1.0 115.541 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.795 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . . . 66.09 175.72 0.23 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.725 2.41 . . . . 1.0 112.982 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -131.31 84.06 2.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.672 1.589 . . . . 1.0 109.784 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 86.8 mttt -87.25 111.59 21.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 105.366 -2.087 . . . . 1.0 105.366 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.69 HG21 ' HG2' ' A' ' 87' ' ' GLN . 14.7 p -133.97 122.19 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.95 1.7 . . . . 1.0 107.819 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.8 t -139.06 148.25 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 128.377 2.671 . . . . 1.0 112.588 -172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.85 143.89 49.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.394 -1.441 . . . . 1.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.73 113.26 21.18 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.112 0.482 . . . . 1.0 110.513 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.05 -178.16 37.12 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.412 2.435 . . . . 1.0 114.173 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -176.37 0.72 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 126.129 1.771 . . . . 1.0 115.457 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.4 95.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 125.441 1.497 . . . . 1.0 113.692 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.25 -4.0 5.92 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 124.616 3.544 . . . . 1.0 117.944 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER 29.23 79.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 130.159 3.383 . . . . 1.0 115.552 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.23 51.57 0.01 OUTLIER Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.841 1.21 . . . . 1.0 113.574 -171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.7 m -129.54 94.05 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.138 1.775 . . . . 1.0 108.604 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -91.12 117.46 29.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.47 1.508 . . . . 1.0 111.627 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.97 111.84 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 105.678 -1.971 . . . . 1.0 105.678 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -112.56 114.03 26.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 0.1 OUTLIER -125.77 111.55 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.478 -1.389 . . . . 1.0 113.425 -170.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.619 ' HG2' ' H ' ' A' ' 67' ' ' ALA . 15.8 ttm -138.8 172.7 12.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.728 2.121 . . . . 1.0 116.728 -172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.619 ' H ' ' HG2' ' A' ' 66' ' ' MET . . . -98.45 143.94 28.34 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.724 1.249 . . . . 1.0 110.278 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.55 100.07 0.21 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 128.019 2.723 . . . . 1.0 112.424 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 27.6 t-20 -124.05 -39.21 2.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.765 2.426 . . . . 1.0 109.629 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.9 -45.3 30.46 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 129.012 2.925 . . . . 1.0 112.706 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -144.03 -11.94 0.65 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.46 2.304 . . . . 1.0 116.256 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 m120 84.37 151.78 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 130.525 3.53 . . . . 1.0 110.367 -170.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 33.26 43.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 128.519 2.728 . . . . 1.0 114.862 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -83.52 -26.27 30.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.331 3.052 . . . . 1.0 114.482 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -141.65 122.2 14.18 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 120.167 1.349 . . . . 1.0 112.088 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -58.23 172.13 0.48 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.13 2.27 . . . . 1.0 117.13 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.909 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 3.8 pp -116.07 167.27 11.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.637 3.175 . . . . 1.0 110.816 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 3.4 mtp180 -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.577 -0.702 . . . . 1.0 110.212 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 81' ' ' THR . 3.2 m-20 73.34 12.21 4.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.259 1.824 . . . . 1.0 111.65 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.909 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -62.92 7.11 0.09 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.171 1.388 . . . . 1.0 114.35 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 79' ' ' ASN . 48.6 p -105.98 110.76 23.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.479 1.111 . . . . 1.0 109.705 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.29 135.21 30.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.353 1.461 . . . . 1.0 111.613 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.32 144.06 25.77 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.786 2.034 . . . . 1.0 112.345 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.3 mtm -151.88 -173.72 4.62 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.316 1.846 . . . . 1.0 111.69 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 59' ' ' ASP . 38.9 mttp -110.89 -96.82 0.41 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.477 2.311 . . . . 1.0 109.146 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.14 56.57 4.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.951 2.101 . . . . 1.0 108.836 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.69 ' HG2' HG21 ' A' ' 51' ' ' VAL . 19.0 tt0 51.25 32.46 8.21 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.801 1.64 . . . . 1.0 113.539 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.12 115.39 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.821 2.049 . . . . 1.0 111.845 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.7 147.52 50.11 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.618 1.567 . . . . 1.0 112.102 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 152.71 32.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.76 2.424 . . . . 1.0 111.911 -174.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.6 t80 57.38 -138.63 0.91 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.651 1.98 . . . . 1.0 112.405 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 32.3 t-20 -138.58 137.56 37.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.929 1.692 . . . . 1.0 110.9 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 t0 175.12 67.12 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.939 2.496 . . . . 1.0 112.75 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -160.52 142.74 12.8 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.14 2.576 . . . . 1.0 109.327 171.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 33.0 mtp180 -141.11 118.17 11.23 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.823 1.647 . . . . 1.0 113.897 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -94.07 153.09 18.33 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.456 1.122 . . . . 1.0 113.287 -175.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 2.6 m 49.12 33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.553 2.741 . . . . 1.0 114.476 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.66 25.76 0.1 Allowed Glycine 0 CA--C 1.537 1.43 1 C-N-CA 131.796 4.522 . . . . 1.0 118.002 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.25 9.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 129.237 3.015 . . . . 1.0 111.665 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.2 p -67.59 92.68 0.33 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.692 2.797 . . . . 1.0 110.467 170.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.92 -133.71 4.15 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.55 2.5 . . . . 1.0 113.559 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -66.51 168.58 8.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.96 1.704 . . . . 1.0 112.419 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.34 -81.08 0.2 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.353 0.977 . . . . 1.0 111.019 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 94.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.291 1.837 . . . . 1.0 109.621 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -125.32 108.68 11.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.451 0.7 . . . . 1.0 111.813 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 56.7 t80 -139.21 93.43 2.68 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 128.093 2.557 . . . . 1.0 115.045 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.262 19.4 m -137.61 60.33 1.64 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.034 1.397 . . . . 1.0 109.248 169.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.06 97.18 10.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.59 1.956 . . . . 1.0 108.512 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.0 p -125.62 168.67 13.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.619 2.452 . . . . 1.0 117.619 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.0 tp -123.13 115.79 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.696 2.798 . . . . 1.0 107.666 174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -123.7 108.51 12.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.415 2.286 . . . . 1.0 113.569 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 2.4 t -72.34 147.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.02 -1.675 . . . . 1.0 111.648 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -115.7 48.52 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 1 C-N-CA 132.668 4.387 . . . . 1.0 110.533 -172.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.517 HG23 ' HD2' ' A' ' 116' ' ' PRO . 98.4 m -147.23 162.75 38.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 119.878 -1.764 . . . . 1.0 110.374 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.72 -42.71 11.23 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 126.308 1.843 . . . . 1.0 115.084 -173.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.517 ' HD2' HG23 ' A' ' 114' ' ' THR . 74.9 Cg_endo -88.51 98.64 0.39 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.05 3.833 . . . . 1.0 107.619 168.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.06 118.23 5.56 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.3 2.667 . . . . 1.0 111.564 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.485 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 68.8 mt-30 -109.67 96.85 6.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.725 0.81 . . . . 1.0 110.877 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 m -107.85 122.43 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.982 2.113 . . . . 1.0 112.145 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.02 168.36 19.93 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.82 2.448 . . . . 1.0 112.33 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.3 m -117.31 145.81 43.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.053 -1.654 . . . . 1.0 113.335 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -87.56 115.77 25.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 1.0 107.539 171.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 74.34 170.95 0.29 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.764 2.026 . . . . 1.0 113.984 -172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -133.98 23.97 3.9 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.197 2.599 . . . . 1.0 113.38 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.64 119.39 14.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.863 2.065 . . . . 1.0 110.357 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.82 86.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.851 2.06 . . . . 1.0 110.624 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 11.9 mmtp -126.78 81.57 2.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.883 2.073 . . . . 1.0 111.638 -174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.25 119.05 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 126.492 1.917 . . . . 1.0 109.992 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.5 m -82.57 123.37 29.15 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.697 1.599 . . . . 1.0 110.364 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.13 -35.45 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -40.46 7.38 Favored 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 131.746 4.018 . . . . 1.0 113.967 174.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.52 -154.97 52.98 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 125.495 1.522 . . . . 1.0 115.325 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.8 77.51 1.08 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 124.857 3.705 . . . . 1.0 113.476 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 145.38 96.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.178 3.791 . . . . 1.0 112.015 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.407 0 C-N-CA 124.354 1.061 . . . . 1.0 113.681 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.98 -0.748 . . . . 1.0 108.98 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 tp -143.36 -174.67 4.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 104.373 -2.454 . . . . 1.0 104.373 162.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.93 74.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 121.993 2.179 . . . . 1.0 109.464 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HD2' ' HA ' ' A' ' 28' ' ' PRO . 21.4 mtm105 -47.68 147.29 1.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.295 1.438 . . . . 1.0 112.898 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 122' ' ' TYR . 10.8 t -86.43 -154.53 0.22 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.264 1.826 . . . . 1.0 110.984 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.51 -18.37 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.123 2.169 . . . . 1.0 115.355 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 t -144.03 137.24 13.97 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.212 1.805 . . . . 1.0 111.919 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.491 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.0 Cg_exo -53.61 -19.74 14.77 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.727 2.952 . . . . 1.0 116.64 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -66.33 -23.24 66.33 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.578 1.325 . . . . 1.0 114.578 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.34 124.07 40.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.897 1.279 . . . . 1.0 111.747 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.437 ' CD2' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -139.28 154.62 47.98 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.485 1.661 . . . . 1.0 115.485 -171.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -141.75 164.51 30.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.916 1.686 . . . . 1.0 113.965 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 t -148.91 105.25 3.52 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 126.8 2.04 . . . . 1.0 109.378 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 167.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.217 1 C-N-CA 132.434 4.294 . . . . 1.0 110.346 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.716 ' HG ' ' HD2' ' A' ' 36' ' ' PRO . 1.2 tp -53.9 165.28 0.79 Allowed Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.439 2.295 . . . . 1.0 115.737 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.716 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 40.4 Cg_endo -63.61 146.1 92.24 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.998 3.798 . . . . 1.0 113.776 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.1 p -67.5 -23.85 65.51 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.914 2.086 . . . . 1.0 116.185 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.39 77.51 1.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.692 2.397 . . . . 1.0 109.116 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -155.94 165.62 35.93 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.873 3.269 . . . . 1.0 110.677 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.911 ' HD2' ' HB2' ' A' ' 134' ' ' ARG . 0.6 OUTLIER -68.0 101.72 1.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.227 1.011 . . . . 1.0 110.657 174.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p 9.43 -107.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.545 2.738 . . . . 1.0 114.847 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 171.32 -57.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 1 C-N-CA 132.478 4.311 . . . . 1.0 110.738 170.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.97 -1.25 2.13 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.526 2.33 . . . . 1.0 116.781 172.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . 0.316 1.4 t 142.6 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 1 C-N-CA 131.799 4.04 . . . . 1.0 113.462 172.048 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.83 150.98 17.44 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 127.237 2.215 . . . . 1.0 112.028 171.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.55 35.96 0.45 Allowed 'Trans proline' 0 CA--C 1.554 1.515 1 C-N-CA 125.567 4.178 . . . . 1.0 115.115 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -35.48 -71.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 129.732 3.213 . . . . 1.0 115.709 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.47 -30.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.48 1.912 . . . . 1.0 113.403 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.299 1.8 p90 41.52 39.26 1.04 Allowed 'General case' 0 C--N 1.353 0.756 0 N-CA-C 118.742 2.867 . . . . 1.0 118.742 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -126.25 106.89 9.85 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.769 0.713 . . . . 1.0 112.129 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.56 128.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.182 1.393 . . . . 1.0 110.702 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.55 145.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.771 2.028 . . . . 1.0 114.764 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.26 20.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.679 2.392 . . . . 1.0 108.9 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.98 112.28 16.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.395 1.478 . . . . 1.0 109.408 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.8 -61.49 0.6 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.932 1.253 . . . . 1.0 114.923 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.54 -18.94 11.83 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 118.093 2.627 . . . . 1.0 118.093 -171.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t 44.46 59.42 13.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 127.121 2.168 . . . . 1.0 114.739 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HB2' HG11 ' A' ' 112' ' ' VAL . 94.1 Cg_endo -88.34 109.48 0.58 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.56 2.84 . . . . 1.0 113.488 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.26 134.86 57.43 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.408 -0.807 . . . . 1.0 111.427 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.18 31.97 27.04 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.744 -0.597 . . . . 1.0 111.901 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 84.7 m -71.11 77.73 0.68 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 170.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -78.87 112.84 16.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.925 2.49 . . . . 1.0 111.767 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.52 107.77 18.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.454 -2.054 . . . . 1.0 105.454 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 m -105.36 119.52 39.28 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.753 -1.567 . . . . 1.0 110.042 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.31 116.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.152 -0.968 . . . . 1.0 108.449 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -125.34 81.24 1.95 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.655 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.95 107.4 19.91 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.346 -1.471 . . . . 1.0 107.189 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -39.15 132.25 1.91 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.567 2.508 . . . . 1.0 115.837 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.676 ' ND2' ' HG ' ' A' ' 100' ' ' SER . 5.4 m-80 170.74 -15.42 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.449 1 C-N-CA 131.797 4.039 . . . . 1.0 115.733 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 7.5 m-20 -58.05 -35.83 71.88 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.239 1.836 . . . . 1.0 112.749 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 148.26 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 1 C-N-CA 132.75 4.42 . . . . 1.0 115.414 172.966 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -156.84 -102.36 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 O-C-N 120.153 -1.592 . . . . 1.0 113.876 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.65 15.97 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.861 2.864 . . . . 1.0 113.543 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.1 m -168.63 111.9 0.57 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.277 1.831 . . . . 1.0 110.532 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.39 164.04 13.08 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.307 1.966 . . . . 1.0 116.307 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 156.78 21.41 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 126.577 1.951 . . . . 1.0 115.313 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.589 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -130.76 167.57 18.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.755 2.422 . . . . 1.0 112.409 -174.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.589 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.99 91.87 3.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.916 -1.74 . . . . 1.0 111.425 172.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 81' ' ' THR . 8.1 t30 67.73 12.59 8.92 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.504 1.522 . . . . 1.0 113.058 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -74.83 7.54 3.06 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 120.945 1.702 . . . . 1.0 112.491 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -95.9 113.2 24.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 130.089 3.356 . . . . 1.0 106.897 -177.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.57 160.0 40.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.574 1.95 . . . . 1.0 109.89 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.2 46.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.783 1.633 . . . . 1.0 114.05 173.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.811 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 48.8 mtm -101.01 151.61 21.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 1.0 109.671 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -112.13 -80.2 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.466 1.506 . . . . 1.0 107.545 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -62.27 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.213 0.46 . . . . 1.0 110.044 170.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.02 22.6 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.106 1.762 . . . . 1.0 114.421 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -133.88 119.8 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 126.21 1.804 . . . . 1.0 112.836 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.14 143.77 46.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.635 1.574 . . . . 1.0 109.727 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -106.09 106.1 16.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.794 0.838 . . . . 1.0 109.039 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.63 73.05 5.18 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.052 1.741 . . . . 1.0 111.946 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 94' ' ' LEU . 18.6 p30 -121.66 171.43 8.85 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 129.216 3.006 . . . . 1.0 110.531 172.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 t70 60.48 -20.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 130.179 3.391 . . . . 1.0 117.973 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -42.52 146.42 0.34 Allowed 'General case' 0 C--O 1.238 0.469 1 C-N-CA 133.11 4.564 . . . . 1.0 118.615 -171.441 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -139.95 129.21 23.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.21 -0.996 . . . . 1.0 111.104 170.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -119.85 135.88 54.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.13 1.772 . . . . 1.0 111.836 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 69' ' ' ASN 0.294 4.5 p 52.35 29.77 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 C-N-CA 125.043 1.337 . . . . 1.0 114.386 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.33 72.19 0.61 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 128.039 2.733 . . . . 1.0 113.345 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 132.27 84.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 1 C-N-CA 134.529 5.132 . . . . 1.0 109.425 -175.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.676 ' HG ' ' ND2' ' A' ' 69' ' ' ASN . 7.5 m -78.53 162.05 26.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.849 0.685 . . . . 1.0 112.849 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.34 -23.77 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 117.507 1.763 . . . . 1.0 117.507 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 169.64 150.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 129.771 3.228 . . . . 1.0 111.902 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.07 53.41 14.67 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.186 1.374 . . . . 1.0 115.246 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HG3' HD22 ' A' ' 69' ' ' ASN . 3.9 mptt -68.53 92.34 0.45 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.092 1.757 . . . . 1.0 112.206 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t -122.52 160.85 24.77 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 129.773 3.229 . . . . 1.0 113.973 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -128.4 90.18 3.03 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.021 1.86 . . . . 1.0 116.021 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -101.65 77.45 1.74 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.859 1.664 . . . . 1.0 110.575 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.85 92.84 6.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.561 -1.337 . . . . 1.0 109.255 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.7 t -116.8 122.01 43.19 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.39 114.32 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.003 1.321 . . . . 1.0 108.88 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.9 m -100.83 109.5 21.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.031 2.132 . . . . 1.0 113.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 58' ' ' PRO . 53.7 t -76.39 103.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.411 -1.431 . . . . 1.0 108.462 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.19 3.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.122 1 C-N-CA 134.981 5.312 . . . . 1.0 117.215 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -84.09 178.42 7.84 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.949 2.1 . . . . 1.0 114.02 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -44.93 -54.88 12.15 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.702 1.201 . . . . 1.0 109.814 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.99 116.89 4.72 Favored 'Trans proline' 0 CA--C 1.556 1.575 0 C-N-CA 123.495 2.797 . . . . 1.0 107.984 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.23 94.29 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 124.401 3.401 . . . . 1.0 108.603 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.44 92.39 5.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 -172.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -108.22 124.59 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 1.0 112.228 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.08 26.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.123 1.369 . . . . 1.0 111.692 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.2 m -113.31 140.07 48.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.591 1.957 . . . . 1.0 111.008 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.801 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 1.1 t80 -118.33 139.69 50.97 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.725 1.61 . . . . 1.0 111.843 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.61 64.0 0.8 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.939 1.459 . . . . 1.0 114.939 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.801 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 20.2 tpt85 -59.56 -27.83 66.58 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.859 2.54 . . . . 1.0 117.859 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 51.6 82.26 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 128.345 2.658 . . . . 1.0 114.705 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.46 -89.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 126.192 1.797 . . . . 1.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -88.17 153.9 20.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.585 1.954 . . . . 1.0 110.787 172.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.57 113.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.68 1.192 . . . . 1.0 110.986 173.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.5 m -89.84 126.31 35.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.0 110.81 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' ' 104' ' ' LYS . 10.9 p -92.43 -35.96 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 126.654 1.981 . . . . 1.0 115.485 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -56.21 10.95 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 131.163 3.785 . . . . 1.0 110.964 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 100' ' ' SER . . . 106.81 -79.92 0.27 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.434 2.445 . . . . 1.0 113.576 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.439 ' O ' ' HD2' ' A' ' 40' ' ' ARG . 37.5 Cg_endo -74.0 -10.41 22.89 Favored 'Trans proline' 0 CA--C 1.553 1.438 0 C-N-CA 123.672 2.915 . . . . 1.0 117.692 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.911 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 36.1 ttt180 132.02 -20.93 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 131.444 3.898 . . . . 1.0 116.904 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.337 0 C-N-CA 130.216 3.407 . . . . 1.0 109.952 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.441 -0.79 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -157.45 -175.14 5.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.118 2.567 . . . . 1.0 105.259 -168.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.27 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 121.639 2.018 . . . . 1.0 109.676 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 31' ' ' LEU . 32.5 mtp180 -81.68 141.48 33.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.556 1.542 . . . . 1.0 110.031 169.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 p -81.92 -136.03 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.102 2.161 . . . . 1.0 109.367 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -48.66 -17.2 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.361 -1.462 . . . . 1.0 113.612 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.403 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 43.2 m 75.57 14.96 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 27' ' ' SER . 76.1 Cg_endo -70.32 30.01 0.2 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 124.749 3.633 . . . . 1.0 115.93 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.523 HD21 ' HB2' ' A' ' 56' ' ' ASP . 97.9 m-20 132.81 -20.48 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.478 1 C-N-CA 133.391 4.676 . . . . 1.0 113.581 -176.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -84.96 140.98 30.68 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 1.0 115.2 -171.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.522 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 3.6 pp -148.2 149.57 32.19 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.845 2.458 . . . . 1.0 112.004 171.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 t -129.77 122.14 28.22 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.048 1.339 . . . . 1.0 113.256 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 3.0 t -88.97 96.67 10.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.63 3.172 . . . . 1.0 108.594 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.04 162.58 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 129.988 3.315 . . . . 1.0 111.132 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -126.16 75.46 72.55 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 125.255 1.422 . . . . 1.0 112.386 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.77 -40.49 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 124.309 3.339 . . . . 1.0 113.814 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 m 38.39 45.3 0.81 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.126 3.37 . . . . 1.0 112.622 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . 6.8 p80 44.42 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.497 2.719 . . . . 1.0 114.039 173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -169.43 176.83 4.91 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 128.964 2.906 . . . . 1.0 108.793 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 97' ' ' VAL . 1.4 ptp180 -119.33 166.93 12.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.365 1.066 . . . . 1.0 113.763 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.2 m 75.68 12.83 3.0 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.923 2.564 . . . . 1.0 117.923 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -21.11 -46.94 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 130.674 3.59 . . . . 1.0 117.839 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.805 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 53.81 -29.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 1 C-N-CA 132.565 4.346 . . . . 1.0 119.512 171.583 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m 141.27 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 1 C-N-CA 133.339 4.656 . . . . 1.0 107.718 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.753 HD21 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -83.03 154.32 67.24 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.459 1.104 . . . . 1.0 112.217 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.753 ' HD2' HD21 ' A' ' 45' ' ' LEU . 58.8 Cg_endo -69.13 37.4 0.22 Allowed 'Trans proline' 0 CA--C 1.558 1.689 1 C-N-CA 125.528 4.152 . . . . 1.0 115.746 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 45' ' ' LEU . 26.3 pt -128.43 -29.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.292 3.037 . . . . 1.0 114.449 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.67 -174.0 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 127.417 2.287 . . . . 1.0 115.489 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.46 134.1 51.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.768 2.027 . . . . 1.0 112.847 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 69.8 mttt -130.24 109.35 10.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.599 1.56 . . . . 1.0 109.649 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -106.02 135.78 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.322 1.449 . . . . 1.0 109.02 173.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.56 140.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.394 1.077 . . . . 1.0 110.976 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.32 105.68 15.91 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.54 114.01 26.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.19 2.88 41.74 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.787 1.66 . . . . 1.0 115.923 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB2' HD21 ' A' ' 29' ' ' ASN . 2.1 t0 -133.67 162.05 33.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.741 2.017 . . . . 1.0 113.707 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.3 t -141.32 71.92 26.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.87 1.668 . . . . 1.0 111.661 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 87' ' ' GLN . 68.3 Cg_endo -79.63 -177.94 4.21 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.849 3.699 . . . . 1.0 114.277 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -148.73 95.76 2.47 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.051 2.14 . . . . 1.0 111.43 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.71 17.21 9.3 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 126.057 1.789 . . . . 1.0 116.955 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 81.1 m -52.14 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.688 2.395 . . . . 1.0 113.294 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -77.15 103.27 6.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.217 1.407 . . . . 1.0 110.971 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.47 108.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -112.36 115.85 29.4 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 123.944 0.777 . . . . 1.0 112.634 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.28 111.65 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.128 -0.982 . . . . 1.0 110.253 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.691 ' HG2' ' HB3' ' A' ' 77' ' ' LEU . 32.8 mtm -128.99 165.56 20.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.94 127.31 47.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.337 1.055 . . . . 1.0 109.158 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -35.57 -57.28 0.96 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 125.55 1.548 . . . . 1.0 113.187 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.453 ' H ' ' CB ' ' A' ' 105' ' ' SER . 12.7 t-20 72.94 109.35 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.504 3.522 . . . . 1.0 110.078 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.625 ' HA ' ' HD2' ' A' ' 102' ' ' ARG . 1.0 OUTLIER 54.33 32.91 17.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.202 1.401 . . . . 1.0 112.729 -168.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 53.97 54.92 9.02 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 129.161 2.984 . . . . 1.0 114.096 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' A' ' 73' ' ' TYR 0.361 0.0 OUTLIER -82.37 -108.3 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.494 0.717 . . . . 1.0 111.003 173.036 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.69 ' H ' ' ND2' ' A' ' 72' ' ' ASN . 17.4 m-85 -172.64 70.79 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 130.642 3.577 . . . . 1.0 110.394 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.472 ' HB2' ' HE1' ' A' ' 66' ' ' MET . 66.0 p 63.35 89.75 0.09 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.833 2.053 . . . . 1.0 114.477 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -147.37 74.21 1.32 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.869 1.063 . . . . 1.0 113.869 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 26.1 tt0 161.09 96.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.053 2.141 . . . . 1.0 115.628 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.836 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.98 165.48 24.61 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.615 3.566 . . . . 1.0 107.876 170.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -144.11 82.53 1.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.255 -1.528 . . . . 1.0 111.193 169.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 23.9 m120 84.16 4.07 0.76 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.089 1.756 . . . . 1.0 111.136 -170.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.836 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -64.07 9.85 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.587 3.155 . . . . 1.0 116.592 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 t -118.63 115.13 23.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.527 1.931 . . . . 1.0 110.834 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.1 32.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.589 1.956 . . . . 1.0 112.198 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.82 143.62 26.33 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.923 2.489 . . . . 1.0 111.898 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.435 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -121.37 149.25 43.26 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.876 2.47 . . . . 1.0 112.088 -170.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -79.48 -117.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.063 0.945 . . . . 1.0 111.057 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.7 -8.14 1.2 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.718 2.007 . . . . 1.0 115.246 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.604 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 135.69 6.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.192 1 C-N-CA 133.109 4.563 . . . . 1.0 113.128 -171.354 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.54 144.66 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 120.405 1.457 . . . . 1.0 112.613 -169.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 51' ' ' VAL . . . -99.92 146.34 26.79 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.188 2.195 . . . . 1.0 113.637 173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.938 2.495 . . . . 1.0 110.844 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 t80 45.93 -78.9 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.421 3.088 . . . . 1.0 116.842 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 44.88 160.99 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.537 1 C-N-CA 131.773 4.029 . . . . 1.0 118.497 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.55 -54.9 4.43 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.627 2.371 . . . . 1.0 113.567 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt 40.82 120.18 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.403 1 C-N-CA 133.093 4.557 . . . . 1.0 117.321 172.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.805 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.92 115.34 22.39 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.783 1.629 . . . . 1.0 113.196 -170.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -99.95 136.28 40.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.464 1.505 . . . . 1.0 110.82 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 1.8 t 50.43 56.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.848 -1.167 . . . . 1.0 107.848 -171.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -91.06 -8.06 65.18 Favored Glycine 0 N--CA 1.479 1.501 1 N-CA-C 126.499 5.36 . . . . 1.0 126.499 -167.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . 0.253 1.3 tmm_? -146.9 48.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.88 3.34 . . . . 1.0 117.488 -177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . 0.278 3.4 t 144.53 -81.49 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 132.126 4.17 . . . . 1.0 111.059 171.171 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 85.55 1.59 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.041 1.291 . . . . 1.0 114.799 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.625 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -44.41 -60.35 1.99 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 129.211 3.004 . . . . 1.0 116.951 -176.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.82 -79.95 0.03 OUTLIER Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.287 1.899 . . . . 1.0 111.592 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.64 98.1 1.91 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.701 1.6 . . . . 1.0 114.516 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.453 ' CB ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -127.51 136.13 51.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.824 2.05 . . . . 1.0 113.142 173.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.8 114.05 12.23 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.168 1.787 . . . . 1.0 111.747 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -139.21 75.84 1.54 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.939 1.696 . . . . 1.0 111.288 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.56 108.9 8.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 1.0 110.046 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -117.74 115.25 24.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.2 1.4 . . . . 1.0 112.14 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.4 116.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.472 1.509 . . . . 1.0 107.197 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -113.77 107.34 15.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.201 1.001 . . . . 1.0 113.239 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 55.5 t -77.3 145.56 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.514 1.526 . . . . 1.0 111.846 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -104.1 -6.99 20.56 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.316 3.046 . . . . 1.0 114.627 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.729 HG23 ' HD2' ' A' ' 116' ' ' PRO . 8.6 m -72.28 171.47 12.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.869 2.868 . . . . 1.0 111.742 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.99 -52.53 9.15 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.403 -1.284 . . . . 1.0 111.778 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.729 ' HD2' HG23 ' A' ' 114' ' ' THR . 58.1 Cg_endo -78.24 110.74 2.93 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 124.624 3.55 . . . . 1.0 109.534 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 106.37 1.88 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.009 2.473 . . . . 1.0 109.624 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.626 HE22 ' HB2' ' A' ' 116' ' ' PRO . 1.7 mp0 -106.68 101.48 10.92 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 1.0 111.15 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.78 114.38 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.631 1.973 . . . . 1.0 111.423 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.08 127.66 32.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.91 1.684 . . . . 1.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 t -123.88 148.67 46.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.218 1.807 . . . . 1.0 114.712 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -87.32 112.66 22.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 1.0 109.073 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.42 49.91 2.28 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.006 2.522 . . . . 1.0 112.097 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -136.48 -99.94 0.21 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.217 2.207 . . . . 1.0 114.222 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.48 58.78 0.29 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 116.175 1.917 . . . . 1.0 116.175 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.27 72.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.329 2.252 . . . . 1.0 114.256 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -128.98 159.67 35.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.276 2.23 . . . . 1.0 111.769 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HA ' ' HB2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -149.88 161.21 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.899 2.079 . . . . 1.0 111.235 174.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.7 m -99.06 124.05 43.79 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.46 1.904 . . . . 1.0 110.334 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.85 -30.91 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 115.733 1.753 . . . . 1.0 115.733 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.55 -49.88 75.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.189 2.195 . . . . 1.0 112.605 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 40' ' ' ARG . . . -41.31 95.57 0.01 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 129.203 3.287 . . . . 1.0 112.635 171.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.46 166.6 12.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.564 2.842 . . . . 1.0 115.257 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -68.79 -39.69 80.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.454 1.901 . . . . 1.0 113.302 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 CA--C 1.561 1.382 0 C-N-CA 128.357 2.663 . . . . 1.0 114.867 -172.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 119.663 -0.208 . . . . 1.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mt -148.51 -173.89 4.46 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.689 2.396 . . . . 1.0 106.273 150.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.28 71.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 120.951 1.705 . . . . 1.0 106.677 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -127.98 82.04 2.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.269 3.428 . . . . 1.0 108.216 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.0 p -100.68 -73.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.433 1.893 . . . . 1.0 110.047 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.593 1.557 . . . . 1.0 114.01 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 29' ' ' ASN . 11.0 m 75.19 36.38 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 117.161 2.282 . . . . 1.0 117.161 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.74 37.37 0.24 Allowed 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 124.481 3.454 . . . . 1.0 112.971 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 27' ' ' SER 0.27 84.8 m-20 73.24 16.0 4.26 Favored 'General case' 0 CA--C 1.56 1.33 1 C-N-CA 132.328 4.251 . . . . 1.0 114.052 -170.457 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -108.68 137.14 47.09 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.495 1.665 . . . . 1.0 115.495 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 pp -122.31 122.1 38.29 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.557 2.343 . . . . 1.0 111.923 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 t -115.27 147.07 40.85 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.336 1.854 . . . . 1.0 112.65 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -130.14 95.17 3.86 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.969 2.908 . . . . 1.0 110.689 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -144.64 139.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 128.625 2.77 . . . . 1.0 110.877 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.77 146.69 80.16 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 126.252 1.821 . . . . 1.0 114.424 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.65 99.51 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.622 3.548 . . . . 1.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.5 t -93.69 -8.14 41.73 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 116.192 1.923 . . . . 1.0 116.192 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.1 p80 31.57 56.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 128.815 2.846 . . . . 1.0 115.869 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.79 176.15 9.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.927 2.091 . . . . 1.0 113.749 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.28 101.64 1.95 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.304 2.242 . . . . 1.0 109.569 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.49 -65.84 0.96 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.248 -0.908 . . . . 1.0 109.621 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 45.11 56.71 5.25 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.228 1.411 . . . . 1.0 113.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HB2' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER 68.93 1.66 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.966 2.58 . . . . 1.0 117.966 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -23.42 57.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.781 2.141 . . . . 1.0 116.781 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 109.63 10.31 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.549 1.522 . . . . 1.0 109.833 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.34 144.3 11.53 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 123.87 3.046 . . . . 1.0 110.731 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.58 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -141.34 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.556 1.543 . . . . 1.0 110.932 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.42 119.49 3.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.599 1.96 . . . . 1.0 109.75 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.58 ' CZ ' HG12 ' A' ' 47' ' ' ILE . 9.0 m-85 -122.98 113.4 19.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.134 1.773 . . . . 1.0 109.12 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -126.61 118.8 25.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.809 1.244 . . . . 1.0 109.964 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.4 t -134.56 134.75 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.909 1.284 . . . . 1.0 110.323 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.77 142.0 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.775 1.63 . . . . 1.0 110.69 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.63 146.33 37.63 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.136 1.375 . . . . 1.0 111.047 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -74.55 139.57 43.84 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.281 0.632 . . . . 1.0 110.257 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.93 -177.27 19.17 Favored Glycine 0 CA--C 1.545 1.96 0 C-N-CA 126.811 2.148 . . . . 1.0 112.225 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.99 94.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.311 1.044 . . . . 1.0 112.452 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 7.5 p -156.26 147.48 16.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.065 2.146 . . . . 1.0 112.427 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.7 Cg_endo -58.36 151.0 63.77 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.797 2.331 . . . . 1.0 112.455 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 69.59 97.11 0.06 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.602 2.361 . . . . 1.0 112.811 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.05 -14.76 25.68 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 126.821 2.153 . . . . 1.0 115.104 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 95.13 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 127.722 2.409 . . . . 1.0 114.231 171.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 110' ' ' ILE . 7.0 mp -103.77 129.02 51.12 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.981 1.474 . . . . 1.0 114.981 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -93.72 116.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.53 2.332 . . . . 1.0 105.37 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 p -129.2 117.54 20.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.121 2.169 . . . . 1.0 110.975 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.305 11.0 m -109.93 110.44 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.078 -1.014 . . . . 1.0 110.52 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.488 ' HB2' HG22 ' A' ' 107' ' ' THR . 53.4 mtt -144.42 107.72 4.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.494 2.317 . . . . 1.0 110.625 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.1 106.03 16.46 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 121.376 -0.828 . . . . 1.0 111.446 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.06 167.67 27.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.913 2.197 . . . . 1.0 112.278 172.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 104' ' ' LYS 0.265 0.1 OUTLIER 57.51 -33.01 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.27 2.628 . . . . 1.0 117.218 -175.563 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.625 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 38.9 t70 -64.73 -22.21 66.93 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 129.313 3.045 . . . . 1.0 113.515 170.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE1' ' HB2' ' A' ' 72' ' ' ASN . 9.6 tm-20 -120.78 -67.08 1.0 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.644 2.778 . . . . 1.0 109.629 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.502 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 3.1 m-80 -145.47 -85.23 0.12 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.906 2.082 . . . . 1.0 111.131 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -168.24 10.73 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.511 1.925 . . . . 1.0 114.994 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.2 m -59.51 -72.54 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.91 1.684 . . . . 1.0 113.995 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 46.75 -156.68 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.516 1.526 . . . . 1.0 114.965 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.755 ' HB2' ' HB2' ' A' ' 100' ' ' SER . 7.0 tp10 65.11 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.404 3.082 . . . . 1.0 115.227 -172.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.846 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -134.02 165.52 24.85 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.438 ' HD3' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -122.33 83.79 2.16 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.963 1.305 . . . . 1.0 109.603 172.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 81' ' ' THR . 4.1 m-20 70.82 10.63 7.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.865 0.866 . . . . 1.0 113.109 -176.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -65.51 2.63 0.87 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.304 1.411 . . . . 1.0 113.387 169.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 79' ' ' ASN . 5.4 t -100.02 112.61 24.9 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.044 0.938 . . . . 1.0 109.715 170.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.41 122.51 14.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.39 1.876 . . . . 1.0 109.689 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.8 153.48 18.84 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.184 0.994 . . . . 1.0 112.537 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.428 ' HB2' ' HE1' ' A' ' 84' ' ' MET . 3.1 mpp? -126.24 167.62 15.2 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.384 1.874 . . . . 1.0 110.084 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 -80.13 0.6 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.671 1.588 . . . . 1.0 110.389 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.65 45.71 0.81 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.23 1.412 . . . . 1.0 112.072 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 61.15 22.04 12.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.573 2.749 . . . . 1.0 114.752 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.89 133.25 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.76 129.88 49.23 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 130.383 3.473 . . . . 1.0 111.393 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.01 160.07 39.75 Favored 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 132.028 4.131 . . . . 1.0 110.334 176.29 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.5 t80 108.04 178.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 129.499 3.119 . . . . 1.0 114.717 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -82.32 -157.06 0.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 127.738 2.415 . . . . 1.0 108.252 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 66.99 47.53 1.38 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 117.724 2.49 . . . . 1.0 117.724 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 1.9 mp -139.25 123.92 18.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.371 2.268 . . . . 1.0 109.427 172.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -144.69 149.51 35.75 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-N 122.698 2.499 . . . . 1.0 115.371 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -118.31 169.11 10.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.935 2.094 . . . . 1.0 115.746 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 38.7 t 60.4 70.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.047 2.139 . . . . 1.0 109.927 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.59 -11.52 37.96 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 127.464 2.459 . . . . 1.0 115.906 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 99' ' ' ARG . 3.4 ttp180 73.05 -16.67 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 129.563 3.145 . . . . 1.0 118.57 173.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.755 ' HB2' ' HB2' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 30.78 -5.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 2 C-N-CA 134.807 5.243 . . . . 1.0 122.502 172.187 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.77 49.28 1.52 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 128.696 3.046 . . . . 1.0 110.653 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 90.7 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 129.861 3.264 . . . . 1.0 109.186 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.96 62.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 114.875 0.71 . . . . 1.0 114.875 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -71.48 84.93 0.83 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 123.153 1.454 . . . . 1.0 107.765 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -130.84 113.17 13.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.001 2.52 . . . . 1.0 113.177 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.625 ' CD1' ' HB2' ' A' ' 70' ' ' ASP . 22.7 t80 -87.45 83.25 7.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.06 0.944 . . . . 1.0 108.988 174.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 66' ' ' MET . 5.0 t -148.65 52.05 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -96.26 68.35 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.442 1.497 . . . . 1.0 112.866 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 50.8 m 172.28 -77.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 128.944 2.898 . . . . 1.0 113.701 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -133.17 155.04 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.1 m -135.05 106.3 6.74 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.131 2.172 . . . . 1.0 111.612 170.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.22 103.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 123.379 1.561 . . . . 1.0 109.707 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.14 73.47 0.47 Allowed 'General case' 0 CA--C 1.545 0.773 1 C-N-CA 133.203 4.601 . . . . 1.0 109.771 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 116' ' ' PRO . 93.7 m -152.37 163.09 40.18 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.376 2.27 . . . . 1.0 109.41 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.98 -41.91 32.16 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.419 -1.277 . . . . 1.0 114.046 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.691 ' HD2' HG23 ' A' ' 114' ' ' THR . 83.5 Cg_endo -92.08 101.57 0.2 Allowed 'Trans proline' 0 CA--C 1.561 1.875 1 C-N-CA 125.883 4.389 . . . . 1.0 107.501 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.15 119.59 6.64 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 124.144 3.229 . . . . 1.0 111.138 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -118.92 102.45 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.3 1.048 . . . . 1.0 111.299 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.3 144.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.126 2.171 . . . . 1.0 113.163 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -122.45 155.1 36.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.805 1.642 . . . . 1.0 112.402 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 t -127.54 139.34 52.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.562 1.945 . . . . 1.0 113.319 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 9.4 t80 -89.11 109.82 20.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.074 -1.016 . . . . 1.0 108.773 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -97.0 57.19 1.47 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.979 0.895 . . . . 1.0 113.137 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.576 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -133.19 -61.73 0.82 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.24 2.616 . . . . 1.0 112.258 -175.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.09 -15.27 61.06 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.2 mm 11.94 -86.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 1 C-N-CA 131.848 4.059 . . . . 1.0 114.66 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 48.9 tptt -79.69 97.35 6.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.5 1.92 . . . . 1.0 110.57 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.458 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.87 161.74 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.73 1.612 . . . . 1.0 112.176 -178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.13 125.61 49.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.325 1.45 . . . . 1.0 112.804 -172.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.01 -56.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.94 1.296 . . . . 1.0 112.032 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -99.1 -70.56 0.72 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.372 1.869 . . . . 1.0 112.83 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.48 156.74 24.77 Favored Glycine 0 CA--C 1.555 2.583 0 C-N-CA 126.366 1.936 . . . . 1.0 114.009 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.49 159.92 51.77 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.553 2.835 . . . . 1.0 114.932 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.512 ' HD3' ' HG2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -140.8 -47.42 0.41 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.958 2.103 . . . . 1.0 115.652 -176.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.512 ' HG2' ' HD3' ' A' ' 134' ' ' ARG . 7.4 pt-20 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 130.789 3.636 . . . . 1.0 111.148 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.301 -0.857 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 -173.91 4.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.356 2.663 . . . . 1.0 106.478 -160.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.9 t -72.96 71.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 122.143 2.247 . . . . 1.0 107.891 171.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.87 123.33 49.91 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 1.0 108.05 170.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.311 9.7 t -129.52 -101.1 0.32 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.553 0.946 . . . . 1.0 113.553 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -57.04 -34.89 68.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 127.746 2.418 . . . . 1.0 115.895 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.695 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 63.1 m -139.22 109.05 7.49 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.079 1.752 . . . . 1.0 107.616 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -46.26 -19.51 0.64 Allowed 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 124.706 3.604 . . . . 1.0 115.547 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.06 -36.59 70.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.544 2.738 . . . . 1.0 113.395 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -101.95 110.46 22.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.801 1.24 . . . . 1.0 109.813 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -117.96 122.28 42.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.028 1.731 . . . . 1.0 113.331 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.591 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 14.3 m -114.98 164.08 14.66 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.172 1.389 . . . . 1.0 113.861 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -152.06 126.96 9.64 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.793 1.637 . . . . 1.0 113.176 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.31 152.81 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 130.566 3.546 . . . . 1.0 109.375 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.55 150.8 95.57 Favored Pre-proline 0 CA--C 1.56 1.353 0 O-C-N 121.761 -0.587 . . . . 1.0 112.529 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.5 80.0 1.13 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.222 3.281 . . . . 1.0 112.414 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 p -77.64 -80.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.519 1.128 . . . . 1.0 110.246 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 44.37 78.21 0.06 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.844 2.458 . . . . 1.0 111.77 -173.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.521 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 1.6 p90 -166.28 173.56 9.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.474 2.309 . . . . 1.0 111.55 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 135' ' ' GLU . 4.5 ttp180 -66.43 100.87 0.69 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.785 1.234 . . . . 1.0 110.908 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -87.23 -50.78 6.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.962 1.705 . . . . 1.0 113.446 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.509 ' C ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t-20 56.28 8.65 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 125.913 1.685 . . . . 1.0 114.528 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.804 ' HB2' ' HB2' ' A' ' 95' ' ' ARG 0.267 5.4 ttpt 65.42 27.31 11.84 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 130.806 3.643 . . . . 1.0 114.82 -170.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -57.51 -55.39 35.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 130.045 3.338 . . . . 1.0 114.457 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.21 106.49 17.77 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.867 2.067 . . . . 1.0 109.751 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.62 134.54 16.93 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.095 3.197 . . . . 1.0 113.301 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.87 -11.66 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.822 1.649 . . . . 1.0 114.563 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 68.51 162.09 0.2 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.133 2.573 . . . . 1.0 115.693 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -128.02 129.06 46.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.123 2.169 . . . . 1.0 109.506 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -124.67 109.13 12.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.02 1.328 . . . . 1.0 110.094 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.75 144.11 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.525 1.53 . . . . 1.0 111.459 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 147.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.476 3.11 . . . . 1.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.39 158.93 43.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.79 1.774 . . . . 1.0 115.79 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.4 mt -100.43 112.48 24.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.803 2.041 . . . . 1.0 108.2 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.27 168.72 34.48 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 125.492 1.52 . . . . 1.0 111.282 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.539 ' OD1' ' HD2' ' A' ' 58' ' ' PRO . 9.3 t0 56.8 169.38 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.656 ' HA ' ' HG2' ' A' ' 87' ' ' GLN 0.332 1.3 p -149.54 -43.86 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 115.788 1.773 . . . . 1.0 115.788 172.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 46.6 Cg_endo -81.16 169.41 16.04 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.282 2.654 . . . . 1.0 111.91 171.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 16.75 -122.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 129.367 3.067 . . . . 1.0 114.386 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 86' ' ' ASN . . . 144.42 -70.5 0.39 Allowed Glycine 0 C--N 1.342 0.861 0 C-N-CA 126.274 1.893 . . . . 1.0 113.951 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -139.82 165.17 28.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.596 1.702 . . . . 1.0 115.596 -169.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 111' ' ' THR . 38.3 mt -108.42 106.22 16.24 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.632 3.173 . . . . 1.0 106.305 168.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.87 107.72 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 -173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.9 m -111.57 119.59 39.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.241 1.017 . . . . 1.0 111.157 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.67 114.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 120.948 -1.095 . . . . 1.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.781 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 8.1 mtt -121.12 78.03 1.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.127 0.971 . . . . 1.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.02 106.69 19.02 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.136 -1.431 . . . . 1.0 107.136 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.57 171.19 54.95 Favored Glycine 0 CA--C 1.543 1.8 0 C-N-CA 126.542 2.02 . . . . 1.0 116.838 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 17.8 p-10 -145.35 91.7 2.16 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.046 2.938 . . . . 1.0 110.135 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.92 20.37 12.18 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 126.426 1.89 . . . . 1.0 114.874 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.602 ' HG2' ' HB3' ' A' ' 73' ' ' TYR . 4.4 tt0 -148.41 -25.98 0.33 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.141 2.177 . . . . 1.0 116.279 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 45.09 38.7 3.33 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.963 2.105 . . . . 1.0 114.301 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.602 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 60.9 t80 -149.84 68.67 1.01 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.645 1.978 . . . . 1.0 111.973 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.781 ' HB2' ' HG2' ' A' ' 66' ' ' MET . 42.5 t 63.08 78.79 0.28 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 128.664 2.785 . . . . 1.0 116.73 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.79 -62.82 1.4 Allowed 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' CD ' HH21 ' A' ' 95' ' ' ARG . 0.1 OUTLIER 173.22 143.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.894 2.878 . . . . 1.0 112.165 174.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.63 163.26 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.65 2.38 . . . . 1.0 110.782 170.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.766 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . 56.1 mtt-85 -141.08 90.03 2.29 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.092 2.157 . . . . 1.0 109.173 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.64 ' C ' ' H ' ' A' ' 81' ' ' THR . 1.3 t-20 88.84 -2.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.801 2.04 . . . . 1.0 110.848 -172.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 77' ' ' LEU 0.334 . . -76.01 34.12 0.13 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 123.272 2.76 . . . . 1.0 114.475 170.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.64 ' H ' ' C ' ' A' ' 79' ' ' ASN . 1.2 t -126.56 108.37 11.08 Favored 'General case' 0 CA--C 1.542 0.653 1 C-N-CA 132.704 4.402 . . . . 1.0 101.238 167.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.18 152.82 42.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.57 1.148 . . . . 1.0 112.113 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.15 159.4 15.3 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 129.452 3.101 . . . . 1.0 114.1 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 88' ' ' VAL 0.306 0.5 OUTLIER 86.54 -127.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 128.057 2.543 . . . . 1.0 113.041 176.278 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 110' ' ' ILE . 5.9 tmtt? 70.08 -25.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 128.267 2.627 . . . . 1.0 117.13 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 2.4 m-20 -81.48 0.99 35.34 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 120.057 1.299 . . . . 1.0 113.497 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.656 ' HG2' ' HA ' ' A' ' 57' ' ' VAL . 4.1 tp-100 -148.41 -47.54 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.037 2.135 . . . . 1.0 112.395 170.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 84' ' ' MET . 90.7 t -133.9 134.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 114.972 1.471 . . . . 1.0 114.972 -172.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.24 121.62 16.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.775 1.63 . . . . 1.0 110.632 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.15 158.8 43.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.497 2.319 . . . . 1.0 110.23 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.45 -167.6 0.19 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.548 1.539 . . . . 1.0 114.565 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.63 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 9.0 p30 -107.99 -174.44 2.52 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.02 2.128 . . . . 1.0 111.559 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.63 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.265 8.4 m-20 121.0 74.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.565 3.546 . . . . 1.0 112.379 174.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 2.9 pp -160.2 141.72 12.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.198 2.599 . . . . 1.0 109.299 169.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.804 ' HB2' ' HB2' ' A' ' 43' ' ' LYS . 3.7 ttt180 -129.49 148.48 51.4 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 119.073 0.851 . . . . 1.0 112.166 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.45 152.0 38.32 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.453 1.649 . . . . 1.0 115.453 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.3 m 43.95 31.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 129.194 2.998 . . . . 1.0 117.569 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.54 -35.18 36.44 Favored Glycine 0 N--CA 1.48 1.577 0 C-N-CA 128.848 3.118 . . . . 1.0 118.336 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 -0.15 4.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.511 1.924 . . . . 1.0 115.08 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 13.3 p -65.27 119.2 10.47 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.429 1.491 . . . . 1.0 113.122 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -117.17 128.47 7.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.78 1.657 . . . . 1.0 114.004 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER 69.01 164.18 0.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.928 2.891 . . . . 1.0 113.496 179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 42.36 36.4 2.15 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.172 1.844 . . . . 1.0 113.918 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -67.43 101.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.769 2.028 . . . . 1.0 108.701 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -115.5 156.45 25.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 130.614 3.565 . . . . 1.0 110.17 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.9 90.82 2.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.502 1.668 . . . . 1.0 115.502 -171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.0 m -112.38 80.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.545 1.138 . . . . 1.0 112.208 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.4 115.0 19.7 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.611 -1.306 . . . . 1.0 110.949 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.9 m -121.1 111.98 18.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.664 1.186 . . . . 1.0 111.148 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.408 HG22 ' HD2' ' A' ' 85' ' ' LYS . 4.0 mp -93.0 113.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.497 HG21 ' HB2' ' A' ' 62' ' ' LEU . 14.8 t -89.98 151.1 21.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 122.834 0.453 . . . . 1.0 111.769 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.624 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 2.0 p -72.68 170.95 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 123.451 1.596 . . . . 1.0 112.325 172.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -118.15 11.5 13.27 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.891 2.877 . . . . 1.0 114.339 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.7 p -120.59 167.51 12.34 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.222 1.409 . . . . 1.0 112.682 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -29.06 5.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 117.536 2.421 . . . . 1.0 117.536 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -87.6 99.34 0.46 Allowed 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 124.421 3.414 . . . . 1.0 109.715 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.91 94.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.355 1 C-N-CA 125.428 4.085 . . . . 1.0 116.217 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.624 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 1.5 tm0? -97.78 90.47 4.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.152 0.977 . . . . 1.0 108.413 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.23 114.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.191 1.396 . . . . 1.0 108.616 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.42 151.78 27.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.561 2.345 . . . . 1.0 111.516 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 m -118.74 131.01 56.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.135 0.974 . . . . 1.0 112.905 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.24 120.29 23.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.394 1.078 . . . . 1.0 111.518 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -167.17 -166.45 0.8 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.794 2.437 . . . . 1.0 111.484 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -33.62 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 130.077 3.351 . . . . 1.0 117.697 172.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -28.99 -74.97 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 128.915 2.886 . . . . 1.0 115.183 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.3 mm -145.66 169.04 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 130.039 3.336 . . . . 1.0 107.654 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -76.39 150.06 36.84 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.7 -1.25 . . . . 1.0 110.717 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.8 tt -92.32 124.5 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.461 1.904 . . . . 1.0 110.119 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -81.21 125.11 29.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.44 1.496 . . . . 1.0 111.923 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.3 t -53.95 -65.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.786 1.635 . . . . 1.0 114.153 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.44 -2.93 27.77 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.521 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . 92.21 -151.33 20.65 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 125.356 1.455 . . . . 1.0 112.494 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.85 -75.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.223 3.282 . . . . 1.0 113.415 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.453 ' HD2' ' OE1' ' A' ' 135' ' ' GLU . 11.5 ttm105 -135.09 -71.54 0.48 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.627 1.971 . . . . 1.0 110.352 174.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 20.3 mp0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.792 2.037 . . . . 1.0 114.289 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.59 0.219 . . . . 1.0 111.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -152.5 -174.53 4.93 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 23.2 t -67.63 71.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 107.173 -1.417 . . . . 1.0 107.173 170.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.12 169.73 0.77 Allowed 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.965 1.468 . . . . 1.0 114.965 171.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 24.9 p -132.64 176.51 8.39 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.408 2.283 . . . . 1.0 110.17 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.37 21.19 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 128.129 2.572 . . . . 1.0 112.584 171.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.599 ' OG ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -79.11 168.37 27.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 127.269 2.227 . . . . 1.0 114.558 -177.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HD2' ' OG ' ' A' ' 27' ' ' SER . 53.6 Cg_endo -64.55 -33.02 57.9 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.426 2.751 . . . . 1.0 113.741 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -174.19 72.08 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 128.606 2.762 . . . . 1.0 111.303 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -125.4 129.45 49.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.422 -1.424 . . . . 1.0 114.248 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.72 133.88 53.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.697 1.599 . . . . 1.0 112.149 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 70.6 m -119.06 157.91 26.88 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.591 1.557 . . . . 1.0 111.868 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 6.7 t -137.81 98.16 3.6 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.213 2.205 . . . . 1.0 109.779 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.08 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.784 2.434 . . . . 1.0 110.225 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.659 ' HB3' HG12 ' A' ' 47' ' ' ILE . 11.5 tp -72.95 -66.74 0.53 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.65 1.58 . . . . 1.0 112.951 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.579 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 39.5 Cg_endo -66.01 142.43 68.32 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.757 2.972 . . . . 1.0 113.37 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -126.65 -46.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.822 2.049 . . . . 1.0 113.843 175.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 m-70 -138.78 62.8 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.509 1.524 . . . . 1.0 112.23 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.657 ' HB2' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -139.81 157.06 46.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 130.237 3.415 . . . . 1.0 110.628 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 7.9 ttp180 -68.37 104.92 2.0 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.997 1.719 . . . . 1.0 113.372 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.7 t 95.62 113.33 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.586 3.155 . . . . 1.0 116.429 170.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 96' ' ' PHE . 57.2 t30 -57.1 -71.47 0.1 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.701 2.4 . . . . 1.0 112.814 171.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -78.08 165.65 23.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.426 2.29 . . . . 1.0 113.099 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 91.47 -8.22 0.25 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 130.075 3.35 . . . . 1.0 112.496 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.07 162.56 63.99 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 129.643 3.177 . . . . 1.0 113.831 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.37 29.33 0.3 Allowed 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 125.104 3.87 . . . . 1.0 115.243 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.659 HG12 ' HB3' ' A' ' 35' ' ' LEU . 2.4 pp -146.33 172.55 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 129.723 3.209 . . . . 1.0 110.368 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.0 -179.32 5.34 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 128.923 2.889 . . . . 1.0 112.355 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -120.46 143.07 48.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.317 2.247 . . . . 1.0 113.12 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 78.9 mttt -147.27 146.66 29.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.433 1.893 . . . . 1.0 111.212 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . 0.273 1.0 OUTLIER -135.98 135.18 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.445 1.098 . . . . 1.0 109.435 168.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.62 118.11 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.546 1.538 . . . . 1.0 108.286 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . . . -97.79 159.94 14.62 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.493 1.117 . . . . 1.0 111.811 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.65 115.65 23.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.868 1.667 . . . . 1.0 111.687 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.2 169.77 40.88 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.583 1.563 . . . . 1.0 112.742 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 -168.74 0.19 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.12 1.768 . . . . 1.0 114.555 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 7.4 p 169.52 73.08 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 131.191 3.796 . . . . 1.0 109.843 172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -93.76 4.87 2.92 Favored 'Trans proline' 0 CA--C 1.556 1.584 1 C-N-CA 125.402 4.068 . . . . 1.0 117.689 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 30.09 93.4 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 130.669 3.587 . . . . 1.0 118.661 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.98 5.21 3.55 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.899 1.714 . . . . 1.0 115.721 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 m -55.22 111.88 0.96 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.23 2.212 . . . . 1.0 111.775 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.52 111.42 10.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.705 1.602 . . . . 1.0 111.303 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.583 HG11 HG12 ' A' ' 110' ' ' ILE . 35.0 m -93.06 107.64 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 172.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.81 116.86 30.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 123.418 1.58 . . . . 1.0 110.85 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.33 140.99 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 120.685 -1.259 . . . . 1.0 110.519 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -134.91 105.03 6.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.658 0.783 . . . . 1.0 111.436 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 96' ' ' PHE . . . -99.86 109.03 21.44 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.355 -1.466 . . . . 1.0 107.696 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.602 ' HA3' ' HB2' ' A' ' 74' ' ' SER . . . 131.9 91.27 0.52 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.281 2.848 . . . . 1.0 110.424 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -144.75 -87.84 0.11 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.361 2.265 . . . . 1.0 109.468 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 105' ' ' SER . 2.5 m-20 -43.33 -28.64 0.35 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.525 2.73 . . . . 1.0 116.435 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 104' ' ' LYS . 14.1 mm-40 -98.14 -24.69 15.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.963 2.105 . . . . 1.0 115.834 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -162.61 -79.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.399 1.454 . . . . 1.0 113.882 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 t80 136.33 108.3 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.62 1 C-N-CA 132.82 4.448 . . . . 1.0 107.432 -170.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.602 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -124.42 -77.79 0.59 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.381 1.473 . . . . 1.0 111.256 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.76 -2.16 0.1 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.39 1.996 . . . . 1.0 116.39 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.31 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 129.812 3.245 . . . . 1.0 112.612 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 97' ' ' VAL . 5.1 mt -96.61 167.43 11.14 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -171.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -132.85 83.78 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 -169.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.7 OUTLIER 95.25 2.53 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.964 2.906 . . . . 1.0 111.033 -173.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.838 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . . . -46.77 -6.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.991 2.589 . . . . 1.0 117.991 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.567 ' H ' ' C ' ' A' ' 79' ' ' ASN . 98.1 m -115.47 113.68 24.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.563 1.545 . . . . 1.0 111.58 173.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.7 163.0 34.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 128.93 2.892 . . . . 1.0 109.939 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.97 45.58 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.032 2.133 . . . . 1.0 112.563 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 85' ' ' LYS . 17.6 mmt -123.25 158.96 29.75 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.823 1.649 . . . . 1.0 111.195 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 84' ' ' MET . 2.0 mptm? -118.05 -87.01 0.63 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -168.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 8.2 m120 -75.69 43.83 0.27 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 129.041 2.936 . . . . 1.0 110.705 175.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 1.4 pm0 48.94 32.55 3.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.776 2.83 . . . . 1.0 114.02 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.06 144.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.625 1.97 . . . . 1.0 113.449 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.52 146.91 52.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.268 2.627 . . . . 1.0 112.241 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 ptt-85 -136.66 163.16 31.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 129.485 3.114 . . . . 1.0 113.886 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 61.11 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 128.303 2.641 . . . . 1.0 113.456 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.27 -66.72 0.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.198 2.199 . . . . 1.0 109.709 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 69.13 -21.25 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.037 3.335 . . . . 1.0 115.987 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.838 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.79 163.24 30.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 127.052 2.141 . . . . 1.0 115.741 178.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.655 ' HD2' ' HA3' ' A' ' 98' ' ' GLY . 5.5 ttm180 -141.11 115.95 9.73 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.297 1.962 . . . . 1.0 116.297 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.579 ' HZ ' ' HB2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -86.74 126.64 34.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.557 1.943 . . . . 1.0 111.201 177.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.435 ' H ' ' CD2' ' A' ' 77' ' ' LEU 0.289 2.6 m 38.67 41.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 129.247 3.019 . . . . 1.0 112.808 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.655 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -56.95 54.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.093 1 C-N-CA 132.453 4.835 . . . . 1.0 119.238 -171.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 117.88 -5.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 1 C-N-CA 132.735 4.414 . . . . 1.0 113.549 -175.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -141.21 92.48 2.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.604 2.362 . . . . 1.0 111.27 -174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 40' ' ' ARG . . . -168.99 138.42 5.09 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 127.472 2.463 . . . . 1.0 112.04 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -177.17 89.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.899 2.879 . . . . 1.0 107.37 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.06 81.54 0.59 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.759 1.171 . . . . 1.0 112.532 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -153.94 162.01 41.54 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.251 2.22 . . . . 1.0 112.341 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 23.3 t -104.84 154.82 19.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.892 2.077 . . . . 1.0 113.178 172.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.617 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.4 t80 -95.03 103.1 14.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.424 2.29 . . . . 1.0 111.184 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -108.07 82.95 1.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.331 1.063 . . . . 1.0 112.525 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.27 111.25 8.22 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.555 1.542 . . . . 1.0 111.202 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 m -109.02 104.66 13.91 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.384 0.883 . . . . 1.0 113.384 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.583 HG12 HG11 ' A' ' 63' ' ' VAL . 8.8 mt -93.45 113.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.128 -1.607 . . . . 1.0 108.199 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.7 p -111.61 121.2 44.5 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.569 1.948 . . . . 1.0 111.951 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.628 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 0.3 OUTLIER -71.57 172.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 123.0 1.381 . . . . 1.0 112.391 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -131.12 40.07 3.5 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.719 2.408 . . . . 1.0 113.598 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.465 ' H ' HG12 ' A' ' 112' ' ' VAL . 9.8 t -129.58 165.39 21.82 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.803 2.041 . . . . 1.0 111.023 172.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.57 -48.58 68.02 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 126.126 1.77 . . . . 1.0 112.684 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.34 111.54 3.28 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.876 3.05 . . . . 1.0 110.505 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.23 106.8 1.06 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.591 3.527 . . . . 1.0 112.707 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.628 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 7.9 tp-100 -105.32 92.85 4.38 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.812 0.815 . . . . 1.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.74 120.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.495 1.518 . . . . 1.0 111.453 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.53 146.18 44.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.79 2.036 . . . . 1.0 110.966 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.9 m -122.3 141.12 51.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.8 1.64 . . . . 1.0 110.102 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -92.25 143.88 25.96 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.067 0.947 . . . . 1.0 113.183 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -149.39 171.86 15.87 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.499 2.72 . . . . 1.0 111.15 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.533 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 15.2 ttt180 74.46 176.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 127.41 2.284 . . . . 1.0 112.557 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.533 ' H ' ' HG2' ' A' ' 124' ' ' ARG . . . -149.96 164.96 34.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.607 1.706 . . . . 1.0 115.607 175.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.66 -39.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.537 1.935 . . . . 1.0 113.716 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.56 110.32 8.69 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.395 1.478 . . . . 1.0 113.28 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 38' ' ' HIS . 1.2 pp -121.34 124.77 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.734 1.214 . . . . 1.0 110.586 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.657 ' HB ' ' HB2' ' A' ' 39' ' ' TRP . 86.5 m -125.87 120.51 30.67 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 170.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.56 -24.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 115.198 1.555 . . . . 1.0 115.198 -170.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.97 -69.02 0.78 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.757 2.423 . . . . 1.0 113.391 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.66 51.12 3.34 Favored Glycine 0 CA--C 1.549 2.163 0 C-N-CA 127.148 2.309 . . . . 1.0 114.994 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.52 -31.29 51.14 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.561 3.508 . . . . 1.0 114.119 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 145.45 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 1 C-N-CA 133.252 4.621 . . . . 1.0 112.069 174.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 127.893 2.477 . . . . 1.0 116.919 172.563 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -173.63 3.82 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 129.764 3.226 . . . . 1.0 104.753 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.17 74.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 O-C-N 119.664 -1.897 . . . . 1.0 108.533 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 123' ' ' HIS . 73.9 mtt180 -41.72 113.48 0.42 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 130.452 3.501 . . . . 1.0 111.9 171.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.916 ' H ' ' HB2' ' A' ' 30' ' ' PHE . 3.4 t -149.32 92.54 1.96 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.949 0.9 . . . . 1.0 112.791 -170.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 121' ' ' THR . 31.8 t0 118.01 -58.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 1 C-N-CA 133.033 4.533 . . . . 1.0 112.849 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 30' ' ' PHE . 50.9 m 133.47 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.951 1 C-N-CA 132.306 4.242 . . . . 1.0 113.455 -172.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 30.8 Cg_endo -62.43 90.99 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 125.118 3.878 . . . . 1.0 111.969 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 54' ' ' LEU . 3.8 t-20 36.14 58.3 0.98 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.331 2.253 . . . . 1.0 110.686 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.916 ' HB2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -79.77 103.41 9.66 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.461 1.904 . . . . 1.0 111.689 -170.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -139.71 108.9 6.08 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.8 t -114.95 149.71 36.88 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.971 1.308 . . . . 1.0 111.818 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . 3.0 m -126.58 93.61 3.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.125 3.77 . . . . 1.0 108.058 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.597 HG23 ' HD2' ' A' ' 36' ' ' PRO . 5.4 p -149.68 155.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.503 2.321 . . . . 1.0 110.531 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.4 -58.32 0.5 Allowed Pre-proline 0 CA--C 1.552 1.038 0 CA-C-O 117.217 -1.373 . . . . 1.0 114.198 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.769 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 9.6 Cg_endo -50.78 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 1 C-N-CA 125.602 4.201 . . . . 1.0 112.99 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -102.57 -76.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.893 1.677 . . . . 1.0 109.938 -171.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -125.73 44.16 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.964 2.506 . . . . 1.0 113.143 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.777 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 5.5 p90 -161.93 169.19 21.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.244 2.218 . . . . 1.0 114.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -66.52 106.69 1.84 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.745 2.418 . . . . 1.0 114.622 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 42.7 t -81.02 -70.56 0.52 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.511 1.05 . . . . 1.0 111.334 173.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.2 t30 45.31 51.7 9.24 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.315 1.446 . . . . 1.0 113.584 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.37 -7.13 1.22 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.871 2.868 . . . . 1.0 116.492 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -65.19 142.27 58.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.8 1.182 . . . . 1.0 109.89 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 56.39 62.26 6.65 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 126.002 1.721 . . . . 1.0 110.881 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.0 41.83 0.58 Allowed 'Trans proline' 0 CA--C 1.554 1.497 1 C-N-CA 125.762 4.308 . . . . 1.0 114.315 -176.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.07 -1.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 129.892 3.277 . . . . 1.0 114.84 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.13 173.79 0.3 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 129.28 3.032 . . . . 1.0 113.164 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -140.1 166.67 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 5.2 tttp -142.91 135.99 28.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.577 2.351 . . . . 1.0 110.843 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 123.36 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.757 2.423 . . . . 1.0 107.368 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -138.19 131.85 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.059 2.144 . . . . 1.0 109.988 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.45 157.1 36.01 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.325 1.45 . . . . 1.0 111.179 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -128.44 113.05 15.05 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.741 1.386 . . . . 1.0 114.741 174.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.4 3.82 5.55 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 117.965 1.946 . . . . 1.0 117.965 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.85 177.44 4.84 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 128.384 2.673 . . . . 1.0 116.933 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.644 HG12 ' HD2' ' A' ' 58' ' ' PRO . 69.2 t -68.36 157.67 87.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 131.688 3.995 . . . . 1.0 113.495 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.644 ' HD2' HG12 ' A' ' 57' ' ' VAL . 61.1 Cg_endo -70.71 -150.76 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 125.121 3.881 . . . . 1.0 113.275 171.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' H ' ' HB2' ' A' ' 58' ' ' PRO . 9.6 p-10 -50.99 101.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.641 2.376 . . . . 1.0 112.317 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.43 -8.67 0.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.025 -1.43 . . . . 1.0 116.447 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 104.47 4.32 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.759 1.779 . . . . 1.0 108.894 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.56 112.46 16.84 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -89.64 107.32 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 101.93 -3.359 . . . . 1.0 101.93 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -130.9 117.55 19.42 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.812 1.32 . . . . 1.0 112.583 -170.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -106.35 111.54 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.531 1.133 . . . . 1.0 110.534 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.582 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 8.1 mtm -146.98 102.24 3.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.872 2.069 . . . . 1.0 111.431 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.2 107.74 20.15 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.713 1.142 . . . . 1.0 112.125 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.84 147.75 18.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.165 0.888 . . . . 1.0 115.059 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -155.13 -52.61 0.09 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.87 1.268 . . . . 1.0 112.579 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -149.19 -48.25 0.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.281 2.232 . . . . 1.0 114.891 -170.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -147.29 -10.24 0.43 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 130.397 3.479 . . . . 1.0 114.216 -168.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -48.43 -15.57 0.08 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.912 2.885 . . . . 1.0 115.473 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.85 2.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.821 3.648 . . . . 1.0 117.616 171.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.614 ' HB2' HG12 ' A' ' 97' ' ' VAL . 2.8 t -92.33 -99.46 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.732 1.613 . . . . 1.0 113.548 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 57.07 -65.51 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 126.871 2.068 . . . . 1.0 112.496 -169.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.51 137.65 53.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.379 2.272 . . . . 1.0 114.329 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.865 ' HB2' ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.77 165.51 24.39 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 128.317 2.647 . . . . 1.0 111.599 -176.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.66 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -118.11 82.25 1.81 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.347 -0.846 . . . . 1.0 111.321 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.687 ' ND2' HH21 ' A' ' 95' ' ' ARG . 7.6 m-80 78.92 0.59 2.43 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.438 2.295 . . . . 1.0 112.508 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.865 ' HB1' ' HB2' ' A' ' 77' ' ' LEU . . . -57.25 -11.14 1.56 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.554 2.741 . . . . 1.0 117.214 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 m -105.01 112.66 25.88 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.223 1.577 . . . . 1.0 110.93 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 160.75 39.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.998 2.119 . . . . 1.0 111.35 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 127.19 42.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.779 2.432 . . . . 1.0 112.916 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -144.5 -164.7 1.97 Allowed 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 127.988 2.515 . . . . 1.0 112.846 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -112.87 -101.47 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.629 2.372 . . . . 1.0 111.502 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -79.57 45.35 0.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.628 2.371 . . . . 1.0 111.966 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.757 ' HG2' HG12 ' A' ' 110' ' ' ILE . 0.4 OUTLIER 51.24 32.7 8.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.167 2.187 . . . . 1.0 111.609 -171.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -90.39 109.92 21.4 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-O 122.894 1.33 . . . . 1.0 107.526 -171.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.51 116.36 11.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.22 2.208 . . . . 1.0 109.178 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -135.77 128.7 31.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.347 1.859 . . . . 1.0 109.969 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.0 t80 130.87 -151.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 130.696 3.598 . . . . 1.0 111.542 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -122.43 164.21 18.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.604 1.962 . . . . 1.0 110.599 171.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . 0.44 94.1 m-20 108.02 44.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.481 3.512 . . . . 1.0 116.341 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -139.95 132.19 28.21 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.299 2.639 . . . . 1.0 108.604 170.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.687 HH21 ' ND2' ' A' ' 79' ' ' ASN . 0.8 OUTLIER -138.86 120.63 15.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.026 1.739 . . . . 1.0 113.583 -171.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.45 115.99 30.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.714 1.206 . . . . 1.0 110.232 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 74' ' ' SER . 11.0 t 71.13 73.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.756 1.222 . . . . 1.0 107.995 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.63 90.24 0.65 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 128.506 2.955 . . . . 1.0 113.361 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.21 53.98 3.46 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 128.042 2.537 . . . . 1.0 115.01 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.5 t -70.93 -168.5 0.28 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.817 2.047 . . . . 1.0 115.798 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.88 -37.94 0.07 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.911 2.672 . . . . 1.0 115.044 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 159.85 42.72 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.905 2.082 . . . . 1.0 113.739 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.48 57.45 2.93 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.595 1.569 . . . . 1.0 115.188 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 104' ' ' LYS . 7.6 mtmt -68.79 104.7 2.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.223 1.809 . . . . 1.0 109.71 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.9 t -119.62 132.65 55.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.301 3.04 . . . . 1.0 110.878 -174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -84.75 87.12 7.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.185 0.994 . . . . 1.0 110.895 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 66' ' ' MET . 3.8 m -143.36 51.17 1.37 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.95 0.881 . . . . 1.0 111.319 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.35 90.41 3.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.894 2.077 . . . . 1.0 111.037 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 110' ' ' ILE . 10.2 t 152.38 -116.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 128.754 2.822 . . . . 1.0 115.545 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.757 HG12 ' HG2' ' A' ' 87' ' ' GLN . 3.8 mp -133.78 151.69 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 128.25 2.62 . . . . 1.0 111.786 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.9 m -140.18 104.24 4.77 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.586 1.554 . . . . 1.0 113.562 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.48 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 54.3 t -74.05 122.16 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.562 -1.336 . . . . 1.0 107.814 170.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.15 -8.17 56.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.587 3.555 . . . . 1.0 116.971 -175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 2.2 m -82.16 166.11 19.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.762 2.025 . . . . 1.0 112.529 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -45.02 -31.78 0.94 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.601 1.96 . . . . 1.0 114.023 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 114' ' ' THR . 98.1 Cg_endo -95.26 81.8 0.11 Allowed 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 125.41 4.073 . . . . 1.0 106.197 167.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.61 114.08 3.56 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.201 3.267 . . . . 1.0 111.834 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.48 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -99.99 92.48 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 -177.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.86 115.33 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.59 171.23 8.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.592 1.957 . . . . 1.0 112.995 -168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.477 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 63.3 p -124.9 120.05 30.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.742 2.017 . . . . 1.0 113.46 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.06 125.82 33.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.13 1.786 . . . . 1.0 110.523 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 41.3 m-70 -106.82 68.66 0.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.071 1.748 . . . . 1.0 112.181 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.41 -179.7 0.09 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.807 2.843 . . . . 1.0 112.764 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.27 -58.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.689 2.796 . . . . 1.0 116.334 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mt 67.31 -62.12 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 129.085 2.954 . . . . 1.0 112.766 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -124.24 130.84 53.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.672 1.989 . . . . 1.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.25 129.96 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 128.046 2.539 . . . . 1.0 110.382 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -85.32 121.96 28.8 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.053 1.341 . . . . 1.0 109.296 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.74 -28.44 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.063 0.945 . . . . 1.0 112.112 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.52 -29.19 56.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.543 2.337 . . . . 1.0 115.048 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.777 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . 93.11 -157.56 23.4 Favored Glycine 0 CA--C 1.553 2.465 0 C-N-CA 125.822 1.677 . . . . 1.0 114.56 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -73.62 162.71 39.17 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 124.424 3.416 . . . . 1.0 113.143 170.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 82.85 106.05 0.06 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 128.89 2.876 . . . . 1.0 110.112 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 127.842 2.457 . . . . 1.0 114.848 -178.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.75 -172.52 2.9 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 129.086 2.955 . . . . 1.0 105.689 -174.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.08 73.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 O-C-N 119.808 -1.807 . . . . 1.0 107.172 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -61.02 148.2 40.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.61 2.764 . . . . 1.0 113.96 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.528 HG23 HG12 ' A' ' 110' ' ' ILE . 82.5 p -76.47 -167.28 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.509 2.724 . . . . 1.0 110.162 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.704 ' HB2' ' O ' ' A' ' 121' ' ' THR . 4.2 t0 -66.24 12.91 0.06 Allowed 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.561 -1.337 . . . . 1.0 112.959 169.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 25' ' ' THR . 44.9 p -150.72 152.45 32.24 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.109 2.563 . . . . 1.0 114.653 -172.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 -15.54 26.05 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 C-N-CA 123.466 2.778 . . . . 1.0 111.493 168.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -21.48 63.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.918 2.887 . . . . 1.0 115.568 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' HB2' ' OG1' ' A' ' 25' ' ' THR . 26.9 m-85 -138.16 114.51 10.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.993 1.317 . . . . 1.0 110.569 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 3.5 pp -149.91 140.26 22.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.198 1.399 . . . . 1.0 114.422 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 52' ' ' VAL 0.587 0.1 OUTLIER -164.82 173.05 12.17 Favored 'General case' 0 CA--C 1.542 0.644 1 N-CA-C 122.936 4.421 . . . . 1.0 122.936 -173.461 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -97.68 98.25 9.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.714 0.806 . . . . 1.0 110.946 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.61 130.03 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 126.606 1.962 . . . . 1.0 111.812 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.52 126.96 91.75 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.152 1.381 . . . . 1.0 112.413 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.701 ' HB2' ' CD2' ' A' ' 38' ' ' HIS . 72.4 Cg_endo -71.55 148.81 54.49 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 124.016 3.144 . . . . 1.0 113.556 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 ' HB ' ' CG ' ' A' ' 96' ' ' PHE . 5.0 t -83.02 -67.02 0.82 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.827 1.651 . . . . 1.0 114.176 -176.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.701 ' CD2' ' HB2' ' A' ' 36' ' ' PRO . 86.6 m-70 37.26 40.44 0.19 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.291 3.436 . . . . 1.0 116.792 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.49 173.72 14.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.156 1.782 . . . . 1.0 113.717 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.483 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -82.18 103.64 11.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.077 2.151 . . . . 1.0 110.654 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.412 ' HB2' ' C ' ' A' ' 98' ' ' GLY . 13.7 p 51.05 101.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.475 2.71 . . . . 1.0 115.3 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.552 ' OD1' ' HB2' ' A' ' 96' ' ' PHE . 2.0 m120 -47.17 -72.59 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.005 2.122 . . . . 1.0 115.687 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 22.16 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 1 C-N-CA 132.736 4.414 . . . . 1.0 118.417 175.306 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m 68.04 77.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 129.612 3.165 . . . . 1.0 111.922 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 2.3 pt? -161.75 171.54 6.65 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 127.038 2.135 . . . . 1.0 113.412 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.668 ' HD2' ' HB2' ' A' ' 45' ' ' LEU . 43.0 Cg_endo -70.47 140.52 40.2 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.87 3.046 . . . . 1.0 111.681 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 12.9 mm -134.64 -69.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.486 1.514 . . . . 1.0 113.918 -172.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 31.23 90.03 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 130.436 3.495 . . . . 1.0 116.453 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.77 171.04 10.44 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.64 2.089 . . . . 1.0 116.64 -172.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -140.04 146.07 38.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 129.762 3.225 . . . . 1.0 109.948 172.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 2.5 t -130.79 118.86 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 129.236 3.014 . . . . 1.0 110.616 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 ' H ' ' HB2' ' A' ' 32' ' ' CYS 0.278 14.2 m -128.02 145.92 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 120.582 1.537 . . . . 1.0 113.977 173.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . . . -112.12 145.07 40.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.131 1.373 . . . . 1.0 112.495 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 tp -77.12 151.86 35.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.606 1.562 . . . . 1.0 111.701 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.1 -141.62 15.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.954 1.264 . . . . 1.0 113.964 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.34 -169.11 3.18 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 129.101 2.96 . . . . 1.0 111.208 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.704 HG23 ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 78.54 157.81 0.14 Allowed Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 128.864 2.866 . . . . 1.0 115.398 171.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.704 ' HD2' HG23 ' A' ' 57' ' ' VAL . 61.0 Cg_endo -73.58 175.04 11.23 Favored 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 125.015 3.81 . . . . 1.0 114.545 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 41.28 69.14 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.877 2.071 . . . . 1.0 111.293 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.65 -18.63 72.74 Favored Glycine 0 C--N 1.346 1.096 0 C-N-CA 127.081 2.277 . . . . 1.0 117.518 -168.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 t 154.22 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 129.624 3.169 . . . . 1.0 112.715 172.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.98 113.66 14.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.948 2.899 . . . . 1.0 109.1 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.53 118.24 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.291 -1.506 . . . . 1.0 107.961 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -112.21 151.6 29.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.922 2.089 . . . . 1.0 110.199 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.42 127.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.008 1.723 . . . . 1.0 109.363 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 mtt -128.52 107.5 9.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.604 0.762 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.47 108.81 21.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.166 0.984 . . . . 1.0 111.049 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.21 -154.02 6.75 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 128.638 3.018 . . . . 1.0 114.515 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 107.33 -72.42 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 1 C-N-CA 132.276 4.23 . . . . 1.0 109.434 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -47.06 -48.46 22.37 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.919 2.488 . . . . 1.0 113.631 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.48 8.24 44.7 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.04 1.736 . . . . 1.0 113.933 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 94.66 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 131.466 3.906 . . . . 1.0 111.212 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -157.92 65.95 0.47 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.329 1.974 . . . . 1.0 116.329 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -57.73 -56.23 24.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.62 1.568 . . . . 1.0 113.259 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.03 8.34 6.79 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 120.971 3.693 . . . . 1.0 120.971 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 26.1 mp0 -60.11 133.56 56.21 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 121.645 2.02 . . . . 1.0 116.197 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.657 HD21 ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -138.63 166.2 24.96 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.164 2.586 . . . . 1.0 112.556 170.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.703 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -127.86 86.22 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.089 1.755 . . . . 1.0 110.479 169.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.322 46.3 t30 69.24 13.27 8.57 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.635 1.574 . . . . 1.0 114.149 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.657 ' H ' HD21 ' A' ' 77' ' ' LEU . . . -65.24 1.25 1.09 Allowed 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.077 1.351 . . . . 1.0 114.388 169.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.2 p -98.12 111.01 23.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.408 -1.33 . . . . 1.0 107.408 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.7 125.74 21.27 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.792 1.637 . . . . 1.0 112.127 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.78 154.33 17.82 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.039 2.536 . . . . 1.0 114.21 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -133.41 144.17 49.37 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.271 2.229 . . . . 1.0 107.153 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -84.24 0.53 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.585 1.554 . . . . 1.0 107.925 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 55.9 m-20 -82.69 57.01 3.58 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.739 1.216 . . . . 1.0 108.585 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 86' ' ' ASN . 5.4 pt20 56.94 19.98 4.98 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 130.904 3.681 . . . . 1.0 117.931 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.55 135.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 114.804 1.409 . . . . 1.0 114.804 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.98 26.92 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.479 2.311 . . . . 1.0 110.664 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -136.17 142.33 44.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.185 2.194 . . . . 1.0 110.905 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . 0.277 1.4 t80 147.44 -111.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 129.946 3.298 . . . . 1.0 112.973 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 p30 177.3 41.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 127.814 2.446 . . . . 1.0 115.261 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.21 -33.66 49.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 130.018 3.327 . . . . 1.0 115.042 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 2.3 pt? -66.39 139.36 58.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.174 2.589 . . . . 1.0 117.893 -172.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 3.2 mtt85 -140.63 116.58 10.42 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.628 1.558 . . . . 1.0 112.394 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.552 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 35.5 m-85 -83.07 145.93 29.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.033 1.733 . . . . 1.0 113.561 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 100' ' ' SER . 2.4 t 60.45 6.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 127.371 2.268 . . . . 1.0 114.424 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 41' ' ' CYS . . . -9.74 -24.71 0.0 OUTLIER Glycine 0 CA--C 1.547 2.035 2 C-N-CA 136.446 6.736 . . . . 1.0 123.646 -173.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.568 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 15.1 ttt180 -165.93 6.13 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.392 3.077 . . . . 1.0 114.785 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.485 ' HB2' HG13 ' A' ' 97' ' ' VAL . 49.1 m -58.25 -59.94 4.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.958 2.503 . . . . 1.0 114.946 -172.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.86 -174.22 20.27 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 125.441 1.496 . . . . 1.0 114.4 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 109.67 21.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.825 2.45 . . . . 1.0 111.735 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.97 -11.63 3.36 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 126.733 2.111 . . . . 1.0 116.303 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.856 2.462 . . . . 1.0 112.894 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.715 ' HB2' HG13 ' A' ' 126' ' ' ILE . 25.1 p -108.61 130.01 55.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.443 2.297 . . . . 1.0 110.483 172.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -85.22 83.87 7.86 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.048 0.928 . . . . 1.0 112.655 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 m -70.45 92.61 0.83 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.715 1.606 . . . . 1.0 110.162 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.42 101.55 2.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.196 1.398 . . . . 1.0 110.03 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.7 p -86.44 100.15 12.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.606 1.962 . . . . 1.0 109.669 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 25' ' ' THR . 4.1 mp -88.28 110.2 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 100.909 -3.737 . . . . 1.0 100.909 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.0 m -112.61 109.61 19.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.889 1.675 . . . . 1.0 114.087 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.434 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 7.0 t -73.74 143.76 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 123.681 1.705 . . . . 1.0 109.834 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -110.99 10.39 22.17 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 131.573 3.949 . . . . 1.0 113.931 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.1 t -105.53 -179.45 3.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.731 1.613 . . . . 1.0 113.162 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -45.77 -53.11 21.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 126.915 2.086 . . . . 1.0 112.298 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.21 102.04 1.56 Allowed 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 124.705 3.603 . . . . 1.0 109.884 170.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.39 99.66 1.05 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.254 3.303 . . . . 1.0 109.411 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.434 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 16.6 mt-30 -108.19 97.23 6.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.873 0.844 . . . . 1.0 110.842 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.74 114.95 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.011 1.724 . . . . 1.0 108.398 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.11 159.54 20.74 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.722 2.409 . . . . 1.0 110.977 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.704 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.4 m -121.61 121.33 37.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.068 0.947 . . . . 1.0 111.308 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -87.95 120.18 29.03 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.344 0.975 . . . . 1.0 110.912 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -130.6 122.12 26.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.99 2.516 . . . . 1.0 111.422 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.7 -52.1 0.11 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.613 1.565 . . . . 1.0 113.173 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.31 70.85 0.75 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.246 2.218 . . . . 1.0 109.401 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.715 HG13 ' HB2' ' A' ' 105' ' ' SER . 8.6 tp -47.14 -14.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 129.676 3.19 . . . . 1.0 118.296 -171.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -87.13 152.29 22.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 130.807 3.643 . . . . 1.0 115.765 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.58 162.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 128.025 2.53 . . . . 1.0 114.111 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.7 t -75.05 133.07 41.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.11 0.964 . . . . 1.0 112.74 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.74 -58.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.508 1.923 . . . . 1.0 113.196 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -53.77 -37.94 63.96 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.307 1.843 . . . . 1.0 114.452 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 43.65 69.46 0.67 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 127.533 2.492 . . . . 1.0 114.572 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.73 66.53 1.75 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 125.11 3.873 . . . . 1.0 114.395 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.22 8.25 0.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 130.672 3.589 . . . . 1.0 117.09 173.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.487 1.403 1 C-N-CA 132.895 4.478 . . . . 1.0 112.926 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -152.52 -173.68 4.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 131.336 3.854 . . . . 1.0 105.063 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 32' ' ' CYS 0.356 9.9 m -69.01 72.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.54 1.973 . . . . 1.0 109.926 170.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -51.13 158.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.355 2.262 . . . . 1.0 113.54 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 30' ' ' PHE 0.296 9.0 t -101.94 -120.77 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.365 -0.826 . . . . 1.0 110.745 177.155 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -55.88 -37.83 69.35 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.354 1.434 . . . . 1.0 113.169 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 m -136.86 156.83 75.74 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 127.648 2.379 . . . . 1.0 112.663 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -2.4 6.71 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.228 3.285 . . . . 1.0 115.041 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.79 -27.49 60.34 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.03 2.932 . . . . 1.0 114.024 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.631 ' HB2' HG22 ' A' ' 25' ' ' THR . 2.5 m-85 -118.6 108.35 14.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.677 1.591 . . . . 1.0 107.706 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.3 mt -115.12 135.02 54.64 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.894 2.878 . . . . 1.0 112.729 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.719 ' HB2' HG23 ' A' ' 23' ' ' VAL . 4.5 m -118.88 160.09 22.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.899 1.28 . . . . 1.0 112.505 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -138.93 100.02 3.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.413 2.285 . . . . 1.0 108.655 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -137.23 162.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 129.111 2.964 . . . . 1.0 109.362 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -103.57 155.06 37.39 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.394 1.078 . . . . 1.0 110.607 170.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 35' ' ' LEU . 17.1 Cg_exo -51.69 149.85 18.15 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.915 3.077 . . . . 1.0 115.559 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 96' ' ' PHE . 12.9 t -127.85 29.29 5.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 127.12 2.168 . . . . 1.0 114.23 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -64.2 37.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 127.495 2.318 . . . . 1.0 116.195 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -162.28 162.65 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 129.184 2.994 . . . . 1.0 111.746 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' ' 101' ' ' GLY . 0.7 OUTLIER -79.22 150.84 31.5 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.536 1.935 . . . . 1.0 113.987 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.7 t 49.13 71.76 0.35 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.645 1.978 . . . . 1.0 112.53 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -50.69 -39.46 51.31 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.226 1.565 . . . . 1.0 115.226 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt 62.75 171.78 0.14 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.575 2.75 . . . . 1.0 114.541 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -74.82 79.17 2.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.047 1.339 . . . . 1.0 110.741 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 47' ' ' ILE . 22.6 mt -69.37 146.25 96.35 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 125.616 1.566 . . . . 1.0 111.821 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.67 -3.73 8.49 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.098 3.199 . . . . 1.0 116.074 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 45' ' ' LEU . 35.9 pt -59.44 -30.67 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.05 2.94 . . . . 1.0 115.698 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.55 173.5 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 127.331 2.252 . . . . 1.0 114.752 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 94' ' ' LEU . 16.6 m-85 -144.99 151.58 38.81 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -174.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 10.4 tttp -143.92 148.45 35.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.544 1.937 . . . . 1.0 112.525 172.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' A' ' 50' ' ' LYS . 14.0 m -136.97 143.2 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.15 2.18 . . . . 1.0 111.013 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.89 119.5 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 128.077 2.551 . . . . 1.0 108.782 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.65 107.2 9.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.495 1.118 . . . . 1.0 110.744 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mt -90.56 118.07 29.73 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.969 1.707 . . . . 1.0 112.531 -172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.18 -167.69 30.13 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 127.555 2.502 . . . . 1.0 114.07 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.77 -4.42 25.0 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 115.451 1.648 . . . . 1.0 115.451 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.06 142.8 55.97 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.445 1.498 . . . . 1.0 112.081 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.91 -38.89 27.27 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 124.501 3.467 . . . . 1.0 112.951 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.88 -167.62 1.95 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 126.838 2.055 . . . . 1.0 110.542 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.04 -55.73 0.86 Allowed Glycine 0 C--N 1.344 0.984 0 O-C-N 120.032 -1.668 . . . . 1.0 113.091 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t 152.28 -177.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 129.264 3.025 . . . . 1.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.49 116.14 21.33 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.534 2.334 . . . . 1.0 110.542 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 p -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 120.451 -1.406 . . . . 1.0 109.3 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -123.0 123.55 41.14 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.118 1.367 . . . . 1.0 113.307 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 80' ' ' ALA . 2.6 m -96.26 116.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.549 -1.344 . . . . 1.0 108.261 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 93.2 mtp -122.82 113.32 19.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.59 115.12 26.9 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 120.806 1.639 . . . . 1.0 114.071 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.43 -149.48 6.99 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 129.386 3.374 . . . . 1.0 112.451 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' GLU . 67.0 t30 -156.78 40.5 0.33 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.021 1.728 . . . . 1.0 112.145 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 62.85 -26.6 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.778 2.831 . . . . 1.0 114.453 -170.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -140.02 84.52 1.97 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 132.142 4.177 . . . . 1.0 106.702 169.668 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.86 -45.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.876 1.67 . . . . 1.0 113.725 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 43.57 23.72 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.543 3.137 . . . . 1.0 117.25 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -49.28 -30.4 7.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.34 2.656 . . . . 1.0 115.0 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.06 -75.24 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.412 2.285 . . . . 1.0 114.915 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 33.81 99.17 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 131.474 3.909 . . . . 1.0 116.419 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -131.93 165.46 23.85 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.868 1.267 . . . . 1.0 113.377 174.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.66 84.24 2.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.104 2.162 . . . . 1.0 109.797 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.25 8.62 6.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.434 1.493 . . . . 1.0 114.376 -173.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -70.22 13.95 0.14 Allowed 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 120.958 1.708 . . . . 1.0 113.645 168.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 m -100.33 110.52 22.75 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.53 125.02 13.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.979 0.912 . . . . 1.0 113.402 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.09 155.89 17.75 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.21 1.404 . . . . 1.0 113.155 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 63.1 mtp -127.17 148.33 50.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 128.907 2.883 . . . . 1.0 107.889 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -126.53 -73.13 0.63 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.869 1.268 . . . . 1.0 114.287 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -72.93 33.5 0.07 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.419 1.488 . . . . 1.0 111.448 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 62.0 14.24 6.28 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.114 2.966 . . . . 1.0 114.544 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.63 152.61 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 129.556 3.142 . . . . 1.0 112.339 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 91' ' ' PHE . . . -137.91 146.93 43.89 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.248 1.819 . . . . 1.0 113.895 170.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -132.66 123.7 26.85 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 128.199 2.599 . . . . 1.0 111.312 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -172.15 173.39 4.31 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.813 1.783 . . . . 1.0 115.813 -174.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -141.44 1.36 1.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.528 1.931 . . . . 1.0 114.926 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -28.35 59.25 Favored 'General case' 0 CA--C 1.545 0.786 1 C-N-CA 131.824 4.05 . . . . 1.0 115.161 -172.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 6.8 mp -55.53 129.49 39.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.407 2.283 . . . . 1.0 112.176 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 36.4 mtm180 -137.47 123.14 19.85 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.555 1.07 . . . . 1.0 111.741 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.408 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 2.3 m-85 -93.28 143.52 26.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.481 2.712 . . . . 1.0 110.611 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 0.7 OUTLIER 44.61 46.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 125.677 1.591 . . . . 1.0 112.516 -175.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -35.37 -92.27 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 1 C-N-CA 132.956 5.074 . . . . 1.0 116.945 -171.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttp-105 -73.11 42.41 0.11 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.913 2.085 . . . . 1.0 113.94 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 t 73.04 157.21 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 131.596 3.958 . . . . 1.0 115.638 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' ' HB2' ' A' ' 40' ' ' ARG . . . -149.95 169.14 30.06 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 127.982 2.706 . . . . 1.0 112.632 173.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -160.53 142.9 12.89 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.446 1.898 . . . . 1.0 112.465 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.506 ' C ' ' HE2' ' A' ' 127' ' ' LYS . . . 57.72 30.72 63.02 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.298 1.428 . . . . 1.0 116.547 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -126.61 156.87 40.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.146 2.579 . . . . 1.0 112.559 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -109.45 147.44 32.85 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.865 2.466 . . . . 1.0 110.931 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.782 ' CE1' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.25 89.27 7.8 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.229 1.811 . . . . 1.0 111.778 -173.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.4 m -77.39 74.68 3.95 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.642 1.577 . . . . 1.0 110.119 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.782 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 9.0 tt -61.54 119.52 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.229 -0.919 . . . . 1.0 108.968 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 t -127.82 139.97 52.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 123.445 1.593 . . . . 1.0 114.814 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.37 113.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -102.6 114.89 29.49 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.792 1.237 . . . . 1.0 111.894 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 1.2 t -72.26 151.77 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 123.235 1.493 . . . . 1.0 112.446 -174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -102.0 25.35 8.83 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 129.024 2.93 . . . . 1.0 116.671 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.608 HG23 ' HD2' ' A' ' 116' ' ' PRO . 13.6 t -132.31 176.34 8.49 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.687 1.195 . . . . 1.0 113.828 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 70.2 m-80 -43.0 -47.33 13.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 128.213 2.605 . . . . 1.0 113.062 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD2' HG23 ' A' ' 114' ' ' THR . 95.7 Cg_endo -87.96 95.99 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 124.983 3.789 . . . . 1.0 108.272 168.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.85 109.11 1.21 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.656 2.904 . . . . 1.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.407 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -97.65 103.45 15.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.316 1.531 . . . . 1.0 108.772 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.68 114.94 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.882 2.073 . . . . 1.0 108.976 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.73 142.95 50.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.455 2.302 . . . . 1.0 110.77 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 t -121.95 146.5 47.08 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.552 1.541 . . . . 1.0 113.246 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -87.51 128.79 35.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.947 1.356 . . . . 1.0 112.865 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -63.16 103.44 0.48 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.755 2.422 . . . . 1.0 111.591 172.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 96.78 125.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 1 C-N-CA 132.212 4.205 . . . . 1.0 109.285 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.92 -21.1 10.27 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.325 1.602 . . . . 1.0 115.325 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 38.53 122.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 131.144 3.778 . . . . 1.0 115.866 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 103' ' ' GLY . 21.5 tttt -75.55 137.74 41.04 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.979 -1.7 . . . . 1.0 110.689 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -91.59 141.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.838 1.655 . . . . 1.0 113.468 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.2 t -88.67 142.89 27.31 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.533 0.938 . . . . 1.0 113.533 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.64 -53.52 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.521 1.529 . . . . 1.0 110.445 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.37 -70.5 0.74 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.921 2.889 . . . . 1.0 111.378 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.176 0 C-N-CA 126.147 1.832 . . . . 1.0 115.829 -177.117 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 114.322 1.231 . . . . 1.0 114.322 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -148.94 -173.23 4.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 131.138 3.775 . . . . 1.0 105.074 -173.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.89 73.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 O-C-N 120.119 -1.613 . . . . 1.0 107.652 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.603 ' HB2' ' CG ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -60.63 169.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.034 0.933 . . . . 1.0 111.978 169.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.8 p -133.06 -105.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.29 1.036 . . . . 1.0 109.972 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 121' ' ' THR . 1.1 m-20 -143.09 64.83 1.35 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.812 2.845 . . . . 1.0 108.425 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.1 m -157.05 161.61 29.16 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 119.884 -1.76 . . . . 1.0 115.158 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.26 146.74 95.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.259 1.973 . . . . 1.0 109.677 169.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 52.96 32.99 13.66 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 124.867 1.267 . . . . 1.0 113.881 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.603 ' CG ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.61 110.36 16.01 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.895 1.443 . . . . 1.0 114.895 -173.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 1.7 pp -140.08 115.48 9.95 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.562 1.545 . . . . 1.0 113.304 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.788 ' HB2' ' HA ' ' A' ' 51' ' ' VAL 0.253 0.0 OUTLIER -127.15 165.39 19.65 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 123.533 1.635 . . . . 1.0 114.826 175.512 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.626 ' HB2' ' HG2' ' A' ' 50' ' ' LYS . 66.6 m -151.47 93.2 1.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.104 2.962 . . . . 1.0 108.933 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.29 150.06 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 131.152 3.781 . . . . 1.0 107.797 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -65.22 174.35 1.43 Allowed Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 123.803 0.841 . . . . 1.0 113.141 175.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -60.3 165.26 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.105 2.537 . . . . 1.0 113.786 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.8 t -125.0 9.63 8.13 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.44 1.896 . . . . 1.0 114.691 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -67.51 47.69 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.954 2.502 . . . . 1.0 115.747 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.86 173.57 14.36 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.187 1.921 . . . . 1.0 116.187 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.669 ' HD2' ' HB2' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.0 122.97 38.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 128.1 2.56 . . . . 1.0 110.717 177.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.1 t 62.8 95.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.74 2.016 . . . . 1.0 113.769 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.644 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 22.4 t-20 -39.65 -46.04 1.76 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.151 2.181 . . . . 1.0 112.924 171.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 51.7 tttt 74.14 177.33 0.23 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 129.163 2.985 . . . . 1.0 112.25 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 97.6 m -61.18 -33.93 74.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.906 1.282 . . . . 1.0 114.138 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 92' ' ' ASN . 43.6 mt 51.22 87.16 0.14 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 127.126 2.17 . . . . 1.0 114.657 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.9 61.62 0.59 Allowed 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 125.092 3.862 . . . . 1.0 113.489 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 136.85 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 1 C-N-CA 132.431 4.292 . . . . 1.0 108.337 -178.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.38 24.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.845 1.658 . . . . 1.0 111.968 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.05 150.46 42.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.888 1.675 . . . . 1.0 112.113 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.626 ' HG2' ' HB2' ' A' ' 33' ' ' SER . 3.4 ptmm? -131.37 108.8 9.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.759 2.023 . . . . 1.0 108.521 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.788 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . 57.3 t -131.31 121.87 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 117.507 -1.235 . . . . 1.0 109.293 -172.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.47 120.71 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.805 1.642 . . . . 1.0 110.451 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 27' ' ' SER . . . -133.07 106.68 7.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.024 -1.843 . . . . 1.0 106.024 170.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 155.32 37.67 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.086 2.254 . . . . 1.0 117.086 -169.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.39 -26.52 0.97 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.546 2.022 . . . . 1.0 115.218 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.11 86.87 7.34 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.826 2.45 . . . . 1.0 112.225 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.6 -50.02 67.37 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-O 117.573 -1.204 . . . . 1.0 110.042 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 114' ' ' THR . 56.5 Cg_endo -81.58 129.86 6.66 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.294 3.329 . . . . 1.0 111.058 170.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.11 169.34 12.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.131 2.172 . . . . 1.0 115.492 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.13 3.23 45.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.936 2.207 . . . . 1.0 115.241 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.72 ' CG2' ' HB2' ' A' ' 84' ' ' MET . 13.8 t -53.82 121.03 7.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.618 1.709 . . . . 1.0 112.537 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.06 102.77 12.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.832 1.301 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 110' ' ' ILE . 84.0 t -92.03 107.62 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.901 -1.889 . . . . 1.0 105.901 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.5 p -107.76 118.14 35.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.196 -0.911 . . . . 1.0 113.167 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.339 0.5 OUTLIER -107.0 112.98 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.377 -1.452 . . . . 1.0 111.152 -177.559 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 mtt -139.51 171.28 14.48 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.615 1.566 . . . . 1.0 114.591 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . . . -125.83 112.36 15.92 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.76 178.17 40.07 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 128.232 2.825 . . . . 1.0 115.623 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 73' ' ' TYR . 33.6 p-10 -121.74 -61.9 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.789 2.435 . . . . 1.0 108.48 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -113.89 46.73 1.27 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 131.222 3.809 . . . . 1.0 106.534 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 64.82 -26.94 0.09 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.77 2.828 . . . . 1.0 114.209 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -102.35 49.33 0.85 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 129.495 3.118 . . . . 1.0 115.329 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.656 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 4.5 t80 -132.35 -19.2 2.48 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.903 1.681 . . . . 1.0 115.076 173.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 m 14.92 72.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 132.111 4.164 . . . . 1.0 114.654 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.04 149.34 6.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.129 2.172 . . . . 1.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -51.92 142.57 15.28 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.045 2.138 . . . . 1.0 114.161 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -127.59 168.56 14.82 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.495 2.318 . . . . 1.0 112.615 178.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -136.01 102.94 5.19 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.22 1.808 . . . . 1.0 108.536 172.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.9 m120 79.71 -9.03 1.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 117.171 -1.395 . . . . 1.0 111.99 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 77' ' ' LEU 0.259 . . -68.91 20.82 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 122.298 2.317 . . . . 1.0 115.228 174.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -126.29 113.58 17.13 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.353 1.861 . . . . 1.0 109.591 168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.5 151.63 41.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.561 1.545 . . . . 1.0 112.274 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 129.53 40.41 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 127.026 2.13 . . . . 1.0 111.589 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.72 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -124.71 168.93 12.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.165 1.386 . . . . 1.0 113.682 -171.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 2.6 mptt -96.0 -72.05 0.65 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.187 2.595 . . . . 1.0 112.567 -168.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.7 48.39 1.7 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 129.836 3.254 . . . . 1.0 106.475 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.9 26.41 7.82 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.472 2.709 . . . . 1.0 113.143 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 85' ' ' LYS . 12.8 p -92.76 114.35 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 127.955 2.502 . . . . 1.0 112.169 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.06 146.54 24.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.776 2.031 . . . . 1.0 113.181 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 91' ' ' PHE . 20.7 ttp180 -136.69 157.36 46.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.719 2.808 . . . . 1.0 111.796 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.431 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 0.8 OUTLIER 51.33 -139.69 0.94 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.225 1.81 . . . . 1.0 112.654 176.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 45' ' ' LEU . 55.5 t-20 -135.41 109.19 8.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.922 1.237 . . . . 1.0 113.306 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -149.7 68.13 1.01 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.132 2.573 . . . . 1.0 108.458 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -160.88 118.56 2.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.795 1.638 . . . . 1.0 112.266 172.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 38.3 mtp180 -136.75 119.38 16.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 114.212 1.19 . . . . 1.0 114.212 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.644 ' H ' ' HB2' ' A' ' 42' ' ' ASN . 5.5 p90 -93.64 165.75 12.57 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.455 2.302 . . . . 1.0 116.598 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t 46.76 35.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 129.742 3.217 . . . . 1.0 114.584 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.51 -41.46 41.55 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.315 2.388 . . . . 1.0 114.843 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -76.28 -9.24 58.48 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.873 2.069 . . . . 1.0 115.852 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.669 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 4.6 t 58.71 -177.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.165 1.386 . . . . 1.0 114.483 -175.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.15 129.57 3.45 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 128.186 2.803 . . . . 1.0 113.716 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -68.04 164.07 20.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.626 1.97 . . . . 1.0 112.145 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.49 27.64 58.98 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -115.96 150.34 37.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.871 1.668 . . . . 1.0 114.152 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 t -125.21 122.22 36.39 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.319 3.448 . . . . 1.0 110.077 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -84.64 133.6 34.4 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.075 1.88 . . . . 1.0 116.075 -170.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -122.19 105.15 9.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.687 2.395 . . . . 1.0 115.162 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' TYR . 4.8 tt -79.43 90.04 5.03 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.103 -2.184 . . . . 1.0 105.103 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.3 m -92.25 101.47 13.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.799 2.84 . . . . 1.0 110.27 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 63' ' ' VAL . 62.8 mt -92.32 121.14 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.429 1.492 . . . . 1.0 108.015 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -122.93 118.1 27.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.323 1.014 . . . . 1.0 112.14 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.4 OUTLIER -71.7 170.67 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 122.929 1.347 . . . . 1.0 113.286 -176.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 33.3 5.0 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.207 2.203 . . . . 1.0 114.82 -174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.662 HG21 ' HG2' ' A' ' 58' ' ' PRO . 14.2 t -126.64 175.37 8.0 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.019 1.728 . . . . 1.0 112.132 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.52 -49.29 89.38 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 125.981 1.712 . . . . 1.0 113.483 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' A' ' 114' ' ' THR . 68.2 Cg_endo -76.91 111.16 3.18 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 124.348 3.365 . . . . 1.0 110.237 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.79 105.87 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.122 3.215 . . . . 1.0 112.473 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.688 ' H ' HG12 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -100.1 98.72 9.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.793 0.806 . . . . 1.0 109.466 -175.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.59 133.6 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.421 . . . . 1.0 111.744 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.14 154.87 49.17 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.22 1.408 . . . . 1.0 112.828 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 63.3 m -128.32 149.46 50.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.331 1.852 . . . . 1.0 111.596 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 82.9 t80 -83.74 165.47 18.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.579 1.951 . . . . 1.0 112.705 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -57.96 62.73 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 126.177 1.791 . . . . 1.0 111.461 169.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -87.82 98.31 11.4 Favored 'General case' 0 N--CA 1.469 0.502 1 C-N-CA 131.982 4.113 . . . . 1.0 114.364 -170.495 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.83 -103.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.561 2.745 . . . . 1.0 104.862 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 43.15 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 129.388 3.075 . . . . 1.0 113.304 170.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -138.56 161.35 37.3 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.133 1.773 . . . . 1.0 114.684 173.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.3 tt -93.1 146.12 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 127.654 2.382 . . . . 1.0 111.693 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 t -70.33 137.0 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.008 0.744 . . . . 1.0 113.008 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -91.57 -15.55 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.146 1.378 . . . . 1.0 113.424 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -67.64 0.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.606 2.762 . . . . 1.0 112.309 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.862 0 C-N-CA 129.366 3.365 . . . . 1.0 113.629 178.202 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 12.9 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.459 -0.782 . . . . 1.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mt -146.65 -173.61 4.25 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 128.545 2.738 . . . . 1.0 104.989 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 2.4 t -69.77 71.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 119.458 -2.027 . . . . 1.0 109.664 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.97 172.11 0.09 Allowed 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.498 1.666 . . . . 1.0 115.498 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 30' ' ' PHE . 8.2 t -108.28 -135.1 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.814 1.645 . . . . 1.0 108.528 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.2 -47.45 24.26 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.462 1.905 . . . . 1.0 111.579 170.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.5 m -131.38 159.12 73.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.485 1.914 . . . . 1.0 111.843 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.94 -7.32 20.86 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 123.882 3.055 . . . . 1.0 116.191 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -67.18 -36.11 81.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.802 2.441 . . . . 1.0 114.398 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 25' ' ' THR . 75.4 m-85 -104.49 109.72 21.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.189 2.196 . . . . 1.0 110.405 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 155.52 22.48 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.629 1.714 . . . . 1.0 115.629 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 2.7 m -132.41 164.75 25.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.311 2.245 . . . . 1.0 112.038 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 42.9 m -153.4 91.24 1.48 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.455 2.302 . . . . 1.0 108.488 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.82 149.37 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 129.414 3.086 . . . . 1.0 108.933 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.837 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -83.7 178.88 2.16 Favored Pre-proline 0 CA--C 1.561 1.381 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -175.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 50.6 Cg_endo -66.3 48.06 0.25 Allowed 'Trans proline' 0 CA--C 1.557 1.656 1 C-N-CA 125.615 4.21 . . . . 1.0 116.581 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -65.02 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 129.144 2.978 . . . . 1.0 114.04 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.778 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 5.4 p-80 -55.21 69.45 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.98 1 C-N-CA 132.198 4.199 . . . . 1.0 114.4 174.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -154.62 169.29 24.22 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.169 2.188 . . . . 1.0 112.848 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.17 116.29 7.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.533 2.333 . . . . 1.0 110.737 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t 59.04 84.21 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.584 1.954 . . . . 1.0 110.516 -169.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -38.21 73.17 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.334 0.654 . . . . 1.0 112.743 -174.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 tttt 71.77 160.29 0.22 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 131.436 3.894 . . . . 1.0 114.71 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -72.79 68.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.557 1.543 . . . . 1.0 109.907 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 23.3 mt -68.07 159.75 78.21 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.862 1.265 . . . . 1.0 113.704 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.59 -8.37 22.09 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.373 3.382 . . . . 1.0 116.465 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -65.39 -14.65 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.401 1.88 . . . . 1.0 115.541 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.827 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . . . 66.09 175.72 0.23 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.725 2.41 . . . . 1.0 112.982 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -131.31 84.06 2.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.672 1.589 . . . . 1.0 109.784 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 86.8 mttt -87.25 111.59 21.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 105.366 -2.087 . . . . 1.0 105.366 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 87' ' ' GLN . 14.7 p -133.97 122.19 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.95 1.7 . . . . 1.0 107.819 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.8 t -139.06 148.25 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 128.377 2.671 . . . . 1.0 112.588 -172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.85 143.89 49.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.394 -1.441 . . . . 1.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.73 113.26 21.18 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.112 0.482 . . . . 1.0 110.513 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.05 -178.16 37.12 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.412 2.435 . . . . 1.0 114.173 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -176.37 0.72 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 126.129 1.771 . . . . 1.0 115.457 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.4 95.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 125.441 1.497 . . . . 1.0 113.692 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.25 -4.0 5.92 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 124.616 3.544 . . . . 1.0 117.944 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 29.23 79.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 130.159 3.383 . . . . 1.0 115.552 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.23 51.57 0.01 OUTLIER Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.841 1.21 . . . . 1.0 113.574 -171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.434 HG22 HD11 ' A' ' 110' ' ' ILE . 84.7 m -129.54 94.05 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.138 1.775 . . . . 1.0 108.604 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -91.12 117.46 29.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.47 1.508 . . . . 1.0 111.627 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.97 111.84 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 105.678 -1.971 . . . . 1.0 105.678 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 81' ' ' THR . 35.1 p -112.56 114.03 26.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.707 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.269 0.1 OUTLIER -125.77 111.55 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.478 -1.389 . . . . 1.0 113.425 -170.346 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.518 ' HG2' ' H ' ' A' ' 67' ' ' ALA . 15.8 ttm -138.8 172.7 12.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.728 2.121 . . . . 1.0 116.728 -172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.958 ' HB1' ' HB2' ' A' ' 105' ' ' SER . . . -98.45 143.94 28.34 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.724 1.249 . . . . 1.0 110.278 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.55 100.07 0.21 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 128.019 2.723 . . . . 1.0 112.424 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 27.6 t-20 -124.05 -39.21 2.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.765 2.426 . . . . 1.0 109.629 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.9 -45.3 30.46 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 129.012 2.925 . . . . 1.0 112.706 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -144.03 -11.94 0.65 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.46 2.304 . . . . 1.0 116.256 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 m120 84.37 151.78 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 130.525 3.53 . . . . 1.0 110.367 -170.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 33.26 43.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 128.519 2.728 . . . . 1.0 114.862 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -83.52 -26.27 30.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.331 3.052 . . . . 1.0 114.482 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . . . -141.65 122.2 14.18 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 120.167 1.349 . . . . 1.0 112.088 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -58.23 172.13 0.48 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.13 2.27 . . . . 1.0 117.13 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.848 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.8 pp -116.07 167.27 11.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.637 3.175 . . . . 1.0 110.816 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 3.4 mtp180 -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.577 -0.702 . . . . 1.0 110.212 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.34 12.21 4.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.259 1.824 . . . . 1.0 111.65 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -62.92 7.11 0.09 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.171 1.388 . . . . 1.0 114.35 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 64' ' ' THR . 48.6 p -105.98 110.76 23.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.479 1.111 . . . . 1.0 109.705 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.29 135.21 30.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.353 1.461 . . . . 1.0 111.613 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.32 144.06 25.77 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.786 2.034 . . . . 1.0 112.345 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.3 mtm -151.88 -173.72 4.62 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.316 1.846 . . . . 1.0 111.69 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -110.89 -96.82 0.41 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.477 2.311 . . . . 1.0 109.146 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.14 56.57 4.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.951 2.101 . . . . 1.0 108.836 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.678 ' HG2' HG22 ' A' ' 51' ' ' VAL . 19.0 tt0 51.25 32.46 8.21 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.801 1.64 . . . . 1.0 113.539 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.12 115.39 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.821 2.049 . . . . 1.0 111.845 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.7 147.52 50.11 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.618 1.567 . . . . 1.0 112.102 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 152.71 32.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.76 2.424 . . . . 1.0 111.911 -174.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.6 t80 57.38 -138.63 0.91 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.651 1.98 . . . . 1.0 112.405 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.827 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 32.3 t-20 -138.58 137.56 37.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.929 1.692 . . . . 1.0 110.9 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 t0 175.12 67.12 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.939 2.496 . . . . 1.0 112.75 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.689 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -160.52 142.74 12.8 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.14 2.576 . . . . 1.0 109.327 171.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 33.0 mtp180 -141.11 118.17 11.23 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.823 1.647 . . . . 1.0 113.897 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -94.07 153.09 18.33 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.456 1.122 . . . . 1.0 113.287 -175.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' A' ' 67' ' ' ALA 0.285 2.6 m 49.12 33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.553 2.741 . . . . 1.0 114.476 171.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.66 25.76 0.1 Allowed Glycine 0 CA--C 1.537 1.43 1 C-N-CA 131.796 4.522 . . . . 1.0 118.002 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.25 9.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 129.237 3.015 . . . . 1.0 111.665 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.2 p -67.59 92.68 0.33 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.692 2.797 . . . . 1.0 110.467 170.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.92 -133.71 4.15 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.55 2.5 . . . . 1.0 113.559 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -66.51 168.58 8.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.96 1.704 . . . . 1.0 112.419 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.34 -81.08 0.2 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.353 0.977 . . . . 1.0 111.019 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 94.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.291 1.837 . . . . 1.0 109.621 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.958 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -125.32 108.68 11.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.451 0.7 . . . . 1.0 111.813 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 56.7 t80 -139.21 93.43 2.68 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 128.093 2.557 . . . . 1.0 115.045 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.262 19.4 m -137.61 60.33 1.64 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.034 1.397 . . . . 1.0 109.248 169.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.06 97.18 10.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.59 1.956 . . . . 1.0 108.512 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.0 p -125.62 168.67 13.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.619 2.452 . . . . 1.0 117.619 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 61' ' ' THR . 5.0 tp -123.13 115.79 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.696 2.798 . . . . 1.0 107.666 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -123.7 108.51 12.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.415 2.286 . . . . 1.0 113.569 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 2.4 t -72.34 147.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.02 -1.675 . . . . 1.0 111.648 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -115.7 48.52 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 1 C-N-CA 132.668 4.387 . . . . 1.0 110.533 -172.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 116' ' ' PRO . 98.4 m -147.23 162.75 38.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 119.878 -1.764 . . . . 1.0 110.374 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.72 -42.71 11.23 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 126.308 1.843 . . . . 1.0 115.084 -173.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HD2' HG22 ' A' ' 114' ' ' THR . 74.9 Cg_endo -88.51 98.64 0.39 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.05 3.833 . . . . 1.0 107.619 168.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.06 118.23 5.56 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.3 2.667 . . . . 1.0 111.564 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.603 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 68.8 mt-30 -109.67 96.85 6.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.725 0.81 . . . . 1.0 110.877 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 m -107.85 122.43 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.982 2.113 . . . . 1.0 112.145 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.02 168.36 19.93 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.82 2.448 . . . . 1.0 112.33 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.3 m -117.31 145.81 43.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.053 -1.654 . . . . 1.0 113.335 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 123' ' ' HIS . 23.6 t80 -87.56 115.77 25.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 1.0 107.539 171.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 74.34 170.95 0.29 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.764 2.026 . . . . 1.0 113.984 -172.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -133.98 23.97 3.9 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.197 2.599 . . . . 1.0 113.38 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.64 119.39 14.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.863 2.065 . . . . 1.0 110.357 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.82 86.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.851 2.06 . . . . 1.0 110.624 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.778 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 11.9 mmtp -126.78 81.57 2.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.883 2.073 . . . . 1.0 111.638 -174.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.25 119.05 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 126.492 1.917 . . . . 1.0 109.992 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.5 m -82.57 123.37 29.15 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.697 1.599 . . . . 1.0 110.364 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.13 -35.45 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -40.46 7.38 Favored 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 131.746 4.018 . . . . 1.0 113.967 174.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.194 0 C-N-CA 125.495 1.522 . . . . 1.0 115.325 176.57 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.98 -0.748 . . . . 1.0 108.98 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 9.3 tp -143.36 -174.67 4.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 104.373 -2.454 . . . . 1.0 104.373 162.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.93 74.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 121.993 2.179 . . . . 1.0 109.464 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' A' ' 28' ' ' PRO . 21.4 mtm105 -47.68 147.29 1.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.295 1.438 . . . . 1.0 112.898 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' A' ' 122' ' ' TYR . 10.8 t -86.43 -154.53 0.22 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.264 1.826 . . . . 1.0 110.984 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.51 -18.37 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.123 2.169 . . . . 1.0 115.355 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 t -144.03 137.24 13.97 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.212 1.805 . . . . 1.0 111.919 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.0 Cg_exo -53.61 -19.74 14.77 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.727 2.952 . . . . 1.0 116.64 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -66.33 -23.24 66.33 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.578 1.325 . . . . 1.0 114.578 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' HB2' HG22 ' A' ' 25' ' ' THR . 98.1 m-85 -125.34 124.07 40.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.897 1.279 . . . . 1.0 111.747 -174.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' CD2' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -139.28 154.62 47.98 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.485 1.661 . . . . 1.0 115.485 -171.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -141.75 164.51 30.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.916 1.686 . . . . 1.0 113.965 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 t -148.91 105.25 3.52 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 126.8 2.04 . . . . 1.0 109.378 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 167.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.217 1 C-N-CA 132.434 4.294 . . . . 1.0 110.346 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.747 ' HG ' ' HD2' ' A' ' 36' ' ' PRO . 1.2 tp -53.9 165.28 0.79 Allowed Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.439 2.295 . . . . 1.0 115.737 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.747 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 40.4 Cg_endo -63.61 146.1 92.24 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.998 3.798 . . . . 1.0 113.776 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.1 p -67.5 -23.85 65.51 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.914 2.086 . . . . 1.0 116.185 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -113.39 77.51 1.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.692 2.397 . . . . 1.0 109.116 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -155.94 165.62 35.93 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.873 3.269 . . . . 1.0 110.677 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.0 101.72 1.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.227 1.011 . . . . 1.0 110.657 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p 9.43 -107.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.545 2.738 . . . . 1.0 114.847 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 171.32 -57.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 1 C-N-CA 132.478 4.311 . . . . 1.0 110.738 170.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.0 OUTLIER 68.97 -1.25 2.13 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.526 2.33 . . . . 1.0 116.781 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 93' ' ' ASP 0.316 1.4 t 142.6 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 1 C-N-CA 131.799 4.04 . . . . 1.0 113.462 172.048 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.83 150.98 17.44 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 127.237 2.215 . . . . 1.0 112.028 171.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.55 35.96 0.45 Allowed 'Trans proline' 0 CA--C 1.554 1.515 1 C-N-CA 125.567 4.178 . . . . 1.0 115.115 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -35.48 -71.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 129.732 3.213 . . . . 1.0 115.709 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.47 -30.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.48 1.912 . . . . 1.0 113.403 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.299 1.8 p90 41.52 39.26 1.04 Allowed 'General case' 0 C--N 1.353 0.756 0 N-CA-C 118.742 2.867 . . . . 1.0 118.742 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -126.25 106.89 9.85 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.769 0.713 . . . . 1.0 112.129 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.56 128.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.182 1.393 . . . . 1.0 110.702 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.55 145.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.771 2.028 . . . . 1.0 114.764 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.26 20.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.679 2.392 . . . . 1.0 108.9 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.98 112.28 16.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.395 1.478 . . . . 1.0 109.408 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.8 -61.49 0.6 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.932 1.253 . . . . 1.0 114.923 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.54 -18.94 11.83 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 118.093 2.627 . . . . 1.0 118.093 -171.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 57' ' ' VAL . 53.3 t 44.46 59.42 13.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 127.121 2.168 . . . . 1.0 114.739 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 112' ' ' VAL . 94.1 Cg_endo -88.34 109.48 0.58 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.56 2.84 . . . . 1.0 113.488 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.26 134.86 57.43 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.408 -0.807 . . . . 1.0 111.427 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.18 31.97 27.04 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.744 -0.597 . . . . 1.0 111.901 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 84.7 m -71.11 77.73 0.68 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 170.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -78.87 112.84 16.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.925 2.49 . . . . 1.0 111.767 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.52 107.77 18.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.454 -2.054 . . . . 1.0 105.454 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 m -105.36 119.52 39.28 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.753 -1.567 . . . . 1.0 110.042 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.31 116.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.152 -0.968 . . . . 1.0 108.449 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -125.34 81.24 1.95 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.655 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -96.95 107.4 19.91 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.346 -1.471 . . . . 1.0 107.189 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -39.15 132.25 1.91 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.567 2.508 . . . . 1.0 115.837 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.564 ' HB2' HG23 ' A' ' 97' ' ' VAL . 5.4 m-80 170.74 -15.42 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.449 1 C-N-CA 131.797 4.039 . . . . 1.0 115.733 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 7.5 m-20 -58.05 -35.83 71.88 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.239 1.836 . . . . 1.0 112.749 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 148.26 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 1 C-N-CA 132.75 4.42 . . . . 1.0 115.414 172.966 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -156.84 -102.36 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 O-C-N 120.153 -1.592 . . . . 1.0 113.876 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.65 15.97 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.861 2.864 . . . . 1.0 113.543 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.1 m -168.63 111.9 0.57 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.277 1.831 . . . . 1.0 110.532 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -110.39 164.04 13.08 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.307 1.966 . . . . 1.0 116.307 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 156.78 21.41 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 126.577 1.951 . . . . 1.0 115.313 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -130.76 167.57 18.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.755 2.422 . . . . 1.0 112.409 -174.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.99 91.87 3.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.916 -1.74 . . . . 1.0 111.425 172.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 67.73 12.59 8.92 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.504 1.522 . . . . 1.0 113.058 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.51 ' HB2' ' N ' ' A' ' 95' ' ' ARG . . . -74.83 7.54 3.06 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 120.945 1.702 . . . . 1.0 112.491 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 113.2 24.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 130.089 3.356 . . . . 1.0 106.897 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.57 160.0 40.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.574 1.95 . . . . 1.0 109.89 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.2 46.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.783 1.633 . . . . 1.0 114.05 173.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.787 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 48.8 mtm -101.01 151.61 21.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 1.0 109.671 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -112.13 -80.2 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.466 1.506 . . . . 1.0 107.545 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -62.27 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.213 0.46 . . . . 1.0 110.044 170.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.02 22.6 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.106 1.762 . . . . 1.0 114.421 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -133.88 119.8 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 126.21 1.804 . . . . 1.0 112.836 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.14 143.77 46.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.635 1.574 . . . . 1.0 109.727 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -106.09 106.1 16.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.794 0.838 . . . . 1.0 109.039 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.63 73.05 5.18 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.052 1.741 . . . . 1.0 111.946 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -121.66 171.43 8.85 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 129.216 3.006 . . . . 1.0 110.531 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 1.4 t70 60.48 -20.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 130.179 3.391 . . . . 1.0 117.973 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -42.52 146.42 0.34 Allowed 'General case' 0 C--O 1.238 0.469 1 C-N-CA 133.11 4.564 . . . . 1.0 118.615 -171.441 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -139.95 129.21 23.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.21 -0.996 . . . . 1.0 111.104 170.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -119.85 135.88 54.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.13 1.772 . . . . 1.0 111.836 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 69' ' ' ASN 0.294 4.5 p 52.35 29.77 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 C-N-CA 125.043 1.337 . . . . 1.0 114.386 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.33 72.19 0.61 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 128.039 2.733 . . . . 1.0 113.345 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 132.27 84.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 1 C-N-CA 134.529 5.132 . . . . 1.0 109.425 -175.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . 7.5 m -78.53 162.05 26.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.849 0.685 . . . . 1.0 112.849 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.34 -23.77 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 117.507 1.763 . . . . 1.0 117.507 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 169.64 150.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 129.771 3.228 . . . . 1.0 111.902 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.07 53.41 14.67 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.186 1.374 . . . . 1.0 115.246 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 69' ' ' ASN . 3.9 mptt -68.53 92.34 0.45 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.092 1.757 . . . . 1.0 112.206 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t -122.52 160.85 24.77 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 129.773 3.229 . . . . 1.0 113.973 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -128.4 90.18 3.03 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.021 1.86 . . . . 1.0 116.021 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -101.65 77.45 1.74 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.859 1.664 . . . . 1.0 110.575 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.85 92.84 6.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.561 -1.337 . . . . 1.0 109.255 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.7 t -116.8 122.01 43.19 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.39 114.32 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.003 1.321 . . . . 1.0 108.88 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.9 m -100.83 109.5 21.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.031 2.132 . . . . 1.0 113.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 58' ' ' PRO . 53.7 t -76.39 103.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.411 -1.431 . . . . 1.0 108.462 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.19 3.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.122 1 C-N-CA 134.981 5.312 . . . . 1.0 117.215 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -84.09 178.42 7.84 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.949 2.1 . . . . 1.0 114.02 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 28.7 m-20 -44.93 -54.88 12.15 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.702 1.201 . . . . 1.0 109.814 171.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 48.1 Cg_endo -74.99 116.89 4.72 Favored 'Trans proline' 0 CA--C 1.556 1.575 0 C-N-CA 123.495 2.797 . . . . 1.0 107.984 168.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.23 94.29 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 124.401 3.401 . . . . 1.0 108.603 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.44 92.39 5.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 -172.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -108.22 124.59 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 1.0 112.228 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.08 26.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.123 1.369 . . . . 1.0 111.692 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.2 m -113.31 140.07 48.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.591 1.957 . . . . 1.0 111.008 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 1.1 t80 -118.33 139.69 50.97 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.725 1.61 . . . . 1.0 111.843 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.61 64.0 0.8 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.939 1.459 . . . . 1.0 114.939 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.827 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 20.2 tpt85 -59.56 -27.83 66.58 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.859 2.54 . . . . 1.0 117.859 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 51.6 82.26 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 128.345 2.658 . . . . 1.0 114.705 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.46 -89.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 126.192 1.797 . . . . 1.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -88.17 153.9 20.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.585 1.954 . . . . 1.0 110.787 172.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.57 113.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.68 1.192 . . . . 1.0 110.986 173.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.5 m -89.84 126.31 35.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.0 110.81 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.43 -35.96 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 126.654 1.981 . . . . 1.0 115.485 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -56.21 10.95 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 131.163 3.785 . . . . 1.0 110.964 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.532 1.137 0 C-N-CA 127.434 2.445 . . . . 1.0 113.576 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.441 -0.79 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -157.45 -175.14 5.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.118 2.567 . . . . 1.0 105.259 -168.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.27 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 121.639 2.018 . . . . 1.0 109.676 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HG2' ' HB3' ' A' ' 31' ' ' LEU . 32.5 mtp180 -81.68 141.48 33.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.556 1.542 . . . . 1.0 110.031 169.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 p -81.92 -136.03 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.102 2.161 . . . . 1.0 109.367 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -48.66 -17.2 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.361 -1.462 . . . . 1.0 113.612 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.403 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 43.2 m 75.57 14.96 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 27' ' ' SER . 76.1 Cg_endo -70.32 30.01 0.2 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 124.749 3.633 . . . . 1.0 115.93 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 132.81 -20.48 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.478 1 C-N-CA 133.391 4.676 . . . . 1.0 113.581 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -84.96 140.98 30.68 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 1.0 115.2 -171.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 3.6 pp -148.2 149.57 32.19 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.845 2.458 . . . . 1.0 112.004 171.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 t -129.77 122.14 28.22 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.048 1.339 . . . . 1.0 113.256 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 3.0 t -88.97 96.67 10.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.63 3.172 . . . . 1.0 108.594 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.04 162.58 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 129.988 3.315 . . . . 1.0 111.132 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -126.16 75.46 72.55 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 125.255 1.422 . . . . 1.0 112.386 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.77 -40.49 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 124.309 3.339 . . . . 1.0 113.814 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 m 38.39 45.3 0.81 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.126 3.37 . . . . 1.0 112.622 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . 6.8 p80 44.42 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.497 2.719 . . . . 1.0 114.039 173.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -169.43 176.83 4.91 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 128.964 2.906 . . . . 1.0 108.793 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 97' ' ' VAL . 1.4 ptp180 -119.33 166.93 12.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.365 1.066 . . . . 1.0 113.763 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.2 m 75.68 12.83 3.0 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.923 2.564 . . . . 1.0 117.923 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -21.11 -46.94 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 130.674 3.59 . . . . 1.0 117.839 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.981 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 53.81 -29.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 1 C-N-CA 132.565 4.346 . . . . 1.0 119.512 171.583 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m 141.27 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 1 C-N-CA 133.339 4.656 . . . . 1.0 107.718 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.764 HD23 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -83.03 154.32 67.24 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.459 1.104 . . . . 1.0 112.217 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.764 ' HD2' HD23 ' A' ' 45' ' ' LEU . 58.8 Cg_endo -69.13 37.4 0.22 Allowed 'Trans proline' 0 CA--C 1.558 1.689 1 C-N-CA 125.528 4.152 . . . . 1.0 115.746 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG12 ' HB3' ' A' ' 45' ' ' LEU . 26.3 pt -128.43 -29.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.292 3.037 . . . . 1.0 114.449 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.67 -174.0 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 127.417 2.287 . . . . 1.0 115.489 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 46.3 m-85 -126.46 134.1 51.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.768 2.027 . . . . 1.0 112.847 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 69.8 mttt -130.24 109.35 10.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.599 1.56 . . . . 1.0 109.649 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -106.02 135.78 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.322 1.449 . . . . 1.0 109.02 173.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.56 140.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.394 1.077 . . . . 1.0 110.976 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -104.32 105.68 15.91 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 168.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.54 114.01 26.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.19 2.88 41.74 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.787 1.66 . . . . 1.0 115.923 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -133.67 162.05 33.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.741 2.017 . . . . 1.0 113.707 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.3 t -141.32 71.92 26.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.87 1.668 . . . . 1.0 111.661 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 87' ' ' GLN . 68.3 Cg_endo -79.63 -177.94 4.21 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.849 3.699 . . . . 1.0 114.277 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -148.73 95.76 2.47 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.051 2.14 . . . . 1.0 111.43 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.71 17.21 9.3 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 126.057 1.789 . . . . 1.0 116.955 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 81.1 m -52.14 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.688 2.395 . . . . 1.0 113.294 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -77.15 103.27 6.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.217 1.407 . . . . 1.0 110.971 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.47 108.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -112.36 115.85 29.4 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 123.944 0.777 . . . . 1.0 112.634 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG13 ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -98.28 111.65 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.128 -0.982 . . . . 1.0 110.253 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.818 ' HG2' ' HB3' ' A' ' 77' ' ' LEU . 32.8 mtm -128.99 165.56 20.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.94 127.31 47.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.337 1.055 . . . . 1.0 109.158 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -35.57 -57.28 0.96 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 125.55 1.548 . . . . 1.0 113.187 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.509 ' H ' ' CB ' ' A' ' 105' ' ' SER . 12.7 t-20 72.94 109.35 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.504 3.522 . . . . 1.0 110.078 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 102' ' ' ARG . 1.0 OUTLIER 54.33 32.91 17.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.202 1.401 . . . . 1.0 112.729 -168.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 53.97 54.92 9.02 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 129.161 2.984 . . . . 1.0 114.096 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.361 0.1 OUTLIER -82.37 -108.3 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.494 0.717 . . . . 1.0 111.003 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -172.64 70.79 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 130.642 3.577 . . . . 1.0 110.394 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.0 p 63.35 89.75 0.09 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.833 2.053 . . . . 1.0 114.477 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -147.37 74.21 1.32 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.869 1.063 . . . . 1.0 113.869 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 26.1 tt0 161.09 96.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.053 2.141 . . . . 1.0 115.628 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.038 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.98 165.48 24.61 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.615 3.566 . . . . 1.0 107.876 170.076 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -144.11 82.53 1.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.255 -1.528 . . . . 1.0 111.193 169.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 23.9 m120 84.16 4.07 0.76 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.089 1.756 . . . . 1.0 111.136 -170.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -64.07 9.85 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.587 3.155 . . . . 1.0 116.592 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 t -118.63 115.13 23.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.527 1.931 . . . . 1.0 110.834 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.1 32.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.589 1.956 . . . . 1.0 112.198 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.82 143.62 26.33 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.923 2.489 . . . . 1.0 111.898 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -121.37 149.25 43.26 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.876 2.47 . . . . 1.0 112.088 -170.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -79.48 -117.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.063 0.945 . . . . 1.0 111.057 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.7 -8.14 1.2 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.718 2.007 . . . . 1.0 115.246 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 135.69 6.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.192 1 C-N-CA 133.109 4.563 . . . . 1.0 113.128 -171.354 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.54 144.66 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 120.405 1.457 . . . . 1.0 112.613 -169.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -99.92 146.34 26.79 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.188 2.195 . . . . 1.0 113.637 173.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.938 2.495 . . . . 1.0 110.844 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 t80 45.93 -78.9 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.421 3.088 . . . . 1.0 116.842 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 44.88 160.99 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.537 1 C-N-CA 131.773 4.029 . . . . 1.0 118.497 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.55 -54.9 4.43 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.627 2.371 . . . . 1.0 113.567 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 5.5 mt 40.82 120.18 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.403 1 C-N-CA 133.093 4.557 . . . . 1.0 117.321 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.981 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.92 115.34 22.39 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.783 1.629 . . . . 1.0 113.196 -170.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -99.95 136.28 40.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.464 1.505 . . . . 1.0 110.82 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 1.8 t 50.43 56.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.848 -1.167 . . . . 1.0 107.848 -171.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.06 -8.06 65.18 Favored Glycine 0 N--CA 1.479 1.501 1 N-CA-C 126.499 5.36 . . . . 1.0 126.499 -167.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 100' ' ' SER 0.253 1.3 tmm_? -146.9 48.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.88 3.34 . . . . 1.0 117.488 -177.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' ARG 0.278 3.4 t 144.53 -81.49 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 132.126 4.17 . . . . 1.0 111.059 171.171 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 85.55 1.59 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.041 1.291 . . . . 1.0 114.799 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -44.41 -60.35 1.99 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 129.211 3.004 . . . . 1.0 116.951 -176.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.82 -79.95 0.03 OUTLIER Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.287 1.899 . . . . 1.0 111.592 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.64 98.1 1.91 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.701 1.6 . . . . 1.0 114.516 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.509 ' CB ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -127.51 136.13 51.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.824 2.05 . . . . 1.0 113.142 173.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.8 114.05 12.23 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.168 1.787 . . . . 1.0 111.747 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -139.21 75.84 1.54 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.939 1.696 . . . . 1.0 111.288 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.56 108.9 8.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 1.0 110.046 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -117.74 115.25 24.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.2 1.4 . . . . 1.0 112.14 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.4 116.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.472 1.509 . . . . 1.0 107.197 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -113.77 107.34 15.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.201 1.001 . . . . 1.0 113.239 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.59 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 55.5 t -77.3 145.56 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.514 1.526 . . . . 1.0 111.846 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -104.1 -6.99 20.56 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.316 3.046 . . . . 1.0 114.627 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 116' ' ' PRO . 8.6 m -72.28 171.47 12.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.869 2.868 . . . . 1.0 111.742 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.99 -52.53 9.15 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.403 -1.284 . . . . 1.0 111.778 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 114' ' ' THR . 58.1 Cg_endo -78.24 110.74 2.93 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 124.624 3.55 . . . . 1.0 109.534 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 106.37 1.88 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.009 2.473 . . . . 1.0 109.624 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.632 HE22 ' HB2' ' A' ' 116' ' ' PRO . 1.7 mp0 -106.68 101.48 10.92 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 1.0 111.15 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.78 114.38 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.631 1.973 . . . . 1.0 111.423 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.08 127.66 32.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.91 1.684 . . . . 1.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 t -123.88 148.67 46.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.218 1.807 . . . . 1.0 114.712 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -87.32 112.66 22.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 1.0 109.073 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.42 49.91 2.28 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.006 2.522 . . . . 1.0 112.097 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -136.48 -99.94 0.21 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.217 2.207 . . . . 1.0 114.222 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.48 58.78 0.29 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 116.175 1.917 . . . . 1.0 116.175 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.27 72.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.329 2.252 . . . . 1.0 114.256 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -128.98 159.67 35.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.276 2.23 . . . . 1.0 111.769 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -149.88 161.21 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.899 2.079 . . . . 1.0 111.235 174.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.7 m -99.06 124.05 43.79 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.46 1.904 . . . . 1.0 110.334 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.85 -30.91 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 115.733 1.753 . . . . 1.0 115.733 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.55 -49.88 75.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.189 2.195 . . . . 1.0 112.605 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 40' ' ' ARG . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 129.203 3.287 . . . . 1.0 112.635 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 119.663 -0.208 . . . . 1.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mt -148.51 -173.89 4.46 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.689 2.396 . . . . 1.0 106.273 150.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.28 71.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 120.951 1.705 . . . . 1.0 106.677 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -127.98 82.04 2.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.269 3.428 . . . . 1.0 108.216 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.0 p -100.68 -73.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.433 1.893 . . . . 1.0 110.047 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.593 1.557 . . . . 1.0 114.01 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m 75.19 36.38 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 117.161 2.282 . . . . 1.0 117.161 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.74 37.37 0.24 Allowed 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 124.481 3.454 . . . . 1.0 112.971 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . 0.27 84.8 m-20 73.24 16.0 4.26 Favored 'General case' 0 CA--C 1.56 1.33 1 C-N-CA 132.328 4.251 . . . . 1.0 114.052 -170.457 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.73 ' CE1' ' HB2' ' A' ' 53' ' ' ALA . 80.4 m-85 -108.68 137.14 47.09 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.495 1.665 . . . . 1.0 115.495 -174.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 pp -122.31 122.1 38.29 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.557 2.343 . . . . 1.0 111.923 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HB2' HG13 ' A' ' 51' ' ' VAL . 1.6 t -115.27 147.07 40.85 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.336 1.854 . . . . 1.0 112.65 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -130.14 95.17 3.86 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.969 2.908 . . . . 1.0 110.689 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -144.64 139.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 128.625 2.77 . . . . 1.0 110.877 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.77 146.69 80.16 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 126.252 1.821 . . . . 1.0 114.424 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.65 99.51 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.622 3.548 . . . . 1.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.5 t -93.69 -8.14 41.73 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 116.192 1.923 . . . . 1.0 116.192 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.1 p80 31.57 56.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 128.815 2.846 . . . . 1.0 115.869 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.43 ' HA ' ' H ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -164.79 176.15 9.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.927 2.091 . . . . 1.0 113.749 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.28 101.64 1.95 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.304 2.242 . . . . 1.0 109.569 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.49 -65.84 0.96 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.248 -0.908 . . . . 1.0 109.621 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 45.11 56.71 5.25 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.228 1.411 . . . . 1.0 113.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.93 1.66 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.966 2.58 . . . . 1.0 117.966 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -23.42 57.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.781 2.141 . . . . 1.0 116.781 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 109.63 10.31 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.549 1.522 . . . . 1.0 109.833 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.34 144.3 11.53 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 123.87 3.046 . . . . 1.0 110.731 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -141.34 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.556 1.543 . . . . 1.0 110.932 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.42 119.49 3.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.599 1.96 . . . . 1.0 109.75 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 47' ' ' ILE . 9.0 m-85 -122.98 113.4 19.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.134 1.773 . . . . 1.0 109.12 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -126.61 118.8 25.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.809 1.244 . . . . 1.0 109.964 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 32' ' ' CYS . 10.4 t -134.56 134.75 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.909 1.284 . . . . 1.0 110.323 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.77 142.0 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.775 1.63 . . . . 1.0 110.69 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . . . -111.63 146.33 37.63 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.136 1.375 . . . . 1.0 111.047 170.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -74.55 139.57 43.84 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.281 0.632 . . . . 1.0 110.257 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.93 -177.27 19.17 Favored Glycine 0 CA--C 1.545 1.96 0 C-N-CA 126.811 2.148 . . . . 1.0 112.225 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.99 94.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.311 1.044 . . . . 1.0 112.452 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 7.5 p -156.26 147.48 16.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.065 2.146 . . . . 1.0 112.427 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.7 Cg_endo -58.36 151.0 63.77 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.797 2.331 . . . . 1.0 112.455 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 69.59 97.11 0.06 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.602 2.361 . . . . 1.0 112.811 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.05 -14.76 25.68 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 126.821 2.153 . . . . 1.0 115.104 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 95.13 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 127.722 2.409 . . . . 1.0 114.231 171.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' ILE . 7.0 mp -103.77 129.02 51.12 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.981 1.474 . . . . 1.0 114.981 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -93.72 116.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.53 2.332 . . . . 1.0 105.37 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 p -129.2 117.54 20.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.121 2.169 . . . . 1.0 110.975 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 80' ' ' ALA 0.305 11.0 m -109.93 110.44 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.078 -1.014 . . . . 1.0 110.52 171.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.699 ' HB2' HG23 ' A' ' 107' ' ' THR . 53.4 mtt -144.42 107.72 4.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.494 2.317 . . . . 1.0 110.625 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.1 106.03 16.46 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 121.376 -0.828 . . . . 1.0 111.446 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.06 167.67 27.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.913 2.197 . . . . 1.0 112.278 172.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 104' ' ' LYS 0.265 0.1 OUTLIER 57.51 -33.01 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.27 2.628 . . . . 1.0 117.218 -175.563 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.626 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 38.9 t70 -64.73 -22.21 66.93 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 129.313 3.045 . . . . 1.0 113.515 170.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 72' ' ' ASN . 9.6 tm-20 -120.78 -67.08 1.0 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.644 2.778 . . . . 1.0 109.629 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.533 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 3.1 m-80 -145.47 -85.23 0.12 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.906 2.082 . . . . 1.0 111.131 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -168.24 10.73 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.511 1.925 . . . . 1.0 114.994 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.2 m -59.51 -72.54 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.91 1.684 . . . . 1.0 113.995 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 46.75 -156.68 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.516 1.526 . . . . 1.0 114.965 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 100' ' ' SER . 7.0 tp10 65.11 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.404 3.082 . . . . 1.0 115.227 -172.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -134.02 165.52 24.85 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.33 83.79 2.16 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.963 1.305 . . . . 1.0 109.603 172.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 70.82 10.63 7.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.865 0.866 . . . . 1.0 113.109 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -65.51 2.63 0.87 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.304 1.411 . . . . 1.0 113.387 169.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -100.02 112.61 24.9 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.044 0.938 . . . . 1.0 109.715 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.41 122.51 14.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.39 1.876 . . . . 1.0 109.689 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.8 153.48 18.84 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.184 0.994 . . . . 1.0 112.537 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.24 167.62 15.2 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.384 1.874 . . . . 1.0 110.084 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 -80.13 0.6 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.671 1.588 . . . . 1.0 110.389 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.65 45.71 0.81 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.23 1.412 . . . . 1.0 112.072 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 20.9 mp0 61.15 22.04 12.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.573 2.749 . . . . 1.0 114.752 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.89 133.25 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.76 129.88 49.23 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 130.383 3.473 . . . . 1.0 111.393 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -136.01 160.07 39.75 Favored 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 132.028 4.131 . . . . 1.0 110.334 176.29 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 3.5 t80 108.04 178.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 129.499 3.119 . . . . 1.0 114.717 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -82.32 -157.06 0.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 127.738 2.415 . . . . 1.0 108.252 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 66.99 47.53 1.38 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 117.724 2.49 . . . . 1.0 117.724 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 1.9 mp -139.25 123.92 18.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.371 2.268 . . . . 1.0 109.427 172.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.5 mpt_? -144.69 149.51 35.75 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-N 122.698 2.499 . . . . 1.0 115.371 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.717 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -118.31 169.11 10.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.935 2.094 . . . . 1.0 115.746 -177.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 38.7 t 60.4 70.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.047 2.139 . . . . 1.0 109.927 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.59 -11.52 37.96 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 127.464 2.459 . . . . 1.0 115.906 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 73.05 -16.67 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 129.563 3.145 . . . . 1.0 118.57 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.777 ' HB2' ' HB2' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 30.78 -5.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 2 C-N-CA 134.807 5.243 . . . . 1.0 122.502 172.187 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.77 49.28 1.52 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 128.696 3.046 . . . . 1.0 110.653 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 90.7 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 129.861 3.264 . . . . 1.0 109.186 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.96 62.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 114.875 0.71 . . . . 1.0 114.875 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -71.48 84.93 0.83 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 123.153 1.454 . . . . 1.0 107.765 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -130.84 113.17 13.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.001 2.52 . . . . 1.0 113.177 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 70' ' ' ASP . 22.7 t80 -87.45 83.25 7.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.06 0.944 . . . . 1.0 108.988 174.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 66' ' ' MET . 5.0 t -148.65 52.05 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.1 pt? -96.26 68.35 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.442 1.497 . . . . 1.0 112.866 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 50.8 m 172.28 -77.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 128.944 2.898 . . . . 1.0 113.701 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -133.17 155.04 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.1 m -135.05 106.3 6.74 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.131 2.172 . . . . 1.0 111.612 170.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.22 103.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 123.379 1.561 . . . . 1.0 109.707 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.14 73.47 0.47 Allowed 'General case' 0 CA--C 1.545 0.773 1 C-N-CA 133.203 4.601 . . . . 1.0 109.771 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.682 HG22 ' HD2' ' A' ' 116' ' ' PRO . 93.7 m -152.37 163.09 40.18 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.376 2.27 . . . . 1.0 109.41 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.98 -41.91 32.16 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.419 -1.277 . . . . 1.0 114.046 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 114' ' ' THR . 83.5 Cg_endo -92.08 101.57 0.2 Allowed 'Trans proline' 0 CA--C 1.561 1.875 1 C-N-CA 125.883 4.389 . . . . 1.0 107.501 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.15 119.59 6.64 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 124.144 3.229 . . . . 1.0 111.138 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -118.92 102.45 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.3 1.048 . . . . 1.0 111.299 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.3 144.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.126 2.171 . . . . 1.0 113.163 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 110' ' ' ILE . . . -122.45 155.1 36.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.805 1.642 . . . . 1.0 112.402 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 t -127.54 139.34 52.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.562 1.945 . . . . 1.0 113.319 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 9.4 t80 -89.11 109.82 20.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.074 -1.016 . . . . 1.0 108.773 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -97.0 57.19 1.47 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.979 0.895 . . . . 1.0 113.137 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -133.19 -61.73 0.82 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.24 2.616 . . . . 1.0 112.258 -175.086 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.09 -15.27 61.06 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.2 mm 11.94 -86.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 1 C-N-CA 131.848 4.059 . . . . 1.0 114.66 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 48.9 tptt -79.69 97.35 6.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.5 1.92 . . . . 1.0 110.57 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.47 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.87 161.74 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.73 1.612 . . . . 1.0 112.176 -178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -103.13 125.61 49.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.325 1.45 . . . . 1.0 112.804 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.01 -56.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.94 1.296 . . . . 1.0 112.032 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -99.1 -70.56 0.72 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.372 1.869 . . . . 1.0 112.83 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.583 0 C-N-CA 126.366 1.936 . . . . 1.0 114.009 175.379 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.301 -0.857 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 -173.91 4.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.356 2.663 . . . . 1.0 106.478 -160.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.701 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.9 t -72.96 71.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 122.143 2.247 . . . . 1.0 107.891 171.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.87 123.33 49.91 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 1.0 108.05 170.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 26' ' ' ASP 0.311 9.7 t -129.52 -101.1 0.32 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.553 0.946 . . . . 1.0 113.553 -172.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' H ' HG23 ' A' ' 25' ' ' THR . 11.3 t70 -57.04 -34.89 68.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 127.746 2.418 . . . . 1.0 115.895 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.695 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 63.1 m -139.22 109.05 7.49 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.079 1.752 . . . . 1.0 107.616 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -46.26 -19.51 0.64 Allowed 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 124.706 3.604 . . . . 1.0 115.547 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.06 -36.59 70.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.544 2.738 . . . . 1.0 113.395 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -101.95 110.46 22.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.801 1.24 . . . . 1.0 109.813 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -117.96 122.28 42.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.028 1.731 . . . . 1.0 113.331 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.701 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 14.3 m -114.98 164.08 14.66 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.172 1.389 . . . . 1.0 113.861 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -152.06 126.96 9.64 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.793 1.637 . . . . 1.0 113.176 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.31 152.81 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 130.566 3.546 . . . . 1.0 109.375 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.55 150.8 95.57 Favored Pre-proline 0 CA--C 1.56 1.353 0 O-C-N 121.761 -0.587 . . . . 1.0 112.529 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.5 80.0 1.13 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.222 3.281 . . . . 1.0 112.414 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 p -77.64 -80.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.519 1.128 . . . . 1.0 110.246 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 44.37 78.21 0.06 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.844 2.458 . . . . 1.0 111.77 -173.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 1.6 p90 -166.28 173.56 9.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.474 2.309 . . . . 1.0 111.55 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 97' ' ' VAL . 4.5 ttp180 -66.43 100.87 0.69 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.785 1.234 . . . . 1.0 110.908 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -87.23 -50.78 6.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.962 1.705 . . . . 1.0 113.446 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t-20 56.28 8.65 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 125.913 1.685 . . . . 1.0 114.528 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 95' ' ' ARG 0.267 5.4 ttpt 65.42 27.31 11.84 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 130.806 3.643 . . . . 1.0 114.82 -170.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -57.51 -55.39 35.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 130.045 3.338 . . . . 1.0 114.457 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.21 106.49 17.77 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.867 2.067 . . . . 1.0 109.751 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.62 134.54 16.93 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.095 3.197 . . . . 1.0 113.301 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.87 -11.66 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.822 1.649 . . . . 1.0 114.563 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 68.51 162.09 0.2 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.133 2.573 . . . . 1.0 115.693 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -128.02 129.06 46.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.123 2.169 . . . . 1.0 109.506 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -124.67 109.13 12.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.02 1.328 . . . . 1.0 110.094 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.75 144.11 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.525 1.53 . . . . 1.0 111.459 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 147.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.476 3.11 . . . . 1.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 87' ' ' GLN . . . -135.39 158.93 43.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.79 1.774 . . . . 1.0 115.79 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.4 mt -100.43 112.48 24.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.803 2.041 . . . . 1.0 108.2 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.27 168.72 34.48 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 125.492 1.52 . . . . 1.0 111.282 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 58' ' ' PRO . 9.3 t0 56.8 169.38 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.761 ' HA ' ' HG2' ' A' ' 87' ' ' GLN 0.332 1.3 p -149.54 -43.86 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 115.788 1.773 . . . . 1.0 115.788 172.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' A' ' 57' ' ' VAL . 46.6 Cg_endo -81.16 169.41 16.04 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.282 2.654 . . . . 1.0 111.91 171.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 16.75 -122.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 129.367 3.067 . . . . 1.0 114.386 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 86' ' ' ASN . . . 144.42 -70.5 0.39 Allowed Glycine 0 C--N 1.342 0.861 0 C-N-CA 126.274 1.893 . . . . 1.0 113.951 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -139.82 165.17 28.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.596 1.702 . . . . 1.0 115.596 -169.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 111' ' ' THR . 38.3 mt -108.42 106.22 16.24 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.632 3.173 . . . . 1.0 106.305 168.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.87 107.72 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 -173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.9 m -111.57 119.59 39.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.241 1.017 . . . . 1.0 111.157 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.67 114.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 120.948 -1.095 . . . . 1.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.77 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 8.1 mtt -121.12 78.03 1.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.127 0.971 . . . . 1.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.02 106.69 19.02 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.136 -1.431 . . . . 1.0 107.136 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.57 171.19 54.95 Favored Glycine 0 CA--C 1.543 1.8 0 C-N-CA 126.542 2.02 . . . . 1.0 116.838 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 17.8 p-10 -145.35 91.7 2.16 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.046 2.938 . . . . 1.0 110.135 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.92 20.37 12.18 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 126.426 1.89 . . . . 1.0 114.874 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.647 ' HG2' ' HB3' ' A' ' 73' ' ' TYR . 4.4 tt0 -148.41 -25.98 0.33 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.141 2.177 . . . . 1.0 116.279 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 45.09 38.7 3.33 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.963 2.105 . . . . 1.0 114.301 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.647 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 60.9 t80 -149.84 68.67 1.01 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.645 1.978 . . . . 1.0 111.973 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.77 ' HB2' ' HG2' ' A' ' 66' ' ' MET . 42.5 t 63.08 78.79 0.28 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 128.664 2.785 . . . . 1.0 116.73 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.79 -62.82 1.4 Allowed 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 95' ' ' ARG . 0.1 OUTLIER 173.22 143.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.894 2.878 . . . . 1.0 112.165 174.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.63 163.26 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.65 2.38 . . . . 1.0 110.782 170.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.778 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . 56.1 mtt-85 -141.08 90.03 2.29 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.092 2.157 . . . . 1.0 109.173 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' A' ' 81' ' ' THR . 1.3 t-20 88.84 -2.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.801 2.04 . . . . 1.0 110.848 -172.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 94' ' ' LEU 0.334 . . -76.01 34.12 0.13 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 123.272 2.76 . . . . 1.0 114.475 170.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.548 ' H ' ' C ' ' A' ' 79' ' ' ASN . 1.2 t -126.56 108.37 11.08 Favored 'General case' 0 CA--C 1.542 0.653 1 C-N-CA 132.704 4.402 . . . . 1.0 101.238 167.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.18 152.82 42.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.57 1.148 . . . . 1.0 112.113 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.15 159.4 15.3 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 129.452 3.101 . . . . 1.0 114.1 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 88' ' ' VAL 0.306 0.5 OUTLIER 86.54 -127.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 128.057 2.543 . . . . 1.0 113.041 176.278 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 70.08 -25.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 128.267 2.627 . . . . 1.0 117.13 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.487 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 2.4 m-20 -81.48 0.99 35.34 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 120.057 1.299 . . . . 1.0 113.497 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.761 ' HG2' ' HA ' ' A' ' 57' ' ' VAL . 4.1 tp-100 -148.41 -47.54 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.037 2.135 . . . . 1.0 112.395 170.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 84' ' ' MET . 90.7 t -133.9 134.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 114.972 1.471 . . . . 1.0 114.972 -172.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.24 121.62 16.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.775 1.63 . . . . 1.0 110.632 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.15 158.8 43.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.497 2.319 . . . . 1.0 110.23 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.45 -167.6 0.19 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.548 1.539 . . . . 1.0 114.565 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 9.0 p30 -107.99 -174.44 2.52 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.02 2.128 . . . . 1.0 111.559 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.265 8.4 m-20 121.0 74.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.565 3.546 . . . . 1.0 112.379 174.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.722 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 2.9 pp -160.2 141.72 12.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.198 2.599 . . . . 1.0 109.299 169.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.778 ' HD3' ' HB2' ' A' ' 78' ' ' ARG . 3.7 ttt180 -129.49 148.48 51.4 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 119.073 0.851 . . . . 1.0 112.166 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.45 152.0 38.32 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.453 1.649 . . . . 1.0 115.453 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 128' ' ' ILE . 32.3 m 43.95 31.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 129.194 2.998 . . . . 1.0 117.569 168.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.54 -35.18 36.44 Favored Glycine 0 N--CA 1.48 1.577 0 C-N-CA 128.848 3.118 . . . . 1.0 118.336 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 -0.15 4.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.511 1.924 . . . . 1.0 115.08 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 13.3 p -65.27 119.2 10.47 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.429 1.491 . . . . 1.0 113.122 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -117.17 128.47 7.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.78 1.657 . . . . 1.0 114.004 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 69.01 164.18 0.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.928 2.891 . . . . 1.0 113.496 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 42.36 36.4 2.15 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.172 1.844 . . . . 1.0 113.918 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -67.43 101.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.769 2.028 . . . . 1.0 108.701 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -115.5 156.45 25.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 130.614 3.565 . . . . 1.0 110.17 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.9 90.82 2.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.502 1.668 . . . . 1.0 115.502 -171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.0 m -112.38 80.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.545 1.138 . . . . 1.0 112.208 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.4 115.0 19.7 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.611 -1.306 . . . . 1.0 110.949 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.9 m -121.1 111.98 18.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.664 1.186 . . . . 1.0 111.148 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.0 113.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 62' ' ' LEU . 14.8 t -89.98 151.1 21.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 122.834 0.453 . . . . 1.0 111.769 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 2.0 p -72.68 170.95 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 123.451 1.596 . . . . 1.0 112.325 172.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.412 ' H ' HG22 ' A' ' 112' ' ' VAL . 8.9 t80 -118.15 11.5 13.27 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.891 2.877 . . . . 1.0 114.339 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.7 p -120.59 167.51 12.34 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.222 1.409 . . . . 1.0 112.682 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -29.06 5.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 117.536 2.421 . . . . 1.0 117.536 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -87.6 99.34 0.46 Allowed 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 124.421 3.414 . . . . 1.0 109.715 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.91 94.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.355 1 C-N-CA 125.428 4.085 . . . . 1.0 116.217 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.621 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 1.5 tm0? -97.78 90.47 4.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.152 0.977 . . . . 1.0 108.413 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.23 114.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.191 1.396 . . . . 1.0 108.616 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.42 151.78 27.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.561 2.345 . . . . 1.0 111.516 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 m -118.74 131.01 56.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.135 0.974 . . . . 1.0 112.905 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.24 120.29 23.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.394 1.078 . . . . 1.0 111.518 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -167.17 -166.45 0.8 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.794 2.437 . . . . 1.0 111.484 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -33.62 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 130.077 3.351 . . . . 1.0 117.697 172.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -28.99 -74.97 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 128.915 2.886 . . . . 1.0 115.183 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.3 mm -145.66 169.04 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 130.039 3.336 . . . . 1.0 107.654 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -76.39 150.06 36.84 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.7 -1.25 . . . . 1.0 110.717 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 97' ' ' VAL . 18.8 tt -92.32 124.5 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.461 1.904 . . . . 1.0 110.119 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -81.21 125.11 29.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.44 1.496 . . . . 1.0 111.923 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.3 t -53.95 -65.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.786 1.635 . . . . 1.0 114.153 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.44 -2.93 27.77 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . . . . . . 0 CA--C 1.55 2.261 0 C-N-CA 125.356 1.455 . . . . 1.0 112.494 -172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.59 0.219 . . . . 1.0 111.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -152.5 -174.53 4.93 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 23.2 t -67.63 71.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 107.173 -1.417 . . . . 1.0 107.173 170.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.12 169.73 0.77 Allowed 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.965 1.468 . . . . 1.0 114.965 171.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 24.9 p -132.64 176.51 8.39 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.408 2.283 . . . . 1.0 110.17 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.37 21.19 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 128.129 2.572 . . . . 1.0 112.584 171.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.6 ' OG ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -79.11 168.37 27.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 127.269 2.227 . . . . 1.0 114.558 -177.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.6 ' HD2' ' OG ' ' A' ' 27' ' ' SER . 53.6 Cg_endo -64.55 -33.02 57.9 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.426 2.751 . . . . 1.0 113.741 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -174.19 72.08 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 128.606 2.762 . . . . 1.0 111.303 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 27' ' ' SER . 1.7 t80 -125.4 129.45 49.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.422 -1.424 . . . . 1.0 114.248 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.72 133.88 53.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.697 1.599 . . . . 1.0 112.149 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 70.6 m -119.06 157.91 26.88 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.591 1.557 . . . . 1.0 111.868 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 6.7 t -137.81 98.16 3.6 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.213 2.205 . . . . 1.0 109.779 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.08 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.784 2.434 . . . . 1.0 110.225 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 47' ' ' ILE . 11.5 tp -72.95 -66.74 0.53 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.65 1.58 . . . . 1.0 112.951 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 96' ' ' PHE . 39.5 Cg_endo -66.01 142.43 68.32 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.757 2.972 . . . . 1.0 113.37 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -126.65 -46.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.822 2.049 . . . . 1.0 113.843 175.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 m-70 -138.78 62.8 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.509 1.524 . . . . 1.0 112.23 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -139.81 157.06 46.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 130.237 3.415 . . . . 1.0 110.628 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 7.9 ttp180 -68.37 104.92 2.0 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.997 1.719 . . . . 1.0 113.372 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.7 t 95.62 113.33 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.586 3.155 . . . . 1.0 116.429 170.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 57.2 t30 -57.1 -71.47 0.1 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.701 2.4 . . . . 1.0 112.814 171.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' H ' ' A' ' 44' ' ' THR . 24.3 ttmt -78.08 165.65 23.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.426 2.29 . . . . 1.0 113.099 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.543 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 91.47 -8.22 0.25 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 130.075 3.35 . . . . 1.0 112.496 -174.029 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.07 162.56 63.99 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 129.643 3.177 . . . . 1.0 113.831 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.37 29.33 0.3 Allowed 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 125.104 3.87 . . . . 1.0 115.243 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 35' ' ' LEU . 2.4 pp -146.33 172.55 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 129.723 3.209 . . . . 1.0 110.368 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.0 -179.32 5.34 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 128.923 2.889 . . . . 1.0 112.355 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -120.46 143.07 48.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.317 2.247 . . . . 1.0 113.12 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 78.9 mttt -147.27 146.66 29.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.433 1.893 . . . . 1.0 111.212 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 89' ' ' ALA 0.273 1.0 OUTLIER -135.98 135.18 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.445 1.098 . . . . 1.0 109.435 168.972 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.62 118.11 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.546 1.538 . . . . 1.0 108.286 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -97.79 159.94 14.62 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.493 1.117 . . . . 1.0 111.811 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.65 115.65 23.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.868 1.667 . . . . 1.0 111.687 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.2 169.77 40.88 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.583 1.563 . . . . 1.0 112.742 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 -168.74 0.19 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.12 1.768 . . . . 1.0 114.555 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 7.4 p 169.52 73.08 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 131.191 3.796 . . . . 1.0 109.843 172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -93.76 4.87 2.92 Favored 'Trans proline' 0 CA--C 1.556 1.584 1 C-N-CA 125.402 4.068 . . . . 1.0 117.689 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 21.4 m-20 30.09 93.4 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 130.669 3.587 . . . . 1.0 118.661 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.98 5.21 3.55 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.899 1.714 . . . . 1.0 115.721 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 m -55.22 111.88 0.96 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.23 2.212 . . . . 1.0 111.775 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.52 111.42 10.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.705 1.602 . . . . 1.0 111.303 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.729 HG12 HG12 ' A' ' 110' ' ' ILE . 35.0 m -93.06 107.64 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 172.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.81 116.86 30.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 123.418 1.58 . . . . 1.0 110.85 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 40.6 t -101.33 140.99 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 120.685 -1.259 . . . . 1.0 110.519 -172.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -134.91 105.03 6.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.658 0.783 . . . . 1.0 111.436 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.86 109.03 21.44 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.355 -1.466 . . . . 1.0 107.696 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 74' ' ' SER . . . 131.9 91.27 0.52 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.281 2.848 . . . . 1.0 110.424 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -144.75 -87.84 0.11 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.361 2.265 . . . . 1.0 109.468 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.447 ' OD1' ' OG ' ' A' ' 105' ' ' SER . 2.5 m-20 -43.33 -28.64 0.35 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.525 2.73 . . . . 1.0 116.435 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 104' ' ' LYS . 14.1 mm-40 -98.14 -24.69 15.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.963 2.105 . . . . 1.0 115.834 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -162.61 -79.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.399 1.454 . . . . 1.0 113.882 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 t80 136.33 108.3 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.62 1 C-N-CA 132.82 4.448 . . . . 1.0 107.432 -170.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.598 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -124.42 -77.79 0.59 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.381 1.473 . . . . 1.0 111.256 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.76 -2.16 0.1 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.39 1.996 . . . . 1.0 116.39 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.31 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 129.812 3.245 . . . . 1.0 112.612 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -96.61 167.43 11.14 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -171.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.4 ttm180 -132.85 83.78 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 -169.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER 95.25 2.53 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.964 2.906 . . . . 1.0 111.033 -173.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . . . -46.77 -6.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.991 2.589 . . . . 1.0 117.991 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.1 m -115.47 113.68 24.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.563 1.545 . . . . 1.0 111.58 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.7 163.0 34.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 128.93 2.892 . . . . 1.0 109.939 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.97 45.58 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.032 2.133 . . . . 1.0 112.563 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.507 ' C ' ' HD2' ' A' ' 85' ' ' LYS . 17.6 mmt -123.25 158.96 29.75 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.823 1.649 . . . . 1.0 111.195 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HD2' ' C ' ' A' ' 84' ' ' MET . 2.0 mptm? -118.05 -87.01 0.63 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -168.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -75.69 43.83 0.27 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 129.041 2.936 . . . . 1.0 110.705 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 1.4 pm0 48.94 32.55 3.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.776 2.83 . . . . 1.0 114.02 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.06 144.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.625 1.97 . . . . 1.0 113.449 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 51' ' ' VAL . . . -131.52 146.91 52.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.268 2.627 . . . . 1.0 112.241 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 ptt-85 -136.66 163.16 31.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 129.485 3.114 . . . . 1.0 113.886 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 61.11 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 128.303 2.641 . . . . 1.0 113.456 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.27 -66.72 0.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.198 2.199 . . . . 1.0 109.709 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 69.13 -21.25 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.037 3.335 . . . . 1.0 115.987 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.98 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.79 163.24 30.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 127.052 2.141 . . . . 1.0 115.741 178.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.678 ' HD2' ' HA3' ' A' ' 98' ' ' GLY . 5.5 ttm180 -141.11 115.95 9.73 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.297 1.962 . . . . 1.0 116.297 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -86.74 126.64 34.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.557 1.943 . . . . 1.0 111.201 177.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' H ' ' CD2' ' A' ' 77' ' ' LEU 0.289 2.6 m 38.67 41.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 129.247 3.019 . . . . 1.0 112.808 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.678 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -56.95 54.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.093 1 C-N-CA 132.453 4.835 . . . . 1.0 119.238 -171.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 117.88 -5.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 1 C-N-CA 132.735 4.414 . . . . 1.0 113.549 -175.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -141.21 92.48 2.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.604 2.362 . . . . 1.0 111.27 -174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 40' ' ' ARG . . . -168.99 138.42 5.09 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 127.472 2.463 . . . . 1.0 112.04 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -177.17 89.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.899 2.879 . . . . 1.0 107.37 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.06 81.54 0.59 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.759 1.171 . . . . 1.0 112.532 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -153.94 162.01 41.54 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.251 2.22 . . . . 1.0 112.341 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 70' ' ' ASP . 23.3 t -104.84 154.82 19.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.892 2.077 . . . . 1.0 113.178 172.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.4 t80 -95.03 103.1 14.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.424 2.29 . . . . 1.0 111.184 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -108.07 82.95 1.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.331 1.063 . . . . 1.0 112.525 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.27 111.25 8.22 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.555 1.542 . . . . 1.0 111.202 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 m -109.02 104.66 13.91 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.384 0.883 . . . . 1.0 113.384 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 63' ' ' VAL . 8.8 mt -93.45 113.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.128 -1.607 . . . . 1.0 108.199 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.7 p -111.61 121.2 44.5 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.569 1.948 . . . . 1.0 111.951 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.3 OUTLIER -71.57 172.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 123.0 1.381 . . . . 1.0 112.391 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -131.12 40.07 3.5 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.719 2.408 . . . . 1.0 113.598 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.616 ' H ' HG13 ' A' ' 112' ' ' VAL . 9.8 t -129.58 165.39 21.82 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.803 2.041 . . . . 1.0 111.023 172.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.57 -48.58 68.02 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 126.126 1.77 . . . . 1.0 112.684 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.34 111.54 3.28 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.876 3.05 . . . . 1.0 110.505 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.23 106.8 1.06 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.591 3.527 . . . . 1.0 112.707 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.732 ' H ' HG12 ' A' ' 112' ' ' VAL . 7.9 tp-100 -105.32 92.85 4.38 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.812 0.815 . . . . 1.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.74 120.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.495 1.518 . . . . 1.0 111.453 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.53 146.18 44.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.79 2.036 . . . . 1.0 110.966 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.9 m -122.3 141.12 51.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.8 1.64 . . . . 1.0 110.102 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -92.25 143.88 25.96 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.067 0.947 . . . . 1.0 113.183 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -149.39 171.86 15.87 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.499 2.72 . . . . 1.0 111.15 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 15.2 ttt180 74.46 176.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 127.41 2.284 . . . . 1.0 112.557 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 124' ' ' ARG . . . -149.96 164.96 34.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.607 1.706 . . . . 1.0 115.607 175.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.66 -39.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.537 1.935 . . . . 1.0 113.716 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.56 110.32 8.69 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.395 1.478 . . . . 1.0 113.28 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 38' ' ' HIS . 1.2 pp -121.34 124.77 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.734 1.214 . . . . 1.0 110.586 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' A' ' 39' ' ' TRP . 86.5 m -125.87 120.51 30.67 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 170.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.56 -24.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 115.198 1.555 . . . . 1.0 115.198 -170.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.97 -69.02 0.78 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.757 2.423 . . . . 1.0 113.391 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.163 0 C-N-CA 127.148 2.309 . . . . 1.0 114.994 -175.663 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -173.63 3.82 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 129.764 3.226 . . . . 1.0 104.753 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.17 74.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 O-C-N 119.664 -1.897 . . . . 1.0 108.533 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 73.9 mtt180 -41.72 113.48 0.42 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 130.452 3.501 . . . . 1.0 111.9 171.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.827 ' H ' ' HB2' ' A' ' 30' ' ' PHE . 3.4 t -149.32 92.54 1.96 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.949 0.9 . . . . 1.0 112.791 -170.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 121' ' ' THR . 31.8 t0 118.01 -58.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 1 C-N-CA 133.033 4.533 . . . . 1.0 112.849 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 30' ' ' PHE . 50.9 m 133.47 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.951 1 C-N-CA 132.306 4.242 . . . . 1.0 113.455 -172.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 30.8 Cg_endo -62.43 90.99 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 125.118 3.878 . . . . 1.0 111.969 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 54' ' ' LEU . 3.8 t-20 36.14 58.3 0.98 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.331 2.253 . . . . 1.0 110.686 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.827 ' HB2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -79.77 103.41 9.66 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.461 1.904 . . . . 1.0 111.689 -170.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -139.71 108.9 6.08 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.8 t -114.95 149.71 36.88 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.971 1.308 . . . . 1.0 111.818 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . 3.0 m -126.58 93.61 3.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.125 3.77 . . . . 1.0 108.058 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.649 HG22 ' HD2' ' A' ' 36' ' ' PRO . 5.4 p -149.68 155.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.503 2.321 . . . . 1.0 110.531 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.4 -58.32 0.5 Allowed Pre-proline 0 CA--C 1.552 1.038 0 CA-C-O 117.217 -1.373 . . . . 1.0 114.198 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.798 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 9.6 Cg_endo -50.78 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 1 C-N-CA 125.602 4.201 . . . . 1.0 112.99 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -102.57 -76.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.893 1.677 . . . . 1.0 109.938 -171.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -125.73 44.16 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.964 2.506 . . . . 1.0 113.143 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.817 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 5.5 p90 -161.93 169.19 21.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.244 2.218 . . . . 1.0 114.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -66.52 106.69 1.84 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.745 2.418 . . . . 1.0 114.622 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 42.7 t -81.02 -70.56 0.52 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.511 1.05 . . . . 1.0 111.334 173.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.2 t30 45.31 51.7 9.24 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.315 1.446 . . . . 1.0 113.584 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.37 -7.13 1.22 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.871 2.868 . . . . 1.0 116.492 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -65.19 142.27 58.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.8 1.182 . . . . 1.0 109.89 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 56.39 62.26 6.65 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 126.002 1.721 . . . . 1.0 110.881 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.0 41.83 0.58 Allowed 'Trans proline' 0 CA--C 1.554 1.497 1 C-N-CA 125.762 4.308 . . . . 1.0 114.315 -176.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.07 -1.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 129.892 3.277 . . . . 1.0 114.84 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.13 173.79 0.3 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 129.28 3.032 . . . . 1.0 113.164 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -140.1 166.67 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 5.2 tttp -142.91 135.99 28.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.577 2.351 . . . . 1.0 110.843 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 123.36 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.757 2.423 . . . . 1.0 107.368 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -138.19 131.85 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.059 2.144 . . . . 1.0 109.988 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.45 157.1 36.01 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.325 1.45 . . . . 1.0 111.179 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -128.44 113.05 15.05 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.741 1.386 . . . . 1.0 114.741 174.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.4 3.82 5.55 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 117.965 1.946 . . . . 1.0 117.965 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.85 177.44 4.84 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 128.384 2.673 . . . . 1.0 116.933 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 58' ' ' PRO . 69.2 t -68.36 157.67 87.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 131.688 3.995 . . . . 1.0 113.495 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD2' HG13 ' A' ' 57' ' ' VAL . 61.1 Cg_endo -70.71 -150.76 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 125.121 3.881 . . . . 1.0 113.275 171.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 58' ' ' PRO . 9.6 p-10 -50.99 101.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.641 2.376 . . . . 1.0 112.317 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.43 -8.67 0.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.025 -1.43 . . . . 1.0 116.447 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 104.47 4.32 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.759 1.779 . . . . 1.0 108.894 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.56 112.46 16.84 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -89.64 107.32 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 101.93 -3.359 . . . . 1.0 101.93 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -130.9 117.55 19.42 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.812 1.32 . . . . 1.0 112.583 -170.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.882 HG22 ' HB1' ' A' ' 80' ' ' ALA . 35.8 m -106.35 111.54 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.531 1.133 . . . . 1.0 110.534 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.649 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 8.1 mtm -146.98 102.24 3.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.872 2.069 . . . . 1.0 111.431 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -99.2 107.74 20.15 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.713 1.142 . . . . 1.0 112.125 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.84 147.75 18.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.165 0.888 . . . . 1.0 115.059 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -155.13 -52.61 0.09 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.87 1.268 . . . . 1.0 112.579 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -149.19 -48.25 0.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.281 2.232 . . . . 1.0 114.891 -170.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -147.29 -10.24 0.43 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 130.397 3.479 . . . . 1.0 114.216 -168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -48.43 -15.57 0.08 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.912 2.885 . . . . 1.0 115.473 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.85 2.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.821 3.648 . . . . 1.0 117.616 171.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.55 ' HB2' HG13 ' A' ' 97' ' ' VAL . 2.8 t -92.33 -99.46 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.732 1.613 . . . . 1.0 113.548 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB2' ' H ' ' A' ' 105' ' ' SER . . . 57.07 -65.51 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 126.871 2.068 . . . . 1.0 112.496 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.51 137.65 53.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.379 2.272 . . . . 1.0 114.329 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.77 165.51 24.39 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 128.317 2.647 . . . . 1.0 111.599 -176.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -118.11 82.25 1.81 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.347 -0.846 . . . . 1.0 111.321 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.433 HD22 HH12 ' A' ' 78' ' ' ARG . 5.2 m120 78.92 0.59 2.43 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.438 2.295 . . . . 1.0 112.508 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -57.25 -11.14 1.56 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.554 2.741 . . . . 1.0 117.214 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 m -105.01 112.66 25.88 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.223 1.577 . . . . 1.0 110.93 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 160.75 39.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.998 2.119 . . . . 1.0 111.35 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 127.19 42.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.779 2.432 . . . . 1.0 112.916 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -144.5 -164.7 1.97 Allowed 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 127.988 2.515 . . . . 1.0 112.846 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -112.87 -101.47 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.629 2.372 . . . . 1.0 111.502 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -79.57 45.35 0.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.628 2.371 . . . . 1.0 111.966 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 110' ' ' ILE . 0.4 OUTLIER 51.24 32.7 8.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.167 2.187 . . . . 1.0 111.609 -171.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -90.39 109.92 21.4 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-O 122.894 1.33 . . . . 1.0 107.526 -171.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.51 116.36 11.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.22 2.208 . . . . 1.0 109.178 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 31.3 mtm180 -135.77 128.7 31.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.347 1.859 . . . . 1.0 109.969 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 11.0 t80 130.87 -151.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 130.696 3.598 . . . . 1.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 24.6 t-20 -122.43 164.21 18.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.604 1.962 . . . . 1.0 110.599 171.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.44 94.1 m-20 108.02 44.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.481 3.512 . . . . 1.0 116.341 -175.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -139.95 132.19 28.21 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.299 2.639 . . . . 1.0 108.604 170.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.853 ' H ' ' HB2' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -138.86 120.63 15.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.026 1.739 . . . . 1.0 113.583 -171.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.45 115.99 30.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.714 1.206 . . . . 1.0 110.232 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 74' ' ' SER . 11.0 t 71.13 73.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.756 1.222 . . . . 1.0 107.995 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.63 90.24 0.65 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 128.506 2.955 . . . . 1.0 113.361 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.21 53.98 3.46 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 128.042 2.537 . . . . 1.0 115.01 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.5 t -70.93 -168.5 0.28 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.817 2.047 . . . . 1.0 115.798 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.88 -37.94 0.07 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.911 2.672 . . . . 1.0 115.044 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 159.85 42.72 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.905 2.082 . . . . 1.0 113.739 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.48 57.45 2.93 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.595 1.569 . . . . 1.0 115.188 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 104' ' ' LYS . 7.6 mtmt -68.79 104.7 2.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.223 1.809 . . . . 1.0 109.71 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' ALA . 16.9 t -119.62 132.65 55.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.301 3.04 . . . . 1.0 110.878 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -84.75 87.12 7.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.185 0.994 . . . . 1.0 110.895 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 66' ' ' MET . 3.8 m -143.36 51.17 1.37 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.95 0.881 . . . . 1.0 111.319 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -102.35 90.41 3.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.894 2.077 . . . . 1.0 111.037 -174.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.656 HG21 ' C ' ' A' ' 120' ' ' ALA . 10.2 t 152.38 -116.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 128.754 2.822 . . . . 1.0 115.545 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.691 HG12 ' HG2' ' A' ' 87' ' ' GLN . 3.8 mp -133.78 151.69 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 128.25 2.62 . . . . 1.0 111.786 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.9 m -140.18 104.24 4.77 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.586 1.554 . . . . 1.0 113.562 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 54.3 t -74.05 122.16 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.562 -1.336 . . . . 1.0 107.814 170.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.15 -8.17 56.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.587 3.555 . . . . 1.0 116.971 -175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 2.2 m -82.16 166.11 19.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.762 2.025 . . . . 1.0 112.529 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -45.02 -31.78 0.94 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.601 1.96 . . . . 1.0 114.023 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 114' ' ' THR . 98.1 Cg_endo -95.26 81.8 0.11 Allowed 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 125.41 4.073 . . . . 1.0 106.197 167.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.61 114.08 3.56 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.201 3.267 . . . . 1.0 111.834 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -99.99 92.48 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 -177.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.86 115.33 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.656 ' C ' HG21 ' A' ' 109' ' ' THR . . . -99.59 171.23 8.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.592 1.957 . . . . 1.0 112.995 -168.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 63.3 p -124.9 120.05 30.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.742 2.017 . . . . 1.0 113.46 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.06 125.82 33.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.13 1.786 . . . . 1.0 110.523 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -106.82 68.66 0.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.071 1.748 . . . . 1.0 112.181 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.41 -179.7 0.09 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.807 2.843 . . . . 1.0 112.764 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.27 -58.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.689 2.796 . . . . 1.0 116.334 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mt 67.31 -62.12 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 129.085 2.954 . . . . 1.0 112.766 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -124.24 130.84 53.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.672 1.989 . . . . 1.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.25 129.96 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 128.046 2.539 . . . . 1.0 110.382 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -85.32 121.96 28.8 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.053 1.341 . . . . 1.0 109.296 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.74 -28.44 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.063 0.945 . . . . 1.0 112.112 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.52 -29.19 56.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.543 2.337 . . . . 1.0 115.048 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.817 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . . . . . . 0 CA--C 1.553 2.465 0 C-N-CA 125.822 1.677 . . . . 1.0 114.56 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -163.75 -172.52 2.9 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 129.086 2.955 . . . . 1.0 105.689 -174.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.08 73.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 O-C-N 119.808 -1.807 . . . . 1.0 107.172 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -61.02 148.2 40.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.61 2.764 . . . . 1.0 113.96 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 30' ' ' PHE . 82.5 p -76.47 -167.28 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.509 2.724 . . . . 1.0 110.162 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 121' ' ' THR . 4.2 t0 -66.24 12.91 0.06 Allowed 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.561 -1.337 . . . . 1.0 112.959 169.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 p -150.72 152.45 32.24 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.109 2.563 . . . . 1.0 114.653 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 -15.54 26.05 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 C-N-CA 123.466 2.778 . . . . 1.0 111.493 168.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -21.48 63.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.918 2.887 . . . . 1.0 115.568 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.413 ' HB2' ' OG1' ' A' ' 25' ' ' THR . 26.9 m-85 -138.16 114.51 10.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.993 1.317 . . . . 1.0 110.569 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 22' ' ' LEU . 3.5 pp -149.91 140.26 22.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.198 1.399 . . . . 1.0 114.422 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 51' ' ' VAL 0.587 0.1 OUTLIER -164.82 173.05 12.17 Favored 'General case' 0 CA--C 1.542 0.644 1 N-CA-C 122.936 4.421 . . . . 1.0 122.936 -173.461 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -97.68 98.25 9.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.714 0.806 . . . . 1.0 110.946 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.61 130.03 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 126.606 1.962 . . . . 1.0 111.812 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.52 126.96 91.75 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.152 1.381 . . . . 1.0 112.413 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.702 ' HB2' ' CD2' ' A' ' 38' ' ' HIS . 72.4 Cg_endo -71.55 148.81 54.49 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 124.016 3.144 . . . . 1.0 113.556 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' HIS . 5.0 t -83.02 -67.02 0.82 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.827 1.651 . . . . 1.0 114.176 -176.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.702 ' CD2' ' HB2' ' A' ' 36' ' ' PRO . 86.6 m-70 37.26 40.44 0.19 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.291 3.436 . . . . 1.0 116.792 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.453 ' HE1' ' HA ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -161.49 173.72 14.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.156 1.782 . . . . 1.0 113.717 179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -82.18 103.64 11.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.077 2.151 . . . . 1.0 110.654 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 98' ' ' GLY . 13.7 p 51.05 101.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.475 2.71 . . . . 1.0 115.3 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' HB2' ' A' ' 96' ' ' PHE . 2.0 m120 -47.17 -72.59 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.005 2.122 . . . . 1.0 115.687 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 22.16 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 1 C-N-CA 132.736 4.414 . . . . 1.0 118.417 175.306 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m 68.04 77.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 129.612 3.165 . . . . 1.0 111.922 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.638 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 2.3 pt? -161.75 171.54 6.65 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 127.038 2.135 . . . . 1.0 113.412 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 45' ' ' LEU . 43.0 Cg_endo -70.47 140.52 40.2 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.87 3.046 . . . . 1.0 111.681 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 12.9 mm -134.64 -69.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.486 1.514 . . . . 1.0 113.918 -172.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 31.23 90.03 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 130.436 3.495 . . . . 1.0 116.453 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.77 171.04 10.44 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.64 2.089 . . . . 1.0 116.64 -172.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 7.7 mmtp -140.04 146.07 38.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 129.762 3.225 . . . . 1.0 109.948 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 2.5 t -130.79 118.86 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 129.236 3.014 . . . . 1.0 110.616 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.466 ' H ' ' HB2' ' A' ' 32' ' ' CYS 0.278 14.2 m -128.02 145.92 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 120.582 1.537 . . . . 1.0 113.977 173.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -112.12 145.07 40.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.131 1.373 . . . . 1.0 112.495 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 tp -77.12 151.86 35.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.606 1.562 . . . . 1.0 111.701 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.1 -141.62 15.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.954 1.264 . . . . 1.0 113.964 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.34 -169.11 3.18 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 129.101 2.96 . . . . 1.0 111.208 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.774 HG22 ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 78.54 157.81 0.14 Allowed Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 128.864 2.866 . . . . 1.0 115.398 171.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' HG22 ' A' ' 57' ' ' VAL . 61.0 Cg_endo -73.58 175.04 11.23 Favored 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 125.015 3.81 . . . . 1.0 114.545 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 41.28 69.14 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.877 2.071 . . . . 1.0 111.293 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -79.65 -18.63 72.74 Favored Glycine 0 C--N 1.346 1.096 0 C-N-CA 127.081 2.277 . . . . 1.0 117.518 -168.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 60' ' ' GLY . 7.4 t 154.22 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 129.624 3.169 . . . . 1.0 112.715 172.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.98 113.66 14.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.948 2.899 . . . . 1.0 109.1 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.53 118.24 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.291 -1.506 . . . . 1.0 107.961 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -112.21 151.6 29.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.922 2.089 . . . . 1.0 110.199 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.42 127.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.008 1.723 . . . . 1.0 109.363 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 mtt -128.52 107.5 9.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.604 0.762 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.47 108.81 21.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.166 0.984 . . . . 1.0 111.049 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.21 -154.02 6.75 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 128.638 3.018 . . . . 1.0 114.515 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 107.33 -72.42 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 1 C-N-CA 132.276 4.23 . . . . 1.0 109.434 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -47.06 -48.46 22.37 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.919 2.488 . . . . 1.0 113.631 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.48 8.24 44.7 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.04 1.736 . . . . 1.0 113.933 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 94.66 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 131.466 3.906 . . . . 1.0 111.212 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -157.92 65.95 0.47 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.329 1.974 . . . . 1.0 116.329 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -57.73 -56.23 24.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.62 1.568 . . . . 1.0 113.259 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.03 8.34 6.79 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 120.971 3.693 . . . . 1.0 120.971 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 26.1 mp0 -60.11 133.56 56.21 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 121.645 2.02 . . . . 1.0 116.197 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -138.63 166.2 24.96 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.164 2.586 . . . . 1.0 112.556 170.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.669 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -127.86 86.22 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.089 1.755 . . . . 1.0 110.479 169.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.322 46.3 t30 69.24 13.27 8.57 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.635 1.574 . . . . 1.0 114.149 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -65.24 1.25 1.09 Allowed 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.077 1.351 . . . . 1.0 114.388 169.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.2 p -98.12 111.01 23.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.408 -1.33 . . . . 1.0 107.408 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.7 125.74 21.27 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.792 1.637 . . . . 1.0 112.127 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.78 154.33 17.82 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.039 2.536 . . . . 1.0 114.21 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -133.41 144.17 49.37 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.271 2.229 . . . . 1.0 107.153 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -84.24 0.53 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.585 1.554 . . . . 1.0 107.925 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 55.9 m-20 -82.69 57.01 3.58 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.739 1.216 . . . . 1.0 108.585 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 5.4 pt20 56.94 19.98 4.98 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 130.904 3.681 . . . . 1.0 117.931 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.55 135.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 114.804 1.409 . . . . 1.0 114.804 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.98 26.92 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.479 2.311 . . . . 1.0 110.664 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 11.0 mtt-85 -136.17 142.33 44.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.185 2.194 . . . . 1.0 110.905 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 90' ' ' ARG 0.277 1.4 t80 147.44 -111.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 129.946 3.298 . . . . 1.0 112.973 172.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 p30 177.3 41.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 127.814 2.446 . . . . 1.0 115.261 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.21 -33.66 49.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 130.018 3.327 . . . . 1.0 115.042 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 94' ' ' LEU . 2.3 pt? -66.39 139.36 58.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.174 2.589 . . . . 1.0 117.893 -172.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 3.2 mtt85 -140.63 116.58 10.42 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.628 1.558 . . . . 1.0 112.394 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 35.5 m-85 -83.07 145.93 29.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.033 1.733 . . . . 1.0 113.561 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 100' ' ' SER . 2.4 t 60.45 6.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 127.371 2.268 . . . . 1.0 114.424 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' HB2' ' A' ' 41' ' ' CYS . . . -9.74 -24.71 0.0 OUTLIER Glycine 0 CA--C 1.547 2.035 2 C-N-CA 136.446 6.736 . . . . 1.0 123.646 -173.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.569 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 15.1 ttt180 -165.93 6.13 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.392 3.077 . . . . 1.0 114.785 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 97' ' ' VAL . 49.1 m -58.25 -59.94 4.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.958 2.503 . . . . 1.0 114.946 -172.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.86 -174.22 20.27 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 125.441 1.496 . . . . 1.0 114.4 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 109.67 21.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.825 2.45 . . . . 1.0 111.735 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.97 -11.63 3.36 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 126.733 2.111 . . . . 1.0 116.303 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.856 2.462 . . . . 1.0 112.894 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.642 ' HB2' HG13 ' A' ' 126' ' ' ILE . 25.1 p -108.61 130.01 55.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.443 2.297 . . . . 1.0 110.483 172.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -85.22 83.87 7.86 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.048 0.928 . . . . 1.0 112.655 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 m -70.45 92.61 0.83 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.715 1.606 . . . . 1.0 110.162 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -71.42 101.55 2.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.196 1.398 . . . . 1.0 110.03 172.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.7 p -86.44 100.15 12.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.606 1.962 . . . . 1.0 109.669 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 25' ' ' THR . 4.1 mp -88.28 110.2 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 100.909 -3.737 . . . . 1.0 100.909 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.0 m -112.61 109.61 19.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.889 1.675 . . . . 1.0 114.087 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 114' ' ' THR . 7.0 t -73.74 143.76 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 123.681 1.705 . . . . 1.0 109.834 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -110.99 10.39 22.17 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 131.573 3.949 . . . . 1.0 113.931 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.782 HG23 ' HD2' ' A' ' 116' ' ' PRO . 10.1 t -105.53 -179.45 3.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.731 1.613 . . . . 1.0 113.162 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -45.77 -53.11 21.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 126.915 2.086 . . . . 1.0 112.298 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.782 ' HD2' HG23 ' A' ' 114' ' ' THR . 47.1 Cg_endo -76.21 102.04 1.56 Allowed 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 124.705 3.603 . . . . 1.0 109.884 170.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.39 99.66 1.05 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.254 3.303 . . . . 1.0 109.411 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.503 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 16.6 mt-30 -108.19 97.23 6.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.873 0.844 . . . . 1.0 110.842 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.74 114.95 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.011 1.724 . . . . 1.0 108.398 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.11 159.54 20.74 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.722 2.409 . . . . 1.0 110.977 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.4 m -121.61 121.33 37.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.068 0.947 . . . . 1.0 111.308 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 64.1 t80 -87.95 120.18 29.03 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.344 0.975 . . . . 1.0 110.912 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -130.6 122.12 26.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.99 2.516 . . . . 1.0 111.422 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.7 -52.1 0.11 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.613 1.565 . . . . 1.0 113.173 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.31 70.85 0.75 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.246 2.218 . . . . 1.0 109.401 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' ' 105' ' ' SER . 8.6 tp -47.14 -14.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 129.676 3.19 . . . . 1.0 118.296 -171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -87.13 152.29 22.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 130.807 3.643 . . . . 1.0 115.765 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.58 162.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 128.025 2.53 . . . . 1.0 114.111 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.7 t -75.05 133.07 41.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.11 0.964 . . . . 1.0 112.74 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.74 -58.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.508 1.923 . . . . 1.0 113.196 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -53.77 -37.94 63.96 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.307 1.843 . . . . 1.0 114.452 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 127.533 2.492 . . . . 1.0 114.572 -179.32 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -152.52 -173.68 4.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 131.336 3.854 . . . . 1.0 105.063 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 32' ' ' CYS 0.356 9.9 m -69.01 72.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.54 1.973 . . . . 1.0 109.926 170.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -51.13 158.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.355 2.262 . . . . 1.0 113.54 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 30' ' ' PHE 0.296 9.0 t -101.94 -120.77 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.365 -0.826 . . . . 1.0 110.745 177.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -55.88 -37.83 69.35 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.354 1.434 . . . . 1.0 113.169 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 m -136.86 156.83 75.74 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 127.648 2.379 . . . . 1.0 112.663 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -2.4 6.71 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.228 3.285 . . . . 1.0 115.041 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.79 -27.49 60.34 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.03 2.932 . . . . 1.0 114.024 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.631 ' HB2' HG22 ' A' ' 25' ' ' THR . 2.5 m-85 -118.6 108.35 14.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.677 1.591 . . . . 1.0 107.706 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.3 mt -115.12 135.02 54.64 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.894 2.878 . . . . 1.0 112.729 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.719 ' HB2' HG23 ' A' ' 23' ' ' VAL . 4.5 m -118.88 160.09 22.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.899 1.28 . . . . 1.0 112.505 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -138.93 100.02 3.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.413 2.285 . . . . 1.0 108.655 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -137.23 162.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 129.111 2.964 . . . . 1.0 109.362 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -103.57 155.06 37.39 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.394 1.078 . . . . 1.0 110.607 170.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 35' ' ' LEU . 17.1 Cg_exo -51.69 149.85 18.15 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.915 3.077 . . . . 1.0 115.559 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 96' ' ' PHE . 12.9 t -127.85 29.29 5.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 127.12 2.168 . . . . 1.0 114.23 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -64.2 37.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 127.495 2.318 . . . . 1.0 116.195 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -162.28 162.65 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 129.184 2.994 . . . . 1.0 111.746 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' ' 101' ' ' GLY . 0.7 OUTLIER -79.22 150.84 31.5 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.536 1.935 . . . . 1.0 113.987 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.7 t 49.13 71.76 0.35 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.645 1.978 . . . . 1.0 112.53 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -50.69 -39.46 51.31 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.226 1.565 . . . . 1.0 115.226 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt 62.75 171.78 0.14 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.575 2.75 . . . . 1.0 114.541 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -74.82 79.17 2.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.047 1.339 . . . . 1.0 110.741 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 47' ' ' ILE . 22.6 mt -69.37 146.25 96.35 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 125.616 1.566 . . . . 1.0 111.821 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.67 -3.73 8.49 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.098 3.199 . . . . 1.0 116.074 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 45' ' ' LEU . 35.9 pt -59.44 -30.67 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.05 2.94 . . . . 1.0 115.698 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.55 173.5 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 127.331 2.252 . . . . 1.0 114.752 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 94' ' ' LEU . 16.6 m-85 -144.99 151.58 38.81 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -174.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 10.4 tttp -143.92 148.45 35.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.544 1.937 . . . . 1.0 112.525 172.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' A' ' 50' ' ' LYS . 14.0 m -136.97 143.2 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.15 2.18 . . . . 1.0 111.013 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.89 119.5 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 128.077 2.551 . . . . 1.0 108.782 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.65 107.2 9.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.495 1.118 . . . . 1.0 110.744 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mt -90.56 118.07 29.73 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.969 1.707 . . . . 1.0 112.531 -172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.18 -167.69 30.13 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 127.555 2.502 . . . . 1.0 114.07 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.77 -4.42 25.0 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 115.451 1.648 . . . . 1.0 115.451 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.06 142.8 55.97 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.445 1.498 . . . . 1.0 112.081 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.91 -38.89 27.27 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 124.501 3.467 . . . . 1.0 112.951 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.88 -167.62 1.95 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 126.838 2.055 . . . . 1.0 110.542 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.04 -55.73 0.86 Allowed Glycine 0 C--N 1.344 0.984 0 O-C-N 120.032 -1.668 . . . . 1.0 113.091 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t 152.28 -177.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 129.264 3.025 . . . . 1.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.49 116.14 21.33 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.534 2.334 . . . . 1.0 110.542 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 p -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 120.451 -1.406 . . . . 1.0 109.3 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -123.0 123.55 41.14 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.118 1.367 . . . . 1.0 113.307 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 80' ' ' ALA . 2.6 m -96.26 116.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.549 -1.344 . . . . 1.0 108.261 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 93.2 mtp -122.82 113.32 19.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.59 115.12 26.9 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 120.806 1.639 . . . . 1.0 114.071 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.43 -149.48 6.99 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 129.386 3.374 . . . . 1.0 112.451 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' GLU . 67.0 t30 -156.78 40.5 0.33 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.021 1.728 . . . . 1.0 112.145 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 62.85 -26.6 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.778 2.831 . . . . 1.0 114.453 -170.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -140.02 84.52 1.97 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 132.142 4.177 . . . . 1.0 106.702 169.668 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.86 -45.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.876 1.67 . . . . 1.0 113.725 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 43.57 23.72 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.543 3.137 . . . . 1.0 117.25 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -49.28 -30.4 7.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.34 2.656 . . . . 1.0 115.0 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.06 -75.24 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.412 2.285 . . . . 1.0 114.915 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 33.81 99.17 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 131.474 3.909 . . . . 1.0 116.419 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -131.93 165.46 23.85 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.868 1.267 . . . . 1.0 113.377 174.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.66 84.24 2.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.104 2.162 . . . . 1.0 109.797 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.25 8.62 6.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.434 1.493 . . . . 1.0 114.376 -173.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -70.22 13.95 0.14 Allowed 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 120.958 1.708 . . . . 1.0 113.645 168.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 m -100.33 110.52 22.75 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.53 125.02 13.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.979 0.912 . . . . 1.0 113.402 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.09 155.89 17.75 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.21 1.404 . . . . 1.0 113.155 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 63.1 mtp -127.17 148.33 50.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 128.907 2.883 . . . . 1.0 107.889 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -126.53 -73.13 0.63 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.869 1.268 . . . . 1.0 114.287 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -72.93 33.5 0.07 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.419 1.488 . . . . 1.0 111.448 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 62.0 14.24 6.28 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.114 2.966 . . . . 1.0 114.544 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.63 152.61 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 129.556 3.142 . . . . 1.0 112.339 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 91' ' ' PHE . . . -137.91 146.93 43.89 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.248 1.819 . . . . 1.0 113.895 170.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -132.66 123.7 26.85 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 128.199 2.599 . . . . 1.0 111.312 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -172.15 173.39 4.31 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.813 1.783 . . . . 1.0 115.813 -174.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -141.44 1.36 1.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.528 1.931 . . . . 1.0 114.926 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -28.35 59.25 Favored 'General case' 0 CA--C 1.545 0.786 1 C-N-CA 131.824 4.05 . . . . 1.0 115.161 -172.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 6.8 mp -55.53 129.49 39.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.407 2.283 . . . . 1.0 112.176 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 36.4 mtm180 -137.47 123.14 19.85 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.555 1.07 . . . . 1.0 111.741 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.408 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 2.3 m-85 -93.28 143.52 26.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.481 2.712 . . . . 1.0 110.611 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 0.7 OUTLIER 44.61 46.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 125.677 1.591 . . . . 1.0 112.516 -175.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -35.37 -92.27 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 1 C-N-CA 132.956 5.074 . . . . 1.0 116.945 -171.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttp-105 -73.11 42.41 0.11 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.913 2.085 . . . . 1.0 113.94 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 t 73.04 157.21 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 131.596 3.958 . . . . 1.0 115.638 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' ' HB2' ' A' ' 40' ' ' ARG . . . -149.95 169.14 30.06 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 127.982 2.706 . . . . 1.0 112.632 173.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -160.53 142.9 12.89 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.446 1.898 . . . . 1.0 112.465 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.506 ' C ' ' HE2' ' A' ' 127' ' ' LYS . . . 57.72 30.72 63.02 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.298 1.428 . . . . 1.0 116.547 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -126.61 156.87 40.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.146 2.579 . . . . 1.0 112.559 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -109.45 147.44 32.85 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.865 2.466 . . . . 1.0 110.931 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.782 ' CE1' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.25 89.27 7.8 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.229 1.811 . . . . 1.0 111.778 -173.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.4 m -77.39 74.68 3.95 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.642 1.577 . . . . 1.0 110.119 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.782 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 9.0 tt -61.54 119.52 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.229 -0.919 . . . . 1.0 108.968 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 t -127.82 139.97 52.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 123.445 1.593 . . . . 1.0 114.814 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.37 113.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -102.6 114.89 29.49 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.792 1.237 . . . . 1.0 111.894 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 1.2 t -72.26 151.77 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 123.235 1.493 . . . . 1.0 112.446 -174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -102.0 25.35 8.83 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 129.024 2.93 . . . . 1.0 116.671 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.608 HG23 ' HD2' ' A' ' 116' ' ' PRO . 13.6 t -132.31 176.34 8.49 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.687 1.195 . . . . 1.0 113.828 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 70.2 m-80 -43.0 -47.33 13.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 128.213 2.605 . . . . 1.0 113.062 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD2' HG23 ' A' ' 114' ' ' THR . 95.7 Cg_endo -87.96 95.99 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 124.983 3.789 . . . . 1.0 108.272 168.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.85 109.11 1.21 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.656 2.904 . . . . 1.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.407 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -97.65 103.45 15.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.316 1.531 . . . . 1.0 108.772 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.68 114.94 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.882 2.073 . . . . 1.0 108.976 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.73 142.95 50.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.455 2.302 . . . . 1.0 110.77 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 t -121.95 146.5 47.08 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.552 1.541 . . . . 1.0 113.246 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -87.51 128.79 35.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.947 1.356 . . . . 1.0 112.865 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -63.16 103.44 0.48 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.755 2.422 . . . . 1.0 111.591 172.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 96.78 125.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 1 C-N-CA 132.212 4.205 . . . . 1.0 109.285 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.92 -21.1 10.27 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.325 1.602 . . . . 1.0 115.325 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 38.53 122.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 131.144 3.778 . . . . 1.0 115.866 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 103' ' ' GLY . 21.5 tttt -75.55 137.74 41.04 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.979 -1.7 . . . . 1.0 110.689 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -91.59 141.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.838 1.655 . . . . 1.0 113.468 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.2 t -88.67 142.89 27.31 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.533 0.938 . . . . 1.0 113.533 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.64 -53.52 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.521 1.529 . . . . 1.0 110.445 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.37 -70.5 0.74 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.921 2.889 . . . . 1.0 111.378 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.74 177.85 15.52 Favored Glycine 0 CA--C 1.549 2.176 0 C-N-CA 126.147 1.832 . . . . 1.0 115.829 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . 58.4 Cg_endo -71.51 -40.8 2.72 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.211 3.274 . . . . 1.0 113.353 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -174.94 145.26 0.82 Allowed 'General case' 0 N--CA 1.473 0.686 1 C-N-CA 131.884 4.074 . . . . 1.0 109.466 172.856 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.707 2.803 . . . . 1.0 111.157 173.891 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 114.322 1.231 . . . . 1.0 114.322 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -148.94 -173.23 4.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 131.138 3.775 . . . . 1.0 105.074 -173.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.89 73.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 O-C-N 120.119 -1.613 . . . . 1.0 107.652 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.603 ' HB2' ' CG ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -60.63 169.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.034 0.933 . . . . 1.0 111.978 169.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.8 p -133.06 -105.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.29 1.036 . . . . 1.0 109.972 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 121' ' ' THR . 1.1 m-20 -143.09 64.83 1.35 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.812 2.845 . . . . 1.0 108.425 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.1 m -157.05 161.61 29.16 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 119.884 -1.76 . . . . 1.0 115.158 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.26 146.74 95.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.259 1.973 . . . . 1.0 109.677 169.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 52.96 32.99 13.66 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 124.867 1.267 . . . . 1.0 113.881 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.603 ' CG ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.61 110.36 16.01 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.895 1.443 . . . . 1.0 114.895 -173.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 1.7 pp -140.08 115.48 9.95 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.562 1.545 . . . . 1.0 113.304 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.788 ' HB2' ' HA ' ' A' ' 51' ' ' VAL 0.253 0.0 OUTLIER -127.15 165.39 19.65 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 123.533 1.635 . . . . 1.0 114.826 175.512 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.626 ' HB2' ' HG2' ' A' ' 50' ' ' LYS . 66.6 m -151.47 93.2 1.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.104 2.962 . . . . 1.0 108.933 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.29 150.06 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 131.152 3.781 . . . . 1.0 107.797 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -65.22 174.35 1.43 Allowed Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 123.803 0.841 . . . . 1.0 113.141 175.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -60.3 165.26 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.105 2.537 . . . . 1.0 113.786 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.8 t -125.0 9.63 8.13 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.44 1.896 . . . . 1.0 114.691 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -67.51 47.69 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.954 2.502 . . . . 1.0 115.747 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.86 173.57 14.36 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.187 1.921 . . . . 1.0 116.187 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.7 ' HD3' ' HB2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -95.0 122.97 38.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 128.1 2.56 . . . . 1.0 110.717 177.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.1 t 62.8 95.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.74 2.016 . . . . 1.0 113.769 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.644 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 22.4 t-20 -39.65 -46.04 1.76 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.151 2.181 . . . . 1.0 112.924 171.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 51.7 tttt 74.14 177.33 0.23 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 129.163 2.985 . . . . 1.0 112.25 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 97.6 m -61.18 -33.93 74.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.906 1.282 . . . . 1.0 114.138 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 92' ' ' ASN . 43.6 mt 51.22 87.16 0.14 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 127.126 2.17 . . . . 1.0 114.657 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.9 61.62 0.59 Allowed 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 125.092 3.862 . . . . 1.0 113.489 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 136.85 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 1 C-N-CA 132.431 4.292 . . . . 1.0 108.337 -178.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.38 24.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.845 1.658 . . . . 1.0 111.968 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.05 150.46 42.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.888 1.675 . . . . 1.0 112.113 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.626 ' HG2' ' HB2' ' A' ' 33' ' ' SER . 3.4 ptmm? -131.37 108.8 9.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.759 2.023 . . . . 1.0 108.521 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.788 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . 57.3 t -131.31 121.87 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 117.507 -1.235 . . . . 1.0 109.293 -172.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.47 120.71 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.805 1.642 . . . . 1.0 110.451 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 27' ' ' SER . . . -133.07 106.68 7.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.024 -1.843 . . . . 1.0 106.024 170.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 155.32 37.67 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.086 2.254 . . . . 1.0 117.086 -169.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.39 -26.52 0.97 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.546 2.022 . . . . 1.0 115.218 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.11 86.87 7.34 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.826 2.45 . . . . 1.0 112.225 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.6 -50.02 67.37 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-O 117.573 -1.204 . . . . 1.0 110.042 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 114' ' ' THR . 56.5 Cg_endo -81.58 129.86 6.66 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.294 3.329 . . . . 1.0 111.058 170.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.11 169.34 12.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.131 2.172 . . . . 1.0 115.492 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.13 3.23 45.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.936 2.207 . . . . 1.0 115.241 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.72 ' CG2' ' HB2' ' A' ' 84' ' ' MET . 13.8 t -53.82 121.03 7.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.618 1.709 . . . . 1.0 112.537 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.06 102.77 12.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.832 1.301 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 110' ' ' ILE . 84.0 t -92.03 107.62 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.901 -1.889 . . . . 1.0 105.901 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.5 p -107.76 118.14 35.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.196 -0.911 . . . . 1.0 113.167 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.339 0.5 OUTLIER -107.0 112.98 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.377 -1.452 . . . . 1.0 111.152 -177.559 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 mtt -139.51 171.28 14.48 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.615 1.566 . . . . 1.0 114.591 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . . . -125.83 112.36 15.92 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.76 178.17 40.07 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 128.232 2.825 . . . . 1.0 115.623 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 73' ' ' TYR . 33.6 p-10 -121.74 -61.9 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.789 2.435 . . . . 1.0 108.48 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -113.89 46.73 1.27 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 131.222 3.809 . . . . 1.0 106.534 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 64.82 -26.94 0.09 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.77 2.828 . . . . 1.0 114.209 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -102.35 49.33 0.85 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 129.495 3.118 . . . . 1.0 115.329 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.656 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 4.5 t80 -132.35 -19.2 2.48 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.903 1.681 . . . . 1.0 115.076 173.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 m 14.92 72.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 132.111 4.164 . . . . 1.0 114.654 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.04 149.34 6.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.129 2.172 . . . . 1.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -51.92 142.57 15.28 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.045 2.138 . . . . 1.0 114.161 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -127.59 168.56 14.82 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.495 2.318 . . . . 1.0 112.615 178.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -136.01 102.94 5.19 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.22 1.808 . . . . 1.0 108.536 172.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.9 m120 79.71 -9.03 1.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 117.171 -1.395 . . . . 1.0 111.99 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 77' ' ' LEU 0.259 . . -68.91 20.82 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 122.298 2.317 . . . . 1.0 115.228 174.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -126.29 113.58 17.13 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.353 1.861 . . . . 1.0 109.591 168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.5 151.63 41.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.561 1.545 . . . . 1.0 112.274 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 129.53 40.41 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 127.026 2.13 . . . . 1.0 111.589 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.72 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -124.71 168.93 12.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.165 1.386 . . . . 1.0 113.682 -171.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 2.6 mptt -96.0 -72.05 0.65 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.187 2.595 . . . . 1.0 112.567 -168.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.7 48.39 1.7 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 129.836 3.254 . . . . 1.0 106.475 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.9 26.41 7.82 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.472 2.709 . . . . 1.0 113.143 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 85' ' ' LYS . 12.8 p -92.76 114.35 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 127.955 2.502 . . . . 1.0 112.169 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.06 146.54 24.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.776 2.031 . . . . 1.0 113.181 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 91' ' ' PHE . 20.7 ttp180 -136.69 157.36 46.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.719 2.808 . . . . 1.0 111.796 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.431 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 0.8 OUTLIER 51.33 -139.69 0.94 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.225 1.81 . . . . 1.0 112.654 176.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 45' ' ' LEU . 55.5 t-20 -135.41 109.19 8.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.922 1.237 . . . . 1.0 113.306 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -149.7 68.13 1.01 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.132 2.573 . . . . 1.0 108.458 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -160.88 118.56 2.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.795 1.638 . . . . 1.0 112.266 172.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 38.3 mtp180 -136.75 119.38 16.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 114.212 1.19 . . . . 1.0 114.212 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.644 ' H ' ' HB2' ' A' ' 42' ' ' ASN . 5.5 p90 -93.64 165.75 12.57 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.455 2.302 . . . . 1.0 116.598 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t 46.76 35.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 129.742 3.217 . . . . 1.0 114.584 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.51 -41.46 41.55 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.315 2.388 . . . . 1.0 114.843 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -76.28 -9.24 58.48 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.873 2.069 . . . . 1.0 115.852 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.669 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 4.6 t 58.71 -177.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.165 1.386 . . . . 1.0 114.483 -175.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.15 129.57 3.45 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 128.186 2.803 . . . . 1.0 113.716 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -68.04 164.07 20.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.626 1.97 . . . . 1.0 112.145 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.49 27.64 58.98 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -115.96 150.34 37.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.871 1.668 . . . . 1.0 114.152 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 t -125.21 122.22 36.39 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.319 3.448 . . . . 1.0 110.077 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -84.64 133.6 34.4 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.075 1.88 . . . . 1.0 116.075 -170.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -122.19 105.15 9.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.687 2.395 . . . . 1.0 115.162 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' TYR . 4.8 tt -79.43 90.04 5.03 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.103 -2.184 . . . . 1.0 105.103 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.3 m -92.25 101.47 13.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.799 2.84 . . . . 1.0 110.27 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 63' ' ' VAL . 62.8 mt -92.32 121.14 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.429 1.492 . . . . 1.0 108.015 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -122.93 118.1 27.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.323 1.014 . . . . 1.0 112.14 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.4 OUTLIER -71.7 170.67 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 122.929 1.347 . . . . 1.0 113.286 -176.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 33.3 5.0 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.207 2.203 . . . . 1.0 114.82 -174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.662 HG21 ' HG2' ' A' ' 58' ' ' PRO . 14.2 t -126.64 175.37 8.0 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.019 1.728 . . . . 1.0 112.132 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.52 -49.29 89.38 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 125.981 1.712 . . . . 1.0 113.483 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' A' ' 114' ' ' THR . 68.2 Cg_endo -76.91 111.16 3.18 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 124.348 3.365 . . . . 1.0 110.237 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.79 105.87 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.122 3.215 . . . . 1.0 112.473 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.688 ' H ' HG12 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -100.1 98.72 9.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.793 0.806 . . . . 1.0 109.466 -175.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.59 133.6 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.421 . . . . 1.0 111.744 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.14 154.87 49.17 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.22 1.408 . . . . 1.0 112.828 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 63.3 m -128.32 149.46 50.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.331 1.852 . . . . 1.0 111.596 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 82.9 t80 -83.74 165.47 18.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.579 1.951 . . . . 1.0 112.705 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -57.96 62.73 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 126.177 1.791 . . . . 1.0 111.461 169.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -87.82 98.31 11.4 Favored 'General case' 0 N--CA 1.469 0.502 1 C-N-CA 131.982 4.113 . . . . 1.0 114.364 -170.495 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.83 -103.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.561 2.745 . . . . 1.0 104.862 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 43.15 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 129.388 3.075 . . . . 1.0 113.304 170.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -138.56 161.35 37.3 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.133 1.773 . . . . 1.0 114.684 173.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.3 tt -93.1 146.12 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 127.654 2.382 . . . . 1.0 111.693 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 t -70.33 137.0 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.008 0.744 . . . . 1.0 113.008 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -91.57 -15.55 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.146 1.378 . . . . 1.0 113.424 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -67.64 0.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.606 2.762 . . . . 1.0 112.309 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -40.13 95.28 0.01 OUTLIER Glycine 0 CA--C 1.544 1.862 0 C-N-CA 129.366 3.365 . . . . 1.0 113.629 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.23 162.6 41.98 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.578 2.852 . . . . 1.0 115.337 -171.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.7 ' HB2' ' HD3' ' A' ' 40' ' ' ARG . 7.9 ttm180 -120.5 80.93 1.68 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.968 2.507 . . . . 1.0 111.063 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 129.463 3.105 . . . . 1.0 113.386 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 12.9 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.459 -0.782 . . . . 1.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mt -146.65 -173.61 4.25 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 128.545 2.738 . . . . 1.0 104.989 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 2.4 t -69.77 71.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 119.458 -2.027 . . . . 1.0 109.664 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.97 172.11 0.09 Allowed 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.498 1.666 . . . . 1.0 115.498 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 30' ' ' PHE . 8.2 t -108.28 -135.1 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.814 1.645 . . . . 1.0 108.528 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.2 -47.45 24.26 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.462 1.905 . . . . 1.0 111.579 170.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.5 m -131.38 159.12 73.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.485 1.914 . . . . 1.0 111.843 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.94 -7.32 20.86 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 123.882 3.055 . . . . 1.0 116.191 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -67.18 -36.11 81.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.802 2.441 . . . . 1.0 114.398 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 25' ' ' THR . 75.4 m-85 -104.49 109.72 21.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.189 2.196 . . . . 1.0 110.405 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 155.52 22.48 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.629 1.714 . . . . 1.0 115.629 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 2.7 m -132.41 164.75 25.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.311 2.245 . . . . 1.0 112.038 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 42.9 m -153.4 91.24 1.48 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.455 2.302 . . . . 1.0 108.488 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.82 149.37 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 129.414 3.086 . . . . 1.0 108.933 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.837 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -83.7 178.88 2.16 Favored Pre-proline 0 CA--C 1.561 1.381 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -175.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 50.6 Cg_endo -66.3 48.06 0.25 Allowed 'Trans proline' 0 CA--C 1.557 1.656 1 C-N-CA 125.615 4.21 . . . . 1.0 116.581 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -65.02 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 129.144 2.978 . . . . 1.0 114.04 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.778 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 5.4 p-80 -55.21 69.45 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.98 1 C-N-CA 132.198 4.199 . . . . 1.0 114.4 174.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -154.62 169.29 24.22 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.169 2.188 . . . . 1.0 112.848 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.17 116.29 7.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.533 2.333 . . . . 1.0 110.737 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t 59.04 84.21 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.584 1.954 . . . . 1.0 110.516 -169.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -38.21 73.17 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.334 0.654 . . . . 1.0 112.743 -174.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 tttt 71.77 160.29 0.22 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 131.436 3.894 . . . . 1.0 114.71 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -72.79 68.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.557 1.543 . . . . 1.0 109.907 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 23.3 mt -68.07 159.75 78.21 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.862 1.265 . . . . 1.0 113.704 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.59 -8.37 22.09 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.373 3.382 . . . . 1.0 116.465 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -65.39 -14.65 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.401 1.88 . . . . 1.0 115.541 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.827 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . . . 66.09 175.72 0.23 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.725 2.41 . . . . 1.0 112.982 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -131.31 84.06 2.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.672 1.589 . . . . 1.0 109.784 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 86.8 mttt -87.25 111.59 21.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 105.366 -2.087 . . . . 1.0 105.366 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 87' ' ' GLN . 14.7 p -133.97 122.19 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.95 1.7 . . . . 1.0 107.819 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.8 t -139.06 148.25 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 128.377 2.671 . . . . 1.0 112.588 -172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.85 143.89 49.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.394 -1.441 . . . . 1.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.73 113.26 21.18 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.112 0.482 . . . . 1.0 110.513 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.05 -178.16 37.12 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.412 2.435 . . . . 1.0 114.173 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -176.37 0.72 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 126.129 1.771 . . . . 1.0 115.457 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.4 95.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 125.441 1.497 . . . . 1.0 113.692 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.25 -4.0 5.92 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 124.616 3.544 . . . . 1.0 117.944 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 29.23 79.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 130.159 3.383 . . . . 1.0 115.552 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.23 51.57 0.01 OUTLIER Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.841 1.21 . . . . 1.0 113.574 -171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.434 HG22 HD11 ' A' ' 110' ' ' ILE . 84.7 m -129.54 94.05 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.138 1.775 . . . . 1.0 108.604 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -91.12 117.46 29.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.47 1.508 . . . . 1.0 111.627 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.97 111.84 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 105.678 -1.971 . . . . 1.0 105.678 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 81' ' ' THR . 35.1 p -112.56 114.03 26.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.707 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.269 0.1 OUTLIER -125.77 111.55 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.478 -1.389 . . . . 1.0 113.425 -170.346 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.518 ' HG2' ' H ' ' A' ' 67' ' ' ALA . 15.8 ttm -138.8 172.7 12.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.728 2.121 . . . . 1.0 116.728 -172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.958 ' HB1' ' HB2' ' A' ' 105' ' ' SER . . . -98.45 143.94 28.34 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.724 1.249 . . . . 1.0 110.278 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.55 100.07 0.21 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 128.019 2.723 . . . . 1.0 112.424 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 27.6 t-20 -124.05 -39.21 2.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.765 2.426 . . . . 1.0 109.629 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.9 -45.3 30.46 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 129.012 2.925 . . . . 1.0 112.706 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -144.03 -11.94 0.65 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.46 2.304 . . . . 1.0 116.256 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 m120 84.37 151.78 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 130.525 3.53 . . . . 1.0 110.367 -170.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 33.26 43.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 128.519 2.728 . . . . 1.0 114.862 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -83.52 -26.27 30.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.331 3.052 . . . . 1.0 114.482 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . . . -141.65 122.2 14.18 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 120.167 1.349 . . . . 1.0 112.088 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -58.23 172.13 0.48 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.13 2.27 . . . . 1.0 117.13 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.848 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.8 pp -116.07 167.27 11.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.637 3.175 . . . . 1.0 110.816 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 3.4 mtp180 -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.577 -0.702 . . . . 1.0 110.212 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.34 12.21 4.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.259 1.824 . . . . 1.0 111.65 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -62.92 7.11 0.09 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.171 1.388 . . . . 1.0 114.35 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 64' ' ' THR . 48.6 p -105.98 110.76 23.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.479 1.111 . . . . 1.0 109.705 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.29 135.21 30.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.353 1.461 . . . . 1.0 111.613 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.32 144.06 25.77 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.786 2.034 . . . . 1.0 112.345 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.3 mtm -151.88 -173.72 4.62 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.316 1.846 . . . . 1.0 111.69 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -110.89 -96.82 0.41 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.477 2.311 . . . . 1.0 109.146 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.14 56.57 4.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.951 2.101 . . . . 1.0 108.836 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.678 ' HG2' HG22 ' A' ' 51' ' ' VAL . 19.0 tt0 51.25 32.46 8.21 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.801 1.64 . . . . 1.0 113.539 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.12 115.39 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.821 2.049 . . . . 1.0 111.845 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.7 147.52 50.11 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.618 1.567 . . . . 1.0 112.102 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 152.71 32.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.76 2.424 . . . . 1.0 111.911 -174.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.6 t80 57.38 -138.63 0.91 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.651 1.98 . . . . 1.0 112.405 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.827 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 32.3 t-20 -138.58 137.56 37.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.929 1.692 . . . . 1.0 110.9 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 t0 175.12 67.12 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.939 2.496 . . . . 1.0 112.75 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.689 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -160.52 142.74 12.8 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.14 2.576 . . . . 1.0 109.327 171.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 33.0 mtp180 -141.11 118.17 11.23 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.823 1.647 . . . . 1.0 113.897 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -94.07 153.09 18.33 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.456 1.122 . . . . 1.0 113.287 -175.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' A' ' 67' ' ' ALA 0.285 2.6 m 49.12 33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.553 2.741 . . . . 1.0 114.476 171.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.66 25.76 0.1 Allowed Glycine 0 CA--C 1.537 1.43 1 C-N-CA 131.796 4.522 . . . . 1.0 118.002 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.25 9.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 129.237 3.015 . . . . 1.0 111.665 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.2 p -67.59 92.68 0.33 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.692 2.797 . . . . 1.0 110.467 170.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.92 -133.71 4.15 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.55 2.5 . . . . 1.0 113.559 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -66.51 168.58 8.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.96 1.704 . . . . 1.0 112.419 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.34 -81.08 0.2 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.353 0.977 . . . . 1.0 111.019 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 94.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.291 1.837 . . . . 1.0 109.621 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.958 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -125.32 108.68 11.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.451 0.7 . . . . 1.0 111.813 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 56.7 t80 -139.21 93.43 2.68 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 128.093 2.557 . . . . 1.0 115.045 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.262 19.4 m -137.61 60.33 1.64 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.034 1.397 . . . . 1.0 109.248 169.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.06 97.18 10.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.59 1.956 . . . . 1.0 108.512 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.0 p -125.62 168.67 13.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.619 2.452 . . . . 1.0 117.619 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 61' ' ' THR . 5.0 tp -123.13 115.79 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.696 2.798 . . . . 1.0 107.666 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -123.7 108.51 12.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.415 2.286 . . . . 1.0 113.569 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 2.4 t -72.34 147.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.02 -1.675 . . . . 1.0 111.648 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -115.7 48.52 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 1 C-N-CA 132.668 4.387 . . . . 1.0 110.533 -172.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 116' ' ' PRO . 98.4 m -147.23 162.75 38.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 119.878 -1.764 . . . . 1.0 110.374 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.72 -42.71 11.23 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 126.308 1.843 . . . . 1.0 115.084 -173.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HD2' HG22 ' A' ' 114' ' ' THR . 74.9 Cg_endo -88.51 98.64 0.39 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.05 3.833 . . . . 1.0 107.619 168.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.06 118.23 5.56 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.3 2.667 . . . . 1.0 111.564 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.603 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 68.8 mt-30 -109.67 96.85 6.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.725 0.81 . . . . 1.0 110.877 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 m -107.85 122.43 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.982 2.113 . . . . 1.0 112.145 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.02 168.36 19.93 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.82 2.448 . . . . 1.0 112.33 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.3 m -117.31 145.81 43.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.053 -1.654 . . . . 1.0 113.335 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 123' ' ' HIS . 23.6 t80 -87.56 115.77 25.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 1.0 107.539 171.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 74.34 170.95 0.29 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.764 2.026 . . . . 1.0 113.984 -172.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -133.98 23.97 3.9 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.197 2.599 . . . . 1.0 113.38 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.64 119.39 14.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.863 2.065 . . . . 1.0 110.357 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.82 86.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.851 2.06 . . . . 1.0 110.624 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.778 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 11.9 mmtp -126.78 81.57 2.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.883 2.073 . . . . 1.0 111.638 -174.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.25 119.05 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 126.492 1.917 . . . . 1.0 109.992 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.5 m -82.57 123.37 29.15 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.697 1.599 . . . . 1.0 110.364 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.13 -35.45 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -40.46 7.38 Favored 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 131.746 4.018 . . . . 1.0 113.967 174.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.52 -154.97 52.98 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 125.495 1.522 . . . . 1.0 115.325 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.8 77.51 1.08 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 124.857 3.705 . . . . 1.0 113.476 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 145.38 96.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.178 3.791 . . . . 1.0 112.015 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.407 0 C-N-CA 124.354 1.061 . . . . 1.0 113.681 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.98 -0.748 . . . . 1.0 108.98 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 9.3 tp -143.36 -174.67 4.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 104.373 -2.454 . . . . 1.0 104.373 162.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.93 74.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 121.993 2.179 . . . . 1.0 109.464 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' A' ' 28' ' ' PRO . 21.4 mtm105 -47.68 147.29 1.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.295 1.438 . . . . 1.0 112.898 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' A' ' 122' ' ' TYR . 10.8 t -86.43 -154.53 0.22 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.264 1.826 . . . . 1.0 110.984 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.51 -18.37 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.123 2.169 . . . . 1.0 115.355 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 t -144.03 137.24 13.97 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.212 1.805 . . . . 1.0 111.919 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.0 Cg_exo -53.61 -19.74 14.77 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.727 2.952 . . . . 1.0 116.64 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -66.33 -23.24 66.33 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.578 1.325 . . . . 1.0 114.578 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' HB2' HG22 ' A' ' 25' ' ' THR . 98.1 m-85 -125.34 124.07 40.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.897 1.279 . . . . 1.0 111.747 -174.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' CD2' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -139.28 154.62 47.98 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.485 1.661 . . . . 1.0 115.485 -171.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -141.75 164.51 30.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.916 1.686 . . . . 1.0 113.965 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 t -148.91 105.25 3.52 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 126.8 2.04 . . . . 1.0 109.378 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 167.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.217 1 C-N-CA 132.434 4.294 . . . . 1.0 110.346 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.747 ' HG ' ' HD2' ' A' ' 36' ' ' PRO . 1.2 tp -53.9 165.28 0.79 Allowed Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.439 2.295 . . . . 1.0 115.737 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.747 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 40.4 Cg_endo -63.61 146.1 92.24 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.998 3.798 . . . . 1.0 113.776 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.1 p -67.5 -23.85 65.51 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.914 2.086 . . . . 1.0 116.185 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -113.39 77.51 1.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.692 2.397 . . . . 1.0 109.116 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -155.94 165.62 35.93 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.873 3.269 . . . . 1.0 110.677 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.883 ' HD2' ' HB2' ' A' ' 134' ' ' ARG . 0.6 OUTLIER -68.0 101.72 1.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.227 1.011 . . . . 1.0 110.657 174.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p 9.43 -107.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.545 2.738 . . . . 1.0 114.847 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 171.32 -57.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 1 C-N-CA 132.478 4.311 . . . . 1.0 110.738 170.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.0 OUTLIER 68.97 -1.25 2.13 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.526 2.33 . . . . 1.0 116.781 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 93' ' ' ASP 0.316 1.4 t 142.6 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 1 C-N-CA 131.799 4.04 . . . . 1.0 113.462 172.048 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.83 150.98 17.44 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 127.237 2.215 . . . . 1.0 112.028 171.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.55 35.96 0.45 Allowed 'Trans proline' 0 CA--C 1.554 1.515 1 C-N-CA 125.567 4.178 . . . . 1.0 115.115 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -35.48 -71.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 129.732 3.213 . . . . 1.0 115.709 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.47 -30.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.48 1.912 . . . . 1.0 113.403 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.299 1.8 p90 41.52 39.26 1.04 Allowed 'General case' 0 C--N 1.353 0.756 0 N-CA-C 118.742 2.867 . . . . 1.0 118.742 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -126.25 106.89 9.85 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.769 0.713 . . . . 1.0 112.129 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.56 128.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.182 1.393 . . . . 1.0 110.702 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.55 145.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.771 2.028 . . . . 1.0 114.764 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.26 20.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.679 2.392 . . . . 1.0 108.9 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.98 112.28 16.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.395 1.478 . . . . 1.0 109.408 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.8 -61.49 0.6 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.932 1.253 . . . . 1.0 114.923 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.54 -18.94 11.83 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 118.093 2.627 . . . . 1.0 118.093 -171.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 57' ' ' VAL . 53.3 t 44.46 59.42 13.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 127.121 2.168 . . . . 1.0 114.739 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 112' ' ' VAL . 94.1 Cg_endo -88.34 109.48 0.58 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.56 2.84 . . . . 1.0 113.488 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.26 134.86 57.43 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.408 -0.807 . . . . 1.0 111.427 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.18 31.97 27.04 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.744 -0.597 . . . . 1.0 111.901 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 84.7 m -71.11 77.73 0.68 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 170.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -78.87 112.84 16.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.925 2.49 . . . . 1.0 111.767 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.52 107.77 18.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.454 -2.054 . . . . 1.0 105.454 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 m -105.36 119.52 39.28 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.753 -1.567 . . . . 1.0 110.042 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.31 116.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.152 -0.968 . . . . 1.0 108.449 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -125.34 81.24 1.95 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.655 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -96.95 107.4 19.91 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.346 -1.471 . . . . 1.0 107.189 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -39.15 132.25 1.91 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.567 2.508 . . . . 1.0 115.837 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.564 ' HB2' HG23 ' A' ' 97' ' ' VAL . 5.4 m-80 170.74 -15.42 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.449 1 C-N-CA 131.797 4.039 . . . . 1.0 115.733 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 7.5 m-20 -58.05 -35.83 71.88 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.239 1.836 . . . . 1.0 112.749 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 148.26 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 1 C-N-CA 132.75 4.42 . . . . 1.0 115.414 172.966 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -156.84 -102.36 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 O-C-N 120.153 -1.592 . . . . 1.0 113.876 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.65 15.97 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.861 2.864 . . . . 1.0 113.543 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.1 m -168.63 111.9 0.57 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.277 1.831 . . . . 1.0 110.532 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -110.39 164.04 13.08 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.307 1.966 . . . . 1.0 116.307 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 156.78 21.41 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 126.577 1.951 . . . . 1.0 115.313 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -130.76 167.57 18.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.755 2.422 . . . . 1.0 112.409 -174.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.99 91.87 3.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.916 -1.74 . . . . 1.0 111.425 172.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 67.73 12.59 8.92 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.504 1.522 . . . . 1.0 113.058 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.51 ' HB2' ' N ' ' A' ' 95' ' ' ARG . . . -74.83 7.54 3.06 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 120.945 1.702 . . . . 1.0 112.491 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 113.2 24.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 130.089 3.356 . . . . 1.0 106.897 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.57 160.0 40.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.574 1.95 . . . . 1.0 109.89 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.2 46.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.783 1.633 . . . . 1.0 114.05 173.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.787 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 48.8 mtm -101.01 151.61 21.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 1.0 109.671 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -112.13 -80.2 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.466 1.506 . . . . 1.0 107.545 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -62.27 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.213 0.46 . . . . 1.0 110.044 170.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.02 22.6 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.106 1.762 . . . . 1.0 114.421 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -133.88 119.8 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 126.21 1.804 . . . . 1.0 112.836 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.14 143.77 46.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.635 1.574 . . . . 1.0 109.727 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -106.09 106.1 16.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.794 0.838 . . . . 1.0 109.039 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.63 73.05 5.18 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.052 1.741 . . . . 1.0 111.946 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -121.66 171.43 8.85 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 129.216 3.006 . . . . 1.0 110.531 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 1.4 t70 60.48 -20.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 130.179 3.391 . . . . 1.0 117.973 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -42.52 146.42 0.34 Allowed 'General case' 0 C--O 1.238 0.469 1 C-N-CA 133.11 4.564 . . . . 1.0 118.615 -171.441 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -139.95 129.21 23.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.21 -0.996 . . . . 1.0 111.104 170.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -119.85 135.88 54.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.13 1.772 . . . . 1.0 111.836 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 69' ' ' ASN 0.294 4.5 p 52.35 29.77 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 C-N-CA 125.043 1.337 . . . . 1.0 114.386 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.33 72.19 0.61 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 128.039 2.733 . . . . 1.0 113.345 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 132.27 84.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 1 C-N-CA 134.529 5.132 . . . . 1.0 109.425 -175.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . 7.5 m -78.53 162.05 26.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.849 0.685 . . . . 1.0 112.849 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.34 -23.77 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 117.507 1.763 . . . . 1.0 117.507 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 169.64 150.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 129.771 3.228 . . . . 1.0 111.902 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.07 53.41 14.67 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.186 1.374 . . . . 1.0 115.246 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 69' ' ' ASN . 3.9 mptt -68.53 92.34 0.45 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.092 1.757 . . . . 1.0 112.206 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t -122.52 160.85 24.77 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 129.773 3.229 . . . . 1.0 113.973 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -128.4 90.18 3.03 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.021 1.86 . . . . 1.0 116.021 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -101.65 77.45 1.74 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.859 1.664 . . . . 1.0 110.575 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.85 92.84 6.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.561 -1.337 . . . . 1.0 109.255 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.7 t -116.8 122.01 43.19 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.39 114.32 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.003 1.321 . . . . 1.0 108.88 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.9 m -100.83 109.5 21.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.031 2.132 . . . . 1.0 113.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 58' ' ' PRO . 53.7 t -76.39 103.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.411 -1.431 . . . . 1.0 108.462 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.19 3.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.122 1 C-N-CA 134.981 5.312 . . . . 1.0 117.215 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -84.09 178.42 7.84 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.949 2.1 . . . . 1.0 114.02 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 28.7 m-20 -44.93 -54.88 12.15 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.702 1.201 . . . . 1.0 109.814 171.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 48.1 Cg_endo -74.99 116.89 4.72 Favored 'Trans proline' 0 CA--C 1.556 1.575 0 C-N-CA 123.495 2.797 . . . . 1.0 107.984 168.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.23 94.29 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 124.401 3.401 . . . . 1.0 108.603 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.44 92.39 5.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 -172.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -108.22 124.59 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 1.0 112.228 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.08 26.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.123 1.369 . . . . 1.0 111.692 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.2 m -113.31 140.07 48.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.591 1.957 . . . . 1.0 111.008 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 1.1 t80 -118.33 139.69 50.97 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.725 1.61 . . . . 1.0 111.843 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.61 64.0 0.8 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.939 1.459 . . . . 1.0 114.939 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.827 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 20.2 tpt85 -59.56 -27.83 66.58 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.859 2.54 . . . . 1.0 117.859 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 51.6 82.26 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 128.345 2.658 . . . . 1.0 114.705 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.46 -89.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 126.192 1.797 . . . . 1.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -88.17 153.9 20.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.585 1.954 . . . . 1.0 110.787 172.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.57 113.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.68 1.192 . . . . 1.0 110.986 173.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.5 m -89.84 126.31 35.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.0 110.81 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.43 -35.96 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 126.654 1.981 . . . . 1.0 115.485 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -56.21 10.95 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 131.163 3.785 . . . . 1.0 110.964 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 100' ' ' SER . . . 106.81 -79.92 0.27 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.434 2.445 . . . . 1.0 113.576 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 37.5 Cg_endo -74.0 -10.41 22.89 Favored 'Trans proline' 0 CA--C 1.553 1.438 0 C-N-CA 123.672 2.915 . . . . 1.0 117.692 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.883 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 36.1 ttt180 132.02 -20.93 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 131.444 3.898 . . . . 1.0 116.904 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.337 0 C-N-CA 130.216 3.407 . . . . 1.0 109.952 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.441 -0.79 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -157.45 -175.14 5.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.118 2.567 . . . . 1.0 105.259 -168.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.27 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 121.639 2.018 . . . . 1.0 109.676 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HG2' ' HB3' ' A' ' 31' ' ' LEU . 32.5 mtp180 -81.68 141.48 33.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.556 1.542 . . . . 1.0 110.031 169.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 p -81.92 -136.03 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.102 2.161 . . . . 1.0 109.367 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -48.66 -17.2 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.361 -1.462 . . . . 1.0 113.612 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.403 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 43.2 m 75.57 14.96 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 27' ' ' SER . 76.1 Cg_endo -70.32 30.01 0.2 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 124.749 3.633 . . . . 1.0 115.93 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 132.81 -20.48 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.478 1 C-N-CA 133.391 4.676 . . . . 1.0 113.581 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -84.96 140.98 30.68 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 1.0 115.2 -171.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 3.6 pp -148.2 149.57 32.19 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.845 2.458 . . . . 1.0 112.004 171.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 t -129.77 122.14 28.22 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.048 1.339 . . . . 1.0 113.256 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 3.0 t -88.97 96.67 10.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.63 3.172 . . . . 1.0 108.594 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.04 162.58 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 129.988 3.315 . . . . 1.0 111.132 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -126.16 75.46 72.55 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 125.255 1.422 . . . . 1.0 112.386 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.77 -40.49 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 124.309 3.339 . . . . 1.0 113.814 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 m 38.39 45.3 0.81 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.126 3.37 . . . . 1.0 112.622 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . 6.8 p80 44.42 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.497 2.719 . . . . 1.0 114.039 173.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -169.43 176.83 4.91 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 128.964 2.906 . . . . 1.0 108.793 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 97' ' ' VAL . 1.4 ptp180 -119.33 166.93 12.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.365 1.066 . . . . 1.0 113.763 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.2 m 75.68 12.83 3.0 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.923 2.564 . . . . 1.0 117.923 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -21.11 -46.94 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 130.674 3.59 . . . . 1.0 117.839 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.981 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 53.81 -29.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 1 C-N-CA 132.565 4.346 . . . . 1.0 119.512 171.583 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m 141.27 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 1 C-N-CA 133.339 4.656 . . . . 1.0 107.718 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.764 HD23 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -83.03 154.32 67.24 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.459 1.104 . . . . 1.0 112.217 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.764 ' HD2' HD23 ' A' ' 45' ' ' LEU . 58.8 Cg_endo -69.13 37.4 0.22 Allowed 'Trans proline' 0 CA--C 1.558 1.689 1 C-N-CA 125.528 4.152 . . . . 1.0 115.746 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG12 ' HB3' ' A' ' 45' ' ' LEU . 26.3 pt -128.43 -29.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.292 3.037 . . . . 1.0 114.449 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.67 -174.0 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 127.417 2.287 . . . . 1.0 115.489 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 46.3 m-85 -126.46 134.1 51.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.768 2.027 . . . . 1.0 112.847 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 69.8 mttt -130.24 109.35 10.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.599 1.56 . . . . 1.0 109.649 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -106.02 135.78 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.322 1.449 . . . . 1.0 109.02 173.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.56 140.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.394 1.077 . . . . 1.0 110.976 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -104.32 105.68 15.91 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 168.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.54 114.01 26.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.19 2.88 41.74 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.787 1.66 . . . . 1.0 115.923 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -133.67 162.05 33.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.741 2.017 . . . . 1.0 113.707 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.3 t -141.32 71.92 26.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.87 1.668 . . . . 1.0 111.661 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 87' ' ' GLN . 68.3 Cg_endo -79.63 -177.94 4.21 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.849 3.699 . . . . 1.0 114.277 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -148.73 95.76 2.47 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.051 2.14 . . . . 1.0 111.43 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.71 17.21 9.3 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 126.057 1.789 . . . . 1.0 116.955 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 81.1 m -52.14 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.688 2.395 . . . . 1.0 113.294 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -77.15 103.27 6.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.217 1.407 . . . . 1.0 110.971 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.47 108.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -112.36 115.85 29.4 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 123.944 0.777 . . . . 1.0 112.634 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.685 HG13 ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -98.28 111.65 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.128 -0.982 . . . . 1.0 110.253 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.818 ' HG2' ' HB3' ' A' ' 77' ' ' LEU . 32.8 mtm -128.99 165.56 20.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.94 127.31 47.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.337 1.055 . . . . 1.0 109.158 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -35.57 -57.28 0.96 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 125.55 1.548 . . . . 1.0 113.187 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.509 ' H ' ' CB ' ' A' ' 105' ' ' SER . 12.7 t-20 72.94 109.35 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.504 3.522 . . . . 1.0 110.078 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 102' ' ' ARG . 1.0 OUTLIER 54.33 32.91 17.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.202 1.401 . . . . 1.0 112.729 -168.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 53.97 54.92 9.02 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 129.161 2.984 . . . . 1.0 114.096 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.361 0.1 OUTLIER -82.37 -108.3 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.494 0.717 . . . . 1.0 111.003 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -172.64 70.79 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 130.642 3.577 . . . . 1.0 110.394 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.0 p 63.35 89.75 0.09 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.833 2.053 . . . . 1.0 114.477 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -147.37 74.21 1.32 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.869 1.063 . . . . 1.0 113.869 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 26.1 tt0 161.09 96.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.053 2.141 . . . . 1.0 115.628 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.038 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.98 165.48 24.61 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.615 3.566 . . . . 1.0 107.876 170.076 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -144.11 82.53 1.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.255 -1.528 . . . . 1.0 111.193 169.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 23.9 m120 84.16 4.07 0.76 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.089 1.756 . . . . 1.0 111.136 -170.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -64.07 9.85 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.587 3.155 . . . . 1.0 116.592 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 t -118.63 115.13 23.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.527 1.931 . . . . 1.0 110.834 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.1 32.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.589 1.956 . . . . 1.0 112.198 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.82 143.62 26.33 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.923 2.489 . . . . 1.0 111.898 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -121.37 149.25 43.26 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.876 2.47 . . . . 1.0 112.088 -170.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -79.48 -117.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.063 0.945 . . . . 1.0 111.057 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.7 -8.14 1.2 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.718 2.007 . . . . 1.0 115.246 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 135.69 6.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.192 1 C-N-CA 133.109 4.563 . . . . 1.0 113.128 -171.354 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.54 144.66 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 120.405 1.457 . . . . 1.0 112.613 -169.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -99.92 146.34 26.79 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.188 2.195 . . . . 1.0 113.637 173.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.938 2.495 . . . . 1.0 110.844 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 t80 45.93 -78.9 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.421 3.088 . . . . 1.0 116.842 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 44.88 160.99 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.537 1 C-N-CA 131.773 4.029 . . . . 1.0 118.497 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.55 -54.9 4.43 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.627 2.371 . . . . 1.0 113.567 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 5.5 mt 40.82 120.18 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.403 1 C-N-CA 133.093 4.557 . . . . 1.0 117.321 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.981 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.92 115.34 22.39 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.783 1.629 . . . . 1.0 113.196 -170.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -99.95 136.28 40.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.464 1.505 . . . . 1.0 110.82 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 1.8 t 50.43 56.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.848 -1.167 . . . . 1.0 107.848 -171.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.06 -8.06 65.18 Favored Glycine 0 N--CA 1.479 1.501 1 N-CA-C 126.499 5.36 . . . . 1.0 126.499 -167.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 100' ' ' SER 0.253 1.3 tmm_? -146.9 48.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.88 3.34 . . . . 1.0 117.488 -177.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' ARG 0.278 3.4 t 144.53 -81.49 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 132.126 4.17 . . . . 1.0 111.059 171.171 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 85.55 1.59 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.041 1.291 . . . . 1.0 114.799 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -44.41 -60.35 1.99 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 129.211 3.004 . . . . 1.0 116.951 -176.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.82 -79.95 0.03 OUTLIER Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.287 1.899 . . . . 1.0 111.592 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.64 98.1 1.91 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.701 1.6 . . . . 1.0 114.516 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.509 ' CB ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -127.51 136.13 51.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.824 2.05 . . . . 1.0 113.142 173.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.8 114.05 12.23 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.168 1.787 . . . . 1.0 111.747 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -139.21 75.84 1.54 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.939 1.696 . . . . 1.0 111.288 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.56 108.9 8.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 1.0 110.046 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -117.74 115.25 24.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.2 1.4 . . . . 1.0 112.14 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.4 116.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.472 1.509 . . . . 1.0 107.197 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -113.77 107.34 15.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.201 1.001 . . . . 1.0 113.239 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.59 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 55.5 t -77.3 145.56 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.514 1.526 . . . . 1.0 111.846 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -104.1 -6.99 20.56 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.316 3.046 . . . . 1.0 114.627 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 116' ' ' PRO . 8.6 m -72.28 171.47 12.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.869 2.868 . . . . 1.0 111.742 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.99 -52.53 9.15 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.403 -1.284 . . . . 1.0 111.778 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 114' ' ' THR . 58.1 Cg_endo -78.24 110.74 2.93 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 124.624 3.55 . . . . 1.0 109.534 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 106.37 1.88 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.009 2.473 . . . . 1.0 109.624 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.632 HE22 ' HB2' ' A' ' 116' ' ' PRO . 1.7 mp0 -106.68 101.48 10.92 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 1.0 111.15 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.78 114.38 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.631 1.973 . . . . 1.0 111.423 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.08 127.66 32.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.91 1.684 . . . . 1.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 t -123.88 148.67 46.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.218 1.807 . . . . 1.0 114.712 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -87.32 112.66 22.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 1.0 109.073 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.42 49.91 2.28 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.006 2.522 . . . . 1.0 112.097 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -136.48 -99.94 0.21 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.217 2.207 . . . . 1.0 114.222 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.48 58.78 0.29 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 116.175 1.917 . . . . 1.0 116.175 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.27 72.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.329 2.252 . . . . 1.0 114.256 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -128.98 159.67 35.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.276 2.23 . . . . 1.0 111.769 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -149.88 161.21 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.899 2.079 . . . . 1.0 111.235 174.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.7 m -99.06 124.05 43.79 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.46 1.904 . . . . 1.0 110.334 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.85 -30.91 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 115.733 1.753 . . . . 1.0 115.733 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.55 -49.88 75.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.189 2.195 . . . . 1.0 112.605 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 40' ' ' ARG . . . -41.31 95.57 0.01 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 129.203 3.287 . . . . 1.0 112.635 171.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.46 166.6 12.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.564 2.842 . . . . 1.0 115.257 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -68.79 -39.69 80.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.454 1.901 . . . . 1.0 113.302 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 CA--C 1.561 1.382 0 C-N-CA 128.357 2.663 . . . . 1.0 114.867 -172.394 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 119.663 -0.208 . . . . 1.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mt -148.51 -173.89 4.46 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.689 2.396 . . . . 1.0 106.273 150.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.28 71.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 120.951 1.705 . . . . 1.0 106.677 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -127.98 82.04 2.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.269 3.428 . . . . 1.0 108.216 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.0 p -100.68 -73.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.433 1.893 . . . . 1.0 110.047 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.593 1.557 . . . . 1.0 114.01 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m 75.19 36.38 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 117.161 2.282 . . . . 1.0 117.161 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.74 37.37 0.24 Allowed 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 124.481 3.454 . . . . 1.0 112.971 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . 0.27 84.8 m-20 73.24 16.0 4.26 Favored 'General case' 0 CA--C 1.56 1.33 1 C-N-CA 132.328 4.251 . . . . 1.0 114.052 -170.457 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.73 ' CE1' ' HB2' ' A' ' 53' ' ' ALA . 80.4 m-85 -108.68 137.14 47.09 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.495 1.665 . . . . 1.0 115.495 -174.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 pp -122.31 122.1 38.29 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.557 2.343 . . . . 1.0 111.923 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HB2' HG13 ' A' ' 51' ' ' VAL . 1.6 t -115.27 147.07 40.85 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.336 1.854 . . . . 1.0 112.65 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -130.14 95.17 3.86 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.969 2.908 . . . . 1.0 110.689 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -144.64 139.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 128.625 2.77 . . . . 1.0 110.877 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.77 146.69 80.16 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 126.252 1.821 . . . . 1.0 114.424 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.65 99.51 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.622 3.548 . . . . 1.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.5 t -93.69 -8.14 41.73 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 116.192 1.923 . . . . 1.0 116.192 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.1 p80 31.57 56.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 128.815 2.846 . . . . 1.0 115.869 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.43 ' HA ' ' H ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -164.79 176.15 9.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.927 2.091 . . . . 1.0 113.749 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.28 101.64 1.95 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.304 2.242 . . . . 1.0 109.569 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.49 -65.84 0.96 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.248 -0.908 . . . . 1.0 109.621 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 45.11 56.71 5.25 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.228 1.411 . . . . 1.0 113.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.93 1.66 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.966 2.58 . . . . 1.0 117.966 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -23.42 57.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.781 2.141 . . . . 1.0 116.781 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 109.63 10.31 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.549 1.522 . . . . 1.0 109.833 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.34 144.3 11.53 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 123.87 3.046 . . . . 1.0 110.731 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -141.34 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.556 1.543 . . . . 1.0 110.932 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.42 119.49 3.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.599 1.96 . . . . 1.0 109.75 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 47' ' ' ILE . 9.0 m-85 -122.98 113.4 19.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.134 1.773 . . . . 1.0 109.12 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -126.61 118.8 25.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.809 1.244 . . . . 1.0 109.964 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 32' ' ' CYS . 10.4 t -134.56 134.75 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.909 1.284 . . . . 1.0 110.323 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.77 142.0 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.775 1.63 . . . . 1.0 110.69 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . . . -111.63 146.33 37.63 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.136 1.375 . . . . 1.0 111.047 170.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -74.55 139.57 43.84 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.281 0.632 . . . . 1.0 110.257 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.93 -177.27 19.17 Favored Glycine 0 CA--C 1.545 1.96 0 C-N-CA 126.811 2.148 . . . . 1.0 112.225 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.99 94.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.311 1.044 . . . . 1.0 112.452 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 7.5 p -156.26 147.48 16.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.065 2.146 . . . . 1.0 112.427 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.7 Cg_endo -58.36 151.0 63.77 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.797 2.331 . . . . 1.0 112.455 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 69.59 97.11 0.06 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.602 2.361 . . . . 1.0 112.811 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.05 -14.76 25.68 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 126.821 2.153 . . . . 1.0 115.104 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 95.13 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 127.722 2.409 . . . . 1.0 114.231 171.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' ILE . 7.0 mp -103.77 129.02 51.12 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.981 1.474 . . . . 1.0 114.981 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -93.72 116.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.53 2.332 . . . . 1.0 105.37 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 p -129.2 117.54 20.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.121 2.169 . . . . 1.0 110.975 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 80' ' ' ALA 0.305 11.0 m -109.93 110.44 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.078 -1.014 . . . . 1.0 110.52 171.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.699 ' HB2' HG23 ' A' ' 107' ' ' THR . 53.4 mtt -144.42 107.72 4.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.494 2.317 . . . . 1.0 110.625 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.1 106.03 16.46 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 121.376 -0.828 . . . . 1.0 111.446 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.06 167.67 27.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.913 2.197 . . . . 1.0 112.278 172.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 104' ' ' LYS 0.265 0.1 OUTLIER 57.51 -33.01 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.27 2.628 . . . . 1.0 117.218 -175.563 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.626 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 38.9 t70 -64.73 -22.21 66.93 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 129.313 3.045 . . . . 1.0 113.515 170.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 72' ' ' ASN . 9.6 tm-20 -120.78 -67.08 1.0 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.644 2.778 . . . . 1.0 109.629 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.533 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 3.1 m-80 -145.47 -85.23 0.12 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.906 2.082 . . . . 1.0 111.131 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -168.24 10.73 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.511 1.925 . . . . 1.0 114.994 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.2 m -59.51 -72.54 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.91 1.684 . . . . 1.0 113.995 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 46.75 -156.68 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.516 1.526 . . . . 1.0 114.965 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 100' ' ' SER . 7.0 tp10 65.11 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.404 3.082 . . . . 1.0 115.227 -172.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -134.02 165.52 24.85 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.33 83.79 2.16 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.963 1.305 . . . . 1.0 109.603 172.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 70.82 10.63 7.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.865 0.866 . . . . 1.0 113.109 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -65.51 2.63 0.87 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.304 1.411 . . . . 1.0 113.387 169.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -100.02 112.61 24.9 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.044 0.938 . . . . 1.0 109.715 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.41 122.51 14.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.39 1.876 . . . . 1.0 109.689 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.8 153.48 18.84 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.184 0.994 . . . . 1.0 112.537 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.24 167.62 15.2 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.384 1.874 . . . . 1.0 110.084 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 -80.13 0.6 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.671 1.588 . . . . 1.0 110.389 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.65 45.71 0.81 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.23 1.412 . . . . 1.0 112.072 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 20.9 mp0 61.15 22.04 12.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.573 2.749 . . . . 1.0 114.752 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.89 133.25 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.76 129.88 49.23 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 130.383 3.473 . . . . 1.0 111.393 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -136.01 160.07 39.75 Favored 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 132.028 4.131 . . . . 1.0 110.334 176.29 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 3.5 t80 108.04 178.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 129.499 3.119 . . . . 1.0 114.717 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -82.32 -157.06 0.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 127.738 2.415 . . . . 1.0 108.252 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 66.99 47.53 1.38 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 117.724 2.49 . . . . 1.0 117.724 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 1.9 mp -139.25 123.92 18.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.371 2.268 . . . . 1.0 109.427 172.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.5 mpt_? -144.69 149.51 35.75 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-N 122.698 2.499 . . . . 1.0 115.371 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.717 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -118.31 169.11 10.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.935 2.094 . . . . 1.0 115.746 -177.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 38.7 t 60.4 70.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.047 2.139 . . . . 1.0 109.927 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.59 -11.52 37.96 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 127.464 2.459 . . . . 1.0 115.906 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 73.05 -16.67 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 129.563 3.145 . . . . 1.0 118.57 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.777 ' HB2' ' HB2' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 30.78 -5.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 2 C-N-CA 134.807 5.243 . . . . 1.0 122.502 172.187 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.77 49.28 1.52 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 128.696 3.046 . . . . 1.0 110.653 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 90.7 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 129.861 3.264 . . . . 1.0 109.186 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.96 62.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 114.875 0.71 . . . . 1.0 114.875 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -71.48 84.93 0.83 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 123.153 1.454 . . . . 1.0 107.765 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -130.84 113.17 13.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.001 2.52 . . . . 1.0 113.177 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 70' ' ' ASP . 22.7 t80 -87.45 83.25 7.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.06 0.944 . . . . 1.0 108.988 174.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 66' ' ' MET . 5.0 t -148.65 52.05 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.1 pt? -96.26 68.35 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.442 1.497 . . . . 1.0 112.866 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 50.8 m 172.28 -77.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 128.944 2.898 . . . . 1.0 113.701 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -133.17 155.04 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.1 m -135.05 106.3 6.74 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.131 2.172 . . . . 1.0 111.612 170.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.22 103.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 123.379 1.561 . . . . 1.0 109.707 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.14 73.47 0.47 Allowed 'General case' 0 CA--C 1.545 0.773 1 C-N-CA 133.203 4.601 . . . . 1.0 109.771 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.682 HG22 ' HD2' ' A' ' 116' ' ' PRO . 93.7 m -152.37 163.09 40.18 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.376 2.27 . . . . 1.0 109.41 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.98 -41.91 32.16 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.419 -1.277 . . . . 1.0 114.046 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 114' ' ' THR . 83.5 Cg_endo -92.08 101.57 0.2 Allowed 'Trans proline' 0 CA--C 1.561 1.875 1 C-N-CA 125.883 4.389 . . . . 1.0 107.501 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.15 119.59 6.64 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 124.144 3.229 . . . . 1.0 111.138 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -118.92 102.45 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.3 1.048 . . . . 1.0 111.299 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.3 144.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.126 2.171 . . . . 1.0 113.163 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 110' ' ' ILE . . . -122.45 155.1 36.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.805 1.642 . . . . 1.0 112.402 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 t -127.54 139.34 52.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.562 1.945 . . . . 1.0 113.319 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 9.4 t80 -89.11 109.82 20.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.074 -1.016 . . . . 1.0 108.773 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -97.0 57.19 1.47 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.979 0.895 . . . . 1.0 113.137 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -133.19 -61.73 0.82 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.24 2.616 . . . . 1.0 112.258 -175.086 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.09 -15.27 61.06 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.2 mm 11.94 -86.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 1 C-N-CA 131.848 4.059 . . . . 1.0 114.66 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 48.9 tptt -79.69 97.35 6.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.5 1.92 . . . . 1.0 110.57 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.47 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.87 161.74 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.73 1.612 . . . . 1.0 112.176 -178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -103.13 125.61 49.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.325 1.45 . . . . 1.0 112.804 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.01 -56.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.94 1.296 . . . . 1.0 112.032 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -99.1 -70.56 0.72 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.372 1.869 . . . . 1.0 112.83 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.48 156.74 24.77 Favored Glycine 0 CA--C 1.555 2.583 0 C-N-CA 126.366 1.936 . . . . 1.0 114.009 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.49 159.92 51.77 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.553 2.835 . . . . 1.0 114.932 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.533 ' HD3' ' HG2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -140.8 -47.42 0.41 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.958 2.103 . . . . 1.0 115.652 -176.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 134' ' ' ARG . 7.4 pt-20 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 130.789 3.636 . . . . 1.0 111.148 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.301 -0.857 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 -173.91 4.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.356 2.663 . . . . 1.0 106.478 -160.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.701 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.9 t -72.96 71.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 122.143 2.247 . . . . 1.0 107.891 171.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.87 123.33 49.91 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 1.0 108.05 170.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 26' ' ' ASP 0.311 9.7 t -129.52 -101.1 0.32 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.553 0.946 . . . . 1.0 113.553 -172.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' H ' HG23 ' A' ' 25' ' ' THR . 11.3 t70 -57.04 -34.89 68.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 127.746 2.418 . . . . 1.0 115.895 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.695 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 63.1 m -139.22 109.05 7.49 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.079 1.752 . . . . 1.0 107.616 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -46.26 -19.51 0.64 Allowed 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 124.706 3.604 . . . . 1.0 115.547 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.06 -36.59 70.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.544 2.738 . . . . 1.0 113.395 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -101.95 110.46 22.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.801 1.24 . . . . 1.0 109.813 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -117.96 122.28 42.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.028 1.731 . . . . 1.0 113.331 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.701 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 14.3 m -114.98 164.08 14.66 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.172 1.389 . . . . 1.0 113.861 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -152.06 126.96 9.64 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.793 1.637 . . . . 1.0 113.176 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.31 152.81 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 130.566 3.546 . . . . 1.0 109.375 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.55 150.8 95.57 Favored Pre-proline 0 CA--C 1.56 1.353 0 O-C-N 121.761 -0.587 . . . . 1.0 112.529 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.5 80.0 1.13 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.222 3.281 . . . . 1.0 112.414 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 p -77.64 -80.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.519 1.128 . . . . 1.0 110.246 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 44.37 78.21 0.06 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.844 2.458 . . . . 1.0 111.77 -173.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 1.6 p90 -166.28 173.56 9.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.474 2.309 . . . . 1.0 111.55 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 97' ' ' VAL . 4.5 ttp180 -66.43 100.87 0.69 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.785 1.234 . . . . 1.0 110.908 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -87.23 -50.78 6.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.962 1.705 . . . . 1.0 113.446 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t-20 56.28 8.65 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 125.913 1.685 . . . . 1.0 114.528 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 95' ' ' ARG 0.267 5.4 ttpt 65.42 27.31 11.84 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 130.806 3.643 . . . . 1.0 114.82 -170.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -57.51 -55.39 35.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 130.045 3.338 . . . . 1.0 114.457 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.21 106.49 17.77 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.867 2.067 . . . . 1.0 109.751 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.62 134.54 16.93 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.095 3.197 . . . . 1.0 113.301 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.87 -11.66 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.822 1.649 . . . . 1.0 114.563 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 68.51 162.09 0.2 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.133 2.573 . . . . 1.0 115.693 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -128.02 129.06 46.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.123 2.169 . . . . 1.0 109.506 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -124.67 109.13 12.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.02 1.328 . . . . 1.0 110.094 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.75 144.11 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.525 1.53 . . . . 1.0 111.459 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 147.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.476 3.11 . . . . 1.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 87' ' ' GLN . . . -135.39 158.93 43.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.79 1.774 . . . . 1.0 115.79 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.4 mt -100.43 112.48 24.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.803 2.041 . . . . 1.0 108.2 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.27 168.72 34.48 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 125.492 1.52 . . . . 1.0 111.282 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 58' ' ' PRO . 9.3 t0 56.8 169.38 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.761 ' HA ' ' HG2' ' A' ' 87' ' ' GLN 0.332 1.3 p -149.54 -43.86 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 115.788 1.773 . . . . 1.0 115.788 172.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' A' ' 57' ' ' VAL . 46.6 Cg_endo -81.16 169.41 16.04 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.282 2.654 . . . . 1.0 111.91 171.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 16.75 -122.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 129.367 3.067 . . . . 1.0 114.386 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 86' ' ' ASN . . . 144.42 -70.5 0.39 Allowed Glycine 0 C--N 1.342 0.861 0 C-N-CA 126.274 1.893 . . . . 1.0 113.951 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -139.82 165.17 28.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.596 1.702 . . . . 1.0 115.596 -169.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 111' ' ' THR . 38.3 mt -108.42 106.22 16.24 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.632 3.173 . . . . 1.0 106.305 168.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.87 107.72 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 -173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.9 m -111.57 119.59 39.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.241 1.017 . . . . 1.0 111.157 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.67 114.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 120.948 -1.095 . . . . 1.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.77 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 8.1 mtt -121.12 78.03 1.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.127 0.971 . . . . 1.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.02 106.69 19.02 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.136 -1.431 . . . . 1.0 107.136 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.57 171.19 54.95 Favored Glycine 0 CA--C 1.543 1.8 0 C-N-CA 126.542 2.02 . . . . 1.0 116.838 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 17.8 p-10 -145.35 91.7 2.16 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.046 2.938 . . . . 1.0 110.135 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.92 20.37 12.18 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 126.426 1.89 . . . . 1.0 114.874 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.647 ' HG2' ' HB3' ' A' ' 73' ' ' TYR . 4.4 tt0 -148.41 -25.98 0.33 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.141 2.177 . . . . 1.0 116.279 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 45.09 38.7 3.33 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.963 2.105 . . . . 1.0 114.301 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.647 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 60.9 t80 -149.84 68.67 1.01 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.645 1.978 . . . . 1.0 111.973 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.77 ' HB2' ' HG2' ' A' ' 66' ' ' MET . 42.5 t 63.08 78.79 0.28 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 128.664 2.785 . . . . 1.0 116.73 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.79 -62.82 1.4 Allowed 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 95' ' ' ARG . 0.1 OUTLIER 173.22 143.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.894 2.878 . . . . 1.0 112.165 174.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.63 163.26 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.65 2.38 . . . . 1.0 110.782 170.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.778 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . 56.1 mtt-85 -141.08 90.03 2.29 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.092 2.157 . . . . 1.0 109.173 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' A' ' 81' ' ' THR . 1.3 t-20 88.84 -2.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.801 2.04 . . . . 1.0 110.848 -172.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 94' ' ' LEU 0.334 . . -76.01 34.12 0.13 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 123.272 2.76 . . . . 1.0 114.475 170.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.548 ' H ' ' C ' ' A' ' 79' ' ' ASN . 1.2 t -126.56 108.37 11.08 Favored 'General case' 0 CA--C 1.542 0.653 1 C-N-CA 132.704 4.402 . . . . 1.0 101.238 167.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.18 152.82 42.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.57 1.148 . . . . 1.0 112.113 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.15 159.4 15.3 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 129.452 3.101 . . . . 1.0 114.1 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 88' ' ' VAL 0.306 0.5 OUTLIER 86.54 -127.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 128.057 2.543 . . . . 1.0 113.041 176.278 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 70.08 -25.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 128.267 2.627 . . . . 1.0 117.13 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.487 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 2.4 m-20 -81.48 0.99 35.34 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 120.057 1.299 . . . . 1.0 113.497 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.761 ' HG2' ' HA ' ' A' ' 57' ' ' VAL . 4.1 tp-100 -148.41 -47.54 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.037 2.135 . . . . 1.0 112.395 170.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 84' ' ' MET . 90.7 t -133.9 134.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 114.972 1.471 . . . . 1.0 114.972 -172.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.24 121.62 16.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.775 1.63 . . . . 1.0 110.632 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.15 158.8 43.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.497 2.319 . . . . 1.0 110.23 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.45 -167.6 0.19 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.548 1.539 . . . . 1.0 114.565 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 9.0 p30 -107.99 -174.44 2.52 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.02 2.128 . . . . 1.0 111.559 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.265 8.4 m-20 121.0 74.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.565 3.546 . . . . 1.0 112.379 174.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.722 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 2.9 pp -160.2 141.72 12.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.198 2.599 . . . . 1.0 109.299 169.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.778 ' HD3' ' HB2' ' A' ' 78' ' ' ARG . 3.7 ttt180 -129.49 148.48 51.4 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 119.073 0.851 . . . . 1.0 112.166 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.45 152.0 38.32 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.453 1.649 . . . . 1.0 115.453 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 128' ' ' ILE . 32.3 m 43.95 31.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 129.194 2.998 . . . . 1.0 117.569 168.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.54 -35.18 36.44 Favored Glycine 0 N--CA 1.48 1.577 0 C-N-CA 128.848 3.118 . . . . 1.0 118.336 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 -0.15 4.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.511 1.924 . . . . 1.0 115.08 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 13.3 p -65.27 119.2 10.47 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.429 1.491 . . . . 1.0 113.122 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -117.17 128.47 7.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.78 1.657 . . . . 1.0 114.004 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 69.01 164.18 0.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.928 2.891 . . . . 1.0 113.496 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 42.36 36.4 2.15 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.172 1.844 . . . . 1.0 113.918 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -67.43 101.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.769 2.028 . . . . 1.0 108.701 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -115.5 156.45 25.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 130.614 3.565 . . . . 1.0 110.17 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.9 90.82 2.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.502 1.668 . . . . 1.0 115.502 -171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.0 m -112.38 80.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.545 1.138 . . . . 1.0 112.208 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.4 115.0 19.7 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.611 -1.306 . . . . 1.0 110.949 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.9 m -121.1 111.98 18.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.664 1.186 . . . . 1.0 111.148 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.0 113.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 62' ' ' LEU . 14.8 t -89.98 151.1 21.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 122.834 0.453 . . . . 1.0 111.769 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 2.0 p -72.68 170.95 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 123.451 1.596 . . . . 1.0 112.325 172.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.412 ' H ' HG22 ' A' ' 112' ' ' VAL . 8.9 t80 -118.15 11.5 13.27 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.891 2.877 . . . . 1.0 114.339 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.7 p -120.59 167.51 12.34 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.222 1.409 . . . . 1.0 112.682 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -29.06 5.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 117.536 2.421 . . . . 1.0 117.536 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -87.6 99.34 0.46 Allowed 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 124.421 3.414 . . . . 1.0 109.715 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.91 94.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.355 1 C-N-CA 125.428 4.085 . . . . 1.0 116.217 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.621 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 1.5 tm0? -97.78 90.47 4.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.152 0.977 . . . . 1.0 108.413 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.23 114.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.191 1.396 . . . . 1.0 108.616 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.42 151.78 27.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.561 2.345 . . . . 1.0 111.516 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 m -118.74 131.01 56.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.135 0.974 . . . . 1.0 112.905 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.24 120.29 23.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.394 1.078 . . . . 1.0 111.518 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -167.17 -166.45 0.8 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.794 2.437 . . . . 1.0 111.484 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -33.62 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 130.077 3.351 . . . . 1.0 117.697 172.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -28.99 -74.97 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 128.915 2.886 . . . . 1.0 115.183 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.3 mm -145.66 169.04 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 130.039 3.336 . . . . 1.0 107.654 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -76.39 150.06 36.84 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.7 -1.25 . . . . 1.0 110.717 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 97' ' ' VAL . 18.8 tt -92.32 124.5 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.461 1.904 . . . . 1.0 110.119 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -81.21 125.11 29.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.44 1.496 . . . . 1.0 111.923 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.3 t -53.95 -65.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.786 1.635 . . . . 1.0 114.153 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.44 -2.93 27.77 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . 92.21 -151.33 20.65 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 125.356 1.455 . . . . 1.0 112.494 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.85 -75.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.223 3.282 . . . . 1.0 113.415 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 135' ' ' GLU . 11.5 ttm105 -135.09 -71.54 0.48 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.627 1.971 . . . . 1.0 110.352 174.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.429 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 20.3 mp0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.792 2.037 . . . . 1.0 114.289 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.59 0.219 . . . . 1.0 111.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -152.5 -174.53 4.93 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 23.2 t -67.63 71.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 107.173 -1.417 . . . . 1.0 107.173 170.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.12 169.73 0.77 Allowed 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.965 1.468 . . . . 1.0 114.965 171.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 24.9 p -132.64 176.51 8.39 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.408 2.283 . . . . 1.0 110.17 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.37 21.19 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 128.129 2.572 . . . . 1.0 112.584 171.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.6 ' OG ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -79.11 168.37 27.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 127.269 2.227 . . . . 1.0 114.558 -177.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.6 ' HD2' ' OG ' ' A' ' 27' ' ' SER . 53.6 Cg_endo -64.55 -33.02 57.9 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.426 2.751 . . . . 1.0 113.741 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -174.19 72.08 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 128.606 2.762 . . . . 1.0 111.303 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 27' ' ' SER . 1.7 t80 -125.4 129.45 49.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.422 -1.424 . . . . 1.0 114.248 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.72 133.88 53.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.697 1.599 . . . . 1.0 112.149 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 70.6 m -119.06 157.91 26.88 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.591 1.557 . . . . 1.0 111.868 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 6.7 t -137.81 98.16 3.6 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.213 2.205 . . . . 1.0 109.779 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.08 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.784 2.434 . . . . 1.0 110.225 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 47' ' ' ILE . 11.5 tp -72.95 -66.74 0.53 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.65 1.58 . . . . 1.0 112.951 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 96' ' ' PHE . 39.5 Cg_endo -66.01 142.43 68.32 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.757 2.972 . . . . 1.0 113.37 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -126.65 -46.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.822 2.049 . . . . 1.0 113.843 175.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 m-70 -138.78 62.8 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.509 1.524 . . . . 1.0 112.23 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -139.81 157.06 46.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 130.237 3.415 . . . . 1.0 110.628 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 7.9 ttp180 -68.37 104.92 2.0 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.997 1.719 . . . . 1.0 113.372 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.7 t 95.62 113.33 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.586 3.155 . . . . 1.0 116.429 170.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 57.2 t30 -57.1 -71.47 0.1 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.701 2.4 . . . . 1.0 112.814 171.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' H ' ' A' ' 44' ' ' THR . 24.3 ttmt -78.08 165.65 23.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.426 2.29 . . . . 1.0 113.099 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.543 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 91.47 -8.22 0.25 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 130.075 3.35 . . . . 1.0 112.496 -174.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.07 162.56 63.99 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 129.643 3.177 . . . . 1.0 113.831 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.37 29.33 0.3 Allowed 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 125.104 3.87 . . . . 1.0 115.243 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 35' ' ' LEU . 2.4 pp -146.33 172.55 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 129.723 3.209 . . . . 1.0 110.368 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.0 -179.32 5.34 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 128.923 2.889 . . . . 1.0 112.355 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -120.46 143.07 48.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.317 2.247 . . . . 1.0 113.12 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 78.9 mttt -147.27 146.66 29.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.433 1.893 . . . . 1.0 111.212 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 89' ' ' ALA 0.273 1.0 OUTLIER -135.98 135.18 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.445 1.098 . . . . 1.0 109.435 168.972 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.62 118.11 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.546 1.538 . . . . 1.0 108.286 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -97.79 159.94 14.62 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.493 1.117 . . . . 1.0 111.811 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.65 115.65 23.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.868 1.667 . . . . 1.0 111.687 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.2 169.77 40.88 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.583 1.563 . . . . 1.0 112.742 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 -168.74 0.19 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.12 1.768 . . . . 1.0 114.555 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 7.4 p 169.52 73.08 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 131.191 3.796 . . . . 1.0 109.843 172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -93.76 4.87 2.92 Favored 'Trans proline' 0 CA--C 1.556 1.584 1 C-N-CA 125.402 4.068 . . . . 1.0 117.689 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 21.4 m-20 30.09 93.4 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 130.669 3.587 . . . . 1.0 118.661 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.98 5.21 3.55 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.899 1.714 . . . . 1.0 115.721 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 m -55.22 111.88 0.96 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.23 2.212 . . . . 1.0 111.775 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.52 111.42 10.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.705 1.602 . . . . 1.0 111.303 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.729 HG12 HG12 ' A' ' 110' ' ' ILE . 35.0 m -93.06 107.64 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 172.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.81 116.86 30.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 123.418 1.58 . . . . 1.0 110.85 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 40.6 t -101.33 140.99 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 120.685 -1.259 . . . . 1.0 110.519 -172.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -134.91 105.03 6.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.658 0.783 . . . . 1.0 111.436 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.86 109.03 21.44 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.355 -1.466 . . . . 1.0 107.696 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 74' ' ' SER . . . 131.9 91.27 0.52 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.281 2.848 . . . . 1.0 110.424 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -144.75 -87.84 0.11 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.361 2.265 . . . . 1.0 109.468 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.447 ' OD1' ' OG ' ' A' ' 105' ' ' SER . 2.5 m-20 -43.33 -28.64 0.35 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.525 2.73 . . . . 1.0 116.435 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 104' ' ' LYS . 14.1 mm-40 -98.14 -24.69 15.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.963 2.105 . . . . 1.0 115.834 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -162.61 -79.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.399 1.454 . . . . 1.0 113.882 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 t80 136.33 108.3 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.62 1 C-N-CA 132.82 4.448 . . . . 1.0 107.432 -170.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.598 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -124.42 -77.79 0.59 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.381 1.473 . . . . 1.0 111.256 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.76 -2.16 0.1 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.39 1.996 . . . . 1.0 116.39 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.31 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 129.812 3.245 . . . . 1.0 112.612 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -96.61 167.43 11.14 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -171.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.4 ttm180 -132.85 83.78 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 -169.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER 95.25 2.53 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.964 2.906 . . . . 1.0 111.033 -173.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . . . -46.77 -6.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.991 2.589 . . . . 1.0 117.991 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.1 m -115.47 113.68 24.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.563 1.545 . . . . 1.0 111.58 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.7 163.0 34.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 128.93 2.892 . . . . 1.0 109.939 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.97 45.58 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.032 2.133 . . . . 1.0 112.563 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.507 ' C ' ' HD2' ' A' ' 85' ' ' LYS . 17.6 mmt -123.25 158.96 29.75 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.823 1.649 . . . . 1.0 111.195 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HD2' ' C ' ' A' ' 84' ' ' MET . 2.0 mptm? -118.05 -87.01 0.63 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -168.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -75.69 43.83 0.27 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 129.041 2.936 . . . . 1.0 110.705 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 1.4 pm0 48.94 32.55 3.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.776 2.83 . . . . 1.0 114.02 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.06 144.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.625 1.97 . . . . 1.0 113.449 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 51' ' ' VAL . . . -131.52 146.91 52.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.268 2.627 . . . . 1.0 112.241 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 ptt-85 -136.66 163.16 31.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 129.485 3.114 . . . . 1.0 113.886 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 61.11 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 128.303 2.641 . . . . 1.0 113.456 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.27 -66.72 0.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.198 2.199 . . . . 1.0 109.709 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 69.13 -21.25 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.037 3.335 . . . . 1.0 115.987 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.98 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.79 163.24 30.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 127.052 2.141 . . . . 1.0 115.741 178.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.678 ' HD2' ' HA3' ' A' ' 98' ' ' GLY . 5.5 ttm180 -141.11 115.95 9.73 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.297 1.962 . . . . 1.0 116.297 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -86.74 126.64 34.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.557 1.943 . . . . 1.0 111.201 177.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' H ' ' CD2' ' A' ' 77' ' ' LEU 0.289 2.6 m 38.67 41.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 129.247 3.019 . . . . 1.0 112.808 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.678 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -56.95 54.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.093 1 C-N-CA 132.453 4.835 . . . . 1.0 119.238 -171.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 117.88 -5.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 1 C-N-CA 132.735 4.414 . . . . 1.0 113.549 -175.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -141.21 92.48 2.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.604 2.362 . . . . 1.0 111.27 -174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 40' ' ' ARG . . . -168.99 138.42 5.09 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 127.472 2.463 . . . . 1.0 112.04 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -177.17 89.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.899 2.879 . . . . 1.0 107.37 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.06 81.54 0.59 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.759 1.171 . . . . 1.0 112.532 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -153.94 162.01 41.54 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.251 2.22 . . . . 1.0 112.341 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 70' ' ' ASP . 23.3 t -104.84 154.82 19.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.892 2.077 . . . . 1.0 113.178 172.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.4 t80 -95.03 103.1 14.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.424 2.29 . . . . 1.0 111.184 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -108.07 82.95 1.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.331 1.063 . . . . 1.0 112.525 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.27 111.25 8.22 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.555 1.542 . . . . 1.0 111.202 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 m -109.02 104.66 13.91 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.384 0.883 . . . . 1.0 113.384 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 63' ' ' VAL . 8.8 mt -93.45 113.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.128 -1.607 . . . . 1.0 108.199 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.7 p -111.61 121.2 44.5 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.569 1.948 . . . . 1.0 111.951 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.3 OUTLIER -71.57 172.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 123.0 1.381 . . . . 1.0 112.391 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -131.12 40.07 3.5 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.719 2.408 . . . . 1.0 113.598 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.616 ' H ' HG13 ' A' ' 112' ' ' VAL . 9.8 t -129.58 165.39 21.82 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.803 2.041 . . . . 1.0 111.023 172.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.57 -48.58 68.02 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 126.126 1.77 . . . . 1.0 112.684 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.34 111.54 3.28 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.876 3.05 . . . . 1.0 110.505 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.23 106.8 1.06 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.591 3.527 . . . . 1.0 112.707 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.732 ' H ' HG12 ' A' ' 112' ' ' VAL . 7.9 tp-100 -105.32 92.85 4.38 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.812 0.815 . . . . 1.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.74 120.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.495 1.518 . . . . 1.0 111.453 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.53 146.18 44.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.79 2.036 . . . . 1.0 110.966 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.9 m -122.3 141.12 51.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.8 1.64 . . . . 1.0 110.102 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -92.25 143.88 25.96 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.067 0.947 . . . . 1.0 113.183 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -149.39 171.86 15.87 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.499 2.72 . . . . 1.0 111.15 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 15.2 ttt180 74.46 176.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 127.41 2.284 . . . . 1.0 112.557 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 124' ' ' ARG . . . -149.96 164.96 34.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.607 1.706 . . . . 1.0 115.607 175.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.66 -39.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.537 1.935 . . . . 1.0 113.716 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.56 110.32 8.69 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.395 1.478 . . . . 1.0 113.28 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 38' ' ' HIS . 1.2 pp -121.34 124.77 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.734 1.214 . . . . 1.0 110.586 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' A' ' 39' ' ' TRP . 86.5 m -125.87 120.51 30.67 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 170.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.56 -24.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 115.198 1.555 . . . . 1.0 115.198 -170.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.97 -69.02 0.78 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.757 2.423 . . . . 1.0 113.391 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.66 51.12 3.34 Favored Glycine 0 CA--C 1.549 2.163 0 C-N-CA 127.148 2.309 . . . . 1.0 114.994 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.52 -31.29 51.14 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.561 3.508 . . . . 1.0 114.119 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 145.45 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 1 C-N-CA 133.252 4.621 . . . . 1.0 112.069 174.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 127.893 2.477 . . . . 1.0 116.919 172.563 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -173.63 3.82 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 129.764 3.226 . . . . 1.0 104.753 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.17 74.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 O-C-N 119.664 -1.897 . . . . 1.0 108.533 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 73.9 mtt180 -41.72 113.48 0.42 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 130.452 3.501 . . . . 1.0 111.9 171.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.827 ' H ' ' HB2' ' A' ' 30' ' ' PHE . 3.4 t -149.32 92.54 1.96 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.949 0.9 . . . . 1.0 112.791 -170.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 121' ' ' THR . 31.8 t0 118.01 -58.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 1 C-N-CA 133.033 4.533 . . . . 1.0 112.849 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 30' ' ' PHE . 50.9 m 133.47 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.951 1 C-N-CA 132.306 4.242 . . . . 1.0 113.455 -172.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 30.8 Cg_endo -62.43 90.99 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 125.118 3.878 . . . . 1.0 111.969 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 54' ' ' LEU . 3.8 t-20 36.14 58.3 0.98 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.331 2.253 . . . . 1.0 110.686 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.827 ' HB2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -79.77 103.41 9.66 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.461 1.904 . . . . 1.0 111.689 -170.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -139.71 108.9 6.08 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.8 t -114.95 149.71 36.88 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.971 1.308 . . . . 1.0 111.818 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . 3.0 m -126.58 93.61 3.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.125 3.77 . . . . 1.0 108.058 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.649 HG22 ' HD2' ' A' ' 36' ' ' PRO . 5.4 p -149.68 155.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.503 2.321 . . . . 1.0 110.531 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.4 -58.32 0.5 Allowed Pre-proline 0 CA--C 1.552 1.038 0 CA-C-O 117.217 -1.373 . . . . 1.0 114.198 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.798 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 9.6 Cg_endo -50.78 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 1 C-N-CA 125.602 4.201 . . . . 1.0 112.99 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -102.57 -76.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.893 1.677 . . . . 1.0 109.938 -171.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -125.73 44.16 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.964 2.506 . . . . 1.0 113.143 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.817 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 5.5 p90 -161.93 169.19 21.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.244 2.218 . . . . 1.0 114.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -66.52 106.69 1.84 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.745 2.418 . . . . 1.0 114.622 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 42.7 t -81.02 -70.56 0.52 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.511 1.05 . . . . 1.0 111.334 173.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.2 t30 45.31 51.7 9.24 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.315 1.446 . . . . 1.0 113.584 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.37 -7.13 1.22 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.871 2.868 . . . . 1.0 116.492 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -65.19 142.27 58.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.8 1.182 . . . . 1.0 109.89 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 56.39 62.26 6.65 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 126.002 1.721 . . . . 1.0 110.881 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.0 41.83 0.58 Allowed 'Trans proline' 0 CA--C 1.554 1.497 1 C-N-CA 125.762 4.308 . . . . 1.0 114.315 -176.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.07 -1.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 129.892 3.277 . . . . 1.0 114.84 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.13 173.79 0.3 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 129.28 3.032 . . . . 1.0 113.164 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -140.1 166.67 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 5.2 tttp -142.91 135.99 28.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.577 2.351 . . . . 1.0 110.843 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 123.36 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.757 2.423 . . . . 1.0 107.368 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -138.19 131.85 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.059 2.144 . . . . 1.0 109.988 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.45 157.1 36.01 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.325 1.45 . . . . 1.0 111.179 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -128.44 113.05 15.05 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.741 1.386 . . . . 1.0 114.741 174.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.4 3.82 5.55 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 117.965 1.946 . . . . 1.0 117.965 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.85 177.44 4.84 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 128.384 2.673 . . . . 1.0 116.933 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 58' ' ' PRO . 69.2 t -68.36 157.67 87.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 131.688 3.995 . . . . 1.0 113.495 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD2' HG13 ' A' ' 57' ' ' VAL . 61.1 Cg_endo -70.71 -150.76 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 125.121 3.881 . . . . 1.0 113.275 171.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 58' ' ' PRO . 9.6 p-10 -50.99 101.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.641 2.376 . . . . 1.0 112.317 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.43 -8.67 0.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.025 -1.43 . . . . 1.0 116.447 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 104.47 4.32 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.759 1.779 . . . . 1.0 108.894 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.56 112.46 16.84 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -89.64 107.32 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 101.93 -3.359 . . . . 1.0 101.93 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -130.9 117.55 19.42 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.812 1.32 . . . . 1.0 112.583 -170.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.882 HG22 ' HB1' ' A' ' 80' ' ' ALA . 35.8 m -106.35 111.54 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.531 1.133 . . . . 1.0 110.534 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.649 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 8.1 mtm -146.98 102.24 3.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.872 2.069 . . . . 1.0 111.431 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -99.2 107.74 20.15 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.713 1.142 . . . . 1.0 112.125 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.84 147.75 18.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.165 0.888 . . . . 1.0 115.059 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -155.13 -52.61 0.09 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.87 1.268 . . . . 1.0 112.579 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -149.19 -48.25 0.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.281 2.232 . . . . 1.0 114.891 -170.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -147.29 -10.24 0.43 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 130.397 3.479 . . . . 1.0 114.216 -168.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -48.43 -15.57 0.08 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.912 2.885 . . . . 1.0 115.473 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.85 2.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.821 3.648 . . . . 1.0 117.616 171.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.55 ' HB2' HG13 ' A' ' 97' ' ' VAL . 2.8 t -92.33 -99.46 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.732 1.613 . . . . 1.0 113.548 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB2' ' H ' ' A' ' 105' ' ' SER . . . 57.07 -65.51 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 126.871 2.068 . . . . 1.0 112.496 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.51 137.65 53.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.379 2.272 . . . . 1.0 114.329 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.77 165.51 24.39 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 128.317 2.647 . . . . 1.0 111.599 -176.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -118.11 82.25 1.81 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.347 -0.846 . . . . 1.0 111.321 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.433 HD22 HH12 ' A' ' 78' ' ' ARG . 5.2 m120 78.92 0.59 2.43 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.438 2.295 . . . . 1.0 112.508 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -57.25 -11.14 1.56 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.554 2.741 . . . . 1.0 117.214 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 m -105.01 112.66 25.88 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.223 1.577 . . . . 1.0 110.93 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 160.75 39.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.998 2.119 . . . . 1.0 111.35 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 127.19 42.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.779 2.432 . . . . 1.0 112.916 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -144.5 -164.7 1.97 Allowed 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 127.988 2.515 . . . . 1.0 112.846 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -112.87 -101.47 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.629 2.372 . . . . 1.0 111.502 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -79.57 45.35 0.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.628 2.371 . . . . 1.0 111.966 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 110' ' ' ILE . 0.4 OUTLIER 51.24 32.7 8.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.167 2.187 . . . . 1.0 111.609 -171.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -90.39 109.92 21.4 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-O 122.894 1.33 . . . . 1.0 107.526 -171.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.51 116.36 11.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.22 2.208 . . . . 1.0 109.178 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 31.3 mtm180 -135.77 128.7 31.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.347 1.859 . . . . 1.0 109.969 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 11.0 t80 130.87 -151.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 130.696 3.598 . . . . 1.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 24.6 t-20 -122.43 164.21 18.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.604 1.962 . . . . 1.0 110.599 171.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.44 94.1 m-20 108.02 44.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.481 3.512 . . . . 1.0 116.341 -175.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -139.95 132.19 28.21 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.299 2.639 . . . . 1.0 108.604 170.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.853 ' H ' ' HB2' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -138.86 120.63 15.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.026 1.739 . . . . 1.0 113.583 -171.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.45 115.99 30.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.714 1.206 . . . . 1.0 110.232 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 74' ' ' SER . 11.0 t 71.13 73.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.756 1.222 . . . . 1.0 107.995 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.63 90.24 0.65 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 128.506 2.955 . . . . 1.0 113.361 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.21 53.98 3.46 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 128.042 2.537 . . . . 1.0 115.01 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.5 t -70.93 -168.5 0.28 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.817 2.047 . . . . 1.0 115.798 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.88 -37.94 0.07 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.911 2.672 . . . . 1.0 115.044 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 159.85 42.72 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.905 2.082 . . . . 1.0 113.739 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.48 57.45 2.93 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.595 1.569 . . . . 1.0 115.188 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 104' ' ' LYS . 7.6 mtmt -68.79 104.7 2.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.223 1.809 . . . . 1.0 109.71 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' ALA . 16.9 t -119.62 132.65 55.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.301 3.04 . . . . 1.0 110.878 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -84.75 87.12 7.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.185 0.994 . . . . 1.0 110.895 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 66' ' ' MET . 3.8 m -143.36 51.17 1.37 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.95 0.881 . . . . 1.0 111.319 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -102.35 90.41 3.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.894 2.077 . . . . 1.0 111.037 -174.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.656 HG21 ' C ' ' A' ' 120' ' ' ALA . 10.2 t 152.38 -116.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 128.754 2.822 . . . . 1.0 115.545 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.691 HG12 ' HG2' ' A' ' 87' ' ' GLN . 3.8 mp -133.78 151.69 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 128.25 2.62 . . . . 1.0 111.786 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.9 m -140.18 104.24 4.77 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.586 1.554 . . . . 1.0 113.562 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 54.3 t -74.05 122.16 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.562 -1.336 . . . . 1.0 107.814 170.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.15 -8.17 56.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.587 3.555 . . . . 1.0 116.971 -175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 2.2 m -82.16 166.11 19.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.762 2.025 . . . . 1.0 112.529 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -45.02 -31.78 0.94 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.601 1.96 . . . . 1.0 114.023 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 114' ' ' THR . 98.1 Cg_endo -95.26 81.8 0.11 Allowed 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 125.41 4.073 . . . . 1.0 106.197 167.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.61 114.08 3.56 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.201 3.267 . . . . 1.0 111.834 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -99.99 92.48 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 -177.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.86 115.33 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.656 ' C ' HG21 ' A' ' 109' ' ' THR . . . -99.59 171.23 8.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.592 1.957 . . . . 1.0 112.995 -168.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 63.3 p -124.9 120.05 30.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.742 2.017 . . . . 1.0 113.46 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.06 125.82 33.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.13 1.786 . . . . 1.0 110.523 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -106.82 68.66 0.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.071 1.748 . . . . 1.0 112.181 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.41 -179.7 0.09 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.807 2.843 . . . . 1.0 112.764 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.27 -58.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.689 2.796 . . . . 1.0 116.334 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mt 67.31 -62.12 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 129.085 2.954 . . . . 1.0 112.766 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -124.24 130.84 53.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.672 1.989 . . . . 1.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.25 129.96 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 128.046 2.539 . . . . 1.0 110.382 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -85.32 121.96 28.8 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.053 1.341 . . . . 1.0 109.296 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.74 -28.44 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.063 0.945 . . . . 1.0 112.112 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.52 -29.19 56.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.543 2.337 . . . . 1.0 115.048 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.817 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . 93.11 -157.56 23.4 Favored Glycine 0 CA--C 1.553 2.465 0 C-N-CA 125.822 1.677 . . . . 1.0 114.56 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 38.4 Cg_endo -73.62 162.71 39.17 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 124.424 3.416 . . . . 1.0 113.143 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 6.4 mtt85 82.85 106.05 0.06 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 128.89 2.876 . . . . 1.0 110.112 -173.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 127.842 2.457 . . . . 1.0 114.848 -178.917 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -163.75 -172.52 2.9 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 129.086 2.955 . . . . 1.0 105.689 -174.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.08 73.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 O-C-N 119.808 -1.807 . . . . 1.0 107.172 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -61.02 148.2 40.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.61 2.764 . . . . 1.0 113.96 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 30' ' ' PHE . 82.5 p -76.47 -167.28 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.509 2.724 . . . . 1.0 110.162 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 121' ' ' THR . 4.2 t0 -66.24 12.91 0.06 Allowed 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.561 -1.337 . . . . 1.0 112.959 169.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 p -150.72 152.45 32.24 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.109 2.563 . . . . 1.0 114.653 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 -15.54 26.05 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 C-N-CA 123.466 2.778 . . . . 1.0 111.493 168.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -21.48 63.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.918 2.887 . . . . 1.0 115.568 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.413 ' HB2' ' OG1' ' A' ' 25' ' ' THR . 26.9 m-85 -138.16 114.51 10.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.993 1.317 . . . . 1.0 110.569 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 22' ' ' LEU . 3.5 pp -149.91 140.26 22.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.198 1.399 . . . . 1.0 114.422 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 51' ' ' VAL 0.587 0.1 OUTLIER -164.82 173.05 12.17 Favored 'General case' 0 CA--C 1.542 0.644 1 N-CA-C 122.936 4.421 . . . . 1.0 122.936 -173.461 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -97.68 98.25 9.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.714 0.806 . . . . 1.0 110.946 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.61 130.03 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 126.606 1.962 . . . . 1.0 111.812 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.52 126.96 91.75 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.152 1.381 . . . . 1.0 112.413 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.702 ' HB2' ' CD2' ' A' ' 38' ' ' HIS . 72.4 Cg_endo -71.55 148.81 54.49 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 124.016 3.144 . . . . 1.0 113.556 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' HIS . 5.0 t -83.02 -67.02 0.82 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.827 1.651 . . . . 1.0 114.176 -176.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.702 ' CD2' ' HB2' ' A' ' 36' ' ' PRO . 86.6 m-70 37.26 40.44 0.19 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.291 3.436 . . . . 1.0 116.792 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.453 ' HE1' ' HA ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -161.49 173.72 14.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.156 1.782 . . . . 1.0 113.717 179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -82.18 103.64 11.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.077 2.151 . . . . 1.0 110.654 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 98' ' ' GLY . 13.7 p 51.05 101.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.475 2.71 . . . . 1.0 115.3 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' HB2' ' A' ' 96' ' ' PHE . 2.0 m120 -47.17 -72.59 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.005 2.122 . . . . 1.0 115.687 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 22.16 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 1 C-N-CA 132.736 4.414 . . . . 1.0 118.417 175.306 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m 68.04 77.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 129.612 3.165 . . . . 1.0 111.922 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.638 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 2.3 pt? -161.75 171.54 6.65 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 127.038 2.135 . . . . 1.0 113.412 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 45' ' ' LEU . 43.0 Cg_endo -70.47 140.52 40.2 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.87 3.046 . . . . 1.0 111.681 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 12.9 mm -134.64 -69.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.486 1.514 . . . . 1.0 113.918 -172.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 31.23 90.03 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 130.436 3.495 . . . . 1.0 116.453 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.77 171.04 10.44 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.64 2.089 . . . . 1.0 116.64 -172.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 7.7 mmtp -140.04 146.07 38.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 129.762 3.225 . . . . 1.0 109.948 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 2.5 t -130.79 118.86 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 129.236 3.014 . . . . 1.0 110.616 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.466 ' H ' ' HB2' ' A' ' 32' ' ' CYS 0.278 14.2 m -128.02 145.92 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 120.582 1.537 . . . . 1.0 113.977 173.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -112.12 145.07 40.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.131 1.373 . . . . 1.0 112.495 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 tp -77.12 151.86 35.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.606 1.562 . . . . 1.0 111.701 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.1 -141.62 15.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.954 1.264 . . . . 1.0 113.964 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.34 -169.11 3.18 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 129.101 2.96 . . . . 1.0 111.208 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.774 HG22 ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 78.54 157.81 0.14 Allowed Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 128.864 2.866 . . . . 1.0 115.398 171.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' HG22 ' A' ' 57' ' ' VAL . 61.0 Cg_endo -73.58 175.04 11.23 Favored 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 125.015 3.81 . . . . 1.0 114.545 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 41.28 69.14 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.877 2.071 . . . . 1.0 111.293 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -79.65 -18.63 72.74 Favored Glycine 0 C--N 1.346 1.096 0 C-N-CA 127.081 2.277 . . . . 1.0 117.518 -168.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 60' ' ' GLY . 7.4 t 154.22 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 129.624 3.169 . . . . 1.0 112.715 172.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.98 113.66 14.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.948 2.899 . . . . 1.0 109.1 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.53 118.24 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.291 -1.506 . . . . 1.0 107.961 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -112.21 151.6 29.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.922 2.089 . . . . 1.0 110.199 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.42 127.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.008 1.723 . . . . 1.0 109.363 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 mtt -128.52 107.5 9.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.604 0.762 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.47 108.81 21.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.166 0.984 . . . . 1.0 111.049 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.21 -154.02 6.75 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 128.638 3.018 . . . . 1.0 114.515 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 107.33 -72.42 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 1 C-N-CA 132.276 4.23 . . . . 1.0 109.434 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -47.06 -48.46 22.37 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.919 2.488 . . . . 1.0 113.631 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.48 8.24 44.7 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.04 1.736 . . . . 1.0 113.933 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 94.66 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 131.466 3.906 . . . . 1.0 111.212 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -157.92 65.95 0.47 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.329 1.974 . . . . 1.0 116.329 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -57.73 -56.23 24.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.62 1.568 . . . . 1.0 113.259 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.03 8.34 6.79 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 120.971 3.693 . . . . 1.0 120.971 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 26.1 mp0 -60.11 133.56 56.21 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 121.645 2.02 . . . . 1.0 116.197 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -138.63 166.2 24.96 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.164 2.586 . . . . 1.0 112.556 170.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.669 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -127.86 86.22 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.089 1.755 . . . . 1.0 110.479 169.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.322 46.3 t30 69.24 13.27 8.57 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.635 1.574 . . . . 1.0 114.149 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -65.24 1.25 1.09 Allowed 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.077 1.351 . . . . 1.0 114.388 169.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.2 p -98.12 111.01 23.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.408 -1.33 . . . . 1.0 107.408 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.7 125.74 21.27 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.792 1.637 . . . . 1.0 112.127 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.78 154.33 17.82 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.039 2.536 . . . . 1.0 114.21 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -133.41 144.17 49.37 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.271 2.229 . . . . 1.0 107.153 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -84.24 0.53 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.585 1.554 . . . . 1.0 107.925 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 55.9 m-20 -82.69 57.01 3.58 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.739 1.216 . . . . 1.0 108.585 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 5.4 pt20 56.94 19.98 4.98 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 130.904 3.681 . . . . 1.0 117.931 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.55 135.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 114.804 1.409 . . . . 1.0 114.804 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.98 26.92 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.479 2.311 . . . . 1.0 110.664 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 11.0 mtt-85 -136.17 142.33 44.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.185 2.194 . . . . 1.0 110.905 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 90' ' ' ARG 0.277 1.4 t80 147.44 -111.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 129.946 3.298 . . . . 1.0 112.973 172.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 p30 177.3 41.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 127.814 2.446 . . . . 1.0 115.261 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.21 -33.66 49.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 130.018 3.327 . . . . 1.0 115.042 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 94' ' ' LEU . 2.3 pt? -66.39 139.36 58.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.174 2.589 . . . . 1.0 117.893 -172.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 3.2 mtt85 -140.63 116.58 10.42 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.628 1.558 . . . . 1.0 112.394 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 35.5 m-85 -83.07 145.93 29.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.033 1.733 . . . . 1.0 113.561 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 100' ' ' SER . 2.4 t 60.45 6.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 127.371 2.268 . . . . 1.0 114.424 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' HB2' ' A' ' 41' ' ' CYS . . . -9.74 -24.71 0.0 OUTLIER Glycine 0 CA--C 1.547 2.035 2 C-N-CA 136.446 6.736 . . . . 1.0 123.646 -173.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.569 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 15.1 ttt180 -165.93 6.13 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.392 3.077 . . . . 1.0 114.785 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 97' ' ' VAL . 49.1 m -58.25 -59.94 4.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.958 2.503 . . . . 1.0 114.946 -172.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.86 -174.22 20.27 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 125.441 1.496 . . . . 1.0 114.4 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 109.67 21.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.825 2.45 . . . . 1.0 111.735 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.97 -11.63 3.36 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 126.733 2.111 . . . . 1.0 116.303 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.856 2.462 . . . . 1.0 112.894 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.642 ' HB2' HG13 ' A' ' 126' ' ' ILE . 25.1 p -108.61 130.01 55.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.443 2.297 . . . . 1.0 110.483 172.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -85.22 83.87 7.86 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.048 0.928 . . . . 1.0 112.655 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 m -70.45 92.61 0.83 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.715 1.606 . . . . 1.0 110.162 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -71.42 101.55 2.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.196 1.398 . . . . 1.0 110.03 172.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.7 p -86.44 100.15 12.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.606 1.962 . . . . 1.0 109.669 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 25' ' ' THR . 4.1 mp -88.28 110.2 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 100.909 -3.737 . . . . 1.0 100.909 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.0 m -112.61 109.61 19.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.889 1.675 . . . . 1.0 114.087 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 114' ' ' THR . 7.0 t -73.74 143.76 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 123.681 1.705 . . . . 1.0 109.834 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -110.99 10.39 22.17 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 131.573 3.949 . . . . 1.0 113.931 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.782 HG23 ' HD2' ' A' ' 116' ' ' PRO . 10.1 t -105.53 -179.45 3.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.731 1.613 . . . . 1.0 113.162 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -45.77 -53.11 21.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 126.915 2.086 . . . . 1.0 112.298 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.782 ' HD2' HG23 ' A' ' 114' ' ' THR . 47.1 Cg_endo -76.21 102.04 1.56 Allowed 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 124.705 3.603 . . . . 1.0 109.884 170.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.39 99.66 1.05 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.254 3.303 . . . . 1.0 109.411 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.503 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 16.6 mt-30 -108.19 97.23 6.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.873 0.844 . . . . 1.0 110.842 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.74 114.95 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.011 1.724 . . . . 1.0 108.398 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.11 159.54 20.74 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.722 2.409 . . . . 1.0 110.977 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.4 m -121.61 121.33 37.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.068 0.947 . . . . 1.0 111.308 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 64.1 t80 -87.95 120.18 29.03 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.344 0.975 . . . . 1.0 110.912 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -130.6 122.12 26.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.99 2.516 . . . . 1.0 111.422 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.7 -52.1 0.11 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.613 1.565 . . . . 1.0 113.173 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.31 70.85 0.75 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.246 2.218 . . . . 1.0 109.401 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' ' 105' ' ' SER . 8.6 tp -47.14 -14.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 129.676 3.19 . . . . 1.0 118.296 -171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -87.13 152.29 22.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 130.807 3.643 . . . . 1.0 115.765 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.58 162.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 128.025 2.53 . . . . 1.0 114.111 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.7 t -75.05 133.07 41.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.11 0.964 . . . . 1.0 112.74 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.74 -58.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.508 1.923 . . . . 1.0 113.196 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -53.77 -37.94 63.96 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.307 1.843 . . . . 1.0 114.452 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 43.65 69.46 0.67 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 127.533 2.492 . . . . 1.0 114.572 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.73 66.53 1.75 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 125.11 3.873 . . . . 1.0 114.395 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.22 8.25 0.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 130.672 3.589 . . . . 1.0 117.09 173.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.487 1.403 1 C-N-CA 132.895 4.478 . . . . 1.0 112.926 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -152.52 -173.68 4.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 131.336 3.854 . . . . 1.0 105.063 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 32' ' ' CYS 0.356 9.9 m -69.01 72.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.54 1.973 . . . . 1.0 109.926 170.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -51.13 158.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.355 2.262 . . . . 1.0 113.54 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 30' ' ' PHE 0.296 9.0 t -101.94 -120.77 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.365 -0.826 . . . . 1.0 110.745 177.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -55.88 -37.83 69.35 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.354 1.434 . . . . 1.0 113.169 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 m -136.86 156.83 75.74 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 127.648 2.379 . . . . 1.0 112.663 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -2.4 6.71 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.228 3.285 . . . . 1.0 115.041 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.79 -27.49 60.34 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.03 2.932 . . . . 1.0 114.024 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.631 ' HB2' HG22 ' A' ' 25' ' ' THR . 2.5 m-85 -118.6 108.35 14.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.677 1.591 . . . . 1.0 107.706 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.3 mt -115.12 135.02 54.64 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.894 2.878 . . . . 1.0 112.729 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.719 ' HB2' HG23 ' A' ' 23' ' ' VAL . 4.5 m -118.88 160.09 22.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.899 1.28 . . . . 1.0 112.505 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -138.93 100.02 3.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.413 2.285 . . . . 1.0 108.655 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -137.23 162.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 129.111 2.964 . . . . 1.0 109.362 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -103.57 155.06 37.39 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.394 1.078 . . . . 1.0 110.607 170.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 35' ' ' LEU . 17.1 Cg_exo -51.69 149.85 18.15 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.915 3.077 . . . . 1.0 115.559 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 96' ' ' PHE . 12.9 t -127.85 29.29 5.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 127.12 2.168 . . . . 1.0 114.23 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -64.2 37.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 127.495 2.318 . . . . 1.0 116.195 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -162.28 162.65 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 129.184 2.994 . . . . 1.0 111.746 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' ' 101' ' ' GLY . 0.7 OUTLIER -79.22 150.84 31.5 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.536 1.935 . . . . 1.0 113.987 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.7 t 49.13 71.76 0.35 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.645 1.978 . . . . 1.0 112.53 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -50.69 -39.46 51.31 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.226 1.565 . . . . 1.0 115.226 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt 62.75 171.78 0.14 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.575 2.75 . . . . 1.0 114.541 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -74.82 79.17 2.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.047 1.339 . . . . 1.0 110.741 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 47' ' ' ILE . 22.6 mt -69.37 146.25 96.35 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 125.616 1.566 . . . . 1.0 111.821 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.67 -3.73 8.49 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.098 3.199 . . . . 1.0 116.074 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 45' ' ' LEU . 35.9 pt -59.44 -30.67 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.05 2.94 . . . . 1.0 115.698 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.55 173.5 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 127.331 2.252 . . . . 1.0 114.752 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 94' ' ' LEU . 16.6 m-85 -144.99 151.58 38.81 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -174.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 10.4 tttp -143.92 148.45 35.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.544 1.937 . . . . 1.0 112.525 172.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' A' ' 50' ' ' LYS . 14.0 m -136.97 143.2 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.15 2.18 . . . . 1.0 111.013 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.89 119.5 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 128.077 2.551 . . . . 1.0 108.782 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.65 107.2 9.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.495 1.118 . . . . 1.0 110.744 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mt -90.56 118.07 29.73 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.969 1.707 . . . . 1.0 112.531 -172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.18 -167.69 30.13 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 127.555 2.502 . . . . 1.0 114.07 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.77 -4.42 25.0 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 115.451 1.648 . . . . 1.0 115.451 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.06 142.8 55.97 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.445 1.498 . . . . 1.0 112.081 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.91 -38.89 27.27 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 124.501 3.467 . . . . 1.0 112.951 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.88 -167.62 1.95 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 126.838 2.055 . . . . 1.0 110.542 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.04 -55.73 0.86 Allowed Glycine 0 C--N 1.344 0.984 0 O-C-N 120.032 -1.668 . . . . 1.0 113.091 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t 152.28 -177.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 129.264 3.025 . . . . 1.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.49 116.14 21.33 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.534 2.334 . . . . 1.0 110.542 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 p -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 120.451 -1.406 . . . . 1.0 109.3 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -123.0 123.55 41.14 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.118 1.367 . . . . 1.0 113.307 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 80' ' ' ALA . 2.6 m -96.26 116.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.549 -1.344 . . . . 1.0 108.261 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 93.2 mtp -122.82 113.32 19.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.59 115.12 26.9 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 120.806 1.639 . . . . 1.0 114.071 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.43 -149.48 6.99 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 129.386 3.374 . . . . 1.0 112.451 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' GLU . 67.0 t30 -156.78 40.5 0.33 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.021 1.728 . . . . 1.0 112.145 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 62.85 -26.6 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.778 2.831 . . . . 1.0 114.453 -170.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -140.02 84.52 1.97 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 132.142 4.177 . . . . 1.0 106.702 169.668 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.86 -45.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.876 1.67 . . . . 1.0 113.725 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 43.57 23.72 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.543 3.137 . . . . 1.0 117.25 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -49.28 -30.4 7.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.34 2.656 . . . . 1.0 115.0 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.06 -75.24 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.412 2.285 . . . . 1.0 114.915 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 33.81 99.17 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 131.474 3.909 . . . . 1.0 116.419 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -131.93 165.46 23.85 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.868 1.267 . . . . 1.0 113.377 174.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.66 84.24 2.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.104 2.162 . . . . 1.0 109.797 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.25 8.62 6.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.434 1.493 . . . . 1.0 114.376 -173.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -70.22 13.95 0.14 Allowed 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 120.958 1.708 . . . . 1.0 113.645 168.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 m -100.33 110.52 22.75 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.53 125.02 13.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.979 0.912 . . . . 1.0 113.402 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.09 155.89 17.75 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.21 1.404 . . . . 1.0 113.155 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 63.1 mtp -127.17 148.33 50.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 128.907 2.883 . . . . 1.0 107.889 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -126.53 -73.13 0.63 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.869 1.268 . . . . 1.0 114.287 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -72.93 33.5 0.07 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.419 1.488 . . . . 1.0 111.448 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 62.0 14.24 6.28 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.114 2.966 . . . . 1.0 114.544 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.63 152.61 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 129.556 3.142 . . . . 1.0 112.339 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 91' ' ' PHE . . . -137.91 146.93 43.89 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.248 1.819 . . . . 1.0 113.895 170.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -132.66 123.7 26.85 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 128.199 2.599 . . . . 1.0 111.312 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -172.15 173.39 4.31 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.813 1.783 . . . . 1.0 115.813 -174.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -141.44 1.36 1.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.528 1.931 . . . . 1.0 114.926 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -28.35 59.25 Favored 'General case' 0 CA--C 1.545 0.786 1 C-N-CA 131.824 4.05 . . . . 1.0 115.161 -172.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 6.8 mp -55.53 129.49 39.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.407 2.283 . . . . 1.0 112.176 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 36.4 mtm180 -137.47 123.14 19.85 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.555 1.07 . . . . 1.0 111.741 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.408 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 2.3 m-85 -93.28 143.52 26.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.481 2.712 . . . . 1.0 110.611 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 0.7 OUTLIER 44.61 46.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 125.677 1.591 . . . . 1.0 112.516 -175.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -35.37 -92.27 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 1 C-N-CA 132.956 5.074 . . . . 1.0 116.945 -171.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttp-105 -73.11 42.41 0.11 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.913 2.085 . . . . 1.0 113.94 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 t 73.04 157.21 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 131.596 3.958 . . . . 1.0 115.638 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' ' HB2' ' A' ' 40' ' ' ARG . . . -149.95 169.14 30.06 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 127.982 2.706 . . . . 1.0 112.632 173.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -160.53 142.9 12.89 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.446 1.898 . . . . 1.0 112.465 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.506 ' C ' ' HE2' ' A' ' 127' ' ' LYS . . . 57.72 30.72 63.02 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.298 1.428 . . . . 1.0 116.547 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -126.61 156.87 40.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.146 2.579 . . . . 1.0 112.559 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -109.45 147.44 32.85 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.865 2.466 . . . . 1.0 110.931 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.782 ' CE1' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.25 89.27 7.8 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.229 1.811 . . . . 1.0 111.778 -173.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.4 m -77.39 74.68 3.95 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.642 1.577 . . . . 1.0 110.119 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.782 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 9.0 tt -61.54 119.52 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.229 -0.919 . . . . 1.0 108.968 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 t -127.82 139.97 52.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 123.445 1.593 . . . . 1.0 114.814 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.37 113.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -102.6 114.89 29.49 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.792 1.237 . . . . 1.0 111.894 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 1.2 t -72.26 151.77 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 123.235 1.493 . . . . 1.0 112.446 -174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -102.0 25.35 8.83 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 129.024 2.93 . . . . 1.0 116.671 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.608 HG23 ' HD2' ' A' ' 116' ' ' PRO . 13.6 t -132.31 176.34 8.49 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.687 1.195 . . . . 1.0 113.828 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 70.2 m-80 -43.0 -47.33 13.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 128.213 2.605 . . . . 1.0 113.062 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD2' HG23 ' A' ' 114' ' ' THR . 95.7 Cg_endo -87.96 95.99 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 124.983 3.789 . . . . 1.0 108.272 168.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.85 109.11 1.21 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.656 2.904 . . . . 1.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.407 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -97.65 103.45 15.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.316 1.531 . . . . 1.0 108.772 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.68 114.94 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.882 2.073 . . . . 1.0 108.976 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.73 142.95 50.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.455 2.302 . . . . 1.0 110.77 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 t -121.95 146.5 47.08 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.552 1.541 . . . . 1.0 113.246 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -87.51 128.79 35.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.947 1.356 . . . . 1.0 112.865 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -63.16 103.44 0.48 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.755 2.422 . . . . 1.0 111.591 172.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 96.78 125.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 1 C-N-CA 132.212 4.205 . . . . 1.0 109.285 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.92 -21.1 10.27 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.325 1.602 . . . . 1.0 115.325 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 38.53 122.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 131.144 3.778 . . . . 1.0 115.866 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 103' ' ' GLY . 21.5 tttt -75.55 137.74 41.04 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.979 -1.7 . . . . 1.0 110.689 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -91.59 141.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.838 1.655 . . . . 1.0 113.468 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.2 t -88.67 142.89 27.31 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.533 0.938 . . . . 1.0 113.533 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.64 -53.52 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.521 1.529 . . . . 1.0 110.445 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.37 -70.5 0.74 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.921 2.889 . . . . 1.0 111.378 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.176 0 C-N-CA 126.147 1.832 . . . . 1.0 115.829 -177.117 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 114.322 1.231 . . . . 1.0 114.322 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -148.94 -173.23 4.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 131.138 3.775 . . . . 1.0 105.074 -173.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.89 73.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 O-C-N 120.119 -1.613 . . . . 1.0 107.652 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.603 ' HB2' ' CG ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -60.63 169.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.034 0.933 . . . . 1.0 111.978 169.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.8 p -133.06 -105.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.29 1.036 . . . . 1.0 109.972 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 121' ' ' THR . 1.1 m-20 -143.09 64.83 1.35 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.812 2.845 . . . . 1.0 108.425 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.1 m -157.05 161.61 29.16 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 119.884 -1.76 . . . . 1.0 115.158 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.26 146.74 95.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.259 1.973 . . . . 1.0 109.677 169.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 52.96 32.99 13.66 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 124.867 1.267 . . . . 1.0 113.881 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.603 ' CG ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.61 110.36 16.01 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.895 1.443 . . . . 1.0 114.895 -173.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 1.7 pp -140.08 115.48 9.95 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.562 1.545 . . . . 1.0 113.304 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.788 ' HB2' ' HA ' ' A' ' 51' ' ' VAL 0.253 0.0 OUTLIER -127.15 165.39 19.65 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 123.533 1.635 . . . . 1.0 114.826 175.512 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.626 ' HB2' ' HG2' ' A' ' 50' ' ' LYS . 66.6 m -151.47 93.2 1.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.104 2.962 . . . . 1.0 108.933 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.29 150.06 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 131.152 3.781 . . . . 1.0 107.797 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -65.22 174.35 1.43 Allowed Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 123.803 0.841 . . . . 1.0 113.141 175.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -60.3 165.26 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.105 2.537 . . . . 1.0 113.786 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.8 t -125.0 9.63 8.13 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.44 1.896 . . . . 1.0 114.691 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -67.51 47.69 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.954 2.502 . . . . 1.0 115.747 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.86 173.57 14.36 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.187 1.921 . . . . 1.0 116.187 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.669 ' HD2' ' HB2' ' A' ' 100' ' ' SER . 0.0 OUTLIER -95.0 122.97 38.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 128.1 2.56 . . . . 1.0 110.717 177.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.1 t 62.8 95.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.74 2.016 . . . . 1.0 113.769 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.644 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -39.65 -46.04 1.76 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.151 2.181 . . . . 1.0 112.924 171.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 51.7 tttt 74.14 177.33 0.23 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 129.163 2.985 . . . . 1.0 112.25 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 97.6 m -61.18 -33.93 74.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.906 1.282 . . . . 1.0 114.138 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 92' ' ' ASN . 43.6 mt 51.22 87.16 0.14 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 127.126 2.17 . . . . 1.0 114.657 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.9 61.62 0.59 Allowed 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 125.092 3.862 . . . . 1.0 113.489 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 136.85 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 1 C-N-CA 132.431 4.292 . . . . 1.0 108.337 -178.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.38 24.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.845 1.658 . . . . 1.0 111.968 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.05 150.46 42.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.888 1.675 . . . . 1.0 112.113 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.626 ' HG2' ' HB2' ' A' ' 33' ' ' SER . 3.4 ptmm? -131.37 108.8 9.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.759 2.023 . . . . 1.0 108.521 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.788 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . 57.3 t -131.31 121.87 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 117.507 -1.235 . . . . 1.0 109.293 -172.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.47 120.71 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.805 1.642 . . . . 1.0 110.451 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 27' ' ' SER . . . -133.07 106.68 7.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.024 -1.843 . . . . 1.0 106.024 170.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 155.32 37.67 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.086 2.254 . . . . 1.0 117.086 -169.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.39 -26.52 0.97 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.546 2.022 . . . . 1.0 115.218 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.11 86.87 7.34 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.826 2.45 . . . . 1.0 112.225 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.6 -50.02 67.37 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-O 117.573 -1.204 . . . . 1.0 110.042 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 114' ' ' THR . 56.5 Cg_endo -81.58 129.86 6.66 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.294 3.329 . . . . 1.0 111.058 170.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.11 169.34 12.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.131 2.172 . . . . 1.0 115.492 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.13 3.23 45.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.936 2.207 . . . . 1.0 115.241 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.72 ' CG2' ' HB2' ' A' ' 84' ' ' MET . 13.8 t -53.82 121.03 7.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.618 1.709 . . . . 1.0 112.537 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.06 102.77 12.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.832 1.301 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 110' ' ' ILE . 84.0 t -92.03 107.62 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.901 -1.889 . . . . 1.0 105.901 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.5 p -107.76 118.14 35.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.196 -0.911 . . . . 1.0 113.167 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.339 0.5 OUTLIER -107.0 112.98 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.377 -1.452 . . . . 1.0 111.152 -177.559 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 mtt -139.51 171.28 14.48 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.615 1.566 . . . . 1.0 114.591 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . . . -125.83 112.36 15.92 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.76 178.17 40.07 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 128.232 2.825 . . . . 1.0 115.623 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 73' ' ' TYR . 33.6 p-10 -121.74 -61.9 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.789 2.435 . . . . 1.0 108.48 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -113.89 46.73 1.27 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 131.222 3.809 . . . . 1.0 106.534 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 64.82 -26.94 0.09 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.77 2.828 . . . . 1.0 114.209 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -102.35 49.33 0.85 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 129.495 3.118 . . . . 1.0 115.329 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.656 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 4.5 t80 -132.35 -19.2 2.48 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.903 1.681 . . . . 1.0 115.076 173.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 m 14.92 72.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 132.111 4.164 . . . . 1.0 114.654 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.04 149.34 6.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.129 2.172 . . . . 1.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -51.92 142.57 15.28 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.045 2.138 . . . . 1.0 114.161 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -127.59 168.56 14.82 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.495 2.318 . . . . 1.0 112.615 178.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -136.01 102.94 5.19 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.22 1.808 . . . . 1.0 108.536 172.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.9 m120 79.71 -9.03 1.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 117.171 -1.395 . . . . 1.0 111.99 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 77' ' ' LEU 0.259 . . -68.91 20.82 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 122.298 2.317 . . . . 1.0 115.228 174.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -126.29 113.58 17.13 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.353 1.861 . . . . 1.0 109.591 168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.5 151.63 41.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.561 1.545 . . . . 1.0 112.274 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 129.53 40.41 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 127.026 2.13 . . . . 1.0 111.589 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.72 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -124.71 168.93 12.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.165 1.386 . . . . 1.0 113.682 -171.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 2.6 mptt -96.0 -72.05 0.65 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.187 2.595 . . . . 1.0 112.567 -168.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.7 48.39 1.7 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 129.836 3.254 . . . . 1.0 106.475 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.9 26.41 7.82 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.472 2.709 . . . . 1.0 113.143 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 85' ' ' LYS . 12.8 p -92.76 114.35 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 127.955 2.502 . . . . 1.0 112.169 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.06 146.54 24.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.776 2.031 . . . . 1.0 113.181 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 91' ' ' PHE . 20.7 ttp180 -136.69 157.36 46.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.719 2.808 . . . . 1.0 111.796 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.431 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 0.8 OUTLIER 51.33 -139.69 0.94 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.225 1.81 . . . . 1.0 112.654 176.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 45' ' ' LEU . 55.5 t-20 -135.41 109.19 8.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.922 1.237 . . . . 1.0 113.306 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -149.7 68.13 1.01 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.132 2.573 . . . . 1.0 108.458 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -160.88 118.56 2.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.795 1.638 . . . . 1.0 112.266 172.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 38.3 mtp180 -136.75 119.38 16.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 114.212 1.19 . . . . 1.0 114.212 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.644 ' H ' ' HB2' ' A' ' 42' ' ' ASN . 5.5 p90 -93.64 165.75 12.57 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.455 2.302 . . . . 1.0 116.598 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t 46.76 35.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 129.742 3.217 . . . . 1.0 114.584 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.51 -41.46 41.55 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.315 2.388 . . . . 1.0 114.843 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -76.28 -9.24 58.48 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.873 2.069 . . . . 1.0 115.852 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.669 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 4.6 t 58.71 -177.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.165 1.386 . . . . 1.0 114.483 -175.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.15 129.57 3.45 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 128.186 2.803 . . . . 1.0 113.716 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -68.04 164.07 20.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.626 1.97 . . . . 1.0 112.145 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.49 27.64 58.98 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -115.96 150.34 37.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.871 1.668 . . . . 1.0 114.152 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 t -125.21 122.22 36.39 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.319 3.448 . . . . 1.0 110.077 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -84.64 133.6 34.4 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.075 1.88 . . . . 1.0 116.075 -170.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -122.19 105.15 9.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.687 2.395 . . . . 1.0 115.162 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' TYR . 4.8 tt -79.43 90.04 5.03 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.103 -2.184 . . . . 1.0 105.103 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.3 m -92.25 101.47 13.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.799 2.84 . . . . 1.0 110.27 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 63' ' ' VAL . 62.8 mt -92.32 121.14 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.429 1.492 . . . . 1.0 108.015 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -122.93 118.1 27.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.323 1.014 . . . . 1.0 112.14 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.4 OUTLIER -71.7 170.67 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 122.929 1.347 . . . . 1.0 113.286 -176.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 33.3 5.0 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.207 2.203 . . . . 1.0 114.82 -174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.662 HG21 ' HG2' ' A' ' 58' ' ' PRO . 14.2 t -126.64 175.37 8.0 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.019 1.728 . . . . 1.0 112.132 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.52 -49.29 89.38 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 125.981 1.712 . . . . 1.0 113.483 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' A' ' 114' ' ' THR . 68.2 Cg_endo -76.91 111.16 3.18 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 124.348 3.365 . . . . 1.0 110.237 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.79 105.87 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.122 3.215 . . . . 1.0 112.473 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.688 ' H ' HG12 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -100.1 98.72 9.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.793 0.806 . . . . 1.0 109.466 -175.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.59 133.6 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.421 . . . . 1.0 111.744 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.14 154.87 49.17 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.22 1.408 . . . . 1.0 112.828 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 63.3 m -128.32 149.46 50.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.331 1.852 . . . . 1.0 111.596 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 82.9 t80 -83.74 165.47 18.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.579 1.951 . . . . 1.0 112.705 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -57.96 62.73 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 126.177 1.791 . . . . 1.0 111.461 169.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -87.82 98.31 11.4 Favored 'General case' 0 N--CA 1.469 0.502 1 C-N-CA 131.982 4.113 . . . . 1.0 114.364 -170.495 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.83 -103.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.561 2.745 . . . . 1.0 104.862 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 43.15 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 129.388 3.075 . . . . 1.0 113.304 170.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -138.56 161.35 37.3 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.133 1.773 . . . . 1.0 114.684 173.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.3 tt -93.1 146.12 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 127.654 2.382 . . . . 1.0 111.693 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 t -70.33 137.0 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.008 0.744 . . . . 1.0 113.008 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -91.57 -15.55 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.146 1.378 . . . . 1.0 113.424 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -67.64 0.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.606 2.762 . . . . 1.0 112.309 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.862 0 C-N-CA 129.366 3.365 . . . . 1.0 113.629 178.202 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 12.9 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.459 -0.782 . . . . 1.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mt -146.65 -173.61 4.25 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 128.545 2.738 . . . . 1.0 104.989 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 2.4 t -69.77 71.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 119.458 -2.027 . . . . 1.0 109.664 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.97 172.11 0.09 Allowed 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.498 1.666 . . . . 1.0 115.498 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 30' ' ' PHE . 8.2 t -108.28 -135.1 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.814 1.645 . . . . 1.0 108.528 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.2 -47.45 24.26 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.462 1.905 . . . . 1.0 111.579 170.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.5 m -131.38 159.12 73.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.485 1.914 . . . . 1.0 111.843 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.94 -7.32 20.86 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 123.882 3.055 . . . . 1.0 116.191 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -67.18 -36.11 81.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.802 2.441 . . . . 1.0 114.398 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 25' ' ' THR . 75.4 m-85 -104.49 109.72 21.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.189 2.196 . . . . 1.0 110.405 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 155.52 22.48 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.629 1.714 . . . . 1.0 115.629 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 2.7 m -132.41 164.75 25.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.311 2.245 . . . . 1.0 112.038 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 42.9 m -153.4 91.24 1.48 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.455 2.302 . . . . 1.0 108.488 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.82 149.37 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 129.414 3.086 . . . . 1.0 108.933 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.837 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -83.7 178.88 2.16 Favored Pre-proline 0 CA--C 1.561 1.381 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -175.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 50.6 Cg_endo -66.3 48.06 0.25 Allowed 'Trans proline' 0 CA--C 1.557 1.656 1 C-N-CA 125.615 4.21 . . . . 1.0 116.581 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -65.02 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 129.144 2.978 . . . . 1.0 114.04 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.778 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 5.4 p-80 -55.21 69.45 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.98 1 C-N-CA 132.198 4.199 . . . . 1.0 114.4 174.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -154.62 169.29 24.22 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.169 2.188 . . . . 1.0 112.848 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.17 116.29 7.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.533 2.333 . . . . 1.0 110.737 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t 59.04 84.21 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.584 1.954 . . . . 1.0 110.516 -169.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -38.21 73.17 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.334 0.654 . . . . 1.0 112.743 -174.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 tttt 71.77 160.29 0.22 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 131.436 3.894 . . . . 1.0 114.71 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -72.79 68.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.557 1.543 . . . . 1.0 109.907 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 23.3 mt -68.07 159.75 78.21 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.862 1.265 . . . . 1.0 113.704 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.59 -8.37 22.09 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.373 3.382 . . . . 1.0 116.465 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -65.39 -14.65 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.401 1.88 . . . . 1.0 115.541 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.827 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . . . 66.09 175.72 0.23 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.725 2.41 . . . . 1.0 112.982 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -131.31 84.06 2.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.672 1.589 . . . . 1.0 109.784 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 86.8 mttt -87.25 111.59 21.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 105.366 -2.087 . . . . 1.0 105.366 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 87' ' ' GLN . 14.7 p -133.97 122.19 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.95 1.7 . . . . 1.0 107.819 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.8 t -139.06 148.25 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 128.377 2.671 . . . . 1.0 112.588 -172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.85 143.89 49.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.394 -1.441 . . . . 1.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.73 113.26 21.18 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.112 0.482 . . . . 1.0 110.513 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.05 -178.16 37.12 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.412 2.435 . . . . 1.0 114.173 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -176.37 0.72 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 126.129 1.771 . . . . 1.0 115.457 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.4 95.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 125.441 1.497 . . . . 1.0 113.692 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.25 -4.0 5.92 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 124.616 3.544 . . . . 1.0 117.944 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 29.23 79.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 130.159 3.383 . . . . 1.0 115.552 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.23 51.57 0.01 OUTLIER Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.841 1.21 . . . . 1.0 113.574 -171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.434 HG22 HD11 ' A' ' 110' ' ' ILE . 84.7 m -129.54 94.05 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.138 1.775 . . . . 1.0 108.604 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -91.12 117.46 29.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.47 1.508 . . . . 1.0 111.627 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.97 111.84 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 105.678 -1.971 . . . . 1.0 105.678 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 81' ' ' THR . 35.1 p -112.56 114.03 26.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.707 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.269 0.1 OUTLIER -125.77 111.55 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.478 -1.389 . . . . 1.0 113.425 -170.346 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.518 ' HG2' ' H ' ' A' ' 67' ' ' ALA . 15.8 ttm -138.8 172.7 12.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.728 2.121 . . . . 1.0 116.728 -172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.958 ' HB1' ' HB2' ' A' ' 105' ' ' SER . . . -98.45 143.94 28.34 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.724 1.249 . . . . 1.0 110.278 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.55 100.07 0.21 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 128.019 2.723 . . . . 1.0 112.424 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 27.6 t-20 -124.05 -39.21 2.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.765 2.426 . . . . 1.0 109.629 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.9 -45.3 30.46 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 129.012 2.925 . . . . 1.0 112.706 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -144.03 -11.94 0.65 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.46 2.304 . . . . 1.0 116.256 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 m120 84.37 151.78 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 130.525 3.53 . . . . 1.0 110.367 -170.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 33.26 43.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 128.519 2.728 . . . . 1.0 114.862 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -83.52 -26.27 30.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.331 3.052 . . . . 1.0 114.482 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . . . -141.65 122.2 14.18 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 120.167 1.349 . . . . 1.0 112.088 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -58.23 172.13 0.48 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.13 2.27 . . . . 1.0 117.13 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.848 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.8 pp -116.07 167.27 11.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.637 3.175 . . . . 1.0 110.816 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 3.4 mtp180 -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.577 -0.702 . . . . 1.0 110.212 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.34 12.21 4.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.259 1.824 . . . . 1.0 111.65 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -62.92 7.11 0.09 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.171 1.388 . . . . 1.0 114.35 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 64' ' ' THR . 48.6 p -105.98 110.76 23.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.479 1.111 . . . . 1.0 109.705 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.29 135.21 30.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.353 1.461 . . . . 1.0 111.613 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.32 144.06 25.77 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.786 2.034 . . . . 1.0 112.345 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.3 mtm -151.88 -173.72 4.62 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.316 1.846 . . . . 1.0 111.69 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -110.89 -96.82 0.41 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.477 2.311 . . . . 1.0 109.146 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.14 56.57 4.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.951 2.101 . . . . 1.0 108.836 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.678 ' HG2' HG22 ' A' ' 51' ' ' VAL . 19.0 tt0 51.25 32.46 8.21 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.801 1.64 . . . . 1.0 113.539 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.12 115.39 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.821 2.049 . . . . 1.0 111.845 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.7 147.52 50.11 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.618 1.567 . . . . 1.0 112.102 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 152.71 32.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.76 2.424 . . . . 1.0 111.911 -174.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.6 t80 57.38 -138.63 0.91 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.651 1.98 . . . . 1.0 112.405 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.827 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 32.3 t-20 -138.58 137.56 37.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.929 1.692 . . . . 1.0 110.9 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 t0 175.12 67.12 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.939 2.496 . . . . 1.0 112.75 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.689 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -160.52 142.74 12.8 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.14 2.576 . . . . 1.0 109.327 171.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 33.0 mtp180 -141.11 118.17 11.23 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.823 1.647 . . . . 1.0 113.897 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -94.07 153.09 18.33 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.456 1.122 . . . . 1.0 113.287 -175.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' A' ' 67' ' ' ALA 0.285 2.6 m 49.12 33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.553 2.741 . . . . 1.0 114.476 171.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.66 25.76 0.1 Allowed Glycine 0 CA--C 1.537 1.43 1 C-N-CA 131.796 4.522 . . . . 1.0 118.002 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.25 9.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 129.237 3.015 . . . . 1.0 111.665 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.2 p -67.59 92.68 0.33 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.692 2.797 . . . . 1.0 110.467 170.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.92 -133.71 4.15 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.55 2.5 . . . . 1.0 113.559 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -66.51 168.58 8.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.96 1.704 . . . . 1.0 112.419 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.34 -81.08 0.2 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.353 0.977 . . . . 1.0 111.019 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 94.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.291 1.837 . . . . 1.0 109.621 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.958 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -125.32 108.68 11.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.451 0.7 . . . . 1.0 111.813 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 56.7 t80 -139.21 93.43 2.68 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 128.093 2.557 . . . . 1.0 115.045 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.262 19.4 m -137.61 60.33 1.64 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.034 1.397 . . . . 1.0 109.248 169.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.06 97.18 10.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.59 1.956 . . . . 1.0 108.512 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.0 p -125.62 168.67 13.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.619 2.452 . . . . 1.0 117.619 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 61' ' ' THR . 5.0 tp -123.13 115.79 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.696 2.798 . . . . 1.0 107.666 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -123.7 108.51 12.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.415 2.286 . . . . 1.0 113.569 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 2.4 t -72.34 147.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.02 -1.675 . . . . 1.0 111.648 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -115.7 48.52 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 1 C-N-CA 132.668 4.387 . . . . 1.0 110.533 -172.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 116' ' ' PRO . 98.4 m -147.23 162.75 38.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 119.878 -1.764 . . . . 1.0 110.374 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.72 -42.71 11.23 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 126.308 1.843 . . . . 1.0 115.084 -173.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HD2' HG22 ' A' ' 114' ' ' THR . 74.9 Cg_endo -88.51 98.64 0.39 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.05 3.833 . . . . 1.0 107.619 168.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.06 118.23 5.56 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.3 2.667 . . . . 1.0 111.564 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.603 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 68.8 mt-30 -109.67 96.85 6.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.725 0.81 . . . . 1.0 110.877 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 m -107.85 122.43 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.982 2.113 . . . . 1.0 112.145 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.02 168.36 19.93 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.82 2.448 . . . . 1.0 112.33 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.3 m -117.31 145.81 43.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.053 -1.654 . . . . 1.0 113.335 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 123' ' ' HIS . 23.6 t80 -87.56 115.77 25.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 1.0 107.539 171.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 74.34 170.95 0.29 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.764 2.026 . . . . 1.0 113.984 -172.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -133.98 23.97 3.9 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.197 2.599 . . . . 1.0 113.38 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.64 119.39 14.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.863 2.065 . . . . 1.0 110.357 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.82 86.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.851 2.06 . . . . 1.0 110.624 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.778 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 11.9 mmtp -126.78 81.57 2.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.883 2.073 . . . . 1.0 111.638 -174.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.25 119.05 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 126.492 1.917 . . . . 1.0 109.992 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.5 m -82.57 123.37 29.15 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.697 1.599 . . . . 1.0 110.364 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.13 -35.45 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -40.46 7.38 Favored 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 131.746 4.018 . . . . 1.0 113.967 174.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.194 0 C-N-CA 125.495 1.522 . . . . 1.0 115.325 176.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.98 -0.748 . . . . 1.0 108.98 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 9.3 tp -143.36 -174.67 4.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 104.373 -2.454 . . . . 1.0 104.373 162.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.93 74.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 121.993 2.179 . . . . 1.0 109.464 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' A' ' 28' ' ' PRO . 21.4 mtm105 -47.68 147.29 1.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.295 1.438 . . . . 1.0 112.898 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' A' ' 122' ' ' TYR . 10.8 t -86.43 -154.53 0.22 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.264 1.826 . . . . 1.0 110.984 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.51 -18.37 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.123 2.169 . . . . 1.0 115.355 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 t -144.03 137.24 13.97 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.212 1.805 . . . . 1.0 111.919 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.0 Cg_exo -53.61 -19.74 14.77 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.727 2.952 . . . . 1.0 116.64 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -66.33 -23.24 66.33 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.578 1.325 . . . . 1.0 114.578 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' HB2' HG22 ' A' ' 25' ' ' THR . 98.1 m-85 -125.34 124.07 40.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.897 1.279 . . . . 1.0 111.747 -174.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' CD2' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -139.28 154.62 47.98 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.485 1.661 . . . . 1.0 115.485 -171.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -141.75 164.51 30.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.916 1.686 . . . . 1.0 113.965 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 t -148.91 105.25 3.52 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 126.8 2.04 . . . . 1.0 109.378 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 167.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.217 1 C-N-CA 132.434 4.294 . . . . 1.0 110.346 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.747 ' HG ' ' HD2' ' A' ' 36' ' ' PRO . 1.2 tp -53.9 165.28 0.79 Allowed Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.439 2.295 . . . . 1.0 115.737 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.747 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 40.4 Cg_endo -63.61 146.1 92.24 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.998 3.798 . . . . 1.0 113.776 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.1 p -67.5 -23.85 65.51 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.914 2.086 . . . . 1.0 116.185 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.39 77.51 1.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.692 2.397 . . . . 1.0 109.116 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -155.94 165.62 35.93 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.873 3.269 . . . . 1.0 110.677 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.0 101.72 1.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.227 1.011 . . . . 1.0 110.657 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p 9.43 -107.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.545 2.738 . . . . 1.0 114.847 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 171.32 -57.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 1 C-N-CA 132.478 4.311 . . . . 1.0 110.738 170.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.0 OUTLIER 68.97 -1.25 2.13 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.526 2.33 . . . . 1.0 116.781 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 93' ' ' ASP 0.316 1.4 t 142.6 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 1 C-N-CA 131.799 4.04 . . . . 1.0 113.462 172.048 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.83 150.98 17.44 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 127.237 2.215 . . . . 1.0 112.028 171.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.55 35.96 0.45 Allowed 'Trans proline' 0 CA--C 1.554 1.515 1 C-N-CA 125.567 4.178 . . . . 1.0 115.115 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -35.48 -71.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 129.732 3.213 . . . . 1.0 115.709 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.47 -30.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.48 1.912 . . . . 1.0 113.403 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.299 1.8 p90 41.52 39.26 1.04 Allowed 'General case' 0 C--N 1.353 0.756 0 N-CA-C 118.742 2.867 . . . . 1.0 118.742 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -126.25 106.89 9.85 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.769 0.713 . . . . 1.0 112.129 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.56 128.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.182 1.393 . . . . 1.0 110.702 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.55 145.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.771 2.028 . . . . 1.0 114.764 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.26 20.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.679 2.392 . . . . 1.0 108.9 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.98 112.28 16.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.395 1.478 . . . . 1.0 109.408 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.8 -61.49 0.6 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.932 1.253 . . . . 1.0 114.923 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.54 -18.94 11.83 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 118.093 2.627 . . . . 1.0 118.093 -171.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 57' ' ' VAL . 53.3 t 44.46 59.42 13.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 127.121 2.168 . . . . 1.0 114.739 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 112' ' ' VAL . 94.1 Cg_endo -88.34 109.48 0.58 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.56 2.84 . . . . 1.0 113.488 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.26 134.86 57.43 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.408 -0.807 . . . . 1.0 111.427 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.18 31.97 27.04 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.744 -0.597 . . . . 1.0 111.901 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 84.7 m -71.11 77.73 0.68 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 170.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -78.87 112.84 16.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.925 2.49 . . . . 1.0 111.767 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.52 107.77 18.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.454 -2.054 . . . . 1.0 105.454 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 m -105.36 119.52 39.28 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.753 -1.567 . . . . 1.0 110.042 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.31 116.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.152 -0.968 . . . . 1.0 108.449 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -125.34 81.24 1.95 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.655 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -96.95 107.4 19.91 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.346 -1.471 . . . . 1.0 107.189 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -39.15 132.25 1.91 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.567 2.508 . . . . 1.0 115.837 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.564 ' HB2' HG23 ' A' ' 97' ' ' VAL . 5.4 m-80 170.74 -15.42 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.449 1 C-N-CA 131.797 4.039 . . . . 1.0 115.733 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 7.5 m-20 -58.05 -35.83 71.88 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.239 1.836 . . . . 1.0 112.749 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 148.26 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 1 C-N-CA 132.75 4.42 . . . . 1.0 115.414 172.966 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -156.84 -102.36 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 O-C-N 120.153 -1.592 . . . . 1.0 113.876 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.65 15.97 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.861 2.864 . . . . 1.0 113.543 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.1 m -168.63 111.9 0.57 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.277 1.831 . . . . 1.0 110.532 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -110.39 164.04 13.08 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.307 1.966 . . . . 1.0 116.307 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 156.78 21.41 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 126.577 1.951 . . . . 1.0 115.313 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -130.76 167.57 18.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.755 2.422 . . . . 1.0 112.409 -174.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.99 91.87 3.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.916 -1.74 . . . . 1.0 111.425 172.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 67.73 12.59 8.92 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.504 1.522 . . . . 1.0 113.058 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.51 ' HB2' ' N ' ' A' ' 95' ' ' ARG . . . -74.83 7.54 3.06 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 120.945 1.702 . . . . 1.0 112.491 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 113.2 24.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 130.089 3.356 . . . . 1.0 106.897 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.57 160.0 40.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.574 1.95 . . . . 1.0 109.89 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.2 46.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.783 1.633 . . . . 1.0 114.05 173.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.787 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 48.8 mtm -101.01 151.61 21.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 1.0 109.671 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -112.13 -80.2 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.466 1.506 . . . . 1.0 107.545 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -62.27 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.213 0.46 . . . . 1.0 110.044 170.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.02 22.6 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.106 1.762 . . . . 1.0 114.421 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -133.88 119.8 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 126.21 1.804 . . . . 1.0 112.836 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.14 143.77 46.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.635 1.574 . . . . 1.0 109.727 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -106.09 106.1 16.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.794 0.838 . . . . 1.0 109.039 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.63 73.05 5.18 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.052 1.741 . . . . 1.0 111.946 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -121.66 171.43 8.85 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 129.216 3.006 . . . . 1.0 110.531 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 1.4 t70 60.48 -20.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 130.179 3.391 . . . . 1.0 117.973 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -42.52 146.42 0.34 Allowed 'General case' 0 C--O 1.238 0.469 1 C-N-CA 133.11 4.564 . . . . 1.0 118.615 -171.441 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -139.95 129.21 23.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.21 -0.996 . . . . 1.0 111.104 170.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -119.85 135.88 54.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.13 1.772 . . . . 1.0 111.836 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 69' ' ' ASN 0.294 4.5 p 52.35 29.77 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 C-N-CA 125.043 1.337 . . . . 1.0 114.386 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.33 72.19 0.61 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 128.039 2.733 . . . . 1.0 113.345 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 132.27 84.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 1 C-N-CA 134.529 5.132 . . . . 1.0 109.425 -175.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . 7.5 m -78.53 162.05 26.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.849 0.685 . . . . 1.0 112.849 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.34 -23.77 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 117.507 1.763 . . . . 1.0 117.507 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 169.64 150.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 129.771 3.228 . . . . 1.0 111.902 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.07 53.41 14.67 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.186 1.374 . . . . 1.0 115.246 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 69' ' ' ASN . 3.9 mptt -68.53 92.34 0.45 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.092 1.757 . . . . 1.0 112.206 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t -122.52 160.85 24.77 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 129.773 3.229 . . . . 1.0 113.973 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -128.4 90.18 3.03 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.021 1.86 . . . . 1.0 116.021 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -101.65 77.45 1.74 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.859 1.664 . . . . 1.0 110.575 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.85 92.84 6.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.561 -1.337 . . . . 1.0 109.255 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.7 t -116.8 122.01 43.19 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.39 114.32 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.003 1.321 . . . . 1.0 108.88 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.9 m -100.83 109.5 21.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.031 2.132 . . . . 1.0 113.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 58' ' ' PRO . 53.7 t -76.39 103.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.411 -1.431 . . . . 1.0 108.462 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.19 3.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.122 1 C-N-CA 134.981 5.312 . . . . 1.0 117.215 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -84.09 178.42 7.84 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.949 2.1 . . . . 1.0 114.02 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 28.7 m-20 -44.93 -54.88 12.15 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.702 1.201 . . . . 1.0 109.814 171.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 48.1 Cg_endo -74.99 116.89 4.72 Favored 'Trans proline' 0 CA--C 1.556 1.575 0 C-N-CA 123.495 2.797 . . . . 1.0 107.984 168.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.23 94.29 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 124.401 3.401 . . . . 1.0 108.603 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.44 92.39 5.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 -172.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -108.22 124.59 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 1.0 112.228 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.08 26.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.123 1.369 . . . . 1.0 111.692 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.2 m -113.31 140.07 48.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.591 1.957 . . . . 1.0 111.008 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 1.1 t80 -118.33 139.69 50.97 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.725 1.61 . . . . 1.0 111.843 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.61 64.0 0.8 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.939 1.459 . . . . 1.0 114.939 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.827 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 20.2 tpt85 -59.56 -27.83 66.58 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.859 2.54 . . . . 1.0 117.859 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 51.6 82.26 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 128.345 2.658 . . . . 1.0 114.705 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.46 -89.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 126.192 1.797 . . . . 1.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -88.17 153.9 20.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.585 1.954 . . . . 1.0 110.787 172.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.57 113.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.68 1.192 . . . . 1.0 110.986 173.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.5 m -89.84 126.31 35.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.0 110.81 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.43 -35.96 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 126.654 1.981 . . . . 1.0 115.485 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -56.21 10.95 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 131.163 3.785 . . . . 1.0 110.964 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 100' ' ' SER . . . . . . . . 0 CA--C 1.532 1.137 0 C-N-CA 127.434 2.445 . . . . 1.0 113.576 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.441 -0.79 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -157.45 -175.14 5.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.118 2.567 . . . . 1.0 105.259 -168.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.27 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 121.639 2.018 . . . . 1.0 109.676 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HG2' ' HB3' ' A' ' 31' ' ' LEU . 32.5 mtp180 -81.68 141.48 33.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.556 1.542 . . . . 1.0 110.031 169.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 p -81.92 -136.03 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.102 2.161 . . . . 1.0 109.367 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -48.66 -17.2 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.361 -1.462 . . . . 1.0 113.612 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.403 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 43.2 m 75.57 14.96 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 27' ' ' SER . 76.1 Cg_endo -70.32 30.01 0.2 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 124.749 3.633 . . . . 1.0 115.93 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' A' ' 56' ' ' ASP . 97.9 m-20 132.81 -20.48 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.478 1 C-N-CA 133.391 4.676 . . . . 1.0 113.581 -176.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -84.96 140.98 30.68 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 1.0 115.2 -171.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 3.6 pp -148.2 149.57 32.19 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.845 2.458 . . . . 1.0 112.004 171.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 t -129.77 122.14 28.22 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.048 1.339 . . . . 1.0 113.256 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 3.0 t -88.97 96.67 10.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.63 3.172 . . . . 1.0 108.594 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.04 162.58 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 129.988 3.315 . . . . 1.0 111.132 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -126.16 75.46 72.55 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 125.255 1.422 . . . . 1.0 112.386 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.77 -40.49 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 124.309 3.339 . . . . 1.0 113.814 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 m 38.39 45.3 0.81 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.126 3.37 . . . . 1.0 112.622 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . 6.8 p80 44.42 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.497 2.719 . . . . 1.0 114.039 173.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -169.43 176.83 4.91 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 128.964 2.906 . . . . 1.0 108.793 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 97' ' ' VAL . 1.4 ptp180 -119.33 166.93 12.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.365 1.066 . . . . 1.0 113.763 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.2 m 75.68 12.83 3.0 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.923 2.564 . . . . 1.0 117.923 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -21.11 -46.94 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 130.674 3.59 . . . . 1.0 117.839 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.981 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 53.81 -29.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 1 C-N-CA 132.565 4.346 . . . . 1.0 119.512 171.583 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m 141.27 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 1 C-N-CA 133.339 4.656 . . . . 1.0 107.718 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.764 HD23 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -83.03 154.32 67.24 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.459 1.104 . . . . 1.0 112.217 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.764 ' HD2' HD23 ' A' ' 45' ' ' LEU . 58.8 Cg_endo -69.13 37.4 0.22 Allowed 'Trans proline' 0 CA--C 1.558 1.689 1 C-N-CA 125.528 4.152 . . . . 1.0 115.746 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG12 ' HB3' ' A' ' 45' ' ' LEU . 26.3 pt -128.43 -29.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.292 3.037 . . . . 1.0 114.449 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.67 -174.0 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 127.417 2.287 . . . . 1.0 115.489 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 46.3 m-85 -126.46 134.1 51.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.768 2.027 . . . . 1.0 112.847 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 69.8 mttt -130.24 109.35 10.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.599 1.56 . . . . 1.0 109.649 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -106.02 135.78 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.322 1.449 . . . . 1.0 109.02 173.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.56 140.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.394 1.077 . . . . 1.0 110.976 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -104.32 105.68 15.91 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 168.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.54 114.01 26.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.19 2.88 41.74 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.787 1.66 . . . . 1.0 115.923 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' A' ' 29' ' ' ASN . 2.1 t0 -133.67 162.05 33.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.741 2.017 . . . . 1.0 113.707 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.3 t -141.32 71.92 26.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.87 1.668 . . . . 1.0 111.661 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 87' ' ' GLN . 68.3 Cg_endo -79.63 -177.94 4.21 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.849 3.699 . . . . 1.0 114.277 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -148.73 95.76 2.47 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.051 2.14 . . . . 1.0 111.43 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.71 17.21 9.3 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 126.057 1.789 . . . . 1.0 116.955 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 81.1 m -52.14 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.688 2.395 . . . . 1.0 113.294 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -77.15 103.27 6.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.217 1.407 . . . . 1.0 110.971 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.47 108.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -112.36 115.85 29.4 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 123.944 0.777 . . . . 1.0 112.634 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.685 HG13 ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -98.28 111.65 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.128 -0.982 . . . . 1.0 110.253 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.818 ' HG2' ' HB3' ' A' ' 77' ' ' LEU . 32.8 mtm -128.99 165.56 20.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.94 127.31 47.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.337 1.055 . . . . 1.0 109.158 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -35.57 -57.28 0.96 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 125.55 1.548 . . . . 1.0 113.187 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.509 ' H ' ' CB ' ' A' ' 105' ' ' SER . 12.7 t-20 72.94 109.35 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.504 3.522 . . . . 1.0 110.078 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 102' ' ' ARG . 1.0 OUTLIER 54.33 32.91 17.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.202 1.401 . . . . 1.0 112.729 -168.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 53.97 54.92 9.02 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 129.161 2.984 . . . . 1.0 114.096 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 73' ' ' TYR 0.361 0.0 OUTLIER -82.37 -108.3 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.494 0.717 . . . . 1.0 111.003 173.036 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.673 ' H ' ' ND2' ' A' ' 72' ' ' ASN . 17.4 m-85 -172.64 70.79 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 130.642 3.577 . . . . 1.0 110.394 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.0 p 63.35 89.75 0.09 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.833 2.053 . . . . 1.0 114.477 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -147.37 74.21 1.32 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.869 1.063 . . . . 1.0 113.869 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 26.1 tt0 161.09 96.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.053 2.141 . . . . 1.0 115.628 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.038 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.98 165.48 24.61 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.615 3.566 . . . . 1.0 107.876 170.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -144.11 82.53 1.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.255 -1.528 . . . . 1.0 111.193 169.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 23.9 m120 84.16 4.07 0.76 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.089 1.756 . . . . 1.0 111.136 -170.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -64.07 9.85 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.587 3.155 . . . . 1.0 116.592 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 t -118.63 115.13 23.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.527 1.931 . . . . 1.0 110.834 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.1 32.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.589 1.956 . . . . 1.0 112.198 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.82 143.62 26.33 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.923 2.489 . . . . 1.0 111.898 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -121.37 149.25 43.26 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.876 2.47 . . . . 1.0 112.088 -170.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -79.48 -117.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.063 0.945 . . . . 1.0 111.057 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.7 -8.14 1.2 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.718 2.007 . . . . 1.0 115.246 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 135.69 6.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.192 1 C-N-CA 133.109 4.563 . . . . 1.0 113.128 -171.354 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.54 144.66 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 120.405 1.457 . . . . 1.0 112.613 -169.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -99.92 146.34 26.79 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.188 2.195 . . . . 1.0 113.637 173.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.938 2.495 . . . . 1.0 110.844 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 t80 45.93 -78.9 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.421 3.088 . . . . 1.0 116.842 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 44.88 160.99 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.537 1 C-N-CA 131.773 4.029 . . . . 1.0 118.497 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.55 -54.9 4.43 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.627 2.371 . . . . 1.0 113.567 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 5.5 mt 40.82 120.18 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.403 1 C-N-CA 133.093 4.557 . . . . 1.0 117.321 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.981 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.92 115.34 22.39 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.783 1.629 . . . . 1.0 113.196 -170.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -99.95 136.28 40.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.464 1.505 . . . . 1.0 110.82 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 1.8 t 50.43 56.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.848 -1.167 . . . . 1.0 107.848 -171.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.06 -8.06 65.18 Favored Glycine 0 N--CA 1.479 1.501 1 N-CA-C 126.499 5.36 . . . . 1.0 126.499 -167.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 100' ' ' SER 0.253 1.3 tmm_? -146.9 48.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.88 3.34 . . . . 1.0 117.488 -177.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' ARG 0.278 3.4 t 144.53 -81.49 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 132.126 4.17 . . . . 1.0 111.059 171.171 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 85.55 1.59 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.041 1.291 . . . . 1.0 114.799 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -44.41 -60.35 1.99 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 129.211 3.004 . . . . 1.0 116.951 -176.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.82 -79.95 0.03 OUTLIER Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.287 1.899 . . . . 1.0 111.592 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.64 98.1 1.91 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.701 1.6 . . . . 1.0 114.516 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.509 ' CB ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -127.51 136.13 51.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.824 2.05 . . . . 1.0 113.142 173.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.8 114.05 12.23 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.168 1.787 . . . . 1.0 111.747 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -139.21 75.84 1.54 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.939 1.696 . . . . 1.0 111.288 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.56 108.9 8.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 1.0 110.046 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -117.74 115.25 24.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.2 1.4 . . . . 1.0 112.14 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.4 116.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.472 1.509 . . . . 1.0 107.197 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -113.77 107.34 15.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.201 1.001 . . . . 1.0 113.239 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.59 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 55.5 t -77.3 145.56 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.514 1.526 . . . . 1.0 111.846 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -104.1 -6.99 20.56 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.316 3.046 . . . . 1.0 114.627 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 116' ' ' PRO . 8.6 m -72.28 171.47 12.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.869 2.868 . . . . 1.0 111.742 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.99 -52.53 9.15 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.403 -1.284 . . . . 1.0 111.778 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 114' ' ' THR . 58.1 Cg_endo -78.24 110.74 2.93 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 124.624 3.55 . . . . 1.0 109.534 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 106.37 1.88 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.009 2.473 . . . . 1.0 109.624 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.632 HE22 ' HB2' ' A' ' 116' ' ' PRO . 1.7 mp0 -106.68 101.48 10.92 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 1.0 111.15 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.78 114.38 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.631 1.973 . . . . 1.0 111.423 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.08 127.66 32.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.91 1.684 . . . . 1.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 t -123.88 148.67 46.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.218 1.807 . . . . 1.0 114.712 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -87.32 112.66 22.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 1.0 109.073 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.42 49.91 2.28 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.006 2.522 . . . . 1.0 112.097 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -136.48 -99.94 0.21 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.217 2.207 . . . . 1.0 114.222 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.48 58.78 0.29 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 116.175 1.917 . . . . 1.0 116.175 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.27 72.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.329 2.252 . . . . 1.0 114.256 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -128.98 159.67 35.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.276 2.23 . . . . 1.0 111.769 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -149.88 161.21 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.899 2.079 . . . . 1.0 111.235 174.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.7 m -99.06 124.05 43.79 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.46 1.904 . . . . 1.0 110.334 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.85 -30.91 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 115.733 1.753 . . . . 1.0 115.733 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.55 -49.88 75.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.189 2.195 . . . . 1.0 112.605 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 40' ' ' ARG . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 129.203 3.287 . . . . 1.0 112.635 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 119.663 -0.208 . . . . 1.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mt -148.51 -173.89 4.46 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.689 2.396 . . . . 1.0 106.273 150.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.28 71.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 120.951 1.705 . . . . 1.0 106.677 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -127.98 82.04 2.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.269 3.428 . . . . 1.0 108.216 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.0 p -100.68 -73.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.433 1.893 . . . . 1.0 110.047 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.593 1.557 . . . . 1.0 114.01 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m 75.19 36.38 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 117.161 2.282 . . . . 1.0 117.161 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.74 37.37 0.24 Allowed 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 124.481 3.454 . . . . 1.0 112.971 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . 0.27 84.8 m-20 73.24 16.0 4.26 Favored 'General case' 0 CA--C 1.56 1.33 1 C-N-CA 132.328 4.251 . . . . 1.0 114.052 -170.457 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.73 ' CE1' ' HB2' ' A' ' 53' ' ' ALA . 80.4 m-85 -108.68 137.14 47.09 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.495 1.665 . . . . 1.0 115.495 -174.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 pp -122.31 122.1 38.29 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.557 2.343 . . . . 1.0 111.923 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HB2' HG13 ' A' ' 51' ' ' VAL . 1.6 t -115.27 147.07 40.85 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.336 1.854 . . . . 1.0 112.65 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -130.14 95.17 3.86 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.969 2.908 . . . . 1.0 110.689 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -144.64 139.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 128.625 2.77 . . . . 1.0 110.877 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.77 146.69 80.16 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 126.252 1.821 . . . . 1.0 114.424 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.65 99.51 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.622 3.548 . . . . 1.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.5 t -93.69 -8.14 41.73 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 116.192 1.923 . . . . 1.0 116.192 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.1 p80 31.57 56.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 128.815 2.846 . . . . 1.0 115.869 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.43 ' HA ' ' H ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -164.79 176.15 9.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.927 2.091 . . . . 1.0 113.749 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.28 101.64 1.95 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.304 2.242 . . . . 1.0 109.569 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.49 -65.84 0.96 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.248 -0.908 . . . . 1.0 109.621 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 45.11 56.71 5.25 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.228 1.411 . . . . 1.0 113.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.93 1.66 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.966 2.58 . . . . 1.0 117.966 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -23.42 57.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.781 2.141 . . . . 1.0 116.781 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 109.63 10.31 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.549 1.522 . . . . 1.0 109.833 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.34 144.3 11.53 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 123.87 3.046 . . . . 1.0 110.731 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -141.34 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.556 1.543 . . . . 1.0 110.932 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.42 119.49 3.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.599 1.96 . . . . 1.0 109.75 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 47' ' ' ILE . 9.0 m-85 -122.98 113.4 19.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.134 1.773 . . . . 1.0 109.12 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -126.61 118.8 25.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.809 1.244 . . . . 1.0 109.964 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 32' ' ' CYS . 10.4 t -134.56 134.75 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.909 1.284 . . . . 1.0 110.323 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.77 142.0 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.775 1.63 . . . . 1.0 110.69 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . . . -111.63 146.33 37.63 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.136 1.375 . . . . 1.0 111.047 170.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -74.55 139.57 43.84 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.281 0.632 . . . . 1.0 110.257 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.93 -177.27 19.17 Favored Glycine 0 CA--C 1.545 1.96 0 C-N-CA 126.811 2.148 . . . . 1.0 112.225 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.99 94.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.311 1.044 . . . . 1.0 112.452 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 7.5 p -156.26 147.48 16.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.065 2.146 . . . . 1.0 112.427 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.7 Cg_endo -58.36 151.0 63.77 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.797 2.331 . . . . 1.0 112.455 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 69.59 97.11 0.06 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.602 2.361 . . . . 1.0 112.811 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.05 -14.76 25.68 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 126.821 2.153 . . . . 1.0 115.104 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 95.13 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 127.722 2.409 . . . . 1.0 114.231 171.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' ILE . 7.0 mp -103.77 129.02 51.12 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.981 1.474 . . . . 1.0 114.981 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -93.72 116.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.53 2.332 . . . . 1.0 105.37 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 p -129.2 117.54 20.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.121 2.169 . . . . 1.0 110.975 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 80' ' ' ALA 0.305 11.0 m -109.93 110.44 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.078 -1.014 . . . . 1.0 110.52 171.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.699 ' HB2' HG23 ' A' ' 107' ' ' THR . 53.4 mtt -144.42 107.72 4.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.494 2.317 . . . . 1.0 110.625 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.1 106.03 16.46 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 121.376 -0.828 . . . . 1.0 111.446 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.06 167.67 27.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.913 2.197 . . . . 1.0 112.278 172.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 104' ' ' LYS 0.265 0.1 OUTLIER 57.51 -33.01 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.27 2.628 . . . . 1.0 117.218 -175.563 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.626 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 38.9 t70 -64.73 -22.21 66.93 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 129.313 3.045 . . . . 1.0 113.515 170.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 72' ' ' ASN . 9.6 tm-20 -120.78 -67.08 1.0 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.644 2.778 . . . . 1.0 109.629 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.533 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 3.1 m-80 -145.47 -85.23 0.12 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.906 2.082 . . . . 1.0 111.131 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -168.24 10.73 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.511 1.925 . . . . 1.0 114.994 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.2 m -59.51 -72.54 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.91 1.684 . . . . 1.0 113.995 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 46.75 -156.68 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.516 1.526 . . . . 1.0 114.965 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 100' ' ' SER . 7.0 tp10 65.11 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.404 3.082 . . . . 1.0 115.227 -172.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -134.02 165.52 24.85 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.33 83.79 2.16 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.963 1.305 . . . . 1.0 109.603 172.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 70.82 10.63 7.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.865 0.866 . . . . 1.0 113.109 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -65.51 2.63 0.87 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.304 1.411 . . . . 1.0 113.387 169.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -100.02 112.61 24.9 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.044 0.938 . . . . 1.0 109.715 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.41 122.51 14.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.39 1.876 . . . . 1.0 109.689 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.8 153.48 18.84 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.184 0.994 . . . . 1.0 112.537 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.24 167.62 15.2 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.384 1.874 . . . . 1.0 110.084 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 -80.13 0.6 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.671 1.588 . . . . 1.0 110.389 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.65 45.71 0.81 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.23 1.412 . . . . 1.0 112.072 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 20.9 mp0 61.15 22.04 12.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.573 2.749 . . . . 1.0 114.752 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.89 133.25 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.76 129.88 49.23 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 130.383 3.473 . . . . 1.0 111.393 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -136.01 160.07 39.75 Favored 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 132.028 4.131 . . . . 1.0 110.334 176.29 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 3.5 t80 108.04 178.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 129.499 3.119 . . . . 1.0 114.717 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -82.32 -157.06 0.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 127.738 2.415 . . . . 1.0 108.252 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 66.99 47.53 1.38 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 117.724 2.49 . . . . 1.0 117.724 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 1.9 mp -139.25 123.92 18.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.371 2.268 . . . . 1.0 109.427 172.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.5 mpt_? -144.69 149.51 35.75 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-N 122.698 2.499 . . . . 1.0 115.371 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.717 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -118.31 169.11 10.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.935 2.094 . . . . 1.0 115.746 -177.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 38.7 t 60.4 70.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.047 2.139 . . . . 1.0 109.927 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.59 -11.52 37.96 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 127.464 2.459 . . . . 1.0 115.906 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 73.05 -16.67 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 129.563 3.145 . . . . 1.0 118.57 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.777 ' HB2' ' HB2' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 30.78 -5.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 2 C-N-CA 134.807 5.243 . . . . 1.0 122.502 172.187 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.77 49.28 1.52 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 128.696 3.046 . . . . 1.0 110.653 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 90.7 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 129.861 3.264 . . . . 1.0 109.186 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.96 62.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 114.875 0.71 . . . . 1.0 114.875 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -71.48 84.93 0.83 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 123.153 1.454 . . . . 1.0 107.765 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -130.84 113.17 13.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.001 2.52 . . . . 1.0 113.177 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 70' ' ' ASP . 22.7 t80 -87.45 83.25 7.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.06 0.944 . . . . 1.0 108.988 174.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 66' ' ' MET . 5.0 t -148.65 52.05 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.1 pt? -96.26 68.35 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.442 1.497 . . . . 1.0 112.866 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 50.8 m 172.28 -77.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 128.944 2.898 . . . . 1.0 113.701 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -133.17 155.04 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.1 m -135.05 106.3 6.74 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.131 2.172 . . . . 1.0 111.612 170.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.22 103.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 123.379 1.561 . . . . 1.0 109.707 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.14 73.47 0.47 Allowed 'General case' 0 CA--C 1.545 0.773 1 C-N-CA 133.203 4.601 . . . . 1.0 109.771 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.682 HG22 ' HD2' ' A' ' 116' ' ' PRO . 93.7 m -152.37 163.09 40.18 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.376 2.27 . . . . 1.0 109.41 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.98 -41.91 32.16 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.419 -1.277 . . . . 1.0 114.046 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 114' ' ' THR . 83.5 Cg_endo -92.08 101.57 0.2 Allowed 'Trans proline' 0 CA--C 1.561 1.875 1 C-N-CA 125.883 4.389 . . . . 1.0 107.501 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.15 119.59 6.64 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 124.144 3.229 . . . . 1.0 111.138 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -118.92 102.45 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.3 1.048 . . . . 1.0 111.299 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.3 144.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.126 2.171 . . . . 1.0 113.163 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 110' ' ' ILE . . . -122.45 155.1 36.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.805 1.642 . . . . 1.0 112.402 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 t -127.54 139.34 52.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.562 1.945 . . . . 1.0 113.319 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 9.4 t80 -89.11 109.82 20.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.074 -1.016 . . . . 1.0 108.773 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -97.0 57.19 1.47 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.979 0.895 . . . . 1.0 113.137 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -133.19 -61.73 0.82 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.24 2.616 . . . . 1.0 112.258 -175.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.09 -15.27 61.06 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.2 mm 11.94 -86.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 1 C-N-CA 131.848 4.059 . . . . 1.0 114.66 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 48.9 tptt -79.69 97.35 6.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.5 1.92 . . . . 1.0 110.57 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.47 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.87 161.74 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.73 1.612 . . . . 1.0 112.176 -178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -103.13 125.61 49.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.325 1.45 . . . . 1.0 112.804 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.01 -56.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.94 1.296 . . . . 1.0 112.032 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -99.1 -70.56 0.72 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.372 1.869 . . . . 1.0 112.83 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.583 0 C-N-CA 126.366 1.936 . . . . 1.0 114.009 175.379 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.301 -0.857 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 -173.91 4.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.356 2.663 . . . . 1.0 106.478 -160.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.701 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.9 t -72.96 71.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 122.143 2.247 . . . . 1.0 107.891 171.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.87 123.33 49.91 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 1.0 108.05 170.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 26' ' ' ASP 0.311 9.7 t -129.52 -101.1 0.32 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.553 0.946 . . . . 1.0 113.553 -172.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' H ' HG23 ' A' ' 25' ' ' THR . 11.3 t70 -57.04 -34.89 68.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 127.746 2.418 . . . . 1.0 115.895 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.695 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 63.1 m -139.22 109.05 7.49 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.079 1.752 . . . . 1.0 107.616 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -46.26 -19.51 0.64 Allowed 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 124.706 3.604 . . . . 1.0 115.547 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.06 -36.59 70.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.544 2.738 . . . . 1.0 113.395 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -101.95 110.46 22.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.801 1.24 . . . . 1.0 109.813 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -117.96 122.28 42.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.028 1.731 . . . . 1.0 113.331 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.701 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 14.3 m -114.98 164.08 14.66 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.172 1.389 . . . . 1.0 113.861 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -152.06 126.96 9.64 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.793 1.637 . . . . 1.0 113.176 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.31 152.81 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 130.566 3.546 . . . . 1.0 109.375 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.55 150.8 95.57 Favored Pre-proline 0 CA--C 1.56 1.353 0 O-C-N 121.761 -0.587 . . . . 1.0 112.529 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.5 80.0 1.13 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.222 3.281 . . . . 1.0 112.414 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 p -77.64 -80.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.519 1.128 . . . . 1.0 110.246 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 44.37 78.21 0.06 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.844 2.458 . . . . 1.0 111.77 -173.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 1.6 p90 -166.28 173.56 9.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.474 2.309 . . . . 1.0 111.55 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 97' ' ' VAL . 4.5 ttp180 -66.43 100.87 0.69 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.785 1.234 . . . . 1.0 110.908 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -87.23 -50.78 6.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.962 1.705 . . . . 1.0 113.446 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t-20 56.28 8.65 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 125.913 1.685 . . . . 1.0 114.528 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 95' ' ' ARG 0.267 5.4 ttpt 65.42 27.31 11.84 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 130.806 3.643 . . . . 1.0 114.82 -170.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -57.51 -55.39 35.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 130.045 3.338 . . . . 1.0 114.457 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.21 106.49 17.77 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.867 2.067 . . . . 1.0 109.751 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.62 134.54 16.93 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.095 3.197 . . . . 1.0 113.301 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.87 -11.66 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.822 1.649 . . . . 1.0 114.563 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 68.51 162.09 0.2 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.133 2.573 . . . . 1.0 115.693 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -128.02 129.06 46.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.123 2.169 . . . . 1.0 109.506 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -124.67 109.13 12.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.02 1.328 . . . . 1.0 110.094 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.75 144.11 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.525 1.53 . . . . 1.0 111.459 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 147.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.476 3.11 . . . . 1.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 87' ' ' GLN . . . -135.39 158.93 43.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.79 1.774 . . . . 1.0 115.79 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.4 mt -100.43 112.48 24.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.803 2.041 . . . . 1.0 108.2 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.27 168.72 34.48 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 125.492 1.52 . . . . 1.0 111.282 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 58' ' ' PRO . 9.3 t0 56.8 169.38 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.761 ' HA ' ' HG2' ' A' ' 87' ' ' GLN 0.332 1.3 p -149.54 -43.86 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 115.788 1.773 . . . . 1.0 115.788 172.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' A' ' 57' ' ' VAL . 46.6 Cg_endo -81.16 169.41 16.04 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.282 2.654 . . . . 1.0 111.91 171.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 16.75 -122.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 129.367 3.067 . . . . 1.0 114.386 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 86' ' ' ASN . . . 144.42 -70.5 0.39 Allowed Glycine 0 C--N 1.342 0.861 0 C-N-CA 126.274 1.893 . . . . 1.0 113.951 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -139.82 165.17 28.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.596 1.702 . . . . 1.0 115.596 -169.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 111' ' ' THR . 38.3 mt -108.42 106.22 16.24 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.632 3.173 . . . . 1.0 106.305 168.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.87 107.72 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 -173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.9 m -111.57 119.59 39.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.241 1.017 . . . . 1.0 111.157 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.67 114.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 120.948 -1.095 . . . . 1.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.77 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 8.1 mtt -121.12 78.03 1.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.127 0.971 . . . . 1.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.02 106.69 19.02 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.136 -1.431 . . . . 1.0 107.136 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.57 171.19 54.95 Favored Glycine 0 CA--C 1.543 1.8 0 C-N-CA 126.542 2.02 . . . . 1.0 116.838 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 17.8 p-10 -145.35 91.7 2.16 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.046 2.938 . . . . 1.0 110.135 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.92 20.37 12.18 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 126.426 1.89 . . . . 1.0 114.874 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.647 ' HG2' ' HB3' ' A' ' 73' ' ' TYR . 4.4 tt0 -148.41 -25.98 0.33 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.141 2.177 . . . . 1.0 116.279 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 45.09 38.7 3.33 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.963 2.105 . . . . 1.0 114.301 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.647 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 60.9 t80 -149.84 68.67 1.01 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.645 1.978 . . . . 1.0 111.973 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.77 ' HB2' ' HG2' ' A' ' 66' ' ' MET . 42.5 t 63.08 78.79 0.28 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 128.664 2.785 . . . . 1.0 116.73 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.79 -62.82 1.4 Allowed 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 95' ' ' ARG . 0.1 OUTLIER 173.22 143.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.894 2.878 . . . . 1.0 112.165 174.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.63 163.26 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.65 2.38 . . . . 1.0 110.782 170.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.778 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . 56.1 mtt-85 -141.08 90.03 2.29 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.092 2.157 . . . . 1.0 109.173 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' A' ' 81' ' ' THR . 1.3 t-20 88.84 -2.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.801 2.04 . . . . 1.0 110.848 -172.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 94' ' ' LEU 0.334 . . -76.01 34.12 0.13 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 123.272 2.76 . . . . 1.0 114.475 170.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.548 ' H ' ' C ' ' A' ' 79' ' ' ASN . 1.2 t -126.56 108.37 11.08 Favored 'General case' 0 CA--C 1.542 0.653 1 C-N-CA 132.704 4.402 . . . . 1.0 101.238 167.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.18 152.82 42.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.57 1.148 . . . . 1.0 112.113 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.15 159.4 15.3 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 129.452 3.101 . . . . 1.0 114.1 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 88' ' ' VAL 0.306 0.5 OUTLIER 86.54 -127.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 128.057 2.543 . . . . 1.0 113.041 176.278 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 70.08 -25.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 128.267 2.627 . . . . 1.0 117.13 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.487 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 2.4 m-20 -81.48 0.99 35.34 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 120.057 1.299 . . . . 1.0 113.497 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.761 ' HG2' ' HA ' ' A' ' 57' ' ' VAL . 4.1 tp-100 -148.41 -47.54 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.037 2.135 . . . . 1.0 112.395 170.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 84' ' ' MET . 90.7 t -133.9 134.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 114.972 1.471 . . . . 1.0 114.972 -172.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.24 121.62 16.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.775 1.63 . . . . 1.0 110.632 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.15 158.8 43.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.497 2.319 . . . . 1.0 110.23 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.45 -167.6 0.19 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.548 1.539 . . . . 1.0 114.565 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 9.0 p30 -107.99 -174.44 2.52 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.02 2.128 . . . . 1.0 111.559 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.265 8.4 m-20 121.0 74.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.565 3.546 . . . . 1.0 112.379 174.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.722 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 2.9 pp -160.2 141.72 12.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.198 2.599 . . . . 1.0 109.299 169.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.778 ' HD3' ' HB2' ' A' ' 78' ' ' ARG . 3.7 ttt180 -129.49 148.48 51.4 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 119.073 0.851 . . . . 1.0 112.166 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.45 152.0 38.32 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.453 1.649 . . . . 1.0 115.453 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 128' ' ' ILE . 32.3 m 43.95 31.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 129.194 2.998 . . . . 1.0 117.569 168.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.54 -35.18 36.44 Favored Glycine 0 N--CA 1.48 1.577 0 C-N-CA 128.848 3.118 . . . . 1.0 118.336 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 -0.15 4.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.511 1.924 . . . . 1.0 115.08 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 13.3 p -65.27 119.2 10.47 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.429 1.491 . . . . 1.0 113.122 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -117.17 128.47 7.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.78 1.657 . . . . 1.0 114.004 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 69.01 164.18 0.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.928 2.891 . . . . 1.0 113.496 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 42.36 36.4 2.15 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.172 1.844 . . . . 1.0 113.918 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -67.43 101.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.769 2.028 . . . . 1.0 108.701 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -115.5 156.45 25.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 130.614 3.565 . . . . 1.0 110.17 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.9 90.82 2.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.502 1.668 . . . . 1.0 115.502 -171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.0 m -112.38 80.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.545 1.138 . . . . 1.0 112.208 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.4 115.0 19.7 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.611 -1.306 . . . . 1.0 110.949 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.9 m -121.1 111.98 18.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.664 1.186 . . . . 1.0 111.148 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.0 113.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 62' ' ' LEU . 14.8 t -89.98 151.1 21.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 122.834 0.453 . . . . 1.0 111.769 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 2.0 p -72.68 170.95 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 123.451 1.596 . . . . 1.0 112.325 172.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.412 ' H ' HG22 ' A' ' 112' ' ' VAL . 8.9 t80 -118.15 11.5 13.27 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.891 2.877 . . . . 1.0 114.339 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.7 p -120.59 167.51 12.34 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.222 1.409 . . . . 1.0 112.682 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -29.06 5.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 117.536 2.421 . . . . 1.0 117.536 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -87.6 99.34 0.46 Allowed 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 124.421 3.414 . . . . 1.0 109.715 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.91 94.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.355 1 C-N-CA 125.428 4.085 . . . . 1.0 116.217 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.621 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 1.5 tm0? -97.78 90.47 4.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.152 0.977 . . . . 1.0 108.413 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.23 114.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.191 1.396 . . . . 1.0 108.616 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.42 151.78 27.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.561 2.345 . . . . 1.0 111.516 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 m -118.74 131.01 56.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.135 0.974 . . . . 1.0 112.905 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.24 120.29 23.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.394 1.078 . . . . 1.0 111.518 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -167.17 -166.45 0.8 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.794 2.437 . . . . 1.0 111.484 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -33.62 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 130.077 3.351 . . . . 1.0 117.697 172.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -28.99 -74.97 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 128.915 2.886 . . . . 1.0 115.183 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.3 mm -145.66 169.04 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 130.039 3.336 . . . . 1.0 107.654 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -76.39 150.06 36.84 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.7 -1.25 . . . . 1.0 110.717 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 97' ' ' VAL . 18.8 tt -92.32 124.5 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.461 1.904 . . . . 1.0 110.119 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -81.21 125.11 29.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.44 1.496 . . . . 1.0 111.923 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.3 t -53.95 -65.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.786 1.635 . . . . 1.0 114.153 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.44 -2.93 27.77 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . . . . . . 0 CA--C 1.55 2.261 0 C-N-CA 125.356 1.455 . . . . 1.0 112.494 -172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.59 0.219 . . . . 1.0 111.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -152.5 -174.53 4.93 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 23.2 t -67.63 71.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 107.173 -1.417 . . . . 1.0 107.173 170.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.12 169.73 0.77 Allowed 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.965 1.468 . . . . 1.0 114.965 171.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 24.9 p -132.64 176.51 8.39 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.408 2.283 . . . . 1.0 110.17 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.37 21.19 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 128.129 2.572 . . . . 1.0 112.584 171.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.6 ' OG ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -79.11 168.37 27.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 127.269 2.227 . . . . 1.0 114.558 -177.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.6 ' HD2' ' OG ' ' A' ' 27' ' ' SER . 53.6 Cg_endo -64.55 -33.02 57.9 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.426 2.751 . . . . 1.0 113.741 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -174.19 72.08 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 128.606 2.762 . . . . 1.0 111.303 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 27' ' ' SER . 1.7 t80 -125.4 129.45 49.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.422 -1.424 . . . . 1.0 114.248 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.72 133.88 53.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.697 1.599 . . . . 1.0 112.149 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 70.6 m -119.06 157.91 26.88 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.591 1.557 . . . . 1.0 111.868 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 6.7 t -137.81 98.16 3.6 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.213 2.205 . . . . 1.0 109.779 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.08 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.784 2.434 . . . . 1.0 110.225 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 47' ' ' ILE . 11.5 tp -72.95 -66.74 0.53 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.65 1.58 . . . . 1.0 112.951 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 96' ' ' PHE . 39.5 Cg_endo -66.01 142.43 68.32 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.757 2.972 . . . . 1.0 113.37 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -126.65 -46.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.822 2.049 . . . . 1.0 113.843 175.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 m-70 -138.78 62.8 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.509 1.524 . . . . 1.0 112.23 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -139.81 157.06 46.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 130.237 3.415 . . . . 1.0 110.628 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 7.9 ttp180 -68.37 104.92 2.0 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.997 1.719 . . . . 1.0 113.372 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.7 t 95.62 113.33 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.586 3.155 . . . . 1.0 116.429 170.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 57.2 t30 -57.1 -71.47 0.1 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.701 2.4 . . . . 1.0 112.814 171.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' H ' ' A' ' 44' ' ' THR . 24.3 ttmt -78.08 165.65 23.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.426 2.29 . . . . 1.0 113.099 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.543 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 91.47 -8.22 0.25 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 130.075 3.35 . . . . 1.0 112.496 -174.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.07 162.56 63.99 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 129.643 3.177 . . . . 1.0 113.831 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.37 29.33 0.3 Allowed 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 125.104 3.87 . . . . 1.0 115.243 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 35' ' ' LEU . 2.4 pp -146.33 172.55 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 129.723 3.209 . . . . 1.0 110.368 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.0 -179.32 5.34 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 128.923 2.889 . . . . 1.0 112.355 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -120.46 143.07 48.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.317 2.247 . . . . 1.0 113.12 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 78.9 mttt -147.27 146.66 29.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.433 1.893 . . . . 1.0 111.212 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 89' ' ' ALA 0.273 1.0 OUTLIER -135.98 135.18 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.445 1.098 . . . . 1.0 109.435 168.972 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.62 118.11 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.546 1.538 . . . . 1.0 108.286 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -97.79 159.94 14.62 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.493 1.117 . . . . 1.0 111.811 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.65 115.65 23.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.868 1.667 . . . . 1.0 111.687 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.2 169.77 40.88 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.583 1.563 . . . . 1.0 112.742 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 -168.74 0.19 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.12 1.768 . . . . 1.0 114.555 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 7.4 p 169.52 73.08 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 131.191 3.796 . . . . 1.0 109.843 172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -93.76 4.87 2.92 Favored 'Trans proline' 0 CA--C 1.556 1.584 1 C-N-CA 125.402 4.068 . . . . 1.0 117.689 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 21.4 m-20 30.09 93.4 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 130.669 3.587 . . . . 1.0 118.661 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.98 5.21 3.55 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.899 1.714 . . . . 1.0 115.721 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 m -55.22 111.88 0.96 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.23 2.212 . . . . 1.0 111.775 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.52 111.42 10.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.705 1.602 . . . . 1.0 111.303 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.729 HG12 HG12 ' A' ' 110' ' ' ILE . 35.0 m -93.06 107.64 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 172.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.81 116.86 30.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 123.418 1.58 . . . . 1.0 110.85 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 40.6 t -101.33 140.99 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 120.685 -1.259 . . . . 1.0 110.519 -172.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -134.91 105.03 6.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.658 0.783 . . . . 1.0 111.436 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.86 109.03 21.44 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.355 -1.466 . . . . 1.0 107.696 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 74' ' ' SER . . . 131.9 91.27 0.52 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.281 2.848 . . . . 1.0 110.424 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -144.75 -87.84 0.11 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.361 2.265 . . . . 1.0 109.468 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.447 ' OD1' ' OG ' ' A' ' 105' ' ' SER . 2.5 m-20 -43.33 -28.64 0.35 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.525 2.73 . . . . 1.0 116.435 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 104' ' ' LYS . 14.1 mm-40 -98.14 -24.69 15.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.963 2.105 . . . . 1.0 115.834 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -162.61 -79.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.399 1.454 . . . . 1.0 113.882 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 t80 136.33 108.3 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.62 1 C-N-CA 132.82 4.448 . . . . 1.0 107.432 -170.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.598 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -124.42 -77.79 0.59 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.381 1.473 . . . . 1.0 111.256 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.76 -2.16 0.1 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.39 1.996 . . . . 1.0 116.39 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.31 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 129.812 3.245 . . . . 1.0 112.612 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -96.61 167.43 11.14 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -171.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.4 ttm180 -132.85 83.78 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 -169.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER 95.25 2.53 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.964 2.906 . . . . 1.0 111.033 -173.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . . . -46.77 -6.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.991 2.589 . . . . 1.0 117.991 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.1 m -115.47 113.68 24.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.563 1.545 . . . . 1.0 111.58 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.7 163.0 34.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 128.93 2.892 . . . . 1.0 109.939 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.97 45.58 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.032 2.133 . . . . 1.0 112.563 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.507 ' C ' ' HD2' ' A' ' 85' ' ' LYS . 17.6 mmt -123.25 158.96 29.75 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.823 1.649 . . . . 1.0 111.195 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HD2' ' C ' ' A' ' 84' ' ' MET . 2.0 mptm? -118.05 -87.01 0.63 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -168.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -75.69 43.83 0.27 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 129.041 2.936 . . . . 1.0 110.705 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 1.4 pm0 48.94 32.55 3.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.776 2.83 . . . . 1.0 114.02 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.06 144.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.625 1.97 . . . . 1.0 113.449 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 51' ' ' VAL . . . -131.52 146.91 52.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.268 2.627 . . . . 1.0 112.241 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 ptt-85 -136.66 163.16 31.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 129.485 3.114 . . . . 1.0 113.886 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 61.11 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 128.303 2.641 . . . . 1.0 113.456 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.27 -66.72 0.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.198 2.199 . . . . 1.0 109.709 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 69.13 -21.25 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.037 3.335 . . . . 1.0 115.987 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.98 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.79 163.24 30.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 127.052 2.141 . . . . 1.0 115.741 178.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.678 ' HD2' ' HA3' ' A' ' 98' ' ' GLY . 5.5 ttm180 -141.11 115.95 9.73 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.297 1.962 . . . . 1.0 116.297 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -86.74 126.64 34.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.557 1.943 . . . . 1.0 111.201 177.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' H ' ' CD2' ' A' ' 77' ' ' LEU 0.289 2.6 m 38.67 41.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 129.247 3.019 . . . . 1.0 112.808 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.678 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -56.95 54.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.093 1 C-N-CA 132.453 4.835 . . . . 1.0 119.238 -171.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 117.88 -5.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 1 C-N-CA 132.735 4.414 . . . . 1.0 113.549 -175.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -141.21 92.48 2.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.604 2.362 . . . . 1.0 111.27 -174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 40' ' ' ARG . . . -168.99 138.42 5.09 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 127.472 2.463 . . . . 1.0 112.04 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -177.17 89.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.899 2.879 . . . . 1.0 107.37 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.06 81.54 0.59 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.759 1.171 . . . . 1.0 112.532 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -153.94 162.01 41.54 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.251 2.22 . . . . 1.0 112.341 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 70' ' ' ASP . 23.3 t -104.84 154.82 19.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.892 2.077 . . . . 1.0 113.178 172.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.4 t80 -95.03 103.1 14.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.424 2.29 . . . . 1.0 111.184 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -108.07 82.95 1.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.331 1.063 . . . . 1.0 112.525 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.27 111.25 8.22 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.555 1.542 . . . . 1.0 111.202 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 m -109.02 104.66 13.91 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.384 0.883 . . . . 1.0 113.384 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 63' ' ' VAL . 8.8 mt -93.45 113.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.128 -1.607 . . . . 1.0 108.199 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.7 p -111.61 121.2 44.5 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.569 1.948 . . . . 1.0 111.951 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.3 OUTLIER -71.57 172.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 123.0 1.381 . . . . 1.0 112.391 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -131.12 40.07 3.5 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.719 2.408 . . . . 1.0 113.598 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.616 ' H ' HG13 ' A' ' 112' ' ' VAL . 9.8 t -129.58 165.39 21.82 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.803 2.041 . . . . 1.0 111.023 172.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.57 -48.58 68.02 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 126.126 1.77 . . . . 1.0 112.684 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.34 111.54 3.28 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.876 3.05 . . . . 1.0 110.505 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.23 106.8 1.06 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.591 3.527 . . . . 1.0 112.707 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.732 ' H ' HG12 ' A' ' 112' ' ' VAL . 7.9 tp-100 -105.32 92.85 4.38 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.812 0.815 . . . . 1.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.74 120.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.495 1.518 . . . . 1.0 111.453 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.53 146.18 44.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.79 2.036 . . . . 1.0 110.966 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.9 m -122.3 141.12 51.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.8 1.64 . . . . 1.0 110.102 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -92.25 143.88 25.96 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.067 0.947 . . . . 1.0 113.183 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -149.39 171.86 15.87 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.499 2.72 . . . . 1.0 111.15 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 15.2 ttt180 74.46 176.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 127.41 2.284 . . . . 1.0 112.557 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 124' ' ' ARG . . . -149.96 164.96 34.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.607 1.706 . . . . 1.0 115.607 175.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.66 -39.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.537 1.935 . . . . 1.0 113.716 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.56 110.32 8.69 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.395 1.478 . . . . 1.0 113.28 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 38' ' ' HIS . 1.2 pp -121.34 124.77 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.734 1.214 . . . . 1.0 110.586 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' A' ' 39' ' ' TRP . 86.5 m -125.87 120.51 30.67 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 170.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.56 -24.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 115.198 1.555 . . . . 1.0 115.198 -170.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.97 -69.02 0.78 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.757 2.423 . . . . 1.0 113.391 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.163 0 C-N-CA 127.148 2.309 . . . . 1.0 114.994 -175.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -173.63 3.82 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 129.764 3.226 . . . . 1.0 104.753 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.17 74.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 O-C-N 119.664 -1.897 . . . . 1.0 108.533 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 73.9 mtt180 -41.72 113.48 0.42 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 130.452 3.501 . . . . 1.0 111.9 171.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.827 ' H ' ' HB2' ' A' ' 30' ' ' PHE . 3.4 t -149.32 92.54 1.96 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.949 0.9 . . . . 1.0 112.791 -170.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 121' ' ' THR . 31.8 t0 118.01 -58.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 1 C-N-CA 133.033 4.533 . . . . 1.0 112.849 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 30' ' ' PHE . 50.9 m 133.47 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.951 1 C-N-CA 132.306 4.242 . . . . 1.0 113.455 -172.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 30.8 Cg_endo -62.43 90.99 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 125.118 3.878 . . . . 1.0 111.969 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 54' ' ' LEU . 3.8 t-20 36.14 58.3 0.98 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.331 2.253 . . . . 1.0 110.686 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.827 ' HB2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -79.77 103.41 9.66 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.461 1.904 . . . . 1.0 111.689 -170.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -139.71 108.9 6.08 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.8 t -114.95 149.71 36.88 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.971 1.308 . . . . 1.0 111.818 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . 3.0 m -126.58 93.61 3.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.125 3.77 . . . . 1.0 108.058 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.649 HG22 ' HD2' ' A' ' 36' ' ' PRO . 5.4 p -149.68 155.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.503 2.321 . . . . 1.0 110.531 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.4 -58.32 0.5 Allowed Pre-proline 0 CA--C 1.552 1.038 0 CA-C-O 117.217 -1.373 . . . . 1.0 114.198 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.798 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 9.6 Cg_endo -50.78 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 1 C-N-CA 125.602 4.201 . . . . 1.0 112.99 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -102.57 -76.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.893 1.677 . . . . 1.0 109.938 -171.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -125.73 44.16 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.964 2.506 . . . . 1.0 113.143 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.817 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 5.5 p90 -161.93 169.19 21.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.244 2.218 . . . . 1.0 114.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -66.52 106.69 1.84 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.745 2.418 . . . . 1.0 114.622 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 42.7 t -81.02 -70.56 0.52 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.511 1.05 . . . . 1.0 111.334 173.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.2 t30 45.31 51.7 9.24 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.315 1.446 . . . . 1.0 113.584 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.37 -7.13 1.22 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.871 2.868 . . . . 1.0 116.492 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -65.19 142.27 58.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.8 1.182 . . . . 1.0 109.89 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 56.39 62.26 6.65 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 126.002 1.721 . . . . 1.0 110.881 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.0 41.83 0.58 Allowed 'Trans proline' 0 CA--C 1.554 1.497 1 C-N-CA 125.762 4.308 . . . . 1.0 114.315 -176.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.07 -1.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 129.892 3.277 . . . . 1.0 114.84 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.13 173.79 0.3 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 129.28 3.032 . . . . 1.0 113.164 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -140.1 166.67 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 5.2 tttp -142.91 135.99 28.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.577 2.351 . . . . 1.0 110.843 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 123.36 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.757 2.423 . . . . 1.0 107.368 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -138.19 131.85 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.059 2.144 . . . . 1.0 109.988 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.45 157.1 36.01 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.325 1.45 . . . . 1.0 111.179 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -128.44 113.05 15.05 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.741 1.386 . . . . 1.0 114.741 174.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.4 3.82 5.55 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 117.965 1.946 . . . . 1.0 117.965 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.85 177.44 4.84 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 128.384 2.673 . . . . 1.0 116.933 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 58' ' ' PRO . 69.2 t -68.36 157.67 87.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 131.688 3.995 . . . . 1.0 113.495 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD2' HG13 ' A' ' 57' ' ' VAL . 61.1 Cg_endo -70.71 -150.76 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 125.121 3.881 . . . . 1.0 113.275 171.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 58' ' ' PRO . 9.6 p-10 -50.99 101.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.641 2.376 . . . . 1.0 112.317 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.43 -8.67 0.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.025 -1.43 . . . . 1.0 116.447 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 104.47 4.32 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.759 1.779 . . . . 1.0 108.894 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.56 112.46 16.84 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -89.64 107.32 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 101.93 -3.359 . . . . 1.0 101.93 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -130.9 117.55 19.42 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.812 1.32 . . . . 1.0 112.583 -170.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.882 HG22 ' HB1' ' A' ' 80' ' ' ALA . 35.8 m -106.35 111.54 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.531 1.133 . . . . 1.0 110.534 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.649 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 8.1 mtm -146.98 102.24 3.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.872 2.069 . . . . 1.0 111.431 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -99.2 107.74 20.15 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.713 1.142 . . . . 1.0 112.125 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.84 147.75 18.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.165 0.888 . . . . 1.0 115.059 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -155.13 -52.61 0.09 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.87 1.268 . . . . 1.0 112.579 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -149.19 -48.25 0.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.281 2.232 . . . . 1.0 114.891 -170.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -147.29 -10.24 0.43 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 130.397 3.479 . . . . 1.0 114.216 -168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -48.43 -15.57 0.08 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.912 2.885 . . . . 1.0 115.473 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.85 2.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.821 3.648 . . . . 1.0 117.616 171.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.55 ' HB2' HG13 ' A' ' 97' ' ' VAL . 2.8 t -92.33 -99.46 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.732 1.613 . . . . 1.0 113.548 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB2' ' H ' ' A' ' 105' ' ' SER . . . 57.07 -65.51 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 126.871 2.068 . . . . 1.0 112.496 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.51 137.65 53.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.379 2.272 . . . . 1.0 114.329 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.77 165.51 24.39 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 128.317 2.647 . . . . 1.0 111.599 -176.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -118.11 82.25 1.81 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.347 -0.846 . . . . 1.0 111.321 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.688 HD22 HH21 ' A' ' 95' ' ' ARG . 7.6 m-80 78.92 0.59 2.43 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.438 2.295 . . . . 1.0 112.508 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -57.25 -11.14 1.56 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.554 2.741 . . . . 1.0 117.214 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 m -105.01 112.66 25.88 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.223 1.577 . . . . 1.0 110.93 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 160.75 39.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.998 2.119 . . . . 1.0 111.35 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 127.19 42.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.779 2.432 . . . . 1.0 112.916 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -144.5 -164.7 1.97 Allowed 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 127.988 2.515 . . . . 1.0 112.846 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -112.87 -101.47 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.629 2.372 . . . . 1.0 111.502 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -79.57 45.35 0.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.628 2.371 . . . . 1.0 111.966 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 110' ' ' ILE . 0.4 OUTLIER 51.24 32.7 8.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.167 2.187 . . . . 1.0 111.609 -171.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -90.39 109.92 21.4 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-O 122.894 1.33 . . . . 1.0 107.526 -171.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.51 116.36 11.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.22 2.208 . . . . 1.0 109.178 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 31.3 mtm180 -135.77 128.7 31.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.347 1.859 . . . . 1.0 109.969 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 11.0 t80 130.87 -151.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 130.696 3.598 . . . . 1.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 24.6 t-20 -122.43 164.21 18.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.604 1.962 . . . . 1.0 110.599 171.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.44 94.1 m-20 108.02 44.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.481 3.512 . . . . 1.0 116.341 -175.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -139.95 132.19 28.21 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.299 2.639 . . . . 1.0 108.604 170.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.853 ' H ' ' HB2' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -138.86 120.63 15.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.026 1.739 . . . . 1.0 113.583 -171.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.45 115.99 30.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.714 1.206 . . . . 1.0 110.232 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 74' ' ' SER . 11.0 t 71.13 73.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.756 1.222 . . . . 1.0 107.995 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.63 90.24 0.65 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 128.506 2.955 . . . . 1.0 113.361 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.21 53.98 3.46 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 128.042 2.537 . . . . 1.0 115.01 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.5 t -70.93 -168.5 0.28 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.817 2.047 . . . . 1.0 115.798 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.88 -37.94 0.07 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.911 2.672 . . . . 1.0 115.044 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 159.85 42.72 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.905 2.082 . . . . 1.0 113.739 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.48 57.45 2.93 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.595 1.569 . . . . 1.0 115.188 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 104' ' ' LYS . 7.6 mtmt -68.79 104.7 2.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.223 1.809 . . . . 1.0 109.71 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' ALA . 16.9 t -119.62 132.65 55.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.301 3.04 . . . . 1.0 110.878 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -84.75 87.12 7.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.185 0.994 . . . . 1.0 110.895 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 66' ' ' MET . 3.8 m -143.36 51.17 1.37 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.95 0.881 . . . . 1.0 111.319 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -102.35 90.41 3.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.894 2.077 . . . . 1.0 111.037 -174.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.656 HG21 ' C ' ' A' ' 120' ' ' ALA . 10.2 t 152.38 -116.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 128.754 2.822 . . . . 1.0 115.545 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.691 HG12 ' HG2' ' A' ' 87' ' ' GLN . 3.8 mp -133.78 151.69 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 128.25 2.62 . . . . 1.0 111.786 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.9 m -140.18 104.24 4.77 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.586 1.554 . . . . 1.0 113.562 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 54.3 t -74.05 122.16 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.562 -1.336 . . . . 1.0 107.814 170.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.15 -8.17 56.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.587 3.555 . . . . 1.0 116.971 -175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 2.2 m -82.16 166.11 19.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.762 2.025 . . . . 1.0 112.529 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -45.02 -31.78 0.94 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.601 1.96 . . . . 1.0 114.023 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 114' ' ' THR . 98.1 Cg_endo -95.26 81.8 0.11 Allowed 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 125.41 4.073 . . . . 1.0 106.197 167.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.61 114.08 3.56 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.201 3.267 . . . . 1.0 111.834 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -99.99 92.48 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 -177.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.86 115.33 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.656 ' C ' HG21 ' A' ' 109' ' ' THR . . . -99.59 171.23 8.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.592 1.957 . . . . 1.0 112.995 -168.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 63.3 p -124.9 120.05 30.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.742 2.017 . . . . 1.0 113.46 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.06 125.82 33.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.13 1.786 . . . . 1.0 110.523 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -106.82 68.66 0.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.071 1.748 . . . . 1.0 112.181 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.41 -179.7 0.09 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.807 2.843 . . . . 1.0 112.764 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.27 -58.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.689 2.796 . . . . 1.0 116.334 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mt 67.31 -62.12 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 129.085 2.954 . . . . 1.0 112.766 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -124.24 130.84 53.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.672 1.989 . . . . 1.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.25 129.96 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 128.046 2.539 . . . . 1.0 110.382 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -85.32 121.96 28.8 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.053 1.341 . . . . 1.0 109.296 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.74 -28.44 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.063 0.945 . . . . 1.0 112.112 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.52 -29.19 56.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.543 2.337 . . . . 1.0 115.048 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.817 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . . . . . . 0 CA--C 1.553 2.465 0 C-N-CA 125.822 1.677 . . . . 1.0 114.56 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -163.75 -172.52 2.9 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 129.086 2.955 . . . . 1.0 105.689 -174.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.08 73.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 O-C-N 119.808 -1.807 . . . . 1.0 107.172 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -61.02 148.2 40.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.61 2.764 . . . . 1.0 113.96 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 30' ' ' PHE . 82.5 p -76.47 -167.28 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.509 2.724 . . . . 1.0 110.162 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 121' ' ' THR . 4.2 t0 -66.24 12.91 0.06 Allowed 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.561 -1.337 . . . . 1.0 112.959 169.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 p -150.72 152.45 32.24 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.109 2.563 . . . . 1.0 114.653 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 -15.54 26.05 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 C-N-CA 123.466 2.778 . . . . 1.0 111.493 168.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -21.48 63.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.918 2.887 . . . . 1.0 115.568 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.413 ' HB2' ' OG1' ' A' ' 25' ' ' THR . 26.9 m-85 -138.16 114.51 10.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.993 1.317 . . . . 1.0 110.569 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 22' ' ' LEU . 3.5 pp -149.91 140.26 22.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.198 1.399 . . . . 1.0 114.422 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 51' ' ' VAL 0.587 0.1 OUTLIER -164.82 173.05 12.17 Favored 'General case' 0 CA--C 1.542 0.644 1 N-CA-C 122.936 4.421 . . . . 1.0 122.936 -173.461 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -97.68 98.25 9.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.714 0.806 . . . . 1.0 110.946 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.61 130.03 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 126.606 1.962 . . . . 1.0 111.812 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.52 126.96 91.75 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.152 1.381 . . . . 1.0 112.413 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.702 ' HB2' ' CD2' ' A' ' 38' ' ' HIS . 72.4 Cg_endo -71.55 148.81 54.49 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 124.016 3.144 . . . . 1.0 113.556 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' HIS . 5.0 t -83.02 -67.02 0.82 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.827 1.651 . . . . 1.0 114.176 -176.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.702 ' CD2' ' HB2' ' A' ' 36' ' ' PRO . 86.6 m-70 37.26 40.44 0.19 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.291 3.436 . . . . 1.0 116.792 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.453 ' HE1' ' HA ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -161.49 173.72 14.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.156 1.782 . . . . 1.0 113.717 179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -82.18 103.64 11.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.077 2.151 . . . . 1.0 110.654 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 98' ' ' GLY . 13.7 p 51.05 101.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.475 2.71 . . . . 1.0 115.3 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' HB2' ' A' ' 96' ' ' PHE . 2.0 m120 -47.17 -72.59 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.005 2.122 . . . . 1.0 115.687 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 22.16 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 1 C-N-CA 132.736 4.414 . . . . 1.0 118.417 175.306 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m 68.04 77.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 129.612 3.165 . . . . 1.0 111.922 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.638 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 2.3 pt? -161.75 171.54 6.65 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 127.038 2.135 . . . . 1.0 113.412 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 45' ' ' LEU . 43.0 Cg_endo -70.47 140.52 40.2 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.87 3.046 . . . . 1.0 111.681 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 12.9 mm -134.64 -69.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.486 1.514 . . . . 1.0 113.918 -172.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 31.23 90.03 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 130.436 3.495 . . . . 1.0 116.453 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.77 171.04 10.44 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.64 2.089 . . . . 1.0 116.64 -172.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 7.7 mmtp -140.04 146.07 38.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 129.762 3.225 . . . . 1.0 109.948 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 2.5 t -130.79 118.86 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 129.236 3.014 . . . . 1.0 110.616 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.466 ' H ' ' HB2' ' A' ' 32' ' ' CYS 0.278 14.2 m -128.02 145.92 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 120.582 1.537 . . . . 1.0 113.977 173.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -112.12 145.07 40.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.131 1.373 . . . . 1.0 112.495 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 tp -77.12 151.86 35.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.606 1.562 . . . . 1.0 111.701 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.1 -141.62 15.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.954 1.264 . . . . 1.0 113.964 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.34 -169.11 3.18 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 129.101 2.96 . . . . 1.0 111.208 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.774 HG22 ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 78.54 157.81 0.14 Allowed Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 128.864 2.866 . . . . 1.0 115.398 171.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' HG22 ' A' ' 57' ' ' VAL . 61.0 Cg_endo -73.58 175.04 11.23 Favored 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 125.015 3.81 . . . . 1.0 114.545 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 41.28 69.14 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.877 2.071 . . . . 1.0 111.293 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -79.65 -18.63 72.74 Favored Glycine 0 C--N 1.346 1.096 0 C-N-CA 127.081 2.277 . . . . 1.0 117.518 -168.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 60' ' ' GLY . 7.4 t 154.22 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 129.624 3.169 . . . . 1.0 112.715 172.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.98 113.66 14.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.948 2.899 . . . . 1.0 109.1 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.53 118.24 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.291 -1.506 . . . . 1.0 107.961 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -112.21 151.6 29.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.922 2.089 . . . . 1.0 110.199 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.42 127.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.008 1.723 . . . . 1.0 109.363 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 mtt -128.52 107.5 9.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.604 0.762 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.47 108.81 21.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.166 0.984 . . . . 1.0 111.049 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.21 -154.02 6.75 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 128.638 3.018 . . . . 1.0 114.515 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 107.33 -72.42 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 1 C-N-CA 132.276 4.23 . . . . 1.0 109.434 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -47.06 -48.46 22.37 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.919 2.488 . . . . 1.0 113.631 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.48 8.24 44.7 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.04 1.736 . . . . 1.0 113.933 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 94.66 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 131.466 3.906 . . . . 1.0 111.212 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -157.92 65.95 0.47 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.329 1.974 . . . . 1.0 116.329 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -57.73 -56.23 24.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.62 1.568 . . . . 1.0 113.259 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.03 8.34 6.79 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 120.971 3.693 . . . . 1.0 120.971 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 26.1 mp0 -60.11 133.56 56.21 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 121.645 2.02 . . . . 1.0 116.197 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -138.63 166.2 24.96 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.164 2.586 . . . . 1.0 112.556 170.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.669 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -127.86 86.22 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.089 1.755 . . . . 1.0 110.479 169.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.322 46.3 t30 69.24 13.27 8.57 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.635 1.574 . . . . 1.0 114.149 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -65.24 1.25 1.09 Allowed 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.077 1.351 . . . . 1.0 114.388 169.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.2 p -98.12 111.01 23.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.408 -1.33 . . . . 1.0 107.408 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.7 125.74 21.27 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.792 1.637 . . . . 1.0 112.127 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.78 154.33 17.82 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.039 2.536 . . . . 1.0 114.21 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -133.41 144.17 49.37 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.271 2.229 . . . . 1.0 107.153 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -84.24 0.53 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.585 1.554 . . . . 1.0 107.925 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 55.9 m-20 -82.69 57.01 3.58 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.739 1.216 . . . . 1.0 108.585 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 5.4 pt20 56.94 19.98 4.98 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 130.904 3.681 . . . . 1.0 117.931 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.55 135.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 114.804 1.409 . . . . 1.0 114.804 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.98 26.92 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.479 2.311 . . . . 1.0 110.664 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 11.0 mtt-85 -136.17 142.33 44.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.185 2.194 . . . . 1.0 110.905 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 90' ' ' ARG 0.277 1.4 t80 147.44 -111.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 129.946 3.298 . . . . 1.0 112.973 172.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 p30 177.3 41.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 127.814 2.446 . . . . 1.0 115.261 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.21 -33.66 49.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 130.018 3.327 . . . . 1.0 115.042 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 94' ' ' LEU . 2.3 pt? -66.39 139.36 58.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.174 2.589 . . . . 1.0 117.893 -172.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 3.2 mtt85 -140.63 116.58 10.42 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.628 1.558 . . . . 1.0 112.394 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 35.5 m-85 -83.07 145.93 29.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.033 1.733 . . . . 1.0 113.561 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 100' ' ' SER . 2.4 t 60.45 6.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 127.371 2.268 . . . . 1.0 114.424 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' HB2' ' A' ' 41' ' ' CYS . . . -9.74 -24.71 0.0 OUTLIER Glycine 0 CA--C 1.547 2.035 2 C-N-CA 136.446 6.736 . . . . 1.0 123.646 -173.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.569 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 15.1 ttt180 -165.93 6.13 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.392 3.077 . . . . 1.0 114.785 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 97' ' ' VAL . 49.1 m -58.25 -59.94 4.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.958 2.503 . . . . 1.0 114.946 -172.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.86 -174.22 20.27 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 125.441 1.496 . . . . 1.0 114.4 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 109.67 21.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.825 2.45 . . . . 1.0 111.735 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.97 -11.63 3.36 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 126.733 2.111 . . . . 1.0 116.303 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.856 2.462 . . . . 1.0 112.894 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.642 ' HB2' HG13 ' A' ' 126' ' ' ILE . 25.1 p -108.61 130.01 55.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.443 2.297 . . . . 1.0 110.483 172.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -85.22 83.87 7.86 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.048 0.928 . . . . 1.0 112.655 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 m -70.45 92.61 0.83 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.715 1.606 . . . . 1.0 110.162 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -71.42 101.55 2.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.196 1.398 . . . . 1.0 110.03 172.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.7 p -86.44 100.15 12.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.606 1.962 . . . . 1.0 109.669 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 25' ' ' THR . 4.1 mp -88.28 110.2 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 100.909 -3.737 . . . . 1.0 100.909 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.0 m -112.61 109.61 19.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.889 1.675 . . . . 1.0 114.087 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 114' ' ' THR . 7.0 t -73.74 143.76 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 123.681 1.705 . . . . 1.0 109.834 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -110.99 10.39 22.17 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 131.573 3.949 . . . . 1.0 113.931 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.782 HG23 ' HD2' ' A' ' 116' ' ' PRO . 10.1 t -105.53 -179.45 3.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.731 1.613 . . . . 1.0 113.162 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -45.77 -53.11 21.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 126.915 2.086 . . . . 1.0 112.298 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.782 ' HD2' HG23 ' A' ' 114' ' ' THR . 47.1 Cg_endo -76.21 102.04 1.56 Allowed 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 124.705 3.603 . . . . 1.0 109.884 170.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.39 99.66 1.05 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.254 3.303 . . . . 1.0 109.411 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.503 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 16.6 mt-30 -108.19 97.23 6.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.873 0.844 . . . . 1.0 110.842 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.74 114.95 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.011 1.724 . . . . 1.0 108.398 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.11 159.54 20.74 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.722 2.409 . . . . 1.0 110.977 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.4 m -121.61 121.33 37.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.068 0.947 . . . . 1.0 111.308 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 64.1 t80 -87.95 120.18 29.03 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.344 0.975 . . . . 1.0 110.912 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -130.6 122.12 26.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.99 2.516 . . . . 1.0 111.422 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.7 -52.1 0.11 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.613 1.565 . . . . 1.0 113.173 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.31 70.85 0.75 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.246 2.218 . . . . 1.0 109.401 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' ' 105' ' ' SER . 8.6 tp -47.14 -14.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 129.676 3.19 . . . . 1.0 118.296 -171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -87.13 152.29 22.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 130.807 3.643 . . . . 1.0 115.765 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.58 162.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 128.025 2.53 . . . . 1.0 114.111 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.7 t -75.05 133.07 41.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.11 0.964 . . . . 1.0 112.74 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.74 -58.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.508 1.923 . . . . 1.0 113.196 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -53.77 -37.94 63.96 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.307 1.843 . . . . 1.0 114.452 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 127.533 2.492 . . . . 1.0 114.572 -179.32 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -152.52 -173.68 4.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 131.336 3.854 . . . . 1.0 105.063 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 32' ' ' CYS 0.356 9.9 m -69.01 72.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 121.54 1.973 . . . . 1.0 109.926 170.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -51.13 158.58 0.73 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 127.355 2.262 . . . . 1.0 113.54 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 30' ' ' PHE 0.296 9.0 t -101.94 -120.77 0.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 118.365 -0.826 . . . . 1.0 110.745 177.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -55.88 -37.83 69.35 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 120.354 1.434 . . . . 1.0 113.169 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 m -136.86 156.83 75.74 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 127.648 2.379 . . . . 1.0 112.663 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -2.4 6.71 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.228 3.285 . . . . 1.0 115.041 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.79 -27.49 60.34 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 129.03 2.932 . . . . 1.0 114.024 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.631 ' HB2' HG22 ' A' ' 25' ' ' THR . 2.5 m-85 -118.6 108.35 14.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.677 1.591 . . . . 1.0 107.706 173.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.3 mt -115.12 135.02 54.64 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.894 2.878 . . . . 1.0 112.729 -169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.719 ' HB2' HG23 ' A' ' 23' ' ' VAL . 4.5 m -118.88 160.09 22.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.899 1.28 . . . . 1.0 112.505 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -138.93 100.02 3.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.413 2.285 . . . . 1.0 108.655 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 m -137.23 162.08 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 129.111 2.964 . . . . 1.0 109.362 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -103.57 155.06 37.39 Favored Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 124.394 1.078 . . . . 1.0 110.607 170.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HD2' HD23 ' A' ' 35' ' ' LEU . 17.1 Cg_exo -51.69 149.85 18.15 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.915 3.077 . . . . 1.0 115.559 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 96' ' ' PHE . 12.9 t -127.85 29.29 5.46 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 127.12 2.168 . . . . 1.0 114.23 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -64.2 37.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 127.495 2.318 . . . . 1.0 116.195 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.7 p90 -162.28 162.65 28.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 129.184 2.994 . . . . 1.0 111.746 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' ' 101' ' ' GLY . 0.7 OUTLIER -79.22 150.84 31.5 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.536 1.935 . . . . 1.0 113.987 -177.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.7 t 49.13 71.76 0.35 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.645 1.978 . . . . 1.0 112.53 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -50.69 -39.46 51.31 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.226 1.565 . . . . 1.0 115.226 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttpt 62.75 171.78 0.14 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.575 2.75 . . . . 1.0 114.541 -172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -74.82 79.17 2.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.047 1.339 . . . . 1.0 110.741 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 47' ' ' ILE . 22.6 mt -69.37 146.25 96.35 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 125.616 1.566 . . . . 1.0 111.821 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.67 -3.73 8.49 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 124.098 3.199 . . . . 1.0 116.074 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 45' ' ' LEU . 35.9 pt -59.44 -30.67 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.05 2.94 . . . . 1.0 115.698 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.55 173.5 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 127.331 2.252 . . . . 1.0 114.752 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 94' ' ' LEU . 16.6 m-85 -144.99 151.58 38.81 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -174.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 51' ' ' VAL . 10.4 tttp -143.92 148.45 35.41 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.544 1.937 . . . . 1.0 112.525 172.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' A' ' 50' ' ' LYS . 14.0 m -136.97 143.2 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.15 2.18 . . . . 1.0 111.013 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.89 119.5 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 128.077 2.551 . . . . 1.0 108.782 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.65 107.2 9.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.495 1.118 . . . . 1.0 110.744 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mt -90.56 118.07 29.73 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.969 1.707 . . . . 1.0 112.531 -172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.18 -167.69 30.13 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 127.555 2.502 . . . . 1.0 114.07 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.77 -4.42 25.0 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 115.451 1.648 . . . . 1.0 115.451 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -55.06 142.8 55.97 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.445 1.498 . . . . 1.0 112.081 173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.91 -38.89 27.27 Favored 'Trans proline' 0 C--N 1.363 1.313 0 C-N-CA 124.501 3.467 . . . . 1.0 112.951 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.88 -167.62 1.95 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 126.838 2.055 . . . . 1.0 110.542 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.04 -55.73 0.86 Allowed Glycine 0 C--N 1.344 0.984 0 O-C-N 120.032 -1.668 . . . . 1.0 113.091 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t 152.28 -177.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 129.264 3.025 . . . . 1.0 111.533 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.49 116.14 21.33 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.534 2.334 . . . . 1.0 110.542 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.2 p -92.31 123.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 120.451 -1.406 . . . . 1.0 109.3 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -123.0 123.55 41.14 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.118 1.367 . . . . 1.0 113.307 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 80' ' ' ALA . 2.6 m -96.26 116.1 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.549 -1.344 . . . . 1.0 108.261 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 93.2 mtp -122.82 113.32 19.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.402 0.89 . . . . 1.0 113.402 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.59 115.12 26.9 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 120.806 1.639 . . . . 1.0 114.071 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -128.43 -149.48 6.99 Favored Glycine 0 CA--C 1.544 1.85 0 C-N-CA 129.386 3.374 . . . . 1.0 112.451 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' GLU . 67.0 t30 -156.78 40.5 0.33 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.021 1.728 . . . . 1.0 112.145 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 62.85 -26.6 0.06 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 128.778 2.831 . . . . 1.0 114.453 -170.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -140.02 84.52 1.97 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 132.142 4.177 . . . . 1.0 106.702 169.668 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.86 -45.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.876 1.67 . . . . 1.0 113.725 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 43.57 23.72 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 129.543 3.137 . . . . 1.0 117.25 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 t -49.28 -30.4 7.27 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.34 2.656 . . . . 1.0 115.0 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 64.06 -75.24 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.412 2.285 . . . . 1.0 114.915 171.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 33.81 99.17 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 131.474 3.909 . . . . 1.0 116.419 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -131.93 165.46 23.85 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.868 1.267 . . . . 1.0 113.377 174.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.66 84.24 2.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.104 2.162 . . . . 1.0 109.797 176.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.25 8.62 6.91 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.434 1.493 . . . . 1.0 114.376 -173.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -70.22 13.95 0.14 Allowed 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 120.958 1.708 . . . . 1.0 113.645 168.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.7 m -100.33 110.52 22.75 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.53 125.02 13.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.979 0.912 . . . . 1.0 113.402 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.09 155.89 17.75 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.21 1.404 . . . . 1.0 113.155 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 63.1 mtp -127.17 148.33 50.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 128.907 2.883 . . . . 1.0 107.889 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -126.53 -73.13 0.63 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.869 1.268 . . . . 1.0 114.287 -170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -72.93 33.5 0.07 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.419 1.488 . . . . 1.0 111.448 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 62.0 14.24 6.28 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.114 2.966 . . . . 1.0 114.544 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.63 152.61 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 129.556 3.142 . . . . 1.0 112.339 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 91' ' ' PHE . . . -137.91 146.93 43.89 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.248 1.819 . . . . 1.0 113.895 170.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -132.66 123.7 26.85 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 128.199 2.599 . . . . 1.0 111.312 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -172.15 173.39 4.31 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.813 1.783 . . . . 1.0 115.813 -174.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -141.44 1.36 1.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 126.528 1.931 . . . . 1.0 114.926 172.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.46 -28.35 59.25 Favored 'General case' 0 CA--C 1.545 0.786 1 C-N-CA 131.824 4.05 . . . . 1.0 115.161 -172.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . 6.8 mp -55.53 129.49 39.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.407 2.283 . . . . 1.0 112.176 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 36.4 mtm180 -137.47 123.14 19.85 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.555 1.07 . . . . 1.0 111.741 -178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.408 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 2.3 m-85 -93.28 143.52 26.19 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.481 2.712 . . . . 1.0 110.611 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . 0.285 0.7 OUTLIER 44.61 46.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 125.677 1.591 . . . . 1.0 112.516 -175.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -35.37 -92.27 0.01 OUTLIER Glycine 0 C--N 1.346 1.129 1 C-N-CA 132.956 5.074 . . . . 1.0 116.945 -171.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttp-105 -73.11 42.41 0.11 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.913 2.085 . . . . 1.0 113.94 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.8 t 73.04 157.21 0.18 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 131.596 3.958 . . . . 1.0 115.638 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' H ' ' HB2' ' A' ' 40' ' ' ARG . . . -149.95 169.14 30.06 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 127.982 2.706 . . . . 1.0 112.632 173.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 ptm85 -160.53 142.9 12.89 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.446 1.898 . . . . 1.0 112.465 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.506 ' C ' ' HE2' ' A' ' 127' ' ' LYS . . . 57.72 30.72 63.02 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.298 1.428 . . . . 1.0 116.547 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -126.61 156.87 40.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.146 2.579 . . . . 1.0 112.559 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.2 m -109.45 147.44 32.85 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.865 2.466 . . . . 1.0 110.931 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.782 ' CE1' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -86.25 89.27 7.8 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 126.229 1.811 . . . . 1.0 111.778 -173.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.4 m -77.39 74.68 3.95 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.642 1.577 . . . . 1.0 110.119 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.782 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 9.0 tt -61.54 119.52 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.229 -0.919 . . . . 1.0 108.968 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 t -127.82 139.97 52.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 123.445 1.593 . . . . 1.0 114.814 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.37 113.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 t -102.6 114.89 29.49 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.792 1.237 . . . . 1.0 111.894 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 1.2 t -72.26 151.77 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 123.235 1.493 . . . . 1.0 112.446 -174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -102.0 25.35 8.83 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 129.024 2.93 . . . . 1.0 116.671 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.608 HG23 ' HD2' ' A' ' 116' ' ' PRO . 13.6 t -132.31 176.34 8.49 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.687 1.195 . . . . 1.0 113.828 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 70.2 m-80 -43.0 -47.33 13.98 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 128.213 2.605 . . . . 1.0 113.062 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD2' HG23 ' A' ' 114' ' ' THR . 95.7 Cg_endo -87.96 95.99 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 124.983 3.789 . . . . 1.0 108.272 168.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.85 109.11 1.21 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.656 2.904 . . . . 1.0 110.919 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.407 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -97.65 103.45 15.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.316 1.531 . . . . 1.0 108.772 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.8 m -101.68 114.94 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.882 2.073 . . . . 1.0 108.976 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.73 142.95 50.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.455 2.302 . . . . 1.0 110.77 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 t -121.95 146.5 47.08 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.552 1.541 . . . . 1.0 113.246 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -87.51 128.79 35.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.947 1.356 . . . . 1.0 112.865 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -63.16 103.44 0.48 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.755 2.422 . . . . 1.0 111.591 172.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 96.78 125.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 1 C-N-CA 132.212 4.205 . . . . 1.0 109.285 -175.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.92 -21.1 10.27 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.325 1.602 . . . . 1.0 115.325 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 38.53 122.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 131.144 3.778 . . . . 1.0 115.866 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 103' ' ' GLY . 21.5 tttt -75.55 137.74 41.04 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.979 -1.7 . . . . 1.0 110.689 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pp -91.59 141.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.838 1.655 . . . . 1.0 113.468 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.2 t -88.67 142.89 27.31 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.533 0.938 . . . . 1.0 113.533 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.64 -53.52 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.521 1.529 . . . . 1.0 110.445 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.37 -70.5 0.74 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.921 2.889 . . . . 1.0 111.378 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.74 177.85 15.52 Favored Glycine 0 CA--C 1.549 2.176 0 C-N-CA 126.147 1.832 . . . . 1.0 115.829 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . 58.4 Cg_endo -71.51 -40.8 2.72 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.211 3.274 . . . . 1.0 113.353 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -174.94 145.26 0.82 Allowed 'General case' 0 N--CA 1.473 0.686 1 C-N-CA 131.884 4.074 . . . . 1.0 109.466 172.856 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 128.707 2.803 . . . . 1.0 111.157 173.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 114.322 1.231 . . . . 1.0 114.322 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 0.4 OUTLIER -148.94 -173.23 4.31 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 131.138 3.775 . . . . 1.0 105.074 -173.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.89 73.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 O-C-N 120.119 -1.613 . . . . 1.0 107.652 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.603 ' HB2' ' CG ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -60.63 169.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.034 0.933 . . . . 1.0 111.978 169.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.8 p -133.06 -105.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.29 1.036 . . . . 1.0 109.972 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 121' ' ' THR . 1.1 m-20 -143.09 64.83 1.35 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.812 2.845 . . . . 1.0 108.425 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.1 m -157.05 161.61 29.16 Favored Pre-proline 0 N--CA 1.477 0.916 0 O-C-N 119.884 -1.76 . . . . 1.0 115.158 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.26 146.74 95.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.259 1.973 . . . . 1.0 109.677 169.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 52.96 32.99 13.66 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 124.867 1.267 . . . . 1.0 113.881 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.603 ' CG ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.61 110.36 16.01 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.895 1.443 . . . . 1.0 114.895 -173.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 1.7 pp -140.08 115.48 9.95 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.562 1.545 . . . . 1.0 113.304 175.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.788 ' HB2' ' HA ' ' A' ' 51' ' ' VAL 0.253 0.0 OUTLIER -127.15 165.39 19.65 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 123.533 1.635 . . . . 1.0 114.826 175.512 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.626 ' HB2' ' HG2' ' A' ' 50' ' ' LYS . 66.6 m -151.47 93.2 1.86 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.104 2.962 . . . . 1.0 108.933 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.0 p -136.29 150.06 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 131.152 3.781 . . . . 1.0 107.797 172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -65.22 174.35 1.43 Allowed Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 123.803 0.841 . . . . 1.0 113.141 175.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 18.5 Cg_endo -60.3 165.26 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.105 2.537 . . . . 1.0 113.786 176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 106' ' ' PHE . 3.8 t -125.0 9.63 8.13 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.44 1.896 . . . . 1.0 114.691 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -67.51 47.69 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.954 2.502 . . . . 1.0 115.747 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -161.86 173.57 14.36 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.187 1.921 . . . . 1.0 116.187 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.7 ' HD3' ' HB2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -95.0 122.97 38.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 128.1 2.56 . . . . 1.0 110.717 177.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 54.1 t 62.8 95.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.74 2.016 . . . . 1.0 113.769 -172.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.644 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -39.65 -46.04 1.76 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.151 2.181 . . . . 1.0 112.924 171.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 51.7 tttt 74.14 177.33 0.23 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 129.163 2.985 . . . . 1.0 112.25 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 97.6 m -61.18 -33.93 74.23 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.906 1.282 . . . . 1.0 114.138 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.586 ' HB2' HD21 ' A' ' 92' ' ' ASN . 43.6 mt 51.22 87.16 0.14 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 127.126 2.17 . . . . 1.0 114.657 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.9 61.62 0.59 Allowed 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 125.092 3.862 . . . . 1.0 113.489 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 136.85 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 1 C-N-CA 132.431 4.292 . . . . 1.0 108.337 -178.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.38 24.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.845 1.658 . . . . 1.0 111.968 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.05 150.46 42.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.888 1.675 . . . . 1.0 112.113 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.626 ' HG2' ' HB2' ' A' ' 33' ' ' SER . 3.4 ptmm? -131.37 108.8 9.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.759 2.023 . . . . 1.0 108.521 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.788 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . 57.3 t -131.31 121.87 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 117.507 -1.235 . . . . 1.0 109.293 -172.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.1 t -134.47 120.71 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.805 1.642 . . . . 1.0 110.451 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 27' ' ' SER . . . -133.07 106.68 7.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.024 -1.843 . . . . 1.0 106.024 170.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 155.32 37.67 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.086 2.254 . . . . 1.0 117.086 -169.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.39 -26.52 0.97 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.546 2.022 . . . . 1.0 115.218 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.11 86.87 7.34 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.826 2.45 . . . . 1.0 112.225 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.7 t -64.6 -50.02 67.37 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-O 117.573 -1.204 . . . . 1.0 110.042 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 114' ' ' THR . 56.5 Cg_endo -81.58 129.86 6.66 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.294 3.329 . . . . 1.0 111.058 170.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -69.11 169.34 12.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.131 2.172 . . . . 1.0 115.492 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.13 3.23 45.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.936 2.207 . . . . 1.0 115.241 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.72 ' CG2' ' HB2' ' A' ' 84' ' ' MET . 13.8 t -53.82 121.03 7.09 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 119.618 1.709 . . . . 1.0 112.537 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.06 102.77 12.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.832 1.301 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.496 HG22 HG12 ' A' ' 110' ' ' ILE . 84.0 t -92.03 107.62 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 105.901 -1.889 . . . . 1.0 105.901 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.5 p -107.76 118.14 35.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.196 -0.911 . . . . 1.0 113.167 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.339 0.5 OUTLIER -107.0 112.98 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.377 -1.452 . . . . 1.0 111.152 -177.559 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.2 mtt -139.51 171.28 14.48 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.615 1.566 . . . . 1.0 114.591 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . . . -125.83 112.36 15.92 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.76 178.17 40.07 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 128.232 2.825 . . . . 1.0 115.623 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 73' ' ' TYR . 33.6 p-10 -121.74 -61.9 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.789 2.435 . . . . 1.0 108.48 173.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -113.89 46.73 1.27 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 131.222 3.809 . . . . 1.0 106.534 169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 64.82 -26.94 0.09 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.77 2.828 . . . . 1.0 114.209 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -102.35 49.33 0.85 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 129.495 3.118 . . . . 1.0 115.329 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.656 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 4.5 t80 -132.35 -19.2 2.48 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.903 1.681 . . . . 1.0 115.076 173.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.0 m 14.92 72.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.725 1 C-N-CA 132.111 4.164 . . . . 1.0 114.654 176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.04 149.34 6.77 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.129 2.172 . . . . 1.0 115.075 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -51.92 142.57 15.28 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.045 2.138 . . . . 1.0 114.161 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -127.59 168.56 14.82 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.495 2.318 . . . . 1.0 112.615 178.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.757 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 2.8 mpt_? -136.01 102.94 5.19 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.22 1.808 . . . . 1.0 108.536 172.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.9 m120 79.71 -9.03 1.49 Allowed 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 117.171 -1.395 . . . . 1.0 111.99 -175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 77' ' ' LEU 0.259 . . -68.91 20.82 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 122.298 2.317 . . . . 1.0 115.228 174.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -126.29 113.58 17.13 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.353 1.861 . . . . 1.0 109.591 168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.5 151.63 41.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.561 1.545 . . . . 1.0 112.274 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.97 129.53 40.41 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 127.026 2.13 . . . . 1.0 111.589 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.72 ' HB2' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -124.71 168.93 12.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.165 1.386 . . . . 1.0 113.682 -171.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 2.6 mptt -96.0 -72.05 0.65 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.187 2.595 . . . . 1.0 112.567 -168.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.7 48.39 1.7 Allowed 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 129.836 3.254 . . . . 1.0 106.475 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.9 26.41 7.82 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 128.472 2.709 . . . . 1.0 113.143 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 85' ' ' LYS . 12.8 p -92.76 114.35 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 127.955 2.502 . . . . 1.0 112.169 -172.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.06 146.54 24.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.776 2.031 . . . . 1.0 113.181 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 91' ' ' PHE . 20.7 ttp180 -136.69 157.36 46.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.719 2.808 . . . . 1.0 111.796 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.431 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 0.8 OUTLIER 51.33 -139.69 0.94 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.225 1.81 . . . . 1.0 112.654 176.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.586 HD21 ' HB2' ' A' ' 45' ' ' LEU . 55.5 t-20 -135.41 109.19 8.07 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.922 1.237 . . . . 1.0 113.306 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -149.7 68.13 1.01 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.132 2.573 . . . . 1.0 108.458 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -160.88 118.56 2.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.795 1.638 . . . . 1.0 112.266 172.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 38.3 mtp180 -136.75 119.38 16.04 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 114.212 1.19 . . . . 1.0 114.212 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.644 ' H ' ' HB2' ' A' ' 42' ' ' ASN . 5.5 p90 -93.64 165.75 12.57 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.455 2.302 . . . . 1.0 116.598 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t 46.76 35.02 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 129.742 3.217 . . . . 1.0 114.584 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.51 -41.46 41.55 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 127.315 2.388 . . . . 1.0 114.843 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -76.28 -9.24 58.48 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.873 2.069 . . . . 1.0 115.852 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.669 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 4.6 t 58.71 -177.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.165 1.386 . . . . 1.0 114.483 -175.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.15 129.57 3.45 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 128.186 2.803 . . . . 1.0 113.716 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -68.04 164.07 20.92 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.626 1.97 . . . . 1.0 112.145 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.49 27.64 58.98 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 116.451 1.34 . . . . 1.0 116.451 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -115.96 150.34 37.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.871 1.668 . . . . 1.0 114.152 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 t -125.21 122.22 36.39 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.319 3.448 . . . . 1.0 110.077 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -84.64 133.6 34.4 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 116.075 1.88 . . . . 1.0 116.075 -170.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -122.19 105.15 9.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.687 2.395 . . . . 1.0 115.162 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' TYR . 4.8 tt -79.43 90.04 5.03 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.103 -2.184 . . . . 1.0 105.103 167.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.3 m -92.25 101.47 13.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.799 2.84 . . . . 1.0 110.27 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 63' ' ' VAL . 62.8 mt -92.32 121.14 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.429 1.492 . . . . 1.0 108.015 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -122.93 118.1 27.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.323 1.014 . . . . 1.0 112.14 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.4 OUTLIER -71.7 170.67 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 122.929 1.347 . . . . 1.0 113.286 -176.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.62 33.3 5.0 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.207 2.203 . . . . 1.0 114.82 -174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.662 HG21 ' HG2' ' A' ' 58' ' ' PRO . 14.2 t -126.64 175.37 8.0 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.019 1.728 . . . . 1.0 112.132 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.52 -49.29 89.38 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 125.981 1.712 . . . . 1.0 113.483 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' A' ' 114' ' ' THR . 68.2 Cg_endo -76.91 111.16 3.18 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 124.348 3.365 . . . . 1.0 110.237 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.79 105.87 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.122 3.215 . . . . 1.0 112.473 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.688 ' H ' HG12 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -100.1 98.72 9.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.793 0.806 . . . . 1.0 109.466 -175.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.59 133.6 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.251 1.421 . . . . 1.0 111.744 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.14 154.87 49.17 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.22 1.408 . . . . 1.0 112.828 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 63.3 m -128.32 149.46 50.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.331 1.852 . . . . 1.0 111.596 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.865 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 82.9 t80 -83.74 165.47 18.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.579 1.951 . . . . 1.0 112.705 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -57.96 62.73 0.0 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 126.177 1.791 . . . . 1.0 111.461 169.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -87.82 98.31 11.4 Favored 'General case' 0 N--CA 1.469 0.502 1 C-N-CA 131.982 4.113 . . . . 1.0 114.364 -170.495 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -164.83 -103.89 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.561 2.745 . . . . 1.0 104.862 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 127' ' ' LYS . 0.5 OUTLIER 43.15 -158.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 129.388 3.075 . . . . 1.0 113.304 170.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -138.56 161.35 37.3 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.133 1.773 . . . . 1.0 114.684 173.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.3 tt -93.1 146.12 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 127.654 2.382 . . . . 1.0 111.693 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.5 t -70.33 137.0 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 113.008 0.744 . . . . 1.0 113.008 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -91.57 -15.55 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.146 1.378 . . . . 1.0 113.424 170.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -67.64 0.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.606 2.762 . . . . 1.0 112.309 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -40.13 95.28 0.01 OUTLIER Glycine 0 CA--C 1.544 1.862 0 C-N-CA 129.366 3.365 . . . . 1.0 113.629 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.23 162.6 41.98 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.578 2.852 . . . . 1.0 115.337 -171.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.7 ' HB2' ' HD3' ' A' ' 40' ' ' ARG . 7.9 ttm180 -120.5 80.93 1.68 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.968 2.507 . . . . 1.0 111.063 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 129.463 3.105 . . . . 1.0 113.386 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 12.9 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.459 -0.782 . . . . 1.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mt -146.65 -173.61 4.25 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 128.545 2.738 . . . . 1.0 104.989 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 2.4 t -69.77 71.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 119.458 -2.027 . . . . 1.0 109.664 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -53.97 172.11 0.09 Allowed 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 115.498 1.666 . . . . 1.0 115.498 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 30' ' ' PHE . 8.2 t -108.28 -135.1 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.814 1.645 . . . . 1.0 108.528 172.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.2 -47.45 24.26 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.462 1.905 . . . . 1.0 111.579 170.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.5 m -131.38 159.12 73.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 126.485 1.914 . . . . 1.0 111.843 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.94 -7.32 20.86 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 123.882 3.055 . . . . 1.0 116.191 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -67.18 -36.11 81.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.802 2.441 . . . . 1.0 114.398 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 25' ' ' THR . 75.4 m-85 -104.49 109.72 21.72 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.189 2.196 . . . . 1.0 110.405 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 155.52 22.48 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 115.629 1.714 . . . . 1.0 115.629 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 2.7 m -132.41 164.75 25.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 127.311 2.245 . . . . 1.0 112.038 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 42.9 m -153.4 91.24 1.48 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.455 2.302 . . . . 1.0 108.488 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.82 149.37 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 129.414 3.086 . . . . 1.0 108.933 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.837 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -83.7 178.88 2.16 Favored Pre-proline 0 CA--C 1.561 1.381 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -175.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 35' ' ' LEU . 50.6 Cg_endo -66.3 48.06 0.25 Allowed 'Trans proline' 0 CA--C 1.557 1.656 1 C-N-CA 125.615 4.21 . . . . 1.0 116.581 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -65.02 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 129.144 2.978 . . . . 1.0 114.04 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.778 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 5.4 p-80 -55.21 69.45 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.98 1 C-N-CA 132.198 4.199 . . . . 1.0 114.4 174.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -154.62 169.29 24.22 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.169 2.188 . . . . 1.0 112.848 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.17 116.29 7.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.533 2.333 . . . . 1.0 110.737 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t 59.04 84.21 0.11 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.584 1.954 . . . . 1.0 110.516 -169.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.14 -38.21 73.17 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.334 0.654 . . . . 1.0 112.743 -174.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 tttt 71.77 160.29 0.22 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 131.436 3.894 . . . . 1.0 114.71 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -72.79 68.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.557 1.543 . . . . 1.0 109.907 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 23.3 mt -68.07 159.75 78.21 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 124.862 1.265 . . . . 1.0 113.704 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.59 -8.37 22.09 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 124.373 3.382 . . . . 1.0 116.465 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -65.39 -14.65 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.401 1.88 . . . . 1.0 115.541 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.827 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . . . 66.09 175.72 0.23 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 127.725 2.41 . . . . 1.0 112.982 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -131.31 84.06 2.15 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.672 1.589 . . . . 1.0 109.784 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 86.8 mttt -87.25 111.59 21.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 105.366 -2.087 . . . . 1.0 105.366 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 87' ' ' GLN . 14.7 p -133.97 122.19 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.95 1.7 . . . . 1.0 107.819 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.8 t -139.06 148.25 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 128.377 2.671 . . . . 1.0 112.588 -172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.85 143.89 49.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.394 -1.441 . . . . 1.0 109.726 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.73 113.26 21.18 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.112 0.482 . . . . 1.0 110.513 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.05 -178.16 37.12 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.412 2.435 . . . . 1.0 114.173 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.23 -176.37 0.72 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 126.129 1.771 . . . . 1.0 115.457 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.4 95.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 125.441 1.497 . . . . 1.0 113.692 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.25 -4.0 5.92 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 124.616 3.544 . . . . 1.0 117.944 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 29.23 79.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 130.159 3.383 . . . . 1.0 115.552 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.23 51.57 0.01 OUTLIER Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.841 1.21 . . . . 1.0 113.574 -171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.434 HG22 HD11 ' A' ' 110' ' ' ILE . 84.7 m -129.54 94.05 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.138 1.775 . . . . 1.0 108.604 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -91.12 117.46 29.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.47 1.508 . . . . 1.0 111.627 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.97 111.84 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 105.678 -1.971 . . . . 1.0 105.678 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 81' ' ' THR . 35.1 p -112.56 114.03 26.47 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.22 -1.03 . . . . 1.0 108.22 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.707 HG13 ' HB1' ' A' ' 80' ' ' ALA 0.269 0.1 OUTLIER -125.77 111.55 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 120.478 -1.389 . . . . 1.0 113.425 -170.346 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.518 ' HG2' ' H ' ' A' ' 67' ' ' ALA . 15.8 ttm -138.8 172.7 12.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 116.728 2.121 . . . . 1.0 116.728 -172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.958 ' HB1' ' HB2' ' A' ' 105' ' ' SER . . . -98.45 143.94 28.34 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.724 1.249 . . . . 1.0 110.278 171.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.55 100.07 0.21 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 128.019 2.723 . . . . 1.0 112.424 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 27.6 t-20 -124.05 -39.21 2.39 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.765 2.426 . . . . 1.0 109.629 172.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -47.9 -45.3 30.46 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 129.012 2.925 . . . . 1.0 112.706 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -144.03 -11.94 0.65 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 127.46 2.304 . . . . 1.0 116.256 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 m120 84.37 151.78 0.08 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 130.525 3.53 . . . . 1.0 110.367 -170.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 33.26 43.23 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 128.519 2.728 . . . . 1.0 114.862 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -83.52 -26.27 30.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.331 3.052 . . . . 1.0 114.482 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . . . -141.65 122.2 14.18 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 120.167 1.349 . . . . 1.0 112.088 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -58.23 172.13 0.48 Allowed 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.13 2.27 . . . . 1.0 117.13 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.848 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.8 pp -116.07 167.27 11.13 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.637 3.175 . . . . 1.0 110.816 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 3.4 mtp180 -130.59 82.82 2.08 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.577 -0.702 . . . . 1.0 110.212 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 73.34 12.21 4.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.259 1.824 . . . . 1.0 111.65 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -62.92 7.11 0.09 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.171 1.388 . . . . 1.0 114.35 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.427 HG22 HG22 ' A' ' 64' ' ' THR . 48.6 p -105.98 110.76 23.14 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.479 1.111 . . . . 1.0 109.705 169.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.29 135.21 30.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.353 1.461 . . . . 1.0 111.613 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.32 144.06 25.77 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.786 2.034 . . . . 1.0 112.345 -175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 49.3 mtm -151.88 -173.72 4.62 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.316 1.846 . . . . 1.0 111.69 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -110.89 -96.82 0.41 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 127.477 2.311 . . . . 1.0 109.146 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.14 56.57 4.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.951 2.101 . . . . 1.0 108.836 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.678 ' HG2' HG22 ' A' ' 51' ' ' VAL . 19.0 tt0 51.25 32.46 8.21 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.801 1.64 . . . . 1.0 113.539 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.12 115.39 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.821 2.049 . . . . 1.0 111.845 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.7 147.52 50.11 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.618 1.567 . . . . 1.0 112.102 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 152.71 32.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.76 2.424 . . . . 1.0 111.911 -174.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.6 t80 57.38 -138.63 0.91 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.651 1.98 . . . . 1.0 112.405 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.827 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . 32.3 t-20 -138.58 137.56 37.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.929 1.692 . . . . 1.0 110.9 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 t0 175.12 67.12 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.939 2.496 . . . . 1.0 112.75 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.689 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -160.52 142.74 12.8 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.14 2.576 . . . . 1.0 109.327 171.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 33.0 mtp180 -141.11 118.17 11.23 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.823 1.647 . . . . 1.0 113.897 -171.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -94.07 153.09 18.33 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.456 1.122 . . . . 1.0 113.287 -175.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' A' ' 67' ' ' ALA 0.285 2.6 m 49.12 33.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.553 2.741 . . . . 1.0 114.476 171.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.66 25.76 0.1 Allowed Glycine 0 CA--C 1.537 1.43 1 C-N-CA 131.796 4.522 . . . . 1.0 118.002 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.25 9.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 129.237 3.015 . . . . 1.0 111.665 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.2 p -67.59 92.68 0.33 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.692 2.797 . . . . 1.0 110.467 170.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.92 -133.71 4.15 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.55 2.5 . . . . 1.0 113.559 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.8 mmt85 -66.51 168.58 8.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.96 1.704 . . . . 1.0 112.419 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.34 -81.08 0.2 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.353 0.977 . . . . 1.0 111.019 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 94.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.291 1.837 . . . . 1.0 109.621 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.958 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -125.32 108.68 11.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.451 0.7 . . . . 1.0 111.813 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 56.7 t80 -139.21 93.43 2.68 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 128.093 2.557 . . . . 1.0 115.045 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.262 19.4 m -137.61 60.33 1.64 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.034 1.397 . . . . 1.0 109.248 169.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 mp -92.06 97.18 10.77 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.59 1.956 . . . . 1.0 108.512 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.0 p -125.62 168.67 13.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.619 2.452 . . . . 1.0 117.619 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 61' ' ' THR . 5.0 tp -123.13 115.79 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 128.696 2.798 . . . . 1.0 107.666 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -123.7 108.51 12.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.415 2.286 . . . . 1.0 113.569 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.603 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 2.4 t -72.34 147.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.02 -1.675 . . . . 1.0 111.648 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -115.7 48.52 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 1 C-N-CA 132.668 4.387 . . . . 1.0 110.533 -172.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 116' ' ' PRO . 98.4 m -147.23 162.75 38.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 119.878 -1.764 . . . . 1.0 110.374 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -43.72 -42.71 11.23 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 126.308 1.843 . . . . 1.0 115.084 -173.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HD2' HG22 ' A' ' 114' ' ' THR . 74.9 Cg_endo -88.51 98.64 0.39 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 C-N-CA 125.05 3.833 . . . . 1.0 107.619 168.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.06 118.23 5.56 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.3 2.667 . . . . 1.0 111.564 -174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.603 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 68.8 mt-30 -109.67 96.85 6.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.725 0.81 . . . . 1.0 110.877 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.3 m -107.85 122.43 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.982 2.113 . . . . 1.0 112.145 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.02 168.36 19.93 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.82 2.448 . . . . 1.0 112.33 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 91.3 m -117.31 145.81 43.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.053 -1.654 . . . . 1.0 113.335 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 123' ' ' HIS . 23.6 t80 -87.56 115.77 25.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 1.0 107.539 171.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 74.34 170.95 0.29 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.764 2.026 . . . . 1.0 113.984 -172.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.5 ptt85 -133.98 23.97 3.9 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 128.197 2.599 . . . . 1.0 113.38 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.64 119.39 14.13 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.863 2.065 . . . . 1.0 110.357 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.82 86.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.851 2.06 . . . . 1.0 110.624 175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.778 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 11.9 mmtp -126.78 81.57 2.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.883 2.073 . . . . 1.0 111.638 -174.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.25 119.05 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 126.492 1.917 . . . . 1.0 109.992 173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.5 m -82.57 123.37 29.15 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.697 1.599 . . . . 1.0 110.364 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.13 -35.45 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.22 -40.46 7.38 Favored 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 131.746 4.018 . . . . 1.0 113.967 174.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.52 -154.97 52.98 Favored Glycine 0 CA--C 1.549 2.194 0 C-N-CA 125.495 1.522 . . . . 1.0 115.325 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.8 77.51 1.08 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 124.857 3.705 . . . . 1.0 113.476 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 ttm-85 145.38 96.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 131.178 3.791 . . . . 1.0 112.015 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.407 0 C-N-CA 124.354 1.061 . . . . 1.0 113.681 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 108.98 -0.748 . . . . 1.0 108.98 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 9.3 tp -143.36 -174.67 4.28 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 104.373 -2.454 . . . . 1.0 104.373 162.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.93 74.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 121.993 2.179 . . . . 1.0 109.464 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' A' ' 28' ' ' PRO . 21.4 mtm105 -47.68 147.29 1.9 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.295 1.438 . . . . 1.0 112.898 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.69 ' HA ' ' HB2' ' A' ' 122' ' ' TYR . 10.8 t -86.43 -154.53 0.22 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.264 1.826 . . . . 1.0 110.984 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.51 -18.37 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.123 2.169 . . . . 1.0 115.355 172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.5 t -144.03 137.24 13.97 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.212 1.805 . . . . 1.0 111.919 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HA ' ' HD2' ' A' ' 24' ' ' ARG . 3.0 Cg_exo -53.61 -19.74 14.77 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.727 2.952 . . . . 1.0 116.64 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -66.33 -23.24 66.33 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.578 1.325 . . . . 1.0 114.578 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' HB2' HG22 ' A' ' 25' ' ' THR . 98.1 m-85 -125.34 124.07 40.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.897 1.279 . . . . 1.0 111.747 -174.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' CD2' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -139.28 154.62 47.98 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.485 1.661 . . . . 1.0 115.485 -171.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.1 p -141.75 164.51 30.01 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.916 1.686 . . . . 1.0 113.965 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 t -148.91 105.25 3.52 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 126.8 2.04 . . . . 1.0 109.378 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.73 167.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.217 1 C-N-CA 132.434 4.294 . . . . 1.0 110.346 176.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.747 ' HG ' ' HD2' ' A' ' 36' ' ' PRO . 1.2 tp -53.9 165.28 0.79 Allowed Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.439 2.295 . . . . 1.0 115.737 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.747 ' HD2' ' HG ' ' A' ' 35' ' ' LEU . 40.4 Cg_endo -63.61 146.1 92.24 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 124.998 3.798 . . . . 1.0 113.776 -176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.1 p -67.5 -23.85 65.51 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.914 2.086 . . . . 1.0 116.185 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -113.39 77.51 1.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.692 2.397 . . . . 1.0 109.116 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -155.94 165.62 35.93 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.873 3.269 . . . . 1.0 110.677 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.883 ' HD2' ' HB2' ' A' ' 134' ' ' ARG . 0.6 OUTLIER -68.0 101.72 1.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.227 1.011 . . . . 1.0 110.657 174.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p 9.43 -107.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.545 2.738 . . . . 1.0 114.847 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 171.32 -57.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.723 1 C-N-CA 132.478 4.311 . . . . 1.0 110.738 170.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' THR . 0.0 OUTLIER 68.97 -1.25 2.13 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.526 2.33 . . . . 1.0 116.781 172.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 93' ' ' ASP 0.316 1.4 t 142.6 103.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 1 C-N-CA 131.799 4.04 . . . . 1.0 113.462 172.048 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.83 150.98 17.44 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 127.237 2.215 . . . . 1.0 112.028 171.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.55 35.96 0.45 Allowed 'Trans proline' 0 CA--C 1.554 1.515 1 C-N-CA 125.567 4.178 . . . . 1.0 115.115 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -35.48 -71.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 129.732 3.213 . . . . 1.0 115.709 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.47 -30.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.48 1.912 . . . . 1.0 113.403 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . 0.299 1.8 p90 41.52 39.26 1.04 Allowed 'General case' 0 C--N 1.353 0.756 0 N-CA-C 118.742 2.867 . . . . 1.0 118.742 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -126.25 106.89 9.85 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.769 0.713 . . . . 1.0 112.129 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.56 128.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.182 1.393 . . . . 1.0 110.702 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -134.55 145.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.771 2.028 . . . . 1.0 114.764 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.67 113.26 20.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.679 2.392 . . . . 1.0 108.9 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.98 112.28 16.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.395 1.478 . . . . 1.0 109.408 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.8 -61.49 0.6 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.932 1.253 . . . . 1.0 114.923 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.54 -18.94 11.83 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 118.093 2.627 . . . . 1.0 118.093 -171.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 57' ' ' VAL . 53.3 t 44.46 59.42 13.35 Favored Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 127.121 2.168 . . . . 1.0 114.739 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 112' ' ' VAL . 94.1 Cg_endo -88.34 109.48 0.58 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 123.56 2.84 . . . . 1.0 113.488 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.26 134.86 57.43 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.408 -0.807 . . . . 1.0 111.427 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.18 31.97 27.04 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.744 -0.597 . . . . 1.0 111.901 -170.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 84.7 m -71.11 77.73 0.68 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 170.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -78.87 112.84 16.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.925 2.49 . . . . 1.0 111.767 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.52 107.77 18.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.454 -2.054 . . . . 1.0 105.454 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 m -105.36 119.52 39.28 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.753 -1.567 . . . . 1.0 110.042 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.31 116.1 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.152 -0.968 . . . . 1.0 108.449 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -125.34 81.24 1.95 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.655 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 75' ' ' ALA . . . -96.95 107.4 19.91 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.346 -1.471 . . . . 1.0 107.189 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -39.15 132.25 1.91 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.567 2.508 . . . . 1.0 115.837 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.564 ' HB2' HG23 ' A' ' 97' ' ' VAL . 5.4 m-80 170.74 -15.42 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.449 1 C-N-CA 131.797 4.039 . . . . 1.0 115.733 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 7.5 m-20 -58.05 -35.83 71.88 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.239 1.836 . . . . 1.0 112.749 172.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 148.26 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 1 C-N-CA 132.75 4.42 . . . . 1.0 115.414 172.966 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -156.84 -102.36 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 O-C-N 120.153 -1.592 . . . . 1.0 113.876 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -134.65 15.97 3.65 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.861 2.864 . . . . 1.0 113.543 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.1 m -168.63 111.9 0.57 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.277 1.831 . . . . 1.0 110.532 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -110.39 164.04 13.08 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 116.307 1.966 . . . . 1.0 116.307 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 156.78 21.41 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 126.577 1.951 . . . . 1.0 115.313 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -130.76 167.57 18.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.755 2.422 . . . . 1.0 112.409 -174.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -130.99 91.87 3.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.916 -1.74 . . . . 1.0 111.425 172.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t30 67.73 12.59 8.92 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.504 1.522 . . . . 1.0 113.058 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.51 ' HB2' ' N ' ' A' ' 95' ' ' ARG . . . -74.83 7.54 3.06 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 120.945 1.702 . . . . 1.0 112.491 169.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 113.2 24.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 130.089 3.356 . . . . 1.0 106.897 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.57 160.0 40.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.574 1.95 . . . . 1.0 109.89 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.2 46.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.783 1.633 . . . . 1.0 114.05 173.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.787 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 48.8 mtm -101.01 151.61 21.58 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 1.0 109.671 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -112.13 -80.2 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.466 1.506 . . . . 1.0 107.545 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -62.27 1.74 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.213 0.46 . . . . 1.0 110.044 170.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.02 22.6 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.106 1.762 . . . . 1.0 114.421 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 90.9 t -133.88 119.8 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 126.21 1.804 . . . . 1.0 112.836 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.14 143.77 46.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.635 1.574 . . . . 1.0 109.727 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -106.09 106.1 16.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.794 0.838 . . . . 1.0 109.039 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.63 73.05 5.18 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.052 1.741 . . . . 1.0 111.946 175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -121.66 171.43 8.85 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 129.216 3.006 . . . . 1.0 110.531 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 1.4 t70 60.48 -20.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 130.179 3.391 . . . . 1.0 117.973 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -42.52 146.42 0.34 Allowed 'General case' 0 C--O 1.238 0.469 1 C-N-CA 133.11 4.564 . . . . 1.0 118.615 -171.441 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -139.95 129.21 23.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.21 -0.996 . . . . 1.0 111.104 170.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -119.85 135.88 54.7 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.13 1.772 . . . . 1.0 111.836 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 69' ' ' ASN 0.294 4.5 p 52.35 29.77 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 C-N-CA 125.043 1.337 . . . . 1.0 114.386 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.33 72.19 0.61 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 128.039 2.733 . . . . 1.0 113.345 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 132.27 84.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 1 C-N-CA 134.529 5.132 . . . . 1.0 109.425 -175.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . 7.5 m -78.53 162.05 26.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.849 0.685 . . . . 1.0 112.849 172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.34 -23.77 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 N-CA-C 117.507 1.763 . . . . 1.0 117.507 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 169.64 150.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 129.771 3.228 . . . . 1.0 111.902 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.07 53.41 14.67 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.186 1.374 . . . . 1.0 115.246 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 69' ' ' ASN . 3.9 mptt -68.53 92.34 0.45 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.092 1.757 . . . . 1.0 112.206 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 t -122.52 160.85 24.77 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 129.773 3.229 . . . . 1.0 113.973 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -128.4 90.18 3.03 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 116.021 1.86 . . . . 1.0 116.021 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.7 m -101.65 77.45 1.74 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.859 1.664 . . . . 1.0 110.575 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.85 92.84 6.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.561 -1.337 . . . . 1.0 109.255 173.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.7 t -116.8 122.01 43.19 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 -171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -99.39 114.32 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.003 1.321 . . . . 1.0 108.88 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.9 m -100.83 109.5 21.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.031 2.132 . . . . 1.0 113.153 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 58' ' ' PRO . 53.7 t -76.39 103.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.411 -1.431 . . . . 1.0 108.462 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.19 3.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.122 1 C-N-CA 134.981 5.312 . . . . 1.0 117.215 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -84.09 178.42 7.84 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.949 2.1 . . . . 1.0 114.02 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . 28.7 m-20 -44.93 -54.88 12.15 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 124.702 1.201 . . . . 1.0 109.814 171.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 48.1 Cg_endo -74.99 116.89 4.72 Favored 'Trans proline' 0 CA--C 1.556 1.575 0 C-N-CA 123.495 2.797 . . . . 1.0 107.984 168.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.23 94.29 0.9 Allowed 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 124.401 3.401 . . . . 1.0 108.603 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.44 92.39 5.93 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 105.802 -1.925 . . . . 1.0 105.802 -172.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -108.22 124.59 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 1.0 112.228 -170.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.08 26.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.123 1.369 . . . . 1.0 111.692 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 90.2 m -113.31 140.07 48.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.591 1.957 . . . . 1.0 111.008 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 1.1 t80 -118.33 139.69 50.97 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.725 1.61 . . . . 1.0 111.843 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.61 64.0 0.8 Allowed 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.939 1.459 . . . . 1.0 114.939 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.827 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 20.2 tpt85 -59.56 -27.83 66.58 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.859 2.54 . . . . 1.0 117.859 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 51.6 82.26 0.07 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 128.345 2.658 . . . . 1.0 114.705 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.46 -89.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 126.192 1.797 . . . . 1.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -88.17 153.9 20.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.585 1.954 . . . . 1.0 110.787 172.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.57 113.38 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.68 1.192 . . . . 1.0 110.986 173.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 31.5 m -89.84 126.31 35.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 1.0 110.81 170.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.43 -35.96 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 126.654 1.981 . . . . 1.0 115.485 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -56.21 10.95 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 131.163 3.785 . . . . 1.0 110.964 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 100' ' ' SER . . . 106.81 -79.92 0.27 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.434 2.445 . . . . 1.0 113.576 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 37.5 Cg_endo -74.0 -10.41 22.89 Favored 'Trans proline' 0 CA--C 1.553 1.438 0 C-N-CA 123.672 2.915 . . . . 1.0 117.692 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.883 ' HB2' ' HD2' ' A' ' 40' ' ' ARG . 36.1 ttt180 132.02 -20.93 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 131.444 3.898 . . . . 1.0 116.904 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.337 0 C-N-CA 130.216 3.407 . . . . 1.0 109.952 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.441 -0.79 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mt -157.45 -175.14 5.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.118 2.567 . . . . 1.0 105.259 -168.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.27 72.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 121.639 2.018 . . . . 1.0 109.676 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HG2' ' HB3' ' A' ' 31' ' ' LEU . 32.5 mtp180 -81.68 141.48 33.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.556 1.542 . . . . 1.0 110.031 169.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 p -81.92 -136.03 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.102 2.161 . . . . 1.0 109.367 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -48.66 -17.2 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.361 -1.462 . . . . 1.0 113.612 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.403 ' N ' ' CD ' ' A' ' 28' ' ' PRO . 43.2 m 75.57 14.96 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 27' ' ' SER . 76.1 Cg_endo -70.32 30.01 0.2 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 124.749 3.633 . . . . 1.0 115.93 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' A' ' 56' ' ' ASP . 97.9 m-20 132.81 -20.48 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.478 1 C-N-CA 133.391 4.676 . . . . 1.0 113.581 -176.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -84.96 140.98 30.68 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 120.668 1.576 . . . . 1.0 115.2 -171.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HB3' ' HG2' ' A' ' 24' ' ' ARG . 3.6 pp -148.2 149.57 32.19 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.845 2.458 . . . . 1.0 112.004 171.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 t -129.77 122.14 28.22 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.048 1.339 . . . . 1.0 113.256 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 3.0 t -88.97 96.67 10.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.63 3.172 . . . . 1.0 108.594 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.9 m -152.04 162.58 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 129.988 3.315 . . . . 1.0 111.132 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -126.16 75.46 72.55 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 125.255 1.422 . . . . 1.0 112.386 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.77 -40.49 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 124.309 3.339 . . . . 1.0 113.814 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 m 38.39 45.3 0.81 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.126 3.37 . . . . 1.0 112.622 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . 6.8 p80 44.42 94.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 128.497 2.719 . . . . 1.0 114.039 173.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -169.43 176.83 4.91 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 128.964 2.906 . . . . 1.0 108.793 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 97' ' ' VAL . 1.4 ptp180 -119.33 166.93 12.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.365 1.066 . . . . 1.0 113.763 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.2 m 75.68 12.83 3.0 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.923 2.564 . . . . 1.0 117.923 172.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -21.11 -46.94 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 130.674 3.59 . . . . 1.0 117.839 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.981 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 53.81 -29.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 1 C-N-CA 132.565 4.346 . . . . 1.0 119.512 171.583 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m 141.27 83.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 1 C-N-CA 133.339 4.656 . . . . 1.0 107.718 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.764 HD23 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -83.03 154.32 67.24 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.459 1.104 . . . . 1.0 112.217 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.764 ' HD2' HD23 ' A' ' 45' ' ' LEU . 58.8 Cg_endo -69.13 37.4 0.22 Allowed 'Trans proline' 0 CA--C 1.558 1.689 1 C-N-CA 125.528 4.152 . . . . 1.0 115.746 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG12 ' HB3' ' A' ' 45' ' ' LEU . 26.3 pt -128.43 -29.77 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.292 3.037 . . . . 1.0 114.449 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 54.67 -174.0 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 127.417 2.287 . . . . 1.0 115.489 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 46.3 m-85 -126.46 134.1 51.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.768 2.027 . . . . 1.0 112.847 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 69.8 mttt -130.24 109.35 10.72 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.599 1.56 . . . . 1.0 109.649 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -106.02 135.78 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.322 1.449 . . . . 1.0 109.02 173.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.56 140.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.394 1.077 . . . . 1.0 110.976 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -104.32 105.68 15.91 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 168.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.54 114.01 26.13 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.19 2.88 41.74 Favored Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.787 1.66 . . . . 1.0 115.923 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' A' ' 29' ' ' ASN . 2.1 t0 -133.67 162.05 33.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.741 2.017 . . . . 1.0 113.707 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.3 t -141.32 71.92 26.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.87 1.668 . . . . 1.0 111.661 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD2' ' HB3' ' A' ' 87' ' ' GLN . 68.3 Cg_endo -79.63 -177.94 4.21 Favored 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.849 3.699 . . . . 1.0 114.277 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -148.73 95.76 2.47 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 127.051 2.14 . . . . 1.0 111.43 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.71 17.21 9.3 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 126.057 1.789 . . . . 1.0 116.955 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 84' ' ' MET . 81.1 m -52.14 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 127.688 2.395 . . . . 1.0 113.294 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 38.6 tp -77.15 103.27 6.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.217 1.407 . . . . 1.0 110.971 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.47 108.91 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -112.36 115.85 29.4 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 123.944 0.777 . . . . 1.0 112.634 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.685 HG13 ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -98.28 111.65 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.128 -0.982 . . . . 1.0 110.253 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.818 ' HG2' ' HB3' ' A' ' 77' ' ' LEU . 32.8 mtm -128.99 165.56 20.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.94 127.31 47.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.337 1.055 . . . . 1.0 109.158 169.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -35.57 -57.28 0.96 Allowed Glycine 0 N--CA 1.482 1.727 0 C-N-CA 125.55 1.548 . . . . 1.0 113.187 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.509 ' H ' ' CB ' ' A' ' 105' ' ' SER . 12.7 t-20 72.94 109.35 0.07 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.504 3.522 . . . . 1.0 110.078 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.583 ' HA ' ' HD2' ' A' ' 102' ' ' ARG . 1.0 OUTLIER 54.33 32.91 17.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.202 1.401 . . . . 1.0 112.729 -168.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 53.97 54.92 9.02 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 129.161 2.984 . . . . 1.0 114.096 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 73' ' ' TYR 0.361 0.0 OUTLIER -82.37 -108.3 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 123.494 0.717 . . . . 1.0 111.003 173.036 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.673 ' H ' ' ND2' ' A' ' 72' ' ' ASN . 17.4 m-85 -172.64 70.79 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 130.642 3.577 . . . . 1.0 110.394 -177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.0 p 63.35 89.75 0.09 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.833 2.053 . . . . 1.0 114.477 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 76' ' ' GLU . . . -147.37 74.21 1.32 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.869 1.063 . . . . 1.0 113.869 173.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 26.1 tt0 161.09 96.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.053 2.141 . . . . 1.0 115.628 172.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.038 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.98 165.48 24.61 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.615 3.566 . . . . 1.0 107.876 170.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -144.11 82.53 1.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.255 -1.528 . . . . 1.0 111.193 169.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 23.9 m120 84.16 4.07 0.76 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.089 1.756 . . . . 1.0 111.136 -170.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -64.07 9.85 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.587 3.155 . . . . 1.0 116.592 171.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.3 t -118.63 115.13 23.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.527 1.931 . . . . 1.0 110.834 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.84 145.1 32.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.589 1.956 . . . . 1.0 112.198 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.82 143.62 26.33 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 127.923 2.489 . . . . 1.0 111.898 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.517 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -121.37 149.25 43.26 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.876 2.47 . . . . 1.0 112.088 -170.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -79.48 -117.03 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.063 0.945 . . . . 1.0 111.057 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.7 -8.14 1.2 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.718 2.007 . . . . 1.0 115.246 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.634 ' HB3' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 135.69 6.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.192 1 C-N-CA 133.109 4.563 . . . . 1.0 113.128 -171.354 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.54 144.66 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 120.405 1.457 . . . . 1.0 112.613 -169.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HB2' HG12 ' A' ' 51' ' ' VAL . . . -99.92 146.34 26.79 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.188 2.195 . . . . 1.0 113.637 173.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.9 110.29 19.86 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.938 2.495 . . . . 1.0 110.844 175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 t80 45.93 -78.9 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.421 3.088 . . . . 1.0 116.842 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 44.88 160.99 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.537 1 C-N-CA 131.773 4.029 . . . . 1.0 118.497 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.55 -54.9 4.43 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 127.627 2.371 . . . . 1.0 113.567 -173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 5.5 mt 40.82 120.18 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.403 1 C-N-CA 133.093 4.557 . . . . 1.0 117.321 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.981 ' HG2' ' H ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -121.92 115.34 22.39 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.783 1.629 . . . . 1.0 113.196 -170.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -99.95 136.28 40.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.464 1.505 . . . . 1.0 110.82 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 1.8 t 50.43 56.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.848 -1.167 . . . . 1.0 107.848 -171.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.06 -8.06 65.18 Favored Glycine 0 N--CA 1.479 1.501 1 N-CA-C 126.499 5.36 . . . . 1.0 126.499 -167.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 100' ' ' SER 0.253 1.3 tmm_? -146.9 48.94 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.88 3.34 . . . . 1.0 117.488 -177.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' ARG 0.278 3.4 t 144.53 -81.49 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 1 C-N-CA 132.126 4.17 . . . . 1.0 111.059 171.171 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.4 85.55 1.59 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.041 1.291 . . . . 1.0 114.799 175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.583 ' HD2' ' HA ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -44.41 -60.35 1.99 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 129.211 3.004 . . . . 1.0 116.951 -176.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.82 -79.95 0.03 OUTLIER Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.287 1.899 . . . . 1.0 111.592 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.64 98.1 1.91 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.701 1.6 . . . . 1.0 114.516 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.509 ' CB ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -127.51 136.13 51.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.824 2.05 . . . . 1.0 113.142 173.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -134.8 114.05 12.23 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.168 1.787 . . . . 1.0 111.747 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -139.21 75.84 1.54 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.939 1.696 . . . . 1.0 111.288 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.56 108.9 8.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 1.0 110.046 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 51.6 m -117.74 115.25 24.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.2 1.4 . . . . 1.0 112.14 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.4 116.05 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.472 1.509 . . . . 1.0 107.197 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -113.77 107.34 15.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.201 1.001 . . . . 1.0 113.239 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.59 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 55.5 t -77.3 145.56 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.514 1.526 . . . . 1.0 111.846 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -104.1 -6.99 20.56 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 129.316 3.046 . . . . 1.0 114.627 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 116' ' ' PRO . 8.6 m -72.28 171.47 12.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 128.869 2.868 . . . . 1.0 111.742 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -41.99 -52.53 9.15 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.403 -1.284 . . . . 1.0 111.778 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 114' ' ' THR . 58.1 Cg_endo -78.24 110.74 2.93 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 124.624 3.55 . . . . 1.0 109.534 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.08 106.37 1.88 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.009 2.473 . . . . 1.0 109.624 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.632 HE22 ' HB2' ' A' ' 116' ' ' PRO . 1.7 mp0 -106.68 101.48 10.92 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 1.0 111.15 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.78 114.38 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.631 1.973 . . . . 1.0 111.423 176.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -134.08 127.66 32.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.91 1.684 . . . . 1.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.3 t -123.88 148.67 46.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.218 1.807 . . . . 1.0 114.712 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -87.32 112.66 22.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 1.0 109.073 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.42 49.91 2.28 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 128.006 2.522 . . . . 1.0 112.097 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -136.48 -99.94 0.21 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.217 2.207 . . . . 1.0 114.222 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.48 58.78 0.29 Allowed 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 116.175 1.917 . . . . 1.0 116.175 -171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.27 72.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.329 2.252 . . . . 1.0 114.256 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -128.98 159.67 35.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.276 2.23 . . . . 1.0 111.769 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -149.88 161.21 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.899 2.079 . . . . 1.0 111.235 174.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.7 m -99.06 124.05 43.79 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.46 1.904 . . . . 1.0 110.334 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -72.85 -30.91 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 115.733 1.753 . . . . 1.0 115.733 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.55 -49.88 75.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.189 2.195 . . . . 1.0 112.605 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 40' ' ' ARG . . . -41.31 95.57 0.01 OUTLIER Glycine 0 CA--C 1.541 1.66 0 C-N-CA 129.203 3.287 . . . . 1.0 112.635 171.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.46 166.6 12.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.564 2.842 . . . . 1.0 115.257 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -68.79 -39.69 80.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.454 1.901 . . . . 1.0 113.302 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 CA--C 1.561 1.382 0 C-N-CA 128.357 2.663 . . . . 1.0 114.867 -172.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 119.663 -0.208 . . . . 1.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mt -148.51 -173.89 4.46 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 127.689 2.396 . . . . 1.0 106.273 150.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.2 t -68.28 71.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 120.951 1.705 . . . . 1.0 106.677 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -127.98 82.04 2.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 130.269 3.428 . . . . 1.0 108.216 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.0 p -100.68 -73.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.433 1.893 . . . . 1.0 110.047 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.593 1.557 . . . . 1.0 114.01 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.0 m 75.19 36.38 0.05 OUTLIER Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 117.161 2.282 . . . . 1.0 117.161 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.74 37.37 0.24 Allowed 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 124.481 3.454 . . . . 1.0 112.971 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . 0.27 84.8 m-20 73.24 16.0 4.26 Favored 'General case' 0 CA--C 1.56 1.33 1 C-N-CA 132.328 4.251 . . . . 1.0 114.052 -170.457 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.73 ' CE1' ' HB2' ' A' ' 53' ' ' ALA . 80.4 m-85 -108.68 137.14 47.09 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.495 1.665 . . . . 1.0 115.495 -174.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 pp -122.31 122.1 38.29 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.557 2.343 . . . . 1.0 111.923 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HB2' HG13 ' A' ' 51' ' ' VAL . 1.6 t -115.27 147.07 40.85 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.336 1.854 . . . . 1.0 112.65 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -130.14 95.17 3.86 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.969 2.908 . . . . 1.0 110.689 -175.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -144.64 139.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 128.625 2.77 . . . . 1.0 110.877 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.77 146.69 80.16 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 126.252 1.821 . . . . 1.0 114.424 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.65 99.51 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.622 3.548 . . . . 1.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.5 t -93.69 -8.14 41.73 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 116.192 1.923 . . . . 1.0 116.192 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 29.1 p80 31.57 56.37 0.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 128.815 2.846 . . . . 1.0 115.869 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.43 ' HA ' ' H ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -164.79 176.15 9.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.927 2.091 . . . . 1.0 113.749 178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 97' ' ' VAL . 0.3 OUTLIER -70.28 101.64 1.95 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.304 2.242 . . . . 1.0 109.569 176.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -83.49 -65.84 0.96 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.248 -0.908 . . . . 1.0 109.621 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.0 t30 45.11 56.71 5.25 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.228 1.411 . . . . 1.0 113.003 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.93 1.66 3.24 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.966 2.58 . . . . 1.0 117.966 -177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -23.42 57.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.781 2.141 . . . . 1.0 116.781 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.52 109.63 10.31 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.549 1.522 . . . . 1.0 109.833 176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -83.34 144.3 11.53 Favored 'Trans proline' 0 CA--C 1.552 1.41 0 C-N-CA 123.87 3.046 . . . . 1.0 110.731 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.522 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -141.34 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.556 1.543 . . . . 1.0 110.932 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.42 119.49 3.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.599 1.96 . . . . 1.0 109.75 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.522 ' CZ ' HG12 ' A' ' 47' ' ' ILE . 9.0 m-85 -122.98 113.4 19.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.134 1.773 . . . . 1.0 109.12 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -126.61 118.8 25.56 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.809 1.244 . . . . 1.0 109.964 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 32' ' ' CYS . 10.4 t -134.56 134.75 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.909 1.284 . . . . 1.0 110.323 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.77 142.0 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.775 1.63 . . . . 1.0 110.69 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . . . -111.63 146.33 37.63 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.136 1.375 . . . . 1.0 111.047 170.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -74.55 139.57 43.84 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.281 0.632 . . . . 1.0 110.257 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.93 -177.27 19.17 Favored Glycine 0 CA--C 1.545 1.96 0 C-N-CA 126.811 2.148 . . . . 1.0 112.225 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.99 94.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.311 1.044 . . . . 1.0 112.452 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 7.5 p -156.26 147.48 16.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 127.065 2.146 . . . . 1.0 112.427 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 57' ' ' VAL . 13.7 Cg_endo -58.36 151.0 63.77 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.797 2.331 . . . . 1.0 112.455 171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 69.59 97.11 0.06 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 127.602 2.361 . . . . 1.0 112.811 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.05 -14.76 25.68 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 126.821 2.153 . . . . 1.0 115.104 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 95.13 -172.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 127.722 2.409 . . . . 1.0 114.231 171.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 110' ' ' ILE . 7.0 mp -103.77 129.02 51.12 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.981 1.474 . . . . 1.0 114.981 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -93.72 116.5 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.53 2.332 . . . . 1.0 105.37 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 p -129.2 117.54 20.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.121 2.169 . . . . 1.0 110.975 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 80' ' ' ALA 0.305 11.0 m -109.93 110.44 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.078 -1.014 . . . . 1.0 110.52 171.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.699 ' HB2' HG23 ' A' ' 107' ' ' THR . 53.4 mtt -144.42 107.72 4.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.494 2.317 . . . . 1.0 110.625 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.1 106.03 16.46 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 121.376 -0.828 . . . . 1.0 111.446 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.06 167.67 27.78 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 126.913 2.197 . . . . 1.0 112.278 172.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 104' ' ' LYS 0.265 0.1 OUTLIER 57.51 -33.01 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.27 2.628 . . . . 1.0 117.218 -175.563 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.626 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 38.9 t70 -64.73 -22.21 66.93 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 129.313 3.045 . . . . 1.0 113.515 170.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 72' ' ' ASN . 9.6 tm-20 -120.78 -67.08 1.0 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 128.644 2.778 . . . . 1.0 109.629 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.533 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 3.1 m-80 -145.47 -85.23 0.12 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.906 2.082 . . . . 1.0 111.131 175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -168.24 10.73 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.511 1.925 . . . . 1.0 114.994 -171.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.2 m -59.51 -72.54 0.1 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.91 1.684 . . . . 1.0 113.995 -172.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 46.75 -156.68 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.516 1.526 . . . . 1.0 114.965 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.777 ' HB2' ' HB2' ' A' ' 100' ' ' SER . 7.0 tp10 65.11 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.404 3.082 . . . . 1.0 115.227 -172.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -134.02 165.52 24.85 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.711 1.745 . . . . 1.0 115.711 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.33 83.79 2.16 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.963 1.305 . . . . 1.0 109.603 172.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 70.82 10.63 7.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.865 0.866 . . . . 1.0 113.109 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -65.51 2.63 0.87 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.304 1.411 . . . . 1.0 113.387 169.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -100.02 112.61 24.9 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.044 0.938 . . . . 1.0 109.715 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.41 122.51 14.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.39 1.876 . . . . 1.0 109.689 -175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.8 153.48 18.84 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.184 0.994 . . . . 1.0 112.537 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.24 167.62 15.2 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.384 1.874 . . . . 1.0 110.084 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.83 -80.13 0.6 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.671 1.588 . . . . 1.0 110.389 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -80.65 45.71 0.81 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.23 1.412 . . . . 1.0 112.072 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 20.9 mp0 61.15 22.04 12.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 128.573 2.749 . . . . 1.0 114.752 174.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.89 133.25 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.76 129.88 49.23 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 130.383 3.473 . . . . 1.0 111.393 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -136.01 160.07 39.75 Favored 'General case' 0 N--CA 1.485 1.287 1 C-N-CA 132.028 4.131 . . . . 1.0 110.334 176.29 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 3.5 t80 108.04 178.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 129.499 3.119 . . . . 1.0 114.717 171.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -82.32 -157.06 0.19 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 127.738 2.415 . . . . 1.0 108.252 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 66.99 47.53 1.38 Allowed 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 117.724 2.49 . . . . 1.0 117.724 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 1.9 mp -139.25 123.92 18.48 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.371 2.268 . . . . 1.0 109.427 172.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.5 mpt_? -144.69 149.51 35.75 Favored 'General case' 0 N--CA 1.515 2.796 0 CA-C-N 122.698 2.499 . . . . 1.0 115.371 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.717 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -118.31 169.11 10.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.935 2.094 . . . . 1.0 115.746 -177.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.646 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 38.7 t 60.4 70.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.047 2.139 . . . . 1.0 109.927 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -101.59 -11.52 37.96 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 127.464 2.459 . . . . 1.0 115.906 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 73.05 -16.67 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 129.563 3.145 . . . . 1.0 118.57 173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.777 ' HB2' ' HB2' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 30.78 -5.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 2 C-N-CA 134.807 5.243 . . . . 1.0 122.502 172.187 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.77 49.28 1.52 Allowed Glycine 0 CA--C 1.542 1.74 0 C-N-CA 128.696 3.046 . . . . 1.0 110.653 -171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 90.7 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 129.861 3.264 . . . . 1.0 109.186 -170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 156.96 62.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 114.875 0.71 . . . . 1.0 114.875 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -71.48 84.93 0.83 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 123.153 1.454 . . . . 1.0 107.765 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -130.84 113.17 13.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.001 2.52 . . . . 1.0 113.177 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 70' ' ' ASP . 22.7 t80 -87.45 83.25 7.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.06 0.944 . . . . 1.0 108.988 174.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.699 HG23 ' HB2' ' A' ' 66' ' ' MET . 5.0 t -148.65 52.05 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 114.574 1.324 . . . . 1.0 114.574 -175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.1 pt? -96.26 68.35 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.442 1.497 . . . . 1.0 112.866 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 50.8 m 172.28 -77.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 128.944 2.898 . . . . 1.0 113.701 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -133.17 155.04 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 115.402 1.63 . . . . 1.0 115.402 -173.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 77.1 m -135.05 106.3 6.74 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.131 2.172 . . . . 1.0 111.612 170.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.22 103.57 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-O 123.379 1.561 . . . . 1.0 109.707 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.14 73.47 0.47 Allowed 'General case' 0 CA--C 1.545 0.773 1 C-N-CA 133.203 4.601 . . . . 1.0 109.771 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.682 HG22 ' HD2' ' A' ' 116' ' ' PRO . 93.7 m -152.37 163.09 40.18 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.376 2.27 . . . . 1.0 109.41 175.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.98 -41.91 32.16 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 117.419 -1.277 . . . . 1.0 114.046 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 114' ' ' THR . 83.5 Cg_endo -92.08 101.57 0.2 Allowed 'Trans proline' 0 CA--C 1.561 1.875 1 C-N-CA 125.883 4.389 . . . . 1.0 107.501 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.15 119.59 6.64 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 124.144 3.229 . . . . 1.0 111.138 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -118.92 102.45 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.3 1.048 . . . . 1.0 111.299 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.3 144.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.126 2.171 . . . . 1.0 113.163 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 110' ' ' ILE . . . -122.45 155.1 36.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.805 1.642 . . . . 1.0 112.402 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 t -127.54 139.34 52.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.562 1.945 . . . . 1.0 113.319 -173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 124' ' ' ARG . 9.4 t80 -89.11 109.82 20.63 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.074 -1.016 . . . . 1.0 108.773 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -97.0 57.19 1.47 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.979 0.895 . . . . 1.0 113.137 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.536 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -133.19 -61.73 0.82 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 128.24 2.616 . . . . 1.0 112.258 -175.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -74.09 -15.27 61.06 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 116.506 2.039 . . . . 1.0 116.506 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.2 mm 11.94 -86.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 1 C-N-CA 131.848 4.059 . . . . 1.0 114.66 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 71' ' ' GLU . 48.9 tptt -79.69 97.35 6.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.5 1.92 . . . . 1.0 110.57 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.47 ' H ' ' HG3' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -91.87 161.74 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.73 1.612 . . . . 1.0 112.176 -178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.43 ' H ' ' HA ' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -103.13 125.61 49.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.325 1.45 . . . . 1.0 112.804 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.01 -56.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 124.94 1.296 . . . . 1.0 112.032 -177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -99.1 -70.56 0.72 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.372 1.869 . . . . 1.0 112.83 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -173.48 156.74 24.77 Favored Glycine 0 CA--C 1.555 2.583 0 C-N-CA 126.366 1.936 . . . . 1.0 114.009 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.49 159.92 51.77 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.553 2.835 . . . . 1.0 114.932 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.533 ' HD3' ' HG2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -140.8 -47.42 0.41 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.958 2.103 . . . . 1.0 115.652 -176.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 134' ' ' ARG . 7.4 pt-20 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 130.789 3.636 . . . . 1.0 111.148 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.301 -0.857 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 -173.91 4.57 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.356 2.663 . . . . 1.0 106.478 -160.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.701 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.9 t -72.96 71.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 122.143 2.247 . . . . 1.0 107.891 171.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.87 123.33 49.91 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 1.0 108.05 170.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.497 HG23 ' H ' ' A' ' 26' ' ' ASP 0.311 9.7 t -129.52 -101.1 0.32 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.553 0.946 . . . . 1.0 113.553 -172.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' H ' HG23 ' A' ' 25' ' ' THR . 11.3 t70 -57.04 -34.89 68.67 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 127.746 2.418 . . . . 1.0 115.895 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.695 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 63.1 m -139.22 109.05 7.49 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.079 1.752 . . . . 1.0 107.616 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -46.26 -19.51 0.64 Allowed 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 124.706 3.604 . . . . 1.0 115.547 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.06 -36.59 70.72 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.544 2.738 . . . . 1.0 113.395 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.695 ' CE2' ' HB2' ' A' ' 27' ' ' SER . 0.8 OUTLIER -101.95 110.46 22.43 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.801 1.24 . . . . 1.0 109.813 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -117.96 122.28 42.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.028 1.731 . . . . 1.0 113.331 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.701 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 14.3 m -114.98 164.08 14.66 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.172 1.389 . . . . 1.0 113.861 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.4 m -152.06 126.96 9.64 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.793 1.637 . . . . 1.0 113.176 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -154.31 152.81 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 130.566 3.546 . . . . 1.0 109.375 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.55 150.8 95.57 Favored Pre-proline 0 CA--C 1.56 1.353 0 O-C-N 121.761 -0.587 . . . . 1.0 112.529 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.5 80.0 1.13 Allowed 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 124.222 3.281 . . . . 1.0 112.414 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 p -77.64 -80.77 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.519 1.128 . . . . 1.0 110.246 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 44.37 78.21 0.06 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.844 2.458 . . . . 1.0 111.77 -173.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 1.6 p90 -166.28 173.56 9.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.474 2.309 . . . . 1.0 111.55 -175.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 97' ' ' VAL . 4.5 ttp180 -66.43 100.87 0.69 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.785 1.234 . . . . 1.0 110.908 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -87.23 -50.78 6.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.962 1.705 . . . . 1.0 113.446 -173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' C ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t-20 56.28 8.65 0.43 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 125.913 1.685 . . . . 1.0 114.528 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 95' ' ' ARG 0.267 5.4 ttpt 65.42 27.31 11.84 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 130.806 3.643 . . . . 1.0 114.82 -170.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 m -57.51 -55.39 35.48 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 130.045 3.338 . . . . 1.0 114.457 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.21 106.49 17.77 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.867 2.067 . . . . 1.0 109.751 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -75.62 134.54 16.93 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.095 3.197 . . . . 1.0 113.301 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.87 -11.66 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 125.822 1.649 . . . . 1.0 114.563 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 68.51 162.09 0.2 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.133 2.573 . . . . 1.0 115.693 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -128.02 129.06 46.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.123 2.169 . . . . 1.0 109.506 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -124.67 109.13 12.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.02 1.328 . . . . 1.0 110.094 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.75 144.11 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.525 1.53 . . . . 1.0 111.459 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 147.52 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 129.476 3.11 . . . . 1.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 87' ' ' GLN . . . -135.39 158.93 43.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.79 1.774 . . . . 1.0 115.79 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.4 mt -100.43 112.48 24.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.803 2.041 . . . . 1.0 108.2 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.27 168.72 34.48 Favored Glycine 0 CA--C 1.545 1.935 0 C-N-CA 125.492 1.52 . . . . 1.0 111.282 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.544 ' OD1' ' HD2' ' A' ' 58' ' ' PRO . 9.3 t0 56.8 169.38 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 115.578 1.696 . . . . 1.0 115.578 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.761 ' HA ' ' HG2' ' A' ' 87' ' ' GLN 0.332 1.3 p -149.54 -43.86 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 115.788 1.773 . . . . 1.0 115.788 172.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' A' ' 57' ' ' VAL . 46.6 Cg_endo -81.16 169.41 16.04 Favored 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.282 2.654 . . . . 1.0 111.91 171.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 16.75 -122.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 129.367 3.067 . . . . 1.0 114.386 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 86' ' ' ASN . . . 144.42 -70.5 0.39 Allowed Glycine 0 C--N 1.342 0.861 0 C-N-CA 126.274 1.893 . . . . 1.0 113.951 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -139.82 165.17 28.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.596 1.702 . . . . 1.0 115.596 -169.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 111' ' ' THR . 38.3 mt -108.42 106.22 16.24 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.632 3.173 . . . . 1.0 106.305 168.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -90.87 107.72 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 -173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.9 m -111.57 119.59 39.23 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.241 1.017 . . . . 1.0 111.157 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 m -99.67 114.43 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 120.948 -1.095 . . . . 1.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.77 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 8.1 mtt -121.12 78.03 1.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.127 0.971 . . . . 1.0 111.011 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.02 106.69 19.02 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.136 -1.431 . . . . 1.0 107.136 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.57 171.19 54.95 Favored Glycine 0 CA--C 1.543 1.8 0 C-N-CA 126.542 2.02 . . . . 1.0 116.838 -173.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 17.8 p-10 -145.35 91.7 2.16 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.046 2.938 . . . . 1.0 110.135 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 63.92 20.37 12.18 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 126.426 1.89 . . . . 1.0 114.874 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.647 ' HG2' ' HB3' ' A' ' 73' ' ' TYR . 4.4 tt0 -148.41 -25.98 0.33 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 127.141 2.177 . . . . 1.0 116.279 -173.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 45.09 38.7 3.33 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.963 2.105 . . . . 1.0 114.301 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.647 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 60.9 t80 -149.84 68.67 1.01 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.645 1.978 . . . . 1.0 111.973 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.77 ' HB2' ' HG2' ' A' ' 66' ' ' MET . 42.5 t 63.08 78.79 0.28 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 128.664 2.785 . . . . 1.0 116.73 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.79 -62.82 1.4 Allowed 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 116.023 1.86 . . . . 1.0 116.023 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 95' ' ' ARG . 0.1 OUTLIER 173.22 143.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.894 2.878 . . . . 1.0 112.165 174.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.63 163.26 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.65 2.38 . . . . 1.0 110.782 170.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.778 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . 56.1 mtt-85 -141.08 90.03 2.29 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 127.092 2.157 . . . . 1.0 109.173 172.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' A' ' 81' ' ' THR . 1.3 t-20 88.84 -2.2 0.41 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.801 2.04 . . . . 1.0 110.848 -172.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 94' ' ' LEU 0.334 . . -76.01 34.12 0.13 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 123.272 2.76 . . . . 1.0 114.475 170.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.548 ' H ' ' C ' ' A' ' 79' ' ' ASN . 1.2 t -126.56 108.37 11.08 Favored 'General case' 0 CA--C 1.542 0.653 1 C-N-CA 132.704 4.402 . . . . 1.0 101.238 167.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.18 152.82 42.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.57 1.148 . . . . 1.0 112.113 -172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.15 159.4 15.3 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 129.452 3.101 . . . . 1.0 114.1 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 88' ' ' VAL 0.306 0.5 OUTLIER 86.54 -127.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 128.057 2.543 . . . . 1.0 113.041 176.278 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 70.08 -25.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 128.267 2.627 . . . . 1.0 117.13 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.487 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 2.4 m-20 -81.48 0.99 35.34 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 120.057 1.299 . . . . 1.0 113.497 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.761 ' HG2' ' HA ' ' A' ' 57' ' ' VAL . 4.1 tp-100 -148.41 -47.54 0.15 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.037 2.135 . . . . 1.0 112.395 170.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 84' ' ' MET . 90.7 t -133.9 134.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 114.972 1.471 . . . . 1.0 114.972 -172.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.24 121.62 16.05 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.775 1.63 . . . . 1.0 110.632 166.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.15 158.8 43.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.497 2.319 . . . . 1.0 110.23 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.45 -167.6 0.19 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.548 1.539 . . . . 1.0 114.565 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 9.0 p30 -107.99 -174.44 2.52 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.02 2.128 . . . . 1.0 111.559 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.265 8.4 m-20 121.0 74.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.565 3.546 . . . . 1.0 112.379 174.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.722 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 2.9 pp -160.2 141.72 12.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.198 2.599 . . . . 1.0 109.299 169.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.778 ' HD3' ' HB2' ' A' ' 78' ' ' ARG . 3.7 ttt180 -129.49 148.48 51.4 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 119.073 0.851 . . . . 1.0 112.166 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -146.45 152.0 38.32 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.453 1.649 . . . . 1.0 115.453 175.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 128' ' ' ILE . 32.3 m 43.95 31.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 129.194 2.998 . . . . 1.0 117.569 168.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.54 -35.18 36.44 Favored Glycine 0 N--CA 1.48 1.577 0 C-N-CA 128.848 3.118 . . . . 1.0 118.336 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.08 -0.15 4.15 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.511 1.924 . . . . 1.0 115.08 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 13.3 p -65.27 119.2 10.47 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.429 1.491 . . . . 1.0 113.122 -172.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -117.17 128.47 7.88 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.78 1.657 . . . . 1.0 114.004 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 69.01 164.18 0.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 128.928 2.891 . . . . 1.0 113.496 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 42.36 36.4 2.15 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.172 1.844 . . . . 1.0 113.918 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -67.43 101.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.769 2.028 . . . . 1.0 108.701 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -115.5 156.45 25.67 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 130.614 3.565 . . . . 1.0 110.17 -171.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.9 90.82 2.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.502 1.668 . . . . 1.0 115.502 -171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.0 m -112.38 80.29 1.32 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.545 1.138 . . . . 1.0 112.208 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.1 tt -80.4 115.0 19.7 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 120.611 -1.306 . . . . 1.0 110.949 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 21.9 m -121.1 111.98 18.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.664 1.186 . . . . 1.0 111.148 -175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.0 113.1 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.734 -1.21 . . . . 1.0 107.734 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 62' ' ' LEU . 14.8 t -89.98 151.1 21.84 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 122.834 0.453 . . . . 1.0 111.769 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 118' ' ' GLN . 2.0 p -72.68 170.95 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 123.451 1.596 . . . . 1.0 112.325 172.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.412 ' H ' HG22 ' A' ' 112' ' ' VAL . 8.9 t80 -118.15 11.5 13.27 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 128.891 2.877 . . . . 1.0 114.339 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.7 p -120.59 167.51 12.34 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.222 1.409 . . . . 1.0 112.682 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -29.06 5.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 N-CA-C 117.536 2.421 . . . . 1.0 117.536 -172.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -87.6 99.34 0.46 Allowed 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 124.421 3.414 . . . . 1.0 109.715 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -51.91 94.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.355 1 C-N-CA 125.428 4.085 . . . . 1.0 116.217 -171.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.621 ' H ' ' CG1' ' A' ' 112' ' ' VAL . 1.5 tm0? -97.78 90.47 4.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.152 0.977 . . . . 1.0 108.413 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 t -103.23 114.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.191 1.396 . . . . 1.0 108.616 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.42 151.78 27.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.561 2.345 . . . . 1.0 111.516 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.4 m -118.74 131.01 56.12 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.135 0.974 . . . . 1.0 112.905 -170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -131.24 120.29 23.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.394 1.078 . . . . 1.0 111.518 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -167.17 -166.45 0.8 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.794 2.437 . . . . 1.0 111.484 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -33.62 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 130.077 3.351 . . . . 1.0 117.697 172.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -28.99 -74.97 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 128.915 2.886 . . . . 1.0 115.183 -174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.3 mm -145.66 169.04 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 130.039 3.336 . . . . 1.0 107.654 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -76.39 150.06 36.84 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.7 -1.25 . . . . 1.0 110.717 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 97' ' ' VAL . 18.8 tt -92.32 124.5 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.461 1.904 . . . . 1.0 110.119 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.5 m -81.21 125.11 29.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.44 1.496 . . . . 1.0 111.923 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.3 t -53.95 -65.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.786 1.635 . . . . 1.0 114.153 -173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -102.44 -2.93 27.77 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.486 1.662 . . . . 1.0 115.486 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . 92.21 -151.33 20.65 Favored Glycine 0 CA--C 1.55 2.261 0 C-N-CA 125.356 1.455 . . . . 1.0 112.494 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.85 -75.62 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.223 3.282 . . . . 1.0 113.415 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.429 ' HD2' ' OE1' ' A' ' 135' ' ' GLU . 11.5 ttm105 -135.09 -71.54 0.48 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.627 1.971 . . . . 1.0 110.352 174.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.429 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 20.3 mp0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 126.792 2.037 . . . . 1.0 114.289 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.59 0.219 . . . . 1.0 111.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -152.5 -174.53 4.93 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 23.2 t -67.63 71.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 107.173 -1.417 . . . . 1.0 107.173 170.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.12 169.73 0.77 Allowed 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.965 1.468 . . . . 1.0 114.965 171.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.598 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 24.9 p -132.64 176.51 8.39 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 127.408 2.283 . . . . 1.0 110.17 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.37 21.19 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 128.129 2.572 . . . . 1.0 112.584 171.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.6 ' OG ' ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -79.11 168.37 27.39 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 127.269 2.227 . . . . 1.0 114.558 -177.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.6 ' HD2' ' OG ' ' A' ' 27' ' ' SER . 53.6 Cg_endo -64.55 -33.02 57.9 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.426 2.751 . . . . 1.0 113.741 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -174.19 72.08 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 128.606 2.762 . . . . 1.0 111.303 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.464 ' HB2' ' CB ' ' A' ' 27' ' ' SER . 1.7 t80 -125.4 129.45 49.9 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 120.422 -1.424 . . . . 1.0 114.248 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.72 133.88 53.8 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.697 1.599 . . . . 1.0 112.149 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 70.6 m -119.06 157.91 26.88 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.591 1.557 . . . . 1.0 111.868 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 6.7 t -137.81 98.16 3.6 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.213 2.205 . . . . 1.0 109.779 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.08 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.784 2.434 . . . . 1.0 110.225 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 47' ' ' ILE . 11.5 tp -72.95 -66.74 0.53 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.65 1.58 . . . . 1.0 112.951 177.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 96' ' ' PHE . 39.5 Cg_endo -66.01 142.43 68.32 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.757 2.972 . . . . 1.0 113.37 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -126.65 -46.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.822 2.049 . . . . 1.0 113.843 175.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 m-70 -138.78 62.8 1.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.509 1.524 . . . . 1.0 112.23 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.756 ' HB2' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -139.81 157.06 46.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 130.237 3.415 . . . . 1.0 110.628 173.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 7.9 ttp180 -68.37 104.92 2.0 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.997 1.719 . . . . 1.0 113.372 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 3.7 t 95.62 113.33 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.586 3.155 . . . . 1.0 116.429 170.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HB2' ' H ' ' A' ' 96' ' ' PHE . 57.2 t30 -57.1 -71.47 0.1 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.701 2.4 . . . . 1.0 112.814 171.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' HG2' ' H ' ' A' ' 44' ' ' THR . 24.3 ttmt -78.08 165.65 23.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.426 2.29 . . . . 1.0 113.099 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.543 ' H ' ' HG2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 91.47 -8.22 0.25 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 130.075 3.35 . . . . 1.0 112.496 -174.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.07 162.56 63.99 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 129.643 3.177 . . . . 1.0 113.831 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.37 29.33 0.3 Allowed 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 125.104 3.87 . . . . 1.0 115.243 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 35' ' ' LEU . 2.4 pp -146.33 172.55 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 129.723 3.209 . . . . 1.0 110.368 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.0 -179.32 5.34 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 128.923 2.889 . . . . 1.0 112.355 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -120.46 143.07 48.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.317 2.247 . . . . 1.0 113.12 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 78.9 mttt -147.27 146.66 29.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.433 1.893 . . . . 1.0 111.212 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 89' ' ' ALA 0.273 1.0 OUTLIER -135.98 135.18 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.445 1.098 . . . . 1.0 109.435 168.972 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.2 t -135.62 118.11 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.546 1.538 . . . . 1.0 108.286 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -97.79 159.94 14.62 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.493 1.117 . . . . 1.0 111.811 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.65 115.65 23.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.868 1.667 . . . . 1.0 111.687 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.2 169.77 40.88 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.583 1.563 . . . . 1.0 112.742 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.55 -168.74 0.19 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 126.12 1.768 . . . . 1.0 114.555 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . 0.296 7.4 p 169.52 73.08 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 131.191 3.796 . . . . 1.0 109.843 172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -93.76 4.87 2.92 Favored 'Trans proline' 0 CA--C 1.556 1.584 1 C-N-CA 125.402 4.068 . . . . 1.0 117.689 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 21.4 m-20 30.09 93.4 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 130.669 3.587 . . . . 1.0 118.661 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.98 5.21 3.55 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.899 1.714 . . . . 1.0 115.721 -175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 m -55.22 111.88 0.96 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.23 2.212 . . . . 1.0 111.775 -173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.52 111.42 10.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.705 1.602 . . . . 1.0 111.303 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.729 HG12 HG12 ' A' ' 110' ' ' ILE . 35.0 m -93.06 107.64 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 172.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.81 116.86 30.01 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 123.418 1.58 . . . . 1.0 110.85 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 40.6 t -101.33 140.99 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 O-C-N 120.685 -1.259 . . . . 1.0 110.519 -172.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -134.91 105.03 6.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.658 0.783 . . . . 1.0 111.436 170.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.86 109.03 21.44 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.355 -1.466 . . . . 1.0 107.696 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 74' ' ' SER . . . 131.9 91.27 0.52 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.281 2.848 . . . . 1.0 110.424 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -144.75 -87.84 0.11 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.361 2.265 . . . . 1.0 109.468 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.447 ' OD1' ' OG ' ' A' ' 105' ' ' SER . 2.5 m-20 -43.33 -28.64 0.35 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.525 2.73 . . . . 1.0 116.435 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 104' ' ' LYS . 14.1 mm-40 -98.14 -24.69 15.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.963 2.105 . . . . 1.0 115.834 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -162.61 -79.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.399 1.454 . . . . 1.0 113.882 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 t80 136.33 108.3 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.62 1 C-N-CA 132.82 4.448 . . . . 1.0 107.432 -170.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.598 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -124.42 -77.79 0.59 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.381 1.473 . . . . 1.0 111.256 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.76 -2.16 0.1 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.39 1.996 . . . . 1.0 116.39 -172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.31 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 129.812 3.245 . . . . 1.0 112.612 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -96.61 167.43 11.14 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -171.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 1.4 ttm180 -132.85 83.78 2.09 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 1.0 112.131 -169.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER 95.25 2.53 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.964 2.906 . . . . 1.0 111.033 -173.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.98 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . . . -46.77 -6.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.991 2.589 . . . . 1.0 117.991 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.1 m -115.47 113.68 24.02 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.563 1.545 . . . . 1.0 111.58 173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.7 163.0 34.07 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 128.93 2.892 . . . . 1.0 109.939 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.97 45.58 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.032 2.133 . . . . 1.0 112.563 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.507 ' C ' ' HD2' ' A' ' 85' ' ' LYS . 17.6 mmt -123.25 158.96 29.75 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.823 1.649 . . . . 1.0 111.195 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HD2' ' C ' ' A' ' 84' ' ' MET . 2.0 mptm? -118.05 -87.01 0.63 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -168.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -75.69 43.83 0.27 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 129.041 2.936 . . . . 1.0 110.705 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 1.4 pm0 48.94 32.55 3.88 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 128.776 2.83 . . . . 1.0 114.02 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.06 144.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.625 1.97 . . . . 1.0 113.449 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.406 ' HB3' HG22 ' A' ' 51' ' ' VAL . . . -131.52 146.91 52.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.268 2.627 . . . . 1.0 112.241 173.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.1 ptt-85 -136.66 163.16 31.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 129.485 3.114 . . . . 1.0 113.886 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 61.11 -86.56 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 128.303 2.641 . . . . 1.0 113.456 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -151.27 -66.72 0.18 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.198 2.199 . . . . 1.0 109.709 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 69.13 -21.25 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.037 3.335 . . . . 1.0 115.987 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.98 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -134.79 163.24 30.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 127.052 2.141 . . . . 1.0 115.741 178.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.678 ' HD2' ' HA3' ' A' ' 98' ' ' GLY . 5.5 ttm180 -141.11 115.95 9.73 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.297 1.962 . . . . 1.0 116.297 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -86.74 126.64 34.72 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.557 1.943 . . . . 1.0 111.201 177.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' H ' ' CD2' ' A' ' 77' ' ' LEU 0.289 2.6 m 38.67 41.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 129.247 3.019 . . . . 1.0 112.808 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.678 ' HA3' ' HD2' ' A' ' 95' ' ' ARG . . . -56.95 54.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.093 1 C-N-CA 132.453 4.835 . . . . 1.0 119.238 -171.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 117.88 -5.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 1 C-N-CA 132.735 4.414 . . . . 1.0 113.549 -175.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -141.21 92.48 2.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.604 2.362 . . . . 1.0 111.27 -174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 40' ' ' ARG . . . -168.99 138.42 5.09 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 127.472 2.463 . . . . 1.0 112.04 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -177.17 89.73 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 128.899 2.879 . . . . 1.0 107.37 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.06 81.54 0.59 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.759 1.171 . . . . 1.0 112.532 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -153.94 162.01 41.54 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.251 2.22 . . . . 1.0 112.341 177.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 70' ' ' ASP . 23.3 t -104.84 154.82 19.55 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.892 2.077 . . . . 1.0 113.178 172.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.627 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.4 t80 -95.03 103.1 14.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.424 2.29 . . . . 1.0 111.184 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -108.07 82.95 1.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.331 1.063 . . . . 1.0 112.525 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.27 111.25 8.22 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.555 1.542 . . . . 1.0 111.202 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.0 m -109.02 104.66 13.91 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.384 0.883 . . . . 1.0 113.384 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 63' ' ' VAL . 8.8 mt -93.45 113.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.128 -1.607 . . . . 1.0 108.199 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.7 p -111.61 121.2 44.5 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.569 1.948 . . . . 1.0 111.951 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 118' ' ' GLN . 0.3 OUTLIER -71.57 172.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 123.0 1.381 . . . . 1.0 112.391 -177.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -131.12 40.07 3.5 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.719 2.408 . . . . 1.0 113.598 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.616 ' H ' HG13 ' A' ' 112' ' ' VAL . 9.8 t -129.58 165.39 21.82 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.803 2.041 . . . . 1.0 111.023 172.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -48.57 -48.58 68.02 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 126.126 1.77 . . . . 1.0 112.684 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.34 111.54 3.28 Favored 'Trans proline' 0 CA--C 1.561 1.86 0 C-N-CA 123.876 3.05 . . . . 1.0 110.505 170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.23 106.8 1.06 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.591 3.527 . . . . 1.0 112.707 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.732 ' H ' HG12 ' A' ' 112' ' ' VAL . 7.9 tp-100 -105.32 92.85 4.38 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.812 0.815 . . . . 1.0 110.118 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 p -105.74 120.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.495 1.518 . . . . 1.0 111.453 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.53 146.18 44.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.79 2.036 . . . . 1.0 110.966 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 99.9 m -122.3 141.12 51.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.8 1.64 . . . . 1.0 110.102 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -92.25 143.88 25.96 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.067 0.947 . . . . 1.0 113.183 172.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -149.39 171.86 15.87 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 128.499 2.72 . . . . 1.0 111.15 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 125' ' ' ALA . 15.2 ttt180 74.46 176.51 0.24 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 127.41 2.284 . . . . 1.0 112.557 -172.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 124' ' ' ARG . . . -149.96 164.96 34.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.607 1.706 . . . . 1.0 115.607 175.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tp -129.66 -39.84 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.537 1.935 . . . . 1.0 113.716 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.56 110.32 8.69 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.395 1.478 . . . . 1.0 113.28 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 38' ' ' HIS . 1.2 pp -121.34 124.77 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.734 1.214 . . . . 1.0 110.586 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.756 ' HB ' ' HB2' ' A' ' 39' ' ' TRP . 86.5 m -125.87 120.51 30.67 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 170.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.2 p -78.56 -24.28 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 115.198 1.555 . . . . 1.0 115.198 -170.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.97 -69.02 0.78 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.757 2.423 . . . . 1.0 113.391 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.66 51.12 3.34 Favored Glycine 0 CA--C 1.549 2.163 0 C-N-CA 127.148 2.309 . . . . 1.0 114.994 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.52 -31.29 51.14 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.561 3.508 . . . . 1.0 114.119 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 145.45 86.73 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 1 C-N-CA 133.252 4.621 . . . . 1.0 112.069 174.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 127.893 2.477 . . . . 1.0 116.919 172.563 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 119.204 -0.427 . . . . 1.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -173.63 3.82 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 129.764 3.226 . . . . 1.0 104.753 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.0 t -65.17 74.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 O-C-N 119.664 -1.897 . . . . 1.0 108.533 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 30' ' ' PHE . 73.9 mtt180 -41.72 113.48 0.42 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 130.452 3.501 . . . . 1.0 111.9 171.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.827 ' H ' ' HB2' ' A' ' 30' ' ' PHE . 3.4 t -149.32 92.54 1.96 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.949 0.9 . . . . 1.0 112.791 -170.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 121' ' ' THR . 31.8 t0 118.01 -58.91 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 1 C-N-CA 133.033 4.533 . . . . 1.0 112.849 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.5 ' H ' ' HB3' ' A' ' 30' ' ' PHE . 50.9 m 133.47 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.951 1 C-N-CA 132.306 4.242 . . . . 1.0 113.455 -172.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 30.8 Cg_endo -62.43 90.99 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 125.118 3.878 . . . . 1.0 111.969 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 54' ' ' LEU . 3.8 t-20 36.14 58.3 0.98 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.331 2.253 . . . . 1.0 110.686 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.827 ' HB2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -79.77 103.41 9.66 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 126.461 1.904 . . . . 1.0 111.689 -170.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -139.71 108.9 6.08 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.22 1.563 . . . . 1.0 115.22 -171.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.8 t -114.95 149.71 36.88 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.971 1.308 . . . . 1.0 111.818 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . 3.0 m -126.58 93.61 3.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 131.125 3.77 . . . . 1.0 108.058 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.649 HG22 ' HD2' ' A' ' 36' ' ' PRO . 5.4 p -149.68 155.72 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 127.503 2.321 . . . . 1.0 110.531 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.4 -58.32 0.5 Allowed Pre-proline 0 CA--C 1.552 1.038 0 CA-C-O 117.217 -1.373 . . . . 1.0 114.198 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.798 ' HB3' ' HB2' ' A' ' 41' ' ' CYS . 9.6 Cg_endo -50.78 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.329 1 C-N-CA 125.602 4.201 . . . . 1.0 112.99 -175.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -102.57 -76.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.893 1.677 . . . . 1.0 109.938 -171.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -125.73 44.16 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 127.964 2.506 . . . . 1.0 113.143 -174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.817 ' HB2' ' HA2' ' A' ' 132' ' ' GLY . 5.5 p90 -161.93 169.19 21.63 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 127.244 2.218 . . . . 1.0 114.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -66.52 106.69 1.84 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 127.745 2.418 . . . . 1.0 114.622 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 42.7 t -81.02 -70.56 0.52 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.511 1.05 . . . . 1.0 111.334 173.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.2 t30 45.31 51.7 9.24 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.315 1.446 . . . . 1.0 113.584 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.37 -7.13 1.22 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.871 2.868 . . . . 1.0 116.492 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -65.19 142.27 58.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.8 1.182 . . . . 1.0 109.89 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 56.39 62.26 6.65 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 126.002 1.721 . . . . 1.0 110.881 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.0 41.83 0.58 Allowed 'Trans proline' 0 CA--C 1.554 1.497 1 C-N-CA 125.762 4.308 . . . . 1.0 114.315 -176.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.07 -1.38 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 129.892 3.277 . . . . 1.0 114.84 -172.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.13 173.79 0.3 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 129.28 3.032 . . . . 1.0 113.164 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -140.1 166.67 24.04 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 5.2 tttp -142.91 135.99 28.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.577 2.351 . . . . 1.0 110.843 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.11 123.36 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 127.757 2.423 . . . . 1.0 107.368 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.9 t -138.19 131.85 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 127.059 2.144 . . . . 1.0 109.988 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.45 157.1 36.01 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.325 1.45 . . . . 1.0 111.179 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -128.44 113.05 15.05 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.741 1.386 . . . . 1.0 114.741 174.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.4 3.82 5.55 Favored Glycine 0 CA--C 1.548 2.128 0 N-CA-C 117.965 1.946 . . . . 1.0 117.965 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.85 177.44 4.84 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 128.384 2.673 . . . . 1.0 116.933 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.659 HG13 ' HD2' ' A' ' 58' ' ' PRO . 69.2 t -68.36 157.67 87.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 131.688 3.995 . . . . 1.0 113.495 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD2' HG13 ' A' ' 57' ' ' VAL . 61.1 Cg_endo -70.71 -150.76 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 125.121 3.881 . . . . 1.0 113.275 171.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 58' ' ' PRO . 9.6 p-10 -50.99 101.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.641 2.376 . . . . 1.0 112.317 -177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.43 -8.67 0.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.025 -1.43 . . . . 1.0 116.447 -172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.27 104.47 4.32 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.759 1.779 . . . . 1.0 108.894 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.56 112.46 16.84 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 170.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -89.64 107.32 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 101.93 -3.359 . . . . 1.0 101.93 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -130.9 117.55 19.42 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.812 1.32 . . . . 1.0 112.583 -170.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.882 HG22 ' HB1' ' A' ' 80' ' ' ALA . 35.8 m -106.35 111.54 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.531 1.133 . . . . 1.0 110.534 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.649 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 8.1 mtm -146.98 102.24 3.5 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 126.872 2.069 . . . . 1.0 111.431 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -99.2 107.74 20.15 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.713 1.142 . . . . 1.0 112.125 -176.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.84 147.75 18.14 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.165 0.888 . . . . 1.0 115.059 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -155.13 -52.61 0.09 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.87 1.268 . . . . 1.0 112.579 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -149.19 -48.25 0.14 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.281 2.232 . . . . 1.0 114.891 -170.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -147.29 -10.24 0.43 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 130.397 3.479 . . . . 1.0 114.216 -168.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -48.43 -15.57 0.08 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 128.912 2.885 . . . . 1.0 115.473 175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.85 2.65 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.821 3.648 . . . . 1.0 117.616 171.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.55 ' HB2' HG13 ' A' ' 97' ' ' VAL . 2.8 t -92.33 -99.46 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.732 1.613 . . . . 1.0 113.548 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HB2' ' H ' ' A' ' 105' ' ' SER . . . 57.07 -65.51 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 126.871 2.068 . . . . 1.0 112.496 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -56.51 137.65 53.04 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.379 2.272 . . . . 1.0 114.329 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -132.77 165.51 24.39 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 128.317 2.647 . . . . 1.0 111.599 -176.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -118.11 82.25 1.81 Allowed 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.347 -0.846 . . . . 1.0 111.321 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.688 HD22 HH21 ' A' ' 95' ' ' ARG . 7.6 m-80 78.92 0.59 2.43 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 127.438 2.295 . . . . 1.0 112.508 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.882 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -57.25 -11.14 1.56 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.554 2.741 . . . . 1.0 117.214 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 m -105.01 112.66 25.88 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.223 1.577 . . . . 1.0 110.93 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 160.75 39.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.998 2.119 . . . . 1.0 111.35 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 127.19 42.88 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 127.779 2.432 . . . . 1.0 112.916 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -144.5 -164.7 1.97 Allowed 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 127.988 2.515 . . . . 1.0 112.846 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -112.87 -101.47 0.41 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 127.629 2.372 . . . . 1.0 111.502 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -79.57 45.35 0.67 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.628 2.371 . . . . 1.0 111.966 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.691 ' HG2' HG12 ' A' ' 110' ' ' ILE . 0.4 OUTLIER 51.24 32.7 8.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.167 2.187 . . . . 1.0 111.609 -171.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -90.39 109.92 21.4 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-O 122.894 1.33 . . . . 1.0 107.526 -171.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.51 116.36 11.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.22 2.208 . . . . 1.0 109.178 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 31.3 mtm180 -135.77 128.7 31.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.347 1.859 . . . . 1.0 109.969 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 11.0 t80 130.87 -151.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 130.696 3.598 . . . . 1.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ASP . 24.6 t-20 -122.43 164.21 18.44 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 126.604 1.962 . . . . 1.0 110.599 171.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 92' ' ' ASN 0.44 94.1 m-20 108.02 44.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.481 3.512 . . . . 1.0 116.341 -175.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -139.95 132.19 28.21 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 128.299 2.639 . . . . 1.0 108.604 170.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.853 ' H ' ' HB2' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -138.86 120.63 15.33 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.026 1.739 . . . . 1.0 113.583 -171.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.45 115.99 30.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.714 1.206 . . . . 1.0 110.232 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 74' ' ' SER . 11.0 t 71.13 73.48 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 124.756 1.222 . . . . 1.0 107.995 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.63 90.24 0.65 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 128.506 2.955 . . . . 1.0 113.361 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.21 53.98 3.46 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 128.042 2.537 . . . . 1.0 115.01 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.5 t -70.93 -168.5 0.28 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.817 2.047 . . . . 1.0 115.798 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.88 -37.94 0.07 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 127.911 2.672 . . . . 1.0 115.044 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 159.85 42.72 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.905 2.082 . . . . 1.0 113.739 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.48 57.45 2.93 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.595 1.569 . . . . 1.0 115.188 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 104' ' ' LYS . 7.6 mtmt -68.79 104.7 2.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.223 1.809 . . . . 1.0 109.71 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' ALA . 16.9 t -119.62 132.65 55.75 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.301 3.04 . . . . 1.0 110.878 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -84.75 87.12 7.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.185 0.994 . . . . 1.0 110.895 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 66' ' ' MET . 3.8 m -143.36 51.17 1.37 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.95 0.881 . . . . 1.0 111.319 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -102.35 90.41 3.88 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.894 2.077 . . . . 1.0 111.037 -174.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.656 HG21 ' C ' ' A' ' 120' ' ' ALA . 10.2 t 152.38 -116.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 128.754 2.822 . . . . 1.0 115.545 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.691 HG12 ' HG2' ' A' ' 87' ' ' GLN . 3.8 mp -133.78 151.69 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 128.25 2.62 . . . . 1.0 111.786 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.9 m -140.18 104.24 4.77 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.586 1.554 . . . . 1.0 113.562 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 118' ' ' GLN . 54.3 t -74.05 122.16 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.562 -1.336 . . . . 1.0 107.814 170.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.15 -8.17 56.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.587 3.555 . . . . 1.0 116.971 -175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 2.2 m -82.16 166.11 19.94 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.762 2.025 . . . . 1.0 112.529 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -45.02 -31.78 0.94 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.601 1.96 . . . . 1.0 114.023 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 114' ' ' THR . 98.1 Cg_endo -95.26 81.8 0.11 Allowed 'Trans proline' 0 CA--C 1.564 1.982 1 C-N-CA 125.41 4.073 . . . . 1.0 106.197 167.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.61 114.08 3.56 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.201 3.267 . . . . 1.0 111.834 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -99.99 92.48 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 -177.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 m -99.86 115.33 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.656 ' C ' HG21 ' A' ' 109' ' ' THR . . . -99.59 171.23 8.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.592 1.957 . . . . 1.0 112.995 -168.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.513 ' H ' ' HA ' ' A' ' 26' ' ' ASP . 63.3 p -124.9 120.05 30.53 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.742 2.017 . . . . 1.0 113.46 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.06 125.82 33.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.13 1.786 . . . . 1.0 110.523 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -106.82 68.66 0.74 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.071 1.748 . . . . 1.0 112.181 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.41 -179.7 0.09 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.807 2.843 . . . . 1.0 112.764 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.27 -58.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.689 2.796 . . . . 1.0 116.334 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mt 67.31 -62.12 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 129.085 2.954 . . . . 1.0 112.766 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -124.24 130.84 53.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.672 1.989 . . . . 1.0 111.659 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.25 129.96 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 128.046 2.539 . . . . 1.0 110.382 -176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -85.32 121.96 28.8 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.053 1.341 . . . . 1.0 109.296 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.74 -28.44 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.063 0.945 . . . . 1.0 112.112 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -76.52 -29.19 56.67 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.543 2.337 . . . . 1.0 115.048 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.817 ' HA2' ' HB2' ' A' ' 39' ' ' TRP . . . 93.11 -157.56 23.4 Favored Glycine 0 CA--C 1.553 2.465 0 C-N-CA 125.822 1.677 . . . . 1.0 114.56 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 38.4 Cg_endo -73.62 162.71 39.17 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 124.424 3.416 . . . . 1.0 113.143 170.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 133' ' ' PRO . 6.4 mtt85 82.85 106.05 0.06 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 128.89 2.876 . . . . 1.0 110.112 -173.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 127.842 2.457 . . . . 1.0 114.848 -178.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.454 -0.202 . . . . 1.0 110.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -163.75 -172.52 2.9 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 129.086 2.955 . . . . 1.0 105.689 -174.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 t -64.08 73.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 O-C-N 119.808 -1.807 . . . . 1.0 107.172 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -61.02 148.2 40.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.61 2.764 . . . . 1.0 113.96 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 30' ' ' PHE . 82.5 p -76.47 -167.28 0.77 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.509 2.724 . . . . 1.0 110.162 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 121' ' ' THR . 4.2 t0 -66.24 12.91 0.06 Allowed 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.561 -1.337 . . . . 1.0 112.959 169.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 p -150.72 152.45 32.24 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.109 2.563 . . . . 1.0 114.653 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.0 -15.54 26.05 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 C-N-CA 123.466 2.778 . . . . 1.0 111.493 168.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 -21.48 63.19 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.918 2.887 . . . . 1.0 115.568 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.413 ' HB2' ' OG1' ' A' ' 25' ' ' THR . 26.9 m-85 -138.16 114.51 10.31 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.993 1.317 . . . . 1.0 110.569 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 22' ' ' LEU . 3.5 pp -149.91 140.26 22.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.198 1.399 . . . . 1.0 114.422 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' CB ' ' HA ' ' A' ' 51' ' ' VAL 0.587 0.1 OUTLIER -164.82 173.05 12.17 Favored 'General case' 0 CA--C 1.542 0.644 1 N-CA-C 122.936 4.421 . . . . 1.0 122.936 -173.461 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.2 t -97.68 98.25 9.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.714 0.806 . . . . 1.0 110.946 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.61 130.03 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 126.606 1.962 . . . . 1.0 111.812 -171.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.52 126.96 91.75 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.152 1.381 . . . . 1.0 112.413 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.702 ' HB2' ' CD2' ' A' ' 38' ' ' HIS . 72.4 Cg_endo -71.55 148.81 54.49 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 124.016 3.144 . . . . 1.0 113.556 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' HIS . 5.0 t -83.02 -67.02 0.82 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.827 1.651 . . . . 1.0 114.176 -176.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.702 ' CD2' ' HB2' ' A' ' 36' ' ' PRO . 86.6 m-70 37.26 40.44 0.19 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.291 3.436 . . . . 1.0 116.792 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.453 ' HE1' ' HA ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -161.49 173.72 14.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.156 1.782 . . . . 1.0 113.717 179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -82.18 103.64 11.93 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.077 2.151 . . . . 1.0 110.654 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 98' ' ' GLY . 13.7 p 51.05 101.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 128.475 2.71 . . . . 1.0 115.3 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.502 ' OD1' ' HB2' ' A' ' 96' ' ' PHE . 2.0 m120 -47.17 -72.59 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.005 2.122 . . . . 1.0 115.687 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 22.16 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 1 C-N-CA 132.736 4.414 . . . . 1.0 118.417 175.306 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.7 m 68.04 77.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 129.612 3.165 . . . . 1.0 111.922 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.638 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 2.3 pt? -161.75 171.54 6.65 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 127.038 2.135 . . . . 1.0 113.412 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 45' ' ' LEU . 43.0 Cg_endo -70.47 140.52 40.2 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.87 3.046 . . . . 1.0 111.681 171.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 92' ' ' ASN . 12.9 mm -134.64 -69.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.486 1.514 . . . . 1.0 113.918 -172.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 31.23 90.03 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 130.436 3.495 . . . . 1.0 116.453 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.77 171.04 10.44 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.64 2.089 . . . . 1.0 116.64 -172.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 7.7 mmtp -140.04 146.07 38.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 129.762 3.225 . . . . 1.0 109.948 172.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 2.5 t -130.79 118.86 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 129.236 3.014 . . . . 1.0 110.616 171.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.466 ' H ' ' HB2' ' A' ' 32' ' ' CYS 0.278 14.2 m -128.02 145.92 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 120.582 1.537 . . . . 1.0 113.977 173.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . . . -112.12 145.07 40.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.131 1.373 . . . . 1.0 112.495 174.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.9 tp -77.12 151.86 35.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.606 1.562 . . . . 1.0 111.701 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.1 -141.62 15.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.954 1.264 . . . . 1.0 113.964 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.34 -169.11 3.18 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 129.101 2.96 . . . . 1.0 111.208 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.774 HG22 ' HD2' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 78.54 157.81 0.14 Allowed Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 128.864 2.866 . . . . 1.0 115.398 171.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' HG22 ' A' ' 57' ' ' VAL . 61.0 Cg_endo -73.58 175.04 11.23 Favored 'Trans proline' 0 CA--C 1.553 1.474 0 C-N-CA 125.015 3.81 . . . . 1.0 114.545 172.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 41.28 69.14 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 126.877 2.071 . . . . 1.0 111.293 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -79.65 -18.63 72.74 Favored Glycine 0 C--N 1.346 1.096 0 C-N-CA 127.081 2.277 . . . . 1.0 117.518 -168.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 60' ' ' GLY . 7.4 t 154.22 170.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 129.624 3.169 . . . . 1.0 112.715 172.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.98 113.66 14.26 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.948 2.899 . . . . 1.0 109.1 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.53 118.24 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 120.291 -1.506 . . . . 1.0 107.961 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -112.21 151.6 29.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.922 2.089 . . . . 1.0 110.199 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.42 127.82 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.008 1.723 . . . . 1.0 109.363 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 mtt -128.52 107.5 9.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.604 0.762 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.47 108.81 21.05 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.166 0.984 . . . . 1.0 111.049 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.21 -154.02 6.75 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 128.638 3.018 . . . . 1.0 114.515 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 107.33 -72.42 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 1 C-N-CA 132.276 4.23 . . . . 1.0 109.434 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -47.06 -48.46 22.37 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.919 2.488 . . . . 1.0 113.631 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.48 8.24 44.7 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.04 1.736 . . . . 1.0 113.933 174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 94.66 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 131.466 3.906 . . . . 1.0 111.212 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -157.92 65.95 0.47 Allowed 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 116.329 1.974 . . . . 1.0 116.329 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -57.73 -56.23 24.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.62 1.568 . . . . 1.0 113.259 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.03 8.34 6.79 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 120.971 3.693 . . . . 1.0 120.971 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.44 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 26.1 mp0 -60.11 133.56 56.21 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 121.645 2.02 . . . . 1.0 116.197 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -138.63 166.2 24.96 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.164 2.586 . . . . 1.0 112.556 170.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.669 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -127.86 86.22 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.089 1.755 . . . . 1.0 110.479 169.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.322 46.3 t30 69.24 13.27 8.57 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.635 1.574 . . . . 1.0 114.149 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HB3' ' HB2' ' A' ' 77' ' ' LEU . . . -65.24 1.25 1.09 Allowed 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.077 1.351 . . . . 1.0 114.388 169.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.2 p -98.12 111.01 23.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.408 -1.33 . . . . 1.0 107.408 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.7 125.74 21.27 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.792 1.637 . . . . 1.0 112.127 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.78 154.33 17.82 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 128.039 2.536 . . . . 1.0 114.21 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.1 mtp -133.41 144.17 49.37 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.271 2.229 . . . . 1.0 107.153 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 -84.24 0.53 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.585 1.554 . . . . 1.0 107.925 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 55.9 m-20 -82.69 57.01 3.58 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.739 1.216 . . . . 1.0 108.585 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 53' ' ' ALA . 5.4 pt20 56.94 19.98 4.98 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 130.904 3.681 . . . . 1.0 117.931 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 82.4 t -132.55 135.51 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 114.804 1.409 . . . . 1.0 114.804 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.35 127.98 26.92 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 127.479 2.311 . . . . 1.0 110.664 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 91' ' ' PHE . 11.0 mtt-85 -136.17 142.33 44.14 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.185 2.194 . . . . 1.0 110.905 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 90' ' ' ARG 0.277 1.4 t80 147.44 -111.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 129.946 3.298 . . . . 1.0 112.973 172.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 p30 177.3 41.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 127.814 2.446 . . . . 1.0 115.261 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.21 -33.66 49.83 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 130.018 3.327 . . . . 1.0 115.042 -172.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 94' ' ' LEU . 2.3 pt? -66.39 139.36 58.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.174 2.589 . . . . 1.0 117.893 -172.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 3.2 mtt85 -140.63 116.58 10.42 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.628 1.558 . . . . 1.0 112.394 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB2' ' OD1' ' A' ' 42' ' ' ASN . 35.5 m-85 -83.07 145.93 29.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.033 1.733 . . . . 1.0 113.561 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 100' ' ' SER . 2.4 t 60.45 6.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 127.371 2.268 . . . . 1.0 114.424 174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' C ' ' HB2' ' A' ' 41' ' ' CYS . . . -9.74 -24.71 0.0 OUTLIER Glycine 0 CA--C 1.547 2.035 2 C-N-CA 136.446 6.736 . . . . 1.0 123.646 -173.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.569 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 15.1 ttt180 -165.93 6.13 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 129.392 3.077 . . . . 1.0 114.785 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 97' ' ' VAL . 49.1 m -58.25 -59.94 4.53 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.958 2.503 . . . . 1.0 114.946 -172.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.86 -174.22 20.27 Favored Glycine 0 CA--C 1.541 1.685 0 C-N-CA 125.441 1.496 . . . . 1.0 114.4 -172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 109.67 21.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.825 2.45 . . . . 1.0 111.735 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.97 -11.63 3.36 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 126.733 2.111 . . . . 1.0 116.303 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 127.856 2.462 . . . . 1.0 112.894 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.642 ' HB2' HG13 ' A' ' 126' ' ' ILE . 25.1 p -108.61 130.01 55.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.443 2.297 . . . . 1.0 110.483 172.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -85.22 83.87 7.86 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.048 0.928 . . . . 1.0 112.655 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 m -70.45 92.61 0.83 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.715 1.606 . . . . 1.0 110.162 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -71.42 101.55 2.44 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.196 1.398 . . . . 1.0 110.03 172.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.7 p -86.44 100.15 12.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.606 1.962 . . . . 1.0 109.669 172.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.407 HG12 HG21 ' A' ' 25' ' ' THR . 4.1 mp -88.28 110.2 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 100.909 -3.737 . . . . 1.0 100.909 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.0 m -112.61 109.61 19.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.889 1.675 . . . . 1.0 114.087 -167.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 114' ' ' THR . 7.0 t -73.74 143.76 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 123.681 1.705 . . . . 1.0 109.834 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -110.99 10.39 22.17 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 131.573 3.949 . . . . 1.0 113.931 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.782 HG23 ' HD2' ' A' ' 116' ' ' PRO . 10.1 t -105.53 -179.45 3.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.731 1.613 . . . . 1.0 113.162 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -45.77 -53.11 21.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 126.915 2.086 . . . . 1.0 112.298 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.782 ' HD2' HG23 ' A' ' 114' ' ' THR . 47.1 Cg_endo -76.21 102.04 1.56 Allowed 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 124.705 3.603 . . . . 1.0 109.884 170.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.39 99.66 1.05 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 124.254 3.303 . . . . 1.0 109.411 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.503 ' H ' ' HB ' ' A' ' 112' ' ' VAL . 16.6 mt-30 -108.19 97.23 6.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.873 0.844 . . . . 1.0 110.842 -170.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.74 114.95 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.011 1.724 . . . . 1.0 108.398 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.11 159.54 20.74 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.722 2.409 . . . . 1.0 110.977 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.4 m -121.61 121.33 37.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.068 0.947 . . . . 1.0 111.308 -171.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 64.1 t80 -87.95 120.18 29.03 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.344 0.975 . . . . 1.0 110.912 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -130.6 122.12 26.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.99 2.516 . . . . 1.0 111.422 -176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.7 -52.1 0.11 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.613 1.565 . . . . 1.0 113.173 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.31 70.85 0.75 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.246 2.218 . . . . 1.0 109.401 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.642 HG13 ' HB2' ' A' ' 105' ' ' SER . 8.6 tp -47.14 -14.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 129.676 3.19 . . . . 1.0 118.296 -171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -87.13 152.29 22.47 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 130.807 3.643 . . . . 1.0 115.765 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.58 162.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 128.025 2.53 . . . . 1.0 114.111 175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.7 t -75.05 133.07 41.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.11 0.964 . . . . 1.0 112.74 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.74 -58.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.508 1.923 . . . . 1.0 113.196 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -53.77 -37.94 63.96 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 126.307 1.843 . . . . 1.0 114.452 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 43.65 69.46 0.67 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 127.533 2.492 . . . . 1.0 114.572 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.73 66.53 1.75 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 125.11 3.873 . . . . 1.0 114.395 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.22 8.25 0.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 130.672 3.589 . . . . 1.0 117.09 173.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.487 1.403 1 C-N-CA 132.895 4.478 . . . . 1.0 112.926 178.322 . . . . . . . . 1 1 . 1 stop_ save_